|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/2 ¤W¤È 09:36:27
|
¯E¹©°O¡G 1¡n¯E¹©2015¦~3¤ë¥¿¦¡±q¿³ÂdÂà¤WÂd,«o±q400¤¸¶^¨ì250¤¸ 2¡nÀHµÛ¸Ñª¼®É¶¡±µªñ,¥«³õ¤W°ª«×ªºÃöª`»P°l±·,¿v©³Ãk¤É¨ì750¤¸ªº¤Ñ»ù 3¡n2016/2/21¸Ñª¼«á, ¥Ñ©ó¸Ñª¼¥¼¹F¹w¥ý³]©wªº¥Ø¼Ð, ¦A¥[¤W¦W¼L¥ß©e´CÅé½Ñ¦h¥H³_¶Ç³_,¥H°¾·§¥þ, ¥B¥¼¸gÃҹꪺ«ü±± ÁöµM¤½¥q»¡¯à°÷²£¥Í§ÜÅ骺±Ú¸s´N¯à°÷²£¥ÍÁ{§É¤WªºÀø®Ä,©ó¬O¦³©Ò¿×ªº"¤@ӸѪ¼,¨âºØ¸ÑŪ,¦U¦Ûªíz" ¤@¸ô¤U¶^¨ì350¤¸¥ª¥k 4¡n¦ý¦b2016/3/31²×©óªï¨ÓÀò±oASCO Oral presentationªº®¶¾Ä®ø®§,4¤ë1¤é·M¤H¸`·í¤Ñ,ªï¨Ó¤F¤[¹Hªº¤@¸ôº¦°±ªO 5¡n6¤ëªìªºASCO, ÁÞ¤k§Y±N´¦¶}¦oªº¯«¯µ±¯½ ¨Ì¾Ú²Î¤@§ëÅU±i¥ß¸s¤ÀªR®v¬ã¨s¡G https://www.google.com.tw/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwins9egnPzLAhVikIMKHcc1DN8QFgggMAE&url=http%3A%2F%2Fpcmc.uni-psg.com%2Fvip%2F20160226-01.pdf&usg=AFQjCNHCCWDKl493HzcquFVIcJoolRPgnQ »PµL±¡¤jªº¤ÀªR¡G http://tsjh301.blogspot.tw/2014/08/obipharma.html ¥»µÛªø´Á§ë¸ê, °l®Ú¨s©³ªººë¯«¨Ó±´¯Á¯E¹©ªº§ë¸ê»ùÈ, ¤£¦]µu´ÁªÑ»ùªi°Ê°_¥ñ¦Ó¼vÅT¹ï "¥þ²y²Ä¤@ÁûFirst in class, Best in classªº§ÜÀùÁÞ¤À¤l¥þ·sÃĪ«"§ë¸êªº¼ö±¡ ¨ÃÅé²{¤½¥qÄ@´º: "³Ð³y¥xÆW¥Í§Þ«~µP,¦¨¬°Àù¯gÀøªkªº¥þ²y»â¯èªÌ" "2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP, 2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾É¤½¥q" Åwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~ |
|
·|û¡G´µ¯S10135783 µoªí®É¶¡:2015/6/14 ¤W¤È 07:17:24²Ä 1300 ½g¦^À³
|
·íTumor ±q10cm ÁY¤p¦Ü5cm ¥s Partial response(PR) ·íTumor ±q5cm ªø¤j¦Ü7cm Á{§ÉÂå®v¤w§Pq Progression disease(PD) ¦ý§PŪ¤¤¤ßn¨ì Tumorªø¤j¦Ü12cm ¥H¤W¤~§Pq Progression disease(PD) ¦]¦¹·|¦³»~®t Ó¤HÆ[ÂI |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/14 ¤W¤È 12:46:06²Ä 1299 ½g¦^À³
|
CR/LR 20% »~®t©Î§ó°ª¬O¥i¯àªº, ¥u¬O¬°¦ó¦p¦¹, ¤j®aÁÙ¨S§ä¨ì«H¥ô©Î¦w¤ßªº²z¥Ñ ¦Ñ¥v¤j 2015/6/10 ¤W¤È 11:24:15 ªºPo ¤å, ¤j®a¥i¯à¨S¦³«Üª`·N Tykerb ¹ï·Ó²ÕCR&LRªº»~®tÈ19%, ¹êÅç²ÕCR&LRªº»~®tÈ°ª¹F32% ¤]´N¬O»¡¨C¤TÓ¦³¤@Ó»~§P? §Ú·Q³o¤¤¶¡À³¦³¾Ç°Ý |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/14 ¤W¤È 12:34:56²Ä 1298 ½g¦^À³
|
µ½¤H¤j ¡m¦pªGOBI-822ªºÃĮĤ£«ç»ò¦n? ¼í®õ¥þ¬°¦ó³{§C¥[½X¶R¶i? ¹ê¦b¥Ù¬Þ ·Q¤£³q.¡n Ó¤H²L¨£¬O5/25¥H«á¯E¹©°ª¼h«e©¹°ê¥~¶}°ê»Úªk»¡³s¶}¼Æ¤é´N¬O¸Ñµª¡I ¥H³o¨Ç¤Hªº¸ê¼i¾ú·|¤£·|¥h¦Û¨ú¨ä°d©O¡H¡IÓ¤H·Pı´N®É¶¡¤W³o¨â¥ó¨Æ¨ä¹ê¬O³s¦b¤@°_ªº¨Æ±¡¡A³y¦¸¤F¡I±z°Ñ¦Ò¬Ý¬Ý¡I |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/14 ¤W¤È 12:08:14²Ä 1297 ½g¦^À³
|
²q·Q¤j ÁÂÁ¡A²z¸Ñ¡A²z¸Ñ¡I ¥ô¦óªº±M·~¨ä¹ê¯u¤]±`¬O»Ýn¸g¹L¶V²z¤~·|¶V¸Ñªº¹Lµ{¡A¤j®a¯uªº³£¨¯W¤F¡I ¨Æ¹ê¥ô¦ó¦æ·~³£¥²¶·¡m¦³¤u¥çn¦³°Ó°µ¸gÀç¡A¦³°Ó¤]¥²µMn¦³¤u°µ¤ä¼µ¡n¤~¯à³Ð³y¥X³Ì¤jÈ¡A¯Ê¤@«hÃø¦¨¤j¾¹¤]Ãøª§½÷¡I¤j®a¥[ªo±q¦U¨¤«×¸Ñ¡i¯E¹©ªº°gÂÜ¡j¡I¥u¬O±ẕM·~²Õªº¯uªº¦h¾á«Ý¤F¡I §ï¤é§Ú¾ã²z¦nµ¹°ß±©¤jªº°Ñ¦Ò¦A¥H§Ú̳o¹ï·Ó²ÕªºÅÞ¿è±À²zÅý±z̹êÅç±Àºâ²Õ¯ºªº¶}¤ß¡AµM«á½|§Ú³o¥Õ·ö½|ªºµh§Ö¡A¸Ñ¸Ñ¤j®a¦Û229¥H¨Ó«áªº¨H«¡A¨Æ¹ê§Ú¹L¥hªº¶K¤å¨ä¥\¯à¤]¶È©ó¬OnÅý¤j®a°d½|¤@µf©Î¤@¯º¸m¤§Åý¤j®a·s³¯¥NÁ¤@¤U¡I ±¤ºÖ¤S¤£±Ë229«á¤j®aªººòÂÛ¡IÁÂÁ¤j®a¡I |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/13 ¤U¤È 11:55:13²Ä 1296 ½g¦^À³
|
Ó¤H»{¦PCliff¤jªº¬Ýªk: "Ó¤H»{¬°¡A¦b¾ãÓÁ{§É¸ÕÅ窺¶i¦æ¹Lµ{¤¤¡ALR»PCRªº§PŪ¡u¼Ð·Ç¡vÀ³¸Ó³£¬Û¦P¡]20%¡^¡A®t§O¦b©ó¦U§PŪÂå®v¶¡Ó¤H¥DÆ[§PŪ¡uµ²ªG¡v·|¦³¤£¦P¡A©Ò¥H25¢Mªº»¡ªk¬O¡H" ¦pªGOBI-822ªºÃĮĤ£«ç»ò¦n? ¼í®õ¥þ¬°¦ó³{§C¥[½X¶R¶i? ¹ê¦b¥Ù¬Þ ·Q¤£³q. ²Ä¤@¦¸¤½§i: 104/3/31~104/5/08, ¥æ©ö¼Æ¶q910,000ªÑ, ¨C³æ¦ì»ù®æ332.28¤¸, ¥æ©öÁ`ª÷ÃB302,375,500¤¸, «ùªÑ¡G2,171,648ªÑ ²Ä¤G¦¸¤½§i: 104/5/11~104/5/26, ¥æ©ö¼Æ¶q970,000ªÑ, ¨C³æ¦ì»ù®æ318.46¤¸, ¥æ©öÁ`ª÷ÃB308,907,000¤¸, «ùªÑ¡G3,141,648ªÑ ²Ä¤T¦¸¤½§i: 104/5/27~104/6/11, ¥æ©ö¼Æ¶q1,075,000ªÑ, ¨C³æ¦ì»ù®æ310.79¤¸, ¥æ©öÁ`ª÷ÃB334,098,500¤¸, «ùªÑ¡G4,216,648ªÑ ¤T¦¸¦@¶R¶i2955±i, ¥§¡»ù316.85¤¸, ¥H6¤ë12¤é¦¬½L302.5¤¸, ¥þ³¡®M¨c. |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/13 ¤U¤È 11:47:22²Ä 1295 ½g¦^À³
|
Cliff ¤j, ²q·Q¤j, ¥xÁÞ¤j, ¤¤¹D¤j, ¦U¦ì¤j¤j: Cliff¤j´£¨Ñªº¸ê°T ¦]¬°¡¨¡K At least a 20% increase¡K.¡¨©Ò¥H¬O§_ 25%¤]¦¨¥ß? ¥u¬O¤£½× 20% or 25%, ²z½×¤WCR»PLRÀ³¸Ó¤@P¤~¹ï. ¤½¥q¥ý¦³LR¸ê®Æ, ¦A°eC¨ú±oCR¸ê®Æ(ÁöµMµo¨¥¤H»¡¨S¦³). Y¤£¤@P, °Z¤£¸¨±o©M¤j®a¤@¼Ën°µ«Ü¦h¤£¦Pªº°²³], ¦Ó¨CºØ°²³]³£¦³¤£½T©w©Êªº¦]¯À¦b¤º ? §Ú¥u¬O³æ¯Âªº»{¬°, ¦b¸ÕÅç³]p¤§ªì, ¤£À³·|³o»ò³]p¨Ó³y¦¨§xÂZ. ½Ð±Ð¦U¦ì¤j¤j, §Ú³oºØÅÞ¿è¹ï¶Ü ? |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/13 ¤U¤È 11:03:58²Ä 1294 ½g¦^À³
|
¤¤¹D¤j ±z¤Ó«È®ð¤F n¦V±z©êºpªº¬O ¬Q¤Ñ¤p§Ìªº¤ÀªR ¹ê¦bÂ÷¨Æ¹ê¬Æ»· ½Ð¤d¸U§O©ñ¦b±zªº¦]À³©³®×¸Ì ¦]¬°¥¦¤£²ÅÅÞ¿è ¤p©_¤j¤w«ü¥¿§Ú¤F ¯uªº«Ü©êºp! ¦Ü©ó±z¤µ¤Ñªº°ÝÃD ¡§½Ð°Ý¬°¦óL R/P D»{©w©ñ¼e¦Ü25%¬O¦Y¤U©w¤ß¤Y¡A¦p¦¹¤@¨ÓC R/P D¦bÅã¼v¤W¤£¬O§ó©ö¥i¯à±µªñ¡KL Rªº§PŪ¡H¡¨ ¤p§Ì²³æ»¡©ú¤@¤U·íªìªº·Qªk ¤p§Ì°_ªì¬O³o¼ËÁ¿ªº ¡§¡@§Ú¦b·Q LR¡NCR¦P®É©ñ¼e(¦n¹³¤£¤Ó¥i¯à ¦]¤¤³~§ó°Ê§PÂ_¼Ð·Ç?) ÁÙ¬O¦]LR¡NCR§PŪµ²ªG¬Û®t¤Ó¤j ©Ò¥H¥u©ñ¼eLRºÝ ¦nÅýLR¡NCR§PŪµ²ªG±µªñ °²Y¦p¦¹ LR/CRȪº¦ôºâ ¥i¯à´N»Ý¥Î«O¦uÈ?¡@¡@¡@ÈÐ ³oÓ§Ú»{¬°¤¤³~¤~©ñ¼eLRºÝªº»¡ªk¡@©M±zªº°ÝÃD·Qªk¬O¤@¼Ëªº ¦ý¬O«á¨Ó£«¬Â¤j¦³¼á²M¡@ÈÐ Á{§É¤@¶}©l´N¬O25%.°eLR ¡¨¡@(¶K¦¹¤å®É £«¬Â¤j¤Sªí¥Ü¤£½T©w) §Ú·Q¬JµMÁ{§É¤@¶}©lLRºÝ´N¬O25%¡@Y¢Ñ¢àºÝ¤]¬O¤@¼Ë¼Ð·Ç¡@¨º´N©M§ÚÌ¥ý«e°Q½×ªº¤@¼Ë ³oºØ»~®t¬OLRºÝ©M¢Ñ¢àºÝ¦]§PŪ¨£¸Ñ¤£¦P¡@¦Ó«D¼Ð·Ç¤£¤@P©Ò²£¥Íªº»~®t¡@©M¥ý«eªºª¬ªp¬O¤@¼Ëªº ©Ò¥H¤ð»Ý±Ä¥Î«O¦uȨӦôp¢Ñ¢àÈ¡@©Ò¥H¤p§Ì»¡¦Y¤U©w¤ß¤Y¡@¬O¦¹·N ¦p¤µÁÂÁÂCliff¤j´£¿ô¤p§Ì¡@LRºÝ©M¢Ñ¢àºÝªº¼Ð·ÇÀ³³£¬O¢±¢¯¢H¤~¬O YLRºÝªº¼Ð·Ç¬O¢±¢´¢H¡]©|«Ý¼á²M¡^°²¦p¢Ñ¢àºÝ¤]¬O¢±¢´¢H¡@¨º¼Ð·Ç¤@P¨S°ÝÃD¡@¦ýY¬O¢Ñ¢àºÝªº¼Ð·Ç¬O¢±¢¯¢H ¨º¤p§Ì´N¯uªº¤£ª¾¹D¸Ó«ç»ò·Q¹³¤F¡H ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡GWalden10140608 µoªí®É¶¡:2015/6/13 ¤U¤È 10:37:39²Ä 1293 ½g¦^À³
|
¤¤¹D¤j~ ¹ïªü¡A§Úªº¬Ýªk¸ò±z¤@¼Ë¡A§Úı±o¦pªG©ñ¼e¦Ü25%¡A¤£´Nªí¥Ü¸~½F»ÝnÅܧó¤j¤~·|³QÂå¥Í§P©wPD¤F¶Ü? ³o¼ËLR³Q»~§Pªº¾÷²v²z½×¤W·|°§C¤~¬O |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/13 ¤U¤È 09:50:03²Ä 1292 ½g¦^À³
|
²q·Q¤j¤j¡K¡K¡K¤j »~·|¡A»~·|¡K§é·Ù§Ú¤F¡A¡y«ü¥Ü¡z¤£´±¯uªº¤£´±¬O¡yÀµ½Ð¡z¡A¨Æ¹ê¬O§Ú¤@ª½¥Î«Ü¦h®É¶¡§V¤Oªº¤@ª½«ôŪ±z»P½Ñ¦h¤j¤j±M·~ªº½×z»P·Q¿ìªk¥Î±zªº¼Æ¦r¦Û¤v¾Ç²ßµÛ¸Õºâ¡A¨ì²{¦bªº¶i«×¬O³s°Ý°ÝÃDªº¯à¤O³£ÁÙ¨S¦³¡K¡K¡H¡H¡H ¸g±`¬O¥u¨£º¡®à¶î¾~»P¤@©ïÀY©]¤w¤Ñ©ú¡K¡K Ó¤H·P¨ü¡G¡m¥xÁÞ¤j¡n¦p¨L¬v¤¤¤@®y©ú«Gªº¿O¶ð¦Ó½Ñ¦h¤j¤jªº±M·~»PµL¨p§ó¬Oȱo¾Ç²ßªº¨}®v¡K¦b¸ê¥»¥«³õ±¹ï¥Í§Þ¬ì¾Ç¦³¦p¦¹»Ú¹J¡A¤Ó¬Ã¶Q¤]¤Ó©¯ºÖ¤F¡I ½Ð°Ý¬°¦óL R/P D»{©w©ñ¼e¦Ü25%¬O¦Y¤U©w¤ß¤Y¡A¦p¦¹¤@¨ÓC R/P D¦bÅã¼v¤W¤£¬O§ó©ö¥i¯à±µªñ¡KL Rªº§PŪ¡H |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/13 ¤U¤È 09:41:26²Ä 1291 ½g¦^À³
|
¦pªGCliff¤j»¡ªº822p¹º®Ñ¬O¥¿½Tªº¡A ¨º»ò25%´N¤£¥¿½T¡A¯u²z¥u¦³¤@Ó¡A¤£·| ¦³¨âÓ¼Ð·Ç ²q·Q¤j ÁÂÁ§Aªº¥Î¤ß §A»P¤p©_¤j±M¬ã¦s¬¡¦±½u ¬°¥»ª©¯E¤Íªø´Á´£¨Ñ³Ì¨Îªº¸ê°T¡A¨Ï¤j®a¨ü¯q¡A ¦A«×»¡Án·PÁ¡AÁöµM³oÓ»â°ì§Ú¤£¬O«ÜÀ´¡A ¦ý±q§A»P¤p©_¤jªº¶K¤å¤¤¾Ç¨ì«Ü¦h²Îp¤è±ªºª¾ÃÑ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/13 ¤U¤È 09:05:10²Ä 1290 ½g¦^À³
|
·j´M:¸~½F´c¤ÆPDµû¦ô¼Ð·Ç¡A¦³¹ü¤Æ°ò·þ±ÐÂå°|¸Ñ»¡¡A¤]¦³¤ñ¸ûWHOª©»PRecist 1.1ª©¹ï©TºA¸~½F´c¤Æµû¦ô¤§®t²§¡A¦pªG25%¬O¥¿½Tªº ¡A·|¤£·|822¬O±Ä¥ÎWHOPDµû¦ô¼Ð·Ç¡A¥u¦³³o¤@ª©¤~·|¥X²{¸~½F´c¤ÆÁ`±¿n©M¼W¥[25%©Îµo²{·s¯f¨_ |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/13 ¤U¤È 09:04:35²Ä 1289 ½g¦^À³
|
¤U±ªº¸ê°T¨Ñ°Ñ¦Ò. Pfizer said it would price Ibrance at $9,850 a month, or $118,200 per year. could generate annual sales of $3 billion by 2020. °Ó«~¤¤¤å¦W: Àù±o¬Pª`®g¾¯500²@§J, ¦¨¤À¦W: cyclophosphamide 500mg, °·«O»ù: 156 ±`¥Î¾¯¶q¤ÎÀW¦¸: Adult: PO Part of the conditioning regimen in patients undergoing bone marrow transplantation 60 mg/kg/day for 2 days. Malignancies Low dose regimen: 2-6 mg/kg/wk in divided doses. ´c©Ê½F IV Malignancies Moderate dose regimen: 10-15 mg/kg/wk; high dose regimen: 20-40 mg/kg given every 10-20 days. ±`¨£°Æ§@¥Î: ±¼¾v¡AµL¹¼¤¡A¥Ö½§¤Î«ü¥ÒÃC¦âÅܲ`¡Cµo¿N©Î´HŸ¡A«y¹Â©ÎÁnµ¼R°×¡A³ïÄVµh¡A¤UI³¡©Î°¼¸y¯kµh¡Aäú¤ß©Î¹Ã¦R¡A¤ë¸g¶g´Á§ïÅÜ¡A±Æ§¿§xÃø©Î¯kµh «ö·Ó¤W±ªº¥ÎÃÄÀW¦¸, ¹ï·Ó²Õ¦b36¶g¤~¥´9°w, ¬O«D±`¤£°÷ªº, ¹ï·Ó²Õªº±wªÌ¥i¯à¦b4©Î5Ó¤ë«á´N´c¤Æ? °£«D©_ÂÝ¥X²{. |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/13 ¤U¤È 08:54:00²Ä 1288 ½g¦^À³
|
´NÓ¤H¹ï¬ü°ê&¤¤°ê¥«³õªºÁA¸Ñ ¤½¥qn¦b³o¨âÓ°ê®a¦Û¦æ¾P°âªº¥i¯à©Ê¡Aªñ¥G¹s ¦pªG¬O°í«ù¨«³o±ø¸ô¡A ¥u¦³¤@ºØ¥i¯à¡A´N¬O¤½¥q©Ò»¡ªº¨ÖÁʲ{¦³³q¸ô¤½¥q¡A ¤Ï¹L¨Ó»¡¡A´N¬O¦]¬°¤½¥q¾å±o¦Û¨«·s«Ø¥ß³q¸ô¬O§¹¥þ¤£¥i¯à¡A ©Ò¥H¦³¨ÖÁÊ»¡! |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/13 ¤U¤È 08:28:48²Ä 1287 ½g¦^À³
|
Y¬Â¤j, «D±`·PÁ±zªº¸ê°T. ²q·Q¤j, ¨¯W±z¤F! ¯uªº¤ÓÃø¤F! Cliff¤j, «D±`·PÁ±zªº¸ê°T. ¤]½Ð±Ð±z¤U±ªººÃ°Ý. ¦pªGOBI-822¹ïÀù²ÓM¦³®û¼í²{¶H, ³y¦¨¸~½F¦b¬Y¤@¬q®É¶¡Åܤj, ¦Ó«á¸~½F¤SÁY¤p¤F. ¦pªG¬Y¨Ç¯f±w¦b®û¼í²{¶H®É´Á¦^Âå°|Àˬd, ³QÁ{§ÉÂå®v§PŪ¬°PD, ¬O§_¦]¦¹´N³Q²×¤îÁ{§É¸ÕÅç? ¦pªG¬O, ¨º¤£¬O«ÜÞªP¶Ü? ¦³¨S¦³¸É±Ï±¹¬I? ¤½¥qª¾¹D³oºØ±¡ªp¶Ü? |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/13 ¤U¤È 08:00:43²Ä 1286 ½g¦^À³
|
²q·Q¤j¡G ·Ó£«¬Â¤j©Ò»¡¬JµM¬O¤@¶}©l´N³o¼Ë¡A¨º¥H¤Uªº´Nȱo°Ñ¦Ò¡G¡]822ªºpµe®Ñ¤ºªº¼Ð·Ç»PRECIST 1.1ª©ªº§PŪ¼Ð·Ç¬O¬Û¦Pªº¡^ ¡uProgressive Disease (PD): At least a 20% increase in the sum of diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. (Note: the appearance of one or more new lesions is also considered progression).¡v Ó¤H»{¬°¡A¦b¾ãÓÁ{§É¸ÕÅ窺¶i¦æ¹Lµ{¤¤¡ALR»PCRªº§PŪ¡u¼Ð·Ç¡vÀ³¸Ó³£¬Û¦P¡]20%¡^¡A®t§O¦b©ó¦U§PŪÂå®v¶¡Ó¤H¥DÆ[§PŪ¡uµ²ªG¡v·|¦³¤£¦P¡A©Ò¥H25¢Mªº»¡ªk¬O¡H |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/13 ¤U¤È 05:49:33²Ä 1285 ½g¦^À³
|
º¥ý·PÁÂY¬Â¤jªº¤Î®É¼á²M Åý§Ú̦Y¤U©w¤ß¤Y ÁÂÁ±z¦h¦¸´£¥X«n§PÂ_ªº¸ê®Æ! ¥xÁÞ¤j ±zªº°ÝÃD¥»À³¥Ñ¤p©_¤j¨Ó¸ÑÄÀ ¥L¹ê¦b¬O°ª¤â ¤p§Ì³o¨â¤Ñ³£¦b·Q³oÓPFSªº°ÝÃD ©Ò¥H´N¥Ñ¤p§Ì²³æ¦^µª ¦A½Ð¤p©_¤jªÈ¥¿ °ò¥»¤Wè©Û¶Ò¶i¨Óªº±wªÌ ·|¤À¦¨NED ¡NPR ¡NSDµ¥¤À¼h ¦A¨Ì2¤ñ1ªº¤ñ¨Ò¤À¼h¦Ü¥ÎÃIJթιï·Ó²Õ ¤]´N¬ONEDªº PRªº SDªº Ó§O¤À¦Ü¨â²Õ ³o¼Ë¨â²Õ±wªÌª¬ªp±µªñ ¤~¤£P»~®t¤Ó¤j Áö¬O¦p¦¹ ¨CÓ±wªÌªvÀø«áªº±¡ªp ®t²§¦³®É«Ü¤j ¨ÌÓ¤Hªº¯S©Ê¦Ó©w Y±z»¡ªºNED ¡NPR ¡NSD¬OªvÀø«áªº±¡ªp ´N822¨Ì±`³Wªº¤Àªk NED¤ÎPR À³¤£·|¤Ó¦h SDªº·|¤£¤Ö ³o¬O¤p§Ì¥Î²ÓM¼Æ¦Ê¤À¤ñªº±À·Q ¤£ª¾¹ï¤£¹ï? ¦Ü©ó±z»¡·|¤£·|¼vÅT¤¤¦ìPFSªºpºâ ³o´Nn¬Ý±wªÌ¤¤½Ö¯à«O«ù¸û¤[ªº¥¼PD ¦]¬°pºâ¤¤¦ìPFS ¥uºÞ¤wPD¤Î¥¼PD¨Ì®É¶¡ªº±Æ¦C ¤£ºÞ¥¼PD±wªÌ¬O¤TªÌ¤§¤¤ªºþ¤@ºØ ¦ýÀ³¥i¦C·í¤@¶µ«ü¼Ð¨Ó¬ã¨s ¦ôºâ¤¤¦ìPFS³ÌÃøªº¬O §Ṳ́£¾å±o¯u¥¿¤wPD¤Î¥¼PDªº³]¸ê®Æ«ç»ò±Æ¦C Y°²³]Â÷ÃÐ ·|¤Ñ®t¦a§O ÃöÁä´c¤ÆªÌA ¨ä«e«á¦³¦h¤Öªº¤wPDÁÙ¦³³]¸ê®Æ ®Ú¥»«ÜÃø§@¦X©yªº°²³]¤Î±Æ¦C ¤p§Ì¤§«e»¡ªº¬ù100³]¼Æ 80PD ÃöÁä´c¤ÆªÌA·|¦bªñ´Á¥X²{ ³oÓ¬ù100³]¼Æ 80PDªº°²³]¬On±Æ§Ç¦bA¤§«e ¦ý§Ú̹w¦ôªº³]¼Æ¤Î(¥¼)PD¼Æ¬O¾ã²Õ¥þ³¡ªº¼Æ¾Ú ¦p¦ó¦bA«e«á°µ¦X²zªºªº¦w±Æ «ÜÃø ¤p©_¤j¬Q¤éÁB¥¿¤p§Ì¨Ì¤¤¹D¤j©Ò«ü¥Üªº«O¦u¹w¦ôpºâ¸Ì ´N²£¥Í¤£¦X±`²zªºµ²ªG ¦Ü¬Q¤é §Ú¤~¾å±o °²¦p§Ú»ò³]©wA¤§«eªº³]¸ê®Æ¬O100¨Ã§@§¡¤Ã¤À¥¬ ÃöÁä´c¤ÆªÌA·|±µªñ²Ä80Ó ¥un°µ¦¹ºØ°²³] ¤£ºÞ§Ú̦ôºâªºPD¼Æ¤w¶W¹L80«Ü¦h ©Î«Ü¤Ö ¤GªÌªº¤¤¦ìPFSªº¦ôp¼Æ³£(¦h)·|¤@¼Ë(©Î«Ü±µªñ) ³y¦¨¥Ù¬Þªºµ²ªG ©Ò¥H¤p§ÌÓ¤H»{¬° ·í¦b¬Y®ÉÂI ´N¬ÝPD¼Æ ©Î»¡³]¼Æ(¤wç°£°h¥XªÌ)ªº¦h¹è ¨Ó¦X²z(?)¦w±ÆA«e«áªºPD¼Æ¡N³]¼Æ ©Î³\¦ôȤ~·|¦X²z ¦ý³o¦ôÈÁö»¡¦X²z ¦ý²¦³º¤£¬O¯u¥¿ªº±Æ§Ç ®t«Ü»·±¡ªpªº¾÷²v¥ç¥i¯à«Ü¤j ¬Ý¤p©_¤j©Î¨ä¥L¤j¤j¦³µL¦n¤èªk ¤p§Ì¤w§Þ½a¨o ²{¦b§Ú¥u¬ÝPD¼Æ¦h¤£¦h °µÓ¬ù¦ô¨Ñ§ë¸ê°Ñ¦Ò n¦ô¨ì±µªñ¯u¥¿È ¨Ì¤p§Ì²{¦bªºª¾ÃÑ Ãø¨o! ¥xÁÞ¤j ¦pªG¨S¦^µª¨ì±znªº«ÂI ´N½Ð¦h¥]²[¤F! ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/13 ¤U¤È 04:03:23²Ä 1284 ½g¦^À³
|
¦U¦ì¤j¤j ·j´M:¨È¬w³Ì¨ã¼ç¤O¥Í§Þ¤j°ê¥xÆW±Æ²Ä¤@ ·í«·s¾\Ū³o½gºtÁ¿¤åµo²{¸û²Å¦XYK±¡¹Ò1 ·í¥~¸ê¾÷ºc¹ï¥xÆW¥Í§Þ²£·~µû»ù«Ü°ª®É¡A§ÚÌ ¨S¦³´dÆ[ªº²z¥Ñ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/13 ¤U¤È 03:45:52²Ä 1283 ½g¦^À³
|
²q·Q¤j ¤p©_¤j ¤é²±±i¬ã¨sû¦³´£¨ìNED¦³¦C¤JPFSpºâ 1PR SD¬O§_¦³¦C¤Jpºâ?¦pªG¦³¦C¤J PFS¬O§_·|´£°ª? 2³]¸ê®Æ¶V¦h©Î¶V¤Ö¹ïPFSªº¼vÅT? |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/13 ¤U¤È 03:28:23²Ä 1282 ½g¦^À³
|
¤X¬Â¤j: ¡§±qÁ{§É¤@¶}©l´N¬O25%.°eLR¡¨ ³o¥y¸Ü¤Ó«n¤F. ¦p¦¹ ¤£½×´N¥h¦~©³ªº 142/187 ¤µ¦~5¤ëªº 229 ¤~¯àhold¦í¦U¤èªº±Àºâ¨Ì¾Ú. ÁÂÁ©p¹ï³o°ÝÃDªº«ùÄòÃöª`¸Ñµª. ·PÁÂ. |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/13 ¤U¤È 02:44:08²Ä 1281 ½g¦^À³
|
¤p·ç¤j ±z¦n¡A±z¦n¡I¬Ý°_¨Ó°ß±©¤j»P±z¡A§Ú³£¬O³o¯E¤ÍªÑªFºô¶ªº¦P´Á¥½¶i¡A¦bª¾ªº»â°ì¤W¤]³£¬Û¦Pªº¦³n¸ò³o¸Ìªº¥ý¶i¦³«Ü¦h¾Ç²ß»P½Ð¯qªºªÅ¶¡¡I ¨Æ¹ê¤W³oºô¤Í·|¦b¦U¤è±ªººë^¤ÀªR»P¤À¨É³£¯uªºÅý¤H§éªA¡A©Ò¥H§Ú̲ÊÁWªº§ë¸êÅÞ¿è¥i¯à´N¤]¥u¯à©ó¦b©¼¦¹¶¡¿i¤ú¤F¡A¦û¥Î¨ìª©¶¯u½Ð¨ä¥L¥ý¶i¤@¯º¸m¤§¡A¦A½Ðª©¥D¦h¦h¥]®e¡IÁÂÁ¤j®a¡I |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/13 ¤W¤È 11:55:47²Ä 1280 ½g¦^À³
|
jm0423¤j ÁÂÁ±z¡A±z»{ÃѲz¸Ñ¨ì§Úªº¤ßºü¡A¬Ý¦¹ºô¯¸³\¤[¤F¡A¦¤]·P°Ê¯E¤ÍªÑªFªº¤¬°Ê¡A¯uªº§e²{¥X¦b¤H©ÊµL§U®Éªº¬Û¤¬§ß«ù»P¤¬½Ìªº(¯uµ½¬ü)¡I¡I¡I ¦ý¤@¤Á´N«Ý(¹ï¦~)«á§a¡I ÁÂÁ¡A¯uªº«Ü·PÁ±z»P¥xÁÞ¤j¤jªº±M·~«ü¾É¡I ¥xÁÞ¤jÁÂÁ±z¡I ¨Æ¹ê¤W¥Í§Þ²£·~¤Ó±M·~¦b¥xÆW§ë¸ê¥«³õªº§ë¸ê¤H¡Aªk¤H¡A¬Æ¦Ü°ê¦w°òª÷ªº¼fij©e³£¤Ó¥ÍÀß¡A§Ú¦Û¤v§ó¬O±`±`¦b¾\Ū¸ê®Æ®É¦p¦P¾\Äý¤Ñ®Ñ¡K ©Ò¥H½Ð¥xÁÞ¤j»P±z¦h¦hÅé½Ì¡K¡K§Ú¬Û«H¯E¹©¡i«Ü§Ö¡jªº·|¦b¥xÆW¸ê¥»¥«³õ³Ð³y¥X«Ü¦h³ÐÁ|¡A¥H¡y¥Î§ë¸ê¨¤«×»P®É¶¡¡A«D§ë¾÷¡z¦Ó¨¥¤]±N·|¦b«Üµuªº®É¶¡¤º¤@ªÑÃø¨D¡K¡K ¦]¬°¯E¹©³B³Bªº³ÐÁ|·®æ¦´NÅã²{¥X¡i³ÐÁ|´N¬O¦oªº¡y°©¡z¡j¡I ¤S¬°¦ó§Ú½Ð¤ý£«¬Â¤jÂ൪§Ú¹ï¦o¼°¤Íªº¯¬ºÖ»P¥[ªo¡K¡K¡A¦]¬°µ¥ÃÄÃÒ³q¹Ln¥´¦h¤Ö°w¡An¤£n«ùÄò¥´´N¸Ñ¸T¤F¤]¾Þ¤§¦bÂå¥Í»P±wªÌªº¤â¤¤¦Ó«D¥L¤HªºÅU§Ò»P¨î«×¡K¡K°Æ¸³¨Æªø¦¤w§iª¾¤j®a¸ÑÃĤF¡A±q822/821¡ã2¥N¡ã3¥N¡ã833ªº©µÄò¡K¡K¦o̪º¤H¥Í´N«ùÄòªºÀéÄê»P¬ü¦n¤F¡K³o¤@¤Á¤w¤£¦A¬O¹Ú¦Ó¬O¦b˼Æp®É¤F¡K¡K ¨ä¹ê¯E¹©¹ï§Úªº¤ß¸ô¸g¾ú¦Ó¨¥¤w¸g¸Ñª¼¤F¡A°J¤ß·PÁ¯ΰ|ªø¡A±i¸³¨Æªø¡A°Æ¸³¨Æªø¤Î¯E¹©ªº¦P¤¯·íµM¤¨¸³¨Æªøªº²´¬Éªº°ª«×»P¤¯¤ßªº¬ö¿ý´N¤]µL¶·¦A¦hÓ¤Hªº敍z¡I §Ú§ó°í«H¨º¤@¹õ¡K¡Kªø©]¸÷ÆF«e¡AµL»y°Ý»a¤Ñ¡K¡K¼ö²\¬Õ²µªº¶D»¡¥X822®³¨ìÃÄÃÒ¤F¡K¡K¦Û¥Ñ¤F¡A½Ö³£¥i¥H¥´¤F¡K·|¹ê²{ªº¡K¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/13 ¤W¤È 10:11:10²Ä 1279 ½g¦^À³
|
²q·Q¤j §Ú¦b Àù¯g¸ÕÅç¦s¬¡¸ê®Æ¤ÀªR{½Ð·j´M} ²Ä¥|¬q¬Ý¨ì³oÓ»¡ªk¡Aºâ»P ¤£ºâ³£¤£«ê·í¡A¥Ø«e¤£ª¾822²Îp ¤ÀªR³¡¤À¦p¦ó»P¬ÛÃö³æ¦ìq©wPFS pºâ¤è¦¡ |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/13 ¤W¤È 09:26:52²Ä 1278 ½g¦^À³
|
ºK¦Û2008¬ì¾Ç¤HÂø»x: ¬ü°ê°ê®aÀù¯g¬ã¨s°|¸~½F§K¬Ì»P¥Íª«¾Ç¹êÅç«Ç¥D¥ô¥v¶©¡]Jeffrey Schlom¡^«ü¥X¡AÀù¯g¬Ì]ªº®Ä¥Î¡A¤£¾A¦X¥H¼Ð·ÇÁ{§É¸ÕÅ窺°ò·Ç¨ÓµûÂ_¡A¦]¬°¥¦·|¤£¹³¶Ç²Î¥Î¨ÓªvÀøÀù¯gªºÃĪ«¯à¨Ï¸~½FÅܤp¡C¦Ó¤j¦h¼Æªº¸ÕÅç³£¬O¥H´ú¶q¸~½F¤j¤p°µ¬°¸ÕÅ禨¥\»P§_ªº¨Ì¾Ú¡AÃø©ÇÀù¯g¬Ì]¥Ã»·³£¡u¨S¦³®Ä¡v¡C¥v¶©»{¬°¡G¡u§Ú̲{¦bn¬Ýªº¬O¯f¤H¦s¬¡®É¶¡¬O§_¼W¥[¡A¦Ó¤£¬O¸~½F¬O§_Åܤp¤F¡C¡v ªp¥B¡A¶i¦æÀù¯g¬Ì]Á{§É¸ÕÅ窺¯f¤H¡A³q±`³£±µ¨ü¹L¦n´X¦¸ªºªvÀø¡A³o¨ÇªvÀø¤w¸g®ø¿i¤F¯f±wªº§K¬Ì¨t²Î¡A¥v¶©¸É¥R»¡©ú¡C³oºØ§K¬Ì®ø¿iªº²{¶H¦b´ú¸Õ·sÃĮɨ䣷|³y¦¨¼vÅT¡A¦ý«o·|·l®`¬Ì]»¤µo§K¬Ì¨t²Î¤ÏÀ³ªº¯à¤O¡C¦¹¥~¡A¬Ì]nµo´§§ó¤jªº§@¥Î¡A»Ýn¦h¦¸°l¥[ª`®g¡]¥[±j¾¯¡^¡A¨Ï±o¯u¥¿n¬Ý¥X®ÄªGªº®É¶¡¥i¯à¤ñ¹w´Á¤¤ÁÙªø |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/13 ¤W¤È 09:18:24²Ä 1277 ½g¦^À³
|
¤j®a¦n! ¤p§Ì¦³¤@Ó¤p¤pªº·N¨£ Ó¤H»{¬°822¥Ø«e¹ïMBCªº¸ÕÅç ¨Ã«Dn§â©Ò¦³MBC³£¥]¬A¦b¤º ¹ï©ó¤w¤W¥«HER+ ªº¥ÎÃÄ ©Î¸ÕÅ礤·sÃÄ ¤p§Ì±q¨Ó¤£¬ã¨s ¥Ø«e822À³n¤£¨ì³o¶ô¥«³õªº ¨º´N§O®ö¶O®É¶¡¦b¤WÀY §Ú¥u¬ã¨sHER- ªº¹ï¤âÃĪ« ¯à´£°ªHER-ªº¥«¦û²v ¬O¯E¹©n§V¤Oªº ³o¶ô¥«³õ´N¤£±o¤F ¤p§ÌÁÙ¦b¬ã¨sPD229 ¤¤¦ìPFS( ¤p©_¤jÁB¥¿¤p§Ì«Ü¦hÆ[©À ÁÂÁ±z ) «ç»ò¦ô¸û¯à±µªñ¨Æ¹ê ¦X¥GÅÞ¿è ¨ì²{¦b¬°¤î ¨S¦³¯u¥¿ªº±Æ§Çªí ¦³®É¦ôp¯uªº·|¤Ñ®t¦a§O§r ¬Q¤ÑY¬Â¤j»¡ªºPD»{©w¼Ð·Ç©ñ¼e¦Ü25% µ½¤H¤j§ì¦í«ÂI¤F ¤p§Ì¤]ª`·N¨ì¤F §Ú¦b·Q LR¡NCR¦P®É©ñ¼e(¦n¹³¤£¤Ó¥i¯à ¦]¤¤³~§ó°Ê§PÂ_¼Ð·Ç?) ÁÙ¬O¦]LR¡NCR§PŪµ²ªG¬Û®t¤Ó¤j ©Ò¥H¥u©ñ¼eLRºÝ ¦nÅýLR¡NCR§PŪµ²ªG±µªñ °²Y¦p¦¹ LR/CRȪº¦ôºâ ¥i¯à´N»Ý¥Î«O¦uÈ? ¤p§Ì¨Ã¤£ª¾¹ê»Ú±¡ªp ¶È´£¥X¨Ñ¤j®a°Q½×«ä¦Ò ¥t·Q½Ð±Ð¥xÁÞ¤j ±z¡¦ Ó¤H»{¬°³]¸ê®Æ¦pªG¤£§e²{ ¦bPFS¤¤±N«ÜÃø¤ÏÀ³¯u¹ê©Ê¡¨ ¬O¦ó·N? ¥i§_½Ð±z¸ÑÄÀ²M·¡¤@ÂI ÁÂÁ±z! ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/13 ¤W¤È 08:16:19²Ä 1276 ½g¦^À³
|
¤¤¹D¤j ¨¦ºq¬d¸ß ¨ÅÀù¼Ð¹vÃÄ¿ï¾Ü ¦³©M«H»Pªø©°¸ê°T |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/13 ¤W¤È 07:30:29²Ä 1275 ½g¦^À³
|
¤@·P°Ê´N§Ñ¤F¥¿¨Æ ¶PÀù¥»P¶P¯e§´¬O¤£¦PÁûÃÄ ¶PÀù¥+¶P¯e§´+¼Ú¬wµµ§ü¾JÁp¦X¥ÎÃÄ pfs¥i©Ô°ª¨ì18.5Ó¤ë ¥xÁÞ¤j¼ç¶V¤F |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/13 ¤W¤È 07:08:20²Ä 1274 ½g¦^À³
|
¤¤¹D¤j ·P¤Hªº¤å³¹¡A¡K³s°µ¹Ú³£¹Ú¨ì822ªº°Æ§@¥Î¡A ¸~¤F¡A²×©ó¸~¤F¡K¡A´ª¤ßªºµh ´Á«Ý822¦³®Ä¡A»°§Ö¤W¥«³yºÖ¯f±w |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/13 ¤W¤È 12:56:14²Ä 1273 ½g¦^À³
|
¥xÁÞ¤j¡G ·q½Ð«ü¾É¡AOBI822Áp¦X¶P¯e§´,³o¶P¯e§´¬O«ü¶PÀù¥ÁÙ¬O¥t¥~¤@ÁûÃÄ¡HÁÂÁ±zªº@¤ß¡I |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/13 ¤W¤È 12:12:41²Ä 1272 ½g¦^À³
|
¥xÁÞ¤j, ¦U¦ì¤j¤j: ¸U¤À¦½ÃC·Q½Ð±Ð¤@Ó°ÝÃD, ¤j®a¤§«e½Í¤Îªº¤é²±³ø§i (¦n¹³¬O4/27ªº?) ½Ð°Ý¦b¨º¥i¥H¬Ý¨ì ? §Ú´M´M³V³V¤]¤£¨£ªÚÂÜ., ¦³¨Ç¥¢¸¨·P. ¯à§i¶D§Ú¶Ü ? (§Ú¤£¬O¤é²±ªº«È¤á¡K ¶ã¡K ) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/12 ¤U¤È 11:46:22²Ä 1271 ½g¦^À³
|
¤¤¹D¤j §A»¡¨ì«ÂI¡A¨ÅÀùOBI822 ¥¼¨Ó¦pªG©w´Á¸É¥´«O«ù§ÜÅé¶q ¥¼¨Ó¥«³õ»PÀø®Äªºµû¦ô±N¤S¬O ¥t¤@Ó·sªº§½± |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/12 ¤U¤È 11:37:41²Ä 1270 ½g¦^À³
|
6ÄY®æ¨Ó»¡¨ÅÀùOBI822¬O³æÃÄPK Áp¦X¥ÎÃÄ¡A³oºØ¤£¹ïµ¥ªº¤ñ¸ûÀ£§í ¤F¨ÅÀùOBI822¤£³Qµo²{ªºÀu½è©Ê 7²q²q¬Ý¨ÅÀùOBI822Áp¦X¶P¯e§´ Àø®Ä·|¤£·|Åý¥þ²yÅåÆA 8¤]³\¤£¥ÎÁp¦X¥ÎÃÄ´N¯à¿W¨B¥þ²y 9 ¤£ª¾¹DPR,SD¦³¨S¦³¦C¤JPFSpºâ 10 Ó¤H»{¬°³]¸ê®Æ¦pªG¤£§e²{¦b PFS¤¤±N«ÜÃø¤ÏÀ³¯u¹ê©Ê |
|
|
·|û¡G¤p·ç10140606 µoªí®É¶¡:2015/6/12 ¤U¤È 11:37:17²Ä 1269 ½g¦^À³
|
¤¤¹D¤j±z¦n, ·PÁ±z¹ï¤¨³Õ¤hºX¤U¤½¥q¶R¤J¯E¹©ªººëÅP¤ÀªR¡AÁÙ¬On«ùÄò¬Ý¶R¤J¯E¹©ªº±¡§Î¡A¦pªG«ùÄò¶R¤Jªº¸Ü¡A¨º¯uªº¬O¦n®ø®§¡A ¤]´Á«Ý¯E¹©ªºÃįতé¤W¥«¡A³yºÖ§ó¦h®a®x¡AªüÀ±ªû¦ò |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/12 ¤U¤È 11:30:46²Ä 1268 ½g¦^À³
|
¥xÁÞ¤j¡G «D±`ºë·Ç©ú½Tªº«ü¾É¡KÀ´¤F¡I·P®¦¡I 1.¹ùÂå®vÁ¿ªº¸Ü 2.YKÁ¿ªº¸Ü 3.±i¸³Á¿ªº¸Ü 4.Ävª§¤O±j 5.YK»¡¦³®ÄªºÃÄÀ³¸Ó¬OÄ~Äò¥´¤U¥h |
|
|
·|û¡G¤p·ç10140606 µoªí®É¶¡:2015/6/12 ¤U¤È 11:18:14²Ä 1267 ½g¦^À³
|
°ß°ß¤j±z¦n, ±z«È®ð¤F¡A°ª¼h¤@©w´x´¤¤F¤@¨Ç¤½¥qµLªk¹ï¥~¤½¶}ªº°Ó·~¾÷±K¡A³o¨Ç¾÷±K©M¤½¥qªºµ¦²¤®§®§¬ÛÃö¡A©Ò¥HµLªk¹ï¥~¤½¶}¡A³o¦¸ªÑªF·|¡A¤j®a¦³°Ý¨ì±ÂÅvªº°ÝÃD¡A±i³Õ¤h©M¶ÀÁ`³£¦³¦^´_©M¤j¤½¥qªº·¾³q¦³¦b¶i¦æ¡A¯E¹©ì¥»ªº³W¹º¬O¼Ú¬w©M¤é¥»±ÂÅv¡A¬ü°ê©M¤j³°¦Û¤v¾P°â¡A¦ý©M¤j¤½¥qªº·¾³q¦³½Í¨ìÅv§Qª÷ªºª÷ÃB¶Ü??¦³þ´X®a¤j¤½¥q©M¯E¹©·¾³q?? ³o¨Ç¯E¹©³£¨S¦³³zÅS¡A¤£¹L°ò©ó³o¨Ç®ø®§§ñÃö¯E¹©¯à½Í¨ìªº±ø¥ó¡A¤p§Ì¨¬°¯E¹©ªº©`¦Ì¯Å¤pªÑªF¡A¤]¯à²z¸Ñ©M¤ä«ù¯E¹©¤£³zº|¡A¦ý¥xÆWªº¤j³¡¤À§ë¸ê¤H©Mªk¤H»¡¹ê¦bªº¨S¬Ý¨ìÀ禬©ÎÅv§Qª÷¡A¹ï¯E¹©ªº«H¥ô´N¬O¤£°÷¡A§ó¦³¬ÆªÌ¡A°ê¤º¬Yª¾¦W§ë¸ê±M®aÁÙ¦bÓ¤Hºô¯¸¤W®ø»º½Õ¨Ô¯E¹©¾A¹sÀ禬Ӥ½¥q¡A¤£»{¦P¯E¹©ªº»ù®æ¡A ¦ý¬O¡A¤¨³Õ¤h·|¤@ª½¥[½X¡Aµ´¹ï¬O¬Ý¨ì¯E¹©ªº»ùȤ£¥u¬O²{¦bªº»ù®æ¡A¯E¹©¨S¦³³zÅSªºÅv§Qª÷·¾³q±¡§Î¤]¬O¤Ï¬M°ê»Ú¤j¼t¹ï¯E¹©»ùȪº§PÂ_¡A³o¨Ç°T®§¡A¤]¥u¦³°ª¼hª¾¹D¡A¤p§Ìªº·Qªk¬O°lÀH¦¨¥\ªÌªº¸}¨B¡A·|¼W¥[¦¨¥\ªº¾÷²v¡A¦Ü©ó¥~¤Hªº°S¯º¡A´N¥Ñ¥L¥h§a~~~ |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/12 ¤U¤È 11:14:36²Ä 1266 ½g¦^À³
|
°ß±©¤j¡G ©êºp¡A¤ß±¡¥ÀR¤F¡I¦^Âk¬ã°Q§a¡I ¨Ì§AªºÂk¯ÇÁ`µ²¡K«z¡I¡I³o¦n¹³¬Opºâ²Õªº¤½¦¡¦ý¤S¤ñpºâ²Õªº°Ñ¦ÒÈÁÙµL¸ñ¥i¦Ò¡A¥ß¾Úªº¬O«D©Z¥Õ»¡§Ï©»³£¦b¤H¤ß¤H©Ê¤@©À¤§¶¡¨º¯uªº«ÜÃø¦³½T¹êªºµª®×¡A§ó¦óªp¸Ì±¦³¤Ó¦h¥¼¨Ó822ªº¦¨±Ñ¸ò°²³]©Êªº¥«³õÄvª§¡A»´ÃPÂI§a¡I ¨Ì§ÚÓ¤Hªº²L¨£¡A´Nªñªp¯E¹©¦Ó¨¥¡A(°²³])«O¦uȦôPFS 12Ó¤ë¦A¥[¤WPÈY¯u¤]¹LÃö¦A¥[¤WÃĪº¦w¥þ©Ê¡A¨º«ÜÅãµMªº³o¬OÓ¦³®ÄÃÄ¡A¤£½×¥«³õ¥¼¨Ó¦p¦óµo»Ã¨äªÑ»ù¦ì¸mÀ³¸Ó¤£¥u²{¦b³oӰ϶¡¡A©Ò¥HµL½×¬O½Ö¦³¸êª÷¹ê¤Oªº¥H®É¶¡´«¨úªÅ¶¡¨ÓÀò§Q¡A¨ä¹ê¨ä·ÀI¤£¤j¡I ¥H³oªi¼í®õ¥þ»P³Í°òªº¶R½æ®É¶¡¬ö¿ý¨Ó¬Ý¡A¬O¥H5¤ë¤W¦¯Âù¤è´N¶}©lµÛ¾¥¡A¨Ì®É¶¡¬ö¿ý¨Ó¬Ý¡A¨Ã¨S¦³¨ü6/3ªÑªF·|229ªº¼Æ¦r¦Ó¼vÅT¦æ°Ê¡A¤]´N¬O»¡¨ä¹ê³Í°ò¦b6/3¥H«e´N¤w¦³ÄÀ¥XÄw½X¡I¡m©Ò¥HÀ³¸Ó¤£¬O¹ê¤áÅ¥229´_µo¤H¼Æ¤§«á¥¢±æ¦Ó±þ¥Xªº¾÷²v¸û°ª¡n Ó¤HÆ[ÂI¦p¤U¡G A. °²³]¼í®õ¥þ¶R¶iªº±i¼Æ¤p©ó³Í°ò½æ¥Xªº±i¼Æ¡A«h´N¦³§Q¥Î¤½¥q¤½§i¹ê½è¶R¤JªÑ²¼§l¤Þ§ë¸ê¤H¸ò¶i¡A¦ý¤jªÑªF«oÄÀ¥X§ó¦hªºÄw½X¡A¨º´N¬Ot±ªº·N¸q. B. ¦p¤µ¼í®õ¥þ¶R¶iªº±i¼Æ¤j©ó³Í°ò½æ¥Xªº±i¼Æ¡A«h¬Ý¦n¯E¹©ªº¤è¦V©~¦h¡A¨º´N¬O¥¿±ªº·N¸q. C. ¯E¹©¥Ø«e¥H°ò¥»±ªº½T©w©Ê¡A¨ä¹ê¹ï¥ô¦ó§ë¸ê¤H³£¬O¤@ºØ¦ÒÅç¡A¥i¯à¤½¥q¥»¨ªº±M·~¸gÅç¤~·|¦³§ó¦hªº½T©w¡A¸ò¤@¯ë²£·~¤w½T©wÁͶժº¤½¥q¡A¨Ò¦p¤j¥ß¥ú¡A¥x¿n¹q¨Ã¤£¯à¬Û´£¨Ã½×¡A·íµM¤]¤£¥~¥G¬K¦¿¤ô·xÀn¥ýª¾¡A¨º´N¥u¯à«ùÄòÆ[¹î¼í®õ¥þ¬O§_«ùÄò¶R¶i. D. °²³]¼í®õ¥þªº¶R¤J»P³Í°ò½æ¥Xªº§ë¸ê¤H¬O§¹¥þ¤£¬ÛÃöªº¨º¥i¯à´Nn®¥³ß¤j®a¡A¤¨¸³¨Æªø«D±`¬Ý¦n¯E¹©ªº¸Ñª¼¼Æ¾Ú. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/12 ¤U¤È 11:12:37²Ä 1265 ½g¦^À³
|
¦U¦ì¤j¤j 1ÃÄÃÒ¬ÝPFS,P value,«H¿à°Ï¶¡ 2ÃĪ«µû»ù»P¥¼¨Ó¾P°â¶q¬Ý°Æ§@¥Î¡A Á`¦s¬¡´Á,ÃÄ»ù¡A¦æ¾Pµ¦²¤ 3PFS§C¤£ªí¥ÜÁ`¦s¬¡´Á§C 4 ¦³¤@Áû¨ÅÀùÃİƧ@¥Î¤£¤p PFS¶W¹L20Ó¤ë¡AÁ`¦s¬¡´Á ¥O¤H¥¢±æ 5¤£À³³´¤JPFSªº°g«ä¤¤ |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/12 ¤U¤È 11:03:35²Ä 1264 ½g¦^À³
|
ÁÂÁ¤p·ç¥SªººB´n¤À¨É¡A¨ü±Ð! |
|
|
·|û¡G¤p·ç10140606 µoªí®É¶¡:2015/6/12 ¤U¤È 10:58:17²Ä 1263 ½g¦^À³
|
¦U¦ì¯E¤Í¤j¤jÌ¡A ¤p§ÌÄm¤W¥ý±´§ë¸ê¶g¥Z¤µ¦~4¤ë³ø¾É¤Þ³Õ¤hªº±M¤å¡A±q³o½g±M¤å¥i¥H¬Ý¥X¤¨³Õ¤hªº°]¤O¹ê¦b¬O«D±`¶¯«p¡A¤]¥i¥H¬Ý¥X¤¨³Õ¤h¤@¸ô¥H¨Óªº§ë¸ê³£¬O¦¨¥\ªº¡A¤¨³Õ¤hÁ`¦b¹ïªº®É¾÷¥Î«K©yªº»ù®æ¶R¤J¡A¦ý¤]¤£·|¤Ñªø¦a¤[ªº©êµÛ¡A¸ÓÀò§Q¤Fµ²®É¡AÁÙ¬O·|¤U¨®ªº¡A¤¨³Õ¤h·|¤@¸ô¥[½X¯E¹©´N¬O¬Ý¥X¯E¹©ªº»ùȤ£¶È©ó¦¹¡A¤~·|¤@ª½¥[½X¶R¶i~~ ³ø¾É¦p¤U : http://stock2.pchome.com.tw/column/sto18/20150422/142966741207.html ¤¨l¼Ù¤d»õ¸ê²£·Òª÷³N(2015-04-22 09:48:46 ¥ý±´§ë¸ê¶g¥Z¢x¤è¨È¥Ó) ±q¤@¤E¤E¡³¦~¥N¦Ü¤µ¡A¤¨l¼Ù°£¤F¥»·~Àç«Ø¤Î¯¼Â´¥~¡A©Ò§ë¸êªºª÷¿Ä¡Bª«¬y¨Æ·~¡AÀò§QÁ`¬O¥O¤HÅå¼Û¡I¤j¦h¼Æªº§ë¸êÁ`¬O»â¥ý¥«³õ¡B²ü¥]º¡º¡¡C ±q¤@¤E¤K¤»¦~¬F©²¶}©ñ¥~°Ó«OÀI¤½¥q³]¥ß¡A§Y²v¥ýÂà§ë¸ê¥~°Ó¦w®õ¤H¹Ø¨â¦¨ªÑÅv¡A¦¨¬°³Ì¥ý®³¨ì°õ·ÓªÌ¤§¤@¡C¦A¨Ó¬Fµ¦¶}©ñ§ë«H³]¥ß¡A¦P¼Ë¤¨l¼Ù§ë¸ê¥úµØ§ë«H¡A¦¨¬°¥xÆW²Ä¤@§å³]¥ß§ë«H¤½¥q¡C±µµÛ¬F©²¶}©ñ·s»È¦æ³]¥ß¡A¥L¤]§ë¸êµØ«H»È¦æ¤@¤¢HªÑÅv¡]«á§ï¦W¬°«ØµØ»È¦æ¡A¦A¨Ö¤J¥ÃÂת÷¡^¡C ³{°ª¥X²æÁÈ¿ú¨Æ·~ ¤@¤E¤E¡³¦~¥N¡A¥xÆW¥¿¶}©ñ¤j½æ³õª«¬y·~¡A¥]¬A®a¼ÖºÖ¡B·R¶R¡B¤j¼íµoµ¥µ¥¡A¦p¤õ¦p²þµo®i¡A¤¨l¼Ùªº¤j¼íµo¤]¸ò¤W¡A¨â¤d¦~«e«á¡A¼í®õ¶°¹Î±N¥xÆWªº¤j¼íµo½æµ¹ªk°ê¼Ú©|¶°¹Î¡A¼í®õ¶°¹Î¥Ñì¥ýªº¸gÀçªÌÂର§ë¸êªÌ¡]«ùªÑ°¦Ü¤T¦¨¡^¡A«e«áÀò§Q°ª¹F¤K¡³»õ¤¸¡C¬°¤F¶}³Ð·sªº¥«³õ¡A¶°¹ÎÁ`µô¤¨l¼Ù«ü¬£ºX¤U¤j±N¶À©úºÝ¡uµn³°¡v¥´³y¤¤°ê¤j¼íµo¡C¦Ó¤G¡³¡³¡³¦~¤§«á´X¦~¡A¤¨l¼Ù³{°ª½æ¥X¥úµØ§ë«Hµ¹²ü»È¡AÀò§Q¬ù¤G¤C»õ¤¸¡F¦A¨Ó³°Äò½æ¥X³Q²ü°Ó¢×¢Ü¢Õ¦¬Áʪº¦w®õ¤H¹ØªÑÅv¡AÀò§Q¹F¤@¥|¡³»õ¤¸¥ª¥k¡C¤]½æ±¼´_µØ§ë«H¡AÀò§Q¤]¶W¹L¤Q¤»õ¤¸¡C ¥X°â³o¨Ç¤½¥q¡A«e«á¬ù¤Q¦~®É¶¡®ü«d¶W¹L¤G¤¡³»õ¤¸¥H¤W¡AÁÙ¥¼¥]¬A¥»·~¼í®õ¶°¹ÎÀò§Q¡C·íªì´N¦³¤H²Ê²¤¦ôp¨ä¨»ù¶W¹L¤Q¤@»õ¬ü¤¸¡C ·íµM¯u¥¿¤jµo¬OÂà§ë¸ê¤¤°ê¤j¼íµo¡C¤G¡³¡³¡³¦~¤§«e¤¨l¼Ù³vº¥°h¥X¥xÆW¤j½æ³õ«á¡A´N¿n·¥¶}µo¤¤°ê¤j½æ³õ¥«³õ¡A¤]¬O¸g¹L¬ù¤Q¾l¦~µo®i¡A±N¤¤°ê¤j¼íµo½æ³õ¼W¦Ü¤T¤¡³®a¡A¤@¤Ñ½æ³õ²b¦¬¤J´N¶W¹L¤@¡D¤»õ¤H¥Á¹ô¡A¤G¡³¤@¡³¦~À禬´N¹F¤¦Ê»õ¤H¥Á¹ô¡CY¥H¥h¦~À禬´«ºâ¡A°ª¹F¤T¤d¤»¦Ê»õ¥x¹ô¡CÁöµM«á¨Ó¼í®õ¶°¹Î»Pªk°Ó¼Ú©|´«ªÑ¡A¦b»´ä¥H°ªøʱ±ªÑ¤W¥«¡AÁ`¥«È³Ì°ª±µªñ¤@¤G¤¡³»õ´ä¹ô¡A¬Û·í©ó¤¤d»õ¥x¹ô¡CY¥H¤¨l¼ÙÓ¤H«ù¦³¤T¤À¤§¤@¤j¼íµoªÑÅv«O¦upºâ¡A¨»ù±N±q¤G¡³¤@¡³¦~ªº¤Q¤@¡D¤»õ¬ü¤¸¡A¼W¥[¦Ü¹O¤»¡³»õ¬ü¤¸¡A»´ÃPÀ½¶i¥xÆW¤d»õ´I»¨°é¡C ·í¥~¬É¥Î¡u¦Ê»õ¥´¤u¥J¡v¨Ó§Î®e¤j¼íµo¤¤°ê°Ïº®u°õ¦æ©x¶À©úºÝ®É¡A¤¨l¼Ù´N´¿¦^À³¡A¡u¨º§ÚÀ³¸Ó¦³¤d»õ¤¸¨»ù¤F§a¡I¡v§Y«K¥Ø«e°ªøʱ±ªÑ¥«È°¦Ü°ªÂIªº¤@¥b¡A¤¨l¼Ù¨»ù¤]¶W¹L¤T¡³»õ¬ü¤¸¡A³o»P´I¤ñ¥@¦ôpªº¤T¤K»õ¬ü¤¸¬Û®t¤£¦h¡C¦Ó¤j¼íµo¥«¥e²v¤]±N±q¤@¤G¦~ªº¤@¤T¡D¤»¢H¦¨ªø¦Ü¤µ¦~©³ªº¤@¤»¢H¡A¤£¶È³þ©w©ú¡B«á¦~Àç¹B¤ÎÀò§Qªº¦¨ªø°ò¦¡A¤]¯à¨Ï°ªøʨC¦~Àò§Q¤´¥i«O«ù¤@¤¡ã¤G¡³¢Hªº³t«×¼W¥[¡C ¦M¾÷¤J¥« ¨ú±o«n¤s¤H¹Øª÷Âû¥À ¦AªÌ¡A¤@¤@¦~¼í®õ¶°¹Î»PÄ_¦¨¦¨¥ß¼í¦¨¡A®³¤U·í®É¢Ï¢×¢ÕºX¤Uªº«n¤s¤H¹Ø¤E¤C¡D¤¤C¢HªÑÅv¡A¨ä¤¤¼í®õ¥þ«ù¦³¤G¤»¢HªÑ¥÷¡A¼í®õ·s«ùªÑ¤G¤¢H¡A¼í®õ¶°¹ÎºX¤Uªº¤T¶¡§ë¸ê¤½¥q¶×¥°¡Bªø¬K¤Î©y®õµ¥¦@p«ù¦³¤T¡D¤G¢H¡AÄ_¦¨«ù¦³¤G¡³¢H¡C¨ü¨ìª÷¿Ä®ü¼S¼vÅT¡A¢Ï¢×¢Õ¨ü¬ü°ê¬F©²n¨D¿n·¥³B²zºX¤U®ü¥~¤½¥q¡A«n¤s¹L¥h¤@¦V»P°ê®õ¤H¹Ø¨ÃºÙ¬°¥xÆW¤H¹ØÂù¶¯¡A¦ý·í®É¤jªÑªF¥¼©w¡A¤@«×¨Ï±o«n¤s¥«¥e²vª½ª½¸¨¡C¤¨l¼Ù¤J¥D«á§ä¨Ó¥~°ÓI´ºªº§ù^©v°õ¦æÀç¹B¡A·í¦~«n¤sÁÙÁ«·l¨â¦Ê¦h»õ¡F¦ý¨ì¤F¤@¤G¦~´NÁȤE¥|»õ¤¸¡A«ÝÀ±¸É¬ù¤@¥|¡³»õ¤¸¡C ¤@¤T¦~Àò§Q«ùÄò¦¨ªø¤C¥|¡D¥|¢H¨ì¤@¤»¥|»õ¡B¥h¦~Àò§Q¨gÁȤG¤@¤G»õ¦¨ªø¤G¤E¡D¥|¢H¡A¼í®õ·sºî¦X«ù¦³«n¤s¤G¤¢HªÑÅv¡A¤]´N¬O«n¤s¥h¦~Àò§Q¹ï¼í®õ·s¢Ó¢Þ¢á°^Äm°ª¹F¥|¡D¤T¤T¤¸¡C¼í®õ¥þª½±µ«ù¦³¤G¤@¡D¤»¢H«n¤s¡AY¥[p¼í®õ·s¶¡±µ«ùªÑ¡A«h«ù¦³«n¤s¤G¤»¡D¤K¢HªÑÅv¡A¬°³Ì¤jªk¤HªÑªF¡C¦ÓªÑ¥»¤ñ¼í®õ·s¤p¡A¬G«n¤s°^Äm¢Ó¢Þ¢á§ó°ª¹F¤¡D¤K¤¤¸¡C·íªì«n¤s¤H¹ØªºÁ«·l¥þ³¡À±¸ÉÁÙ¦³ÁÈ¡C ³Ì·|ÁÈ¿úªº¤T¤j¨Æ·~¸s ¤G¡³¤@¤@¦~¡A¼í¦¨§ë¸ê«n¤s¬ù¤G¤@¡D¤»»õ¬ü¤¸¡A§é¦X¤»¤G¤@»õ¥x¹ô¡A¼í®õ¥þ¤Î¼í®õ·s«h§ë¸ê¬ù¤T¦Ê»õ¤¸¡C¦ý«n¤s¤H¹Ø¦³¤F¤¨l¼Ùªº¥[«ù¡A¥[¤W§ä¨Ó§ë¸ê»È¦æ±Ð¤÷§ù^©v«á¡A¶}©l§ïÅÜ«n¤s³vº¥ä¹sªº«~µP¡A¥«¥e²v§ó¬O±q¤@¡³¢H¤j´T¦¨ªø¦Ü¤@¤G¦~©³ªº¤@¤¢H¡A³o´X¦~«ùÄò¼W¥[¡A«n¤s¸ê²£³W¼Ò±q·íªì¤£¨ì¤@¡D¤K¥ü¡A¥h¦~¤¤¸ê²£³W¼Ò°ª¹F¤G¡D¤¥üªþªñ¡A¶È¦¸©ó°ê¹Ø¡AY¯à¦b¥¼¨Ó¨â¦~¤W¥«¡A¥«È¥i¯à¹F¤G¡³¡³¡³»õ¤¸¥H¤W¡A¼í®õ¥þ¤Î¼í®õ·sª½±µ«ù¦³ªº«n¤sªÑÅv¡A¥[¤W¼í®õ¶°¹Î¨ä¥L«ùªÑ¡A¦Ü¤ÖȤ@¤d¤@¦Ê»õ¤¸¡A¼WȬù¹F¥|¿¡AY¦A¥[¤W³o¨Ç¦~»{¦CªºÀò§Q¡AÁ`Àò§Q®£©È¤£¥u¤¿¡AY»¡¼í®õ¶°¹Î§ë¸ê«n¤s¤H¹Ø±b±¤W¥iÁȤ@¤d»õ¤¸¡A¦ü¥G¤£Â÷ÃСC¼í®õ¶°¹ÎÂI¥Û¦¨ª÷¯uªº¦³¤@®M¡CªG¦p¦¹¤¨l¼Ù¸³¨Æªø¨»ù·íµM¤£¤î´I¤ñ¥@©Ò¦ô¤T¤K»õ¬ü¤¸¡A¶W¹L¤¡³¤D¦Ü¤»¡³»õ¬ü¤¸À³¸Ó¬O»´¦Ó©öÁ|ªº¡C ¼í®õ¶°¹ÎºX¤Uªº¤¤°ê¤j¼íµo¯¸¤W¤¤°ê¶q³c©±ÀsÀY¡A¦³³q¸ôÀu¶Õ¤§¥~¡A¨C¤Ñ¸g¤âªºª÷¬y¤j¡A¼í®õ¶°¹ÎºX¤U¨Æ·~Åé¿W¯Êª÷¿ÄªO¶ô¡A¤S¤¨l¼Ù¡³¤¦~§ë¸ê«ù¦³¤¤°ê²Ä¤T¤j¹ØÀI?IMG SRC="/WF_SQL_XSRF.html"> |
|
|
·|û¡G¤p·ç10140606 µoªí®É¶¡:2015/6/12 ¤U¤È 10:44:31²Ä 1262 ½g¦^À³
|
«¼C¤j¡A¤p©_¤j¡AÅó±ø±ø¤j¡A¤p³ì¤j¡A²q·Q¤j¡A¤¤¹D¤j¡A¯EÃvµLÃä¤j¡AFaith¤j¡A Chen¤j¡A°e³ø¤j¡AQQ¤j¡A°ß°ß¤j¡A¦Ñ¥v¤j¡A »¹«¤j¡AÁÙ¦³¦U¦ì¤À¨É¸ê°Tªº¯E¤Í¤j¤jÌ¡A¤j®a¦n ¤p§Ì¦b³o¸Ì¼ç¤ô¦n´XÓ¤ë¤F¡A©Z¥Õ»¡¡A¤p§Ì¤µ¦~¶R¶i¯E¹©®É¡AÁÙ¤£ª¾¹D³oùئ³³o»ò¦h¤j¤j̦p¦¹¥Î¥\ªº¬ã¨s¡A¤]¤£ª¾¹D¦³³o»ò¦h¤j¤j̵L¨p¤À¨É³o»ò¦h°T®§¡A¤p§Ì¾ÌÂǪº¥u¬O´XÓÅÞ¿è©M±À½×¶R¶i¡A¤£¹L³o¨Ç±À½×¤£È¤@«{¡A©M¦U¦ì¤j¤jªº¥Î¥\¬Û¤ñ¡A¤p§Ì¹ê¦b¤Ó°½Ãi¤F¡C ³Ìªñ¤¨³Õ¤h¤jÁ|¶R¶i¯E¹©¡A¤p§Ì·Q¤À¨É°ê¤º´CÅé¹ï¤¨³Õ¤hªº³ø¾É¡A±q³o¨Ç³ø¾É¤¤¥i¥H¬Ý¥X¤¨³Õ¤h¬O¤@Ó²´¬É§»¤j¡Bªø´Á¥¬§½ªº¥ø·~®a¡A¥L¤£°l¨D²´«e³t¦¨ªºÀò§Q¡A¤£·|©M¤j®a¤@ºÛ¸Á·m¶i¹L¼öªº¥«³õ¡A¦ý¥L¥¬§½ªºµ´¹ï¬Oªø´Á¦³Ãzµo©Ê¦¨ªø¡A¦Ó¥B¤j³¡¤À¤H¨S¦³¬Ý¨ì°Ó¾÷©Î¬O§Y¨Ï¬Ý¨ì¤]¤£´±¶i¤J¡A¤¨³Õ¤h´N¬O¦b³o¼Ëªºª^³ò¤U¡A·m±o¥ý¾÷¡AÀò±oÂ׫pªº³ø¹S¡A¥Í§Þ²£·~µ´¹ï¦³¥¦ªº§ë¸ê»ùÈ©M¼ç¤O¡A¤¨³Õ¤h¤~·|Ä@·N§ë¸ê¡A¦ý¤¨³Õ¤h¤]¦³ÃѤH¤§©ú¡A¥L¬Û«H±i³Õ¤h»â¾Éªº¹Î¶¤¡A¤]¤~Ä@·N¤U«ª÷§ë¸ê¡A³o½g³ø¾É¥i¥H¬Ý¥X¤¨³Õ¤h´X¤Q¦~¨Ó¦b¥ø·~§ë¸ê©M¥¬§½¤WÁ`¬O·m±o¥ý¾÷¡A ¤p§Ìªº¬Ýªk¬O1.¤¨³Õ¤h¬Ý¥X¯E¹©ªº»ùȤ£¶È©ó¦¹ 2.¤¨³Õ¤h»{¬°±i³Õ¤hªº±a»â¤U¡A¯E¹©¦³«Ü¤jªº¾÷·|¦¨¬°°ê»Ú¯Åªº¥Í§Þ¥ø·~ ==>>>²{¦b¯E¹©ªº»ù®æ¬O»·§C©ó»ùȪº¡A¤¨³Õ¤h¤~«ùÄò¶R¶i¡A¦pªG¯E¹©¤£È²{¦bªº»ù®æ¡A½æ³£¨Ó¤£¤Î¤F¡A¦óªp¥[½X¡A¦Ó¥BÃöÁä¬O¤¨³Õ¤hı±o²{¦b¬O¶Rªº®É¾÷¡A¦]¬°¥¼¨Ó¥i¯à¦s¦b§Ú̦³¥i¯à¹ê²{¡A¦ý§ë¸ê¤H³£¤£ª¾¹Dªº§Q¦h¡A©Ò¥H¶X®ø®§ÁÙ¨SÃn¥ú«e¡A«ùÄòªº¶R¶i¡A ¤¨³Õ¤h·Q§âÄw½X«ùÄò¶R¦^¡A¨S¦³¤Ó¦h½ÆÂøªº²z¥Ñ¡A¯Âºé´N¬O¯E¹©ªº»ùȤ£¶È©ó¦¹¡A©Ò¥H¤¨¸³·Q¦¬¦^Äw½X¡A¦¬¦^³Q§C¦ôªºÄw½X¡AÅý¯E¹©¦¨¬°¼í®õ¶°¹Î¥¼¨Óªºª÷Âû¥À ¤U¦C³ø¾É¨Ó¦Û©ó°Ó·~¶g¥Z¡A¥i¥H¬Ý¥X¤¨³Õ¤hªº§ë¸ê²´¥ú ¹ï§ë¸ê¡A¤¨l¼Ùªº§PÂ_¡AÁ`¬O¤ñ§O¤H§Ö¤@¨B¡AÅý¥L®³¹L¦h¶µ²Ä¤@¡C Âà§ë¸ê¡A¥Ln·m²Ä¤@¡@´£«e¥d¦ì¯S³\¦æ·~¡A³B¤ÀÀò§QÅå¤H ¤@¤E¤K¤»¦~¡A¶}©ñ¥~°Ó«OÀI¤½¥q³]¥ß¡A¤¨l¼Ù§ë¸êªº¦w®õ¤H¹Ø®³¨ì²Ä¤@±i°õ·Ó¡F¦P¦~¡A§ë¸ê¥úµØ§ë«H¡A¦¨¬°¥xÆW²Ä¤@§å§ë«H¤½¥q¡F¤G¡³¡³¤»¦~¡A¼í®õ¦b¤j³°Âà§ë¸êªºÂרKÀç³y¡A«h®³¨ì¥xÆWº±i¤j³°Àç³y¼t°õ·Ó¡C ¤K¡³¦~¥N¤¤´Á¡A¨³³t¤Á¤J¥xÆWªºª÷¿Ä¡B«OÀI¡BÃҨ饫³õ¡A¸g¹L¤Q¦h¦~ªº¸gÀç¡A¤G¡³¡³¡³¦~¶}©l¡A¤¨l¼Ù¥ý½æ±¼¥úµØ§ë«H¡A¹j¦~§â¦w®õ¤H¹ØÀò§Q¤Fµ²¡A¨â¶µ§ë¸êÅý¥LÓ¤H©M¼í®õ¶°¹Î¤jÁȶW¹L·s¥x¹ô¤@¦Ê¤»¤Q»õ¤¸¡C¤£¶È¦p¦¹¡A³B¤À±¼¥úµØ§ë«HªÑÅv«á¡A¤G¡³¡³¤T¦~¡A¤¨l¼Ù¤S§â´_µØ§ë«HªÑÅv¤]½æ±¼¡A¦A«×Àò§Q¤Q¤C»õ¤K¤d¸U¤¸¡C ¤E¡³¦~¥N¡A¼í®õ¶}©l¤jÁ|¶i§ðª«¬y¶q³c²£·~¡A¦Ó¥B¬O¦b®ü®l¨â©¤¦P¨B¤jÁ|ÂX±i¡C¤G¡³¡³¡³©³¡A¬°¤F¥[³t¦b¤¤°êªºÂX±i¡A¤¨l¼Ù±N¥xÆW¤j¼íµo¤»¤C¢HªÑÅv¡A¥H¨CªÑ¤C¤Q¤»¡D¤E¤¸°ª»ù½æµ¹ªk°Ó¼Ú©|¶°¹Î¡AÀò§Q·s¥x¹ô¤K¤Q»õ¤¸¡C³s¦P«ez³B¤À«OÀI¡BÃÒ¨é·~ªºÀò§Q¡A¤G¤Q¦~¶¡¡A¤¨l¼Ùªº§ë¸êÀò§Q¶W¹L¤G¦Ê¤¤Q»õ¤¸¡C §ë¸êÀò§Q¦p¦¹Åå¤H¡A´¿¸g¾á¥ô¥úµØ§ë«H°òª÷¸g²z¤H¡B²{¬°JF¸ê²£ºÞ²z¶°¹Î¨È¤Ó°Ï°õ¦æªøªº³\¥ß¼y¦^¾Ð¡A¤K¡³¦~¥N¦b¼í®õ¶°¹Î¤u§@®É¡A¤¨¦ÑÁ󴿸gn¥]¬A¥L¦b¤ºªº¹õ¹±¬ã¨s¡A§ä¥X¡u²{¦æªk¥O¨S¦³©ú¤å¸T¤î¡A¦ý¬F©²«oÁÙ¥¼¶}©ñªº¦æ·~¡v¡Cµ²ªG¡A§ä¥X§ë«H¡B«OÀI¡B¥Ò¯ÅÀç³y¼tµ¥¶µ¥Ø¡A±µ¤U¨Ó¡A¼í®õ¶°¹Î¶É¥þ¤O¦V¬F©²ª§¨ú¡B§ë¸ê³o¨Ç¦æ·~¡A¥Ñ©ó³£¬O¯S³\¦æ·~¡AÀò§Q¦ÛµMÅå¤H¡C ´¿¥ô¼í®õÅU°Ý¡B»P¤¨l¼Ù»á¦³¨p¥æªº¹F¤@¼s§i¸³¨Æªø®}¤@»ï«h»{¬°¡A¹L¥h¤G¤Q¦~¡A¤¨l¼Ùªº§ë¸ê´X¥GµL©¹¤£§Q¡AÃöÁä¦b¥LÀ´±o§ë¸ê¤H¯ß¡C ¤¨l¼Ù¦Û¤v«h¦³¤£¦Pªº¬Ýªk¡C¥L»{¬°¡A¤K¡³¦~¥N¥H«e¡A¥xÆW¸gÀÙ´X¥G¬O¸òµÛ¤é¥»ªºy¸ñµo®i¡C¡u¥|¤Q·³¥H«e¡A§Ú¥h¤é¥»¤W¦Ê¦¸¡C¡v¨C¦¸¥h°£¤F«ô³X¥ø·~¬É¡AÁÙ·|§ä¸gÀپǮa½Ð±Ð¡A¡u¥un¬O¤é¥»¥i¥H°µªº¦æ·~¡A¨º®É¥xÆW³£¦³«Ü°ªÉÃè²v¡C¡v°Ñ¦Ò¤é¥»¸gÅç¡AÅý¥L¨M©w§ë¸ê»È¦æ¡BÃÒ¨é©M«OÀI¨Æ·~¡C ¤¨l¼Ùµo²{¡A¥þ²y¨Ñ»Ý¥X²{·¥¤jÂàÅÜ¡C¡u¤E¡³¦~¾¥¦èô¹ï¬ü°êªº¥X¤f¥u¦³¤T¤Q»õ¬ü¤¸¡A¨ì¤G¡³¡³¡³¦~¤w¸g¹F¤@¤d¤G¦Ê»õ¬ü¤¸¥H¤W¡C¡v®ø¶O¥«³õ¤H¤fÅܰʤ£¤j¡A»s³y°Ó«o¦]¬°¤¤°êµ¥¥@¬É¤u¼t¥[¤J¡A³y¦¨¨Ñ»Ý¥¢¿Å¡C ÀHµÛ¶R¤è¥«³õ®É¥N¨ÓÁ{¡A¼í®õ¨M©w©ñ±ó»s³y·~¡A¤@¤E¤E¤C¦~¶}©l¤jÁ|¶ix¬y³q·~¡A¦]¬°³o¬O¾ãӥͲ£¥æ©ö¨ÑÀ³Ã쪺¡u³Ì«á¤@ù¡v¡A¡u½Ö¯à±±¨î¡A½Ö´N¬O¤ý¡C¡v¤¨l¼Ù±o·Nªº»¡µÛ¡C ¦Ü©ó¥¼¨Ó¤Q¦~¡A¥L¤jÁxÂ_¨¥¡G¡u¤G¡³¤@¤¦~¥H«á¡A½æÂæªoªº·|¤ñ½æ´¹¤ùªº¦n¡C¡v ¬Ý¥¼¨Ó¡A¥L©ñ²´¤¤°ê¡@¦b¹ï©¤¿ì¾Ç¡A°ö¾i¤H¤~¡B«Ø¥ß¤H¯ß ¦]¬°·í¤¤°ê©M¦L«×³£´I°_¨Ó®É¡A¤j¶q¤H¤f¹ï¹«~¡B¤×¨ä¬OÀu½è¹«~ªº»Ý¨D¡A¶Õ¥²¤j´T¦¨ªø¡C¡u½Ö¯à¦³®Ä§â¦nªF¦è°e¨ì¥L̼L¸Ì¡A½Ö´N·|ÁÈ¿ú¡I¡v¾¨ºÞ¥Í§Þ·~§ë¸ê·ÀI°ª¡A¤¨l¼Ùªñ¦~«o¿n·¥§ë¤J¡A¤£¶È¦p¦¹¡A¥LÁ٬ݦnÂåÀø©M«Ø§÷²£·~¡A»{¬°³o¨Ç¬O¥¼¨Ó³Ìȱo§ë¸êªº´X¤j²£·~¡C ³o¤T¤j²£·~¤£¥u¦b¥xÆW§ë¸ê¡A¤j³°ªºµo®iªÅ¶¡§ó¤j¡C¬°¤F°ö¾i³o¨Ç¥¼¨Óªº©ú¬P²£·~¡C¦b¤j³°¡A¤¨l¼Ù«ùÄò³z¹L§ë¸ê±Ð¨|¶}©l°ö¾i¤H¤~¡B«Ø¥ß¤H¯ß¡C ±q¤@¤E¤E¥|¦~¡A®½Äm¤@¤d¸U¬ü¤¸¦b¥_¤j¦¨¥ß¡u¥úµØºÞ²z¾Ç°|¡v¶}©l¡A¤¨l¼Ù³°Äò¦b¤W®ü¥æ³q¤j¾Ç³]¥ß¡u¦w®õºÞ²z¾Ç°|¡v¡B´_¥¹¤j¾Ç³]¥ß¡u¤Ó¥¬vª÷¿ÄºÞ²z |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/12 ¤U¤È 10:38:44²Ä 1261 ½g¦^À³
|
¦U¦ì¤j¤j ¯Âºé°²³]¡A¤£¾å±o¦³¨S¦³³oºØ¥i¯à?¦pªG¦³¡A¨º¾÷²v¤S¸Ó¦³¦h¤Ö? (¤º¤å¦³ºî¦X¤F´X¦ì¤j¤jªº¬Ýªk¡A¦p¦³±o¸o¤§³B½Ð®ü²[¡AÁÂÁÂ) ¤w¸g¯à¹w´ú¨ì¸Ñª¼À³¸Ó·|¹LÃö¡A¨Ã¥i¥H¶¶§Q¨ú±oTFDAÃÄÃÒ¡A ¦ý¼ÆȨèS¦³¦n¨ì¥O¤j®aÅåÆv»P¨ì¥@¬É¤j½æªºµ{«×¡A ¥[¤WÃÄÃÒ¨ú±oªº®É¶¡ÁÙ±o2¦~¥ª¥k¡C ¸U¤@¦b³o1~3¦~¶¡¤S³°Äò¦³§ó¨Îªº§K¬ÌÀøªk·sÃÄ¥X²{¡A¥B¥¿¦¡¤W¥«¡A Àø®Ä¬Æ¦Ü©ó¬O822ªº´X¿¦³®Ä¡A°Æ§@¥Î§ó§C(©ÎªÌ°ª¤@¨Ç¤]µL©Ò¿×)¡A ªø§À¼Æ§ó°ª¡A¾A¥Î¸s¸¨§ó¼s¡A¨º............. ²¦³º³o¶ô¤j»æ¬O©Ò¦³°ê»ÚÃļtÁ»¿Ì! ´Nºâ¦¹ÃĹï©ó¼Ú¬ü¤H¨tÀø®Ä¤j¹LªF¤è¤H¨t¡A ³Ì¤jªº¥«³õÁÙ¬O¦b§O¤H¤â¤W¡A¥R¨ä¶q822¥u¯à³ÜÂI¦×´ö¡C °ò©ó¤Wzì¦]¡A822§Y«K¸Ñª¼¹LÃö¡A¥i¯àªÑ»ù¿E±¡¤£¤j¡A §Y«K¦³¡A¤]¬O§CªÅá渡A¬Æ¦Ü´X¤Ñ«á½æÀ£·|¶}¨Ï´é²{¡A ³Ì²×¦]¬°µu´Á¤º¥¢±æ©Ê½æÀ£¦A¦¸º©©µ¨ì©Ò¦³¥Í§Þ±Ú¸s¡C ¤£¦Pªº¬O¡AÂûÀn¸VÃþªº¬y·P¦pªG¦A¨Ó¤@¦¸¡A¥i¯à´N·|¯uªº¶Ëµ¬°Ê°©¡A¶Ë¨ì°ê¥»! ©Ò¥H¡A§Ú¬O¤½¥q¬£¤jªÑªF¡A°®¯Ü¨ÓÓ¤Q±®I¥ñ¡A ´N·í¶¶«KÀ°¦Û¤v¦h¶RÓ«OÀI¡A§A¬Ý........ºCºCªº¦¬Äw½X¦h¦n¡A 1/ÁȦWÁnÝÁÈ«H¥Î¡A¥H«á¸ô§óªø 2/¥§¡¶i»ù¡A´î¤Ö·ÀI 3/¸U¤@ªÑ»ù¸¤Ñ¡A¤£·|³Q»¡ª£§@¡A¤]¬dµL¥i¬d 4/¸U¤@¹J¨ì¨t²Î©Ê·ÀI¡A¦]¬°ªø´Á¤w¦¬¦^«Ü¦hÄw½X¡A ¦b¥~¬y³q¦³¡A¤£·|¹³ÂûÀn¤@¼Ë¡A¶Ë¨ì¦Û¤v¸ò¶°¹Î©Ò¦³ªºªÑ²¼¡A (¦]¬°¼íX¶°¹Î¸ò¤ªX¬O§¹¥þ¤£¦b¤@ÓÀɦ¸¡A©Ò¥H±±ºÞ¤£¦n¡A¶Ë®`·|¤j¦n´X¿) ´Nºâ¶^°±¡A¤j·§¬O«Ü®e©ö´N¥i¥H³Q±±¨î¦bªÑªF¸s¯à®e§Ô½d³ò¡C 5/¸U¤@²Ä4ÂI¯uµo¥Í¡A¦A§Q¥Î¥´¶}¶^°±¡A¤j¶q¦¬¶i¦Û®aªÑ²¼¡A ¥i¥Hªí¥Ü¤½¥qt³d¡A¤]¶¶¹D¤j´T§â«e±¦¬ªº¦¨¥»§¡»ù¡A¤@¦¸©Ê¥´¨ì³Ì§C¡C 6/¤£ºÞÁȨì¦W©Î§Q¡A³£¥iÂÇ¥Ñ822¥h¶}©Ý¥«³õ³q¸ô¸ò°ö¾i¦æ¾PÅé¨tªº§§¤j¡A §_«hÁn¦W¯TÂÇ.......Àð˲³¤H±À³£¨Ó¤£¤Î¡A½Ö²z§AªºW°Jªü¡A ²¦³º°Ó³õ¤W¡AÀA¤W²Kªáªº¦h¡A³·¤¤°e¬´ªº¨S¦³~~~~ «á±ÁÙ¦³833µ¥¦h¾Ô½u¡A®ÄªG·|§ó¦n¡A ¤F¤£°_¦Aµ¥´X¦~¡A¥un¹L³oÃö¡AÁÙ¬O¤@¼Ë¥i¥H"¤é¥XªF¤è¡A±©§Ú¤£±Ñ"! ¦Ü©ó¤U¤@¦¸¡A¦A»¡§a¡I |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/12 ¤U¤È 07:11:46²Ä 1260 ½g¦^À³
|
°ß±©¤j¡K ¡i¬O¡I¡I¡I¡j |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/12 ¤U¤È 05:30:18²Ä 1259 ½g¦^À³
|
¤p³ì¤j¡A ±aÀY¤jôÁÙ¦AÄ~Äò¶R100±i¡A¦³§O©ó¥H©¹¥ô¦ó¤@®a¤½¥qÅ@½L©ÎªÌ®wÂêѪº°µªk ¦pªG¦p³ø¯È¤W»¡ªº¥LnÅ@½Lªº¸ÜÀ³¸Ó¬O¶^ªº®ÉÔ¦A¥X¤â¡A¤£¥²º¦ªº®ÉÔ·Ó±`¶R®ö¶O¤l¼u ¨Ò¦p¤W¤@ªi±q296¤@¸ô¶R¨ì340... §Ú·Q½T¹ê¬O¦³¨ä¥L§ÚÌ©|¥¼©úÁAªº¦]¯À¦b¸Ì±¡Aºî¦X¦U¦ì¤j¤j©Ò»¡ªº¡A¥[¤W§ÚÀH«K²qªº 1.ªø´Á§ë¸ê¡A¯E¹©¬O¤£¿ù¼Ðªºª« 2.¦¬ÁÊ«á½æµ¹µ¦²¤Áp·ù¹Ù¦ñ¡A¨Ò¦px¶®? 3.¼íx¥þ»P¯E¹©ª½±µ¦X§@?¨Ò¦p822¥´¤J¤¤°ê°µ·Ç³Æ? 4.¯uªº¦bÅ@½L¡A¦]¬°¯E¹©û¤uÁÙ¬On320»{ªÑ¡A·d¤£¦n³£É¿ú¶R¡A¶^¤U¨Óû¤uÀ£¤O«Ü¤j Á`¤§¡A1~3¾÷²v¬O¤ñ¸û¤j¡A©Ò¥H§Ú¬O«D±`¬Ý¦n¸Ñª¼¼Æ¾ÚÀ³¸Ó¤£·|¤p©ó18~~ 4ªº¸Ü¤w¸g¶R4000¦h±i¡Aû¤u¤]¤~»{3000±i¡A¤£²Å¤ñ¨Òì«h Ó¤H¬Ýªk~~ |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/12 ¤U¤È 05:07:27²Ä 1258 ½g¦^À³
|
§Ú¦b·Q¡A¬O§_¦³¨ä¥¦·Qªkªº¤H¡A¦ý»¡¥X©È³Q³ò¶Ï¡A©Ò¥Hµo¨¥°¾¤¤¥¿±¡A ¬Æ¦Ü©ó§Úı±o«¼C¥S¦n¹³¨S»¡¥X¯u¥¿·Qªk! ·Pı........¹ïÁÙ¬O¿ù©O¡H |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/12 ¤U¤È 04:17:36²Ä 1257 ½g¦^À³
|
ªGµM¦b©P¤j·þ¨Ãä¤[¤F¡A³£Ñ³Æ¾Ô²¤²´¥ú! ¥t¡A¤¤¹D¤j¡A½Ð°Ý¬O¬G¨Æ¥D¨¤¬O±zªº?¥[ªo~ |
|
|
·|û¡G¤p³ì10135960 µoªí®É¶¡:2015/6/12 ¤U¤È 04:01:28²Ä 1256 ½g¦^À³
|
¦U¦ì¤j ¤µ¤Ñ¼íX¤S¶R¤@¦Ê±i,§Ú©¿µM¦³Ó·Pı,¼íX¶R³o»ò¦h¯EX°£¤F¬Ý¦n¤§¥~,À³¸Ó¬On®³¨Ó°µªø´Á§ë¸êªº ¦]¬°¥¦ªº¥DnÂà§ë¸ê¨Æ·~°ªøʦ¨ªø°Ê¯à¤wÁͽw,¤S¤¨¦ÑÁó¹ï¥Í§Þ²£·~§ß´Ó¤£¿ò¾l¤O,·Q¨Ó·Q¥h¦³¥i¯à¬O§@¬°¥¼¨Ó ¼íXªºÀò§Q¤ÞÀº¤§¤@.¦p¦P¥¦·íªì¥Î°ªøʤÁ¤J¤¤°ê¤@¼Ë,n¸g¹Lªø¤[¯Ñ¯Ð¤~·|¶}ªáµ²ªG,¥u¬O¯EX¤]³\·|§Ö¤@¨Ç, ¥H¤WÓ¤H¤p¤p¬Ýªk |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/12 ¤U¤È 02:36:08²Ä 1255 ½g¦^À³
|
«¼C¤j¡A¤p©_¤j¡AÅó±ø±ø¤j¡A¤p³ì¤j¡A²q·Q¤j¡A¤¤¹D¤j¡A¯EÃvµLÃä¤j¡AFaith¤j¡A Chen¤j¡A°e³ø¤j¡AQQ¤j ¥ý¦b¦¹ÁÂÁ±z̪º«ü±Ð»P¸gÅç¤À¨É¡A (¦p¦³º|¦CªÌ¡A½Ð¨£½Ì¡A³ÌªñºCºCµo²{¦Û¤v¸£ªº¬ÛÃö¯à¤O¶V¨Ó¶V®t) ±q¦¤W¨ì²{¦b¡A³°Äò±N¤j®a·Qªí¹F¡A¸ò§t»W¤ºÀıªº·N«ä¤j¬ù³£·Q²M·¡¡A ¦A¨Ó¡A¬ù²¤¾å±o¤â¤W´¤¦³ªº¨ä¥¦¸ê²£¸Ó«ç»ò¥h¤À°t¡C ¨ä¹ê§ë¸ê¯E¹©¡Aºâ¬OÓ¤H¦³¥v¥H¨Ó³Ì¤jª÷ÃB¤]¬O³Ì¤jÁxªº¤@¦¸¡A ³s¤@¦V±q¤£¤z¹w©M¹L°Ý§ë¸êªº¦Ñ±C¡A³£¦³ÂI¤ß¥Í¤£º¡¡A©È©ã¹L¤j! ¤£©Ç¤º¤H¡A¦]¬°¦b¥¼¹ê²{«e¡A¦oªº¬Ýªk¤]¨S¿ù¡A §ó¦óªp¦o¤£¬O¤£ÃÙ¦P¡A¬é¬O¤£§Æ±æ§Ú§ë¤Ó¦h¡C ±q¤G¤Q¦h¦~«eÁÈ¿ú¨ì²{¦b¡A¤@ª½«Ü§V¤Oªº°µ¤T¥ó¨Æ¡A ¤u§@¡A§ë¸ê¡A®½´Úµ¹¨àºÖ ªÀ·|¤W¦³¤Ó¦h¯u¥¿»ÝnÀ°§Uªº¤H¡A¤×¨ä¬O«Ü¦hªº§x¹Ò©Î¶Ë®`²£¥Í§¡«D¤p«Ä¥i¥H¨M©w¡A ¥Ḻ`±`¬O³Q¢±µ¨üªº¤@¤è¡C §ë¸ê¯E¹©°£¸Ó¦³ªº°ò¥»±¥~¡A«Ü¤jì¦]¬O¦]¬°¥LÌ´¿³\¿Õ¡A ¦pªG·sÃĦ¨¥\¡A¤½¥q·|¼·¥X³¡¤À¤ñ¨Òª÷ÃB¡A¨ó§U¦¬¤J³h§xªº±wªÌ¡A¦^õXªÀ·|¡C §Ú«Ü§Æ±æ¤½¥q¯u¯à~ ¤¯·R¤§¤ß¼s³Õ¤Ñ¤U¡A ¤Ñ¤H¤§¤~µL¥iÁô¨S¡A «j¤H¦Û«j¡A¬G¹F¤H¤§¹D¡A ÂE¹Ï¤j®i¡AÄPµ{¸U¨½! ¸g¦U¦ì¤j¤j»P¤º¤H¶}¥ú«á¡A¥un½T©w¨S¦³¤£¨}¦]¯ÀÁôÂè䤺¡A ÀÀÁÙ¬O·Ó¤¨³Õ¬J¦³¼Ò¦¡¡A ¶}©l°Ê¥Î"°ê¦w°òª÷"³v¨B¥[½X¡AÅý¦Û¤v¦w¥þ¡A¤]¨Ï®a¤H¦w¤ß¡C ¦A¦¸ÁÂÁÂÄ_¶Qªº·N¨£! |
|
|
·|û¡G¹ÇÅó±ø10135894 µoªí®É¶¡:2015/6/12 ¤U¤È 02:13:11²Ä 1254 ½g¦^À³
|
¤¤¹D¤j¡A ·PÁ¤À¨É·P¤Hªº¤p¬G¨Æ¡A³\¦h°Ñ¥[Á{§É¸ÕÅ窺±wªÌ³£¬O¦b"¨«§ëµL¸ô¤U¡A¤£±o¤£ªº¿ï¾Ü" ¦³2/3¾÷·|·|¥´¨ì¹êÅç²Õ¡A¦ý¦b¤@¤Á³£ÁÙ¤£²M·¡ªºª¬ªp¤U¡A®Ú¥»µL±q±oª¾ÃĮĦp¦ó¡A¥u¯à¨«¤@¨Bºâ¤@¨B §Ú»{ÃѤ@ÓªB¤Í¡A¨ìÂå°|®É¤w¸g¨ÅÀù¤T´Á¡A©¯¦n¬OHer2+, ¤@Ó¤ëªá¤Fªñ¤Q¸U¥x¹ô¦Û¶O¥´Herceptin ¦]¬°°·«Oµ¹¥I±ø¥ó...µ¥½ÆÂø°ÝÃD¡Aµ²ªG¥Ø«e¨â¦~¹L¥h¤F¡ANED¤¤~~ §Æ±æ¯à°÷¥Ã»·NED,¦]¬°¤H¥Í¥|¤Q¤~¶}©l.... ¦P¼Ëªº822¦pªG¤]¯à°÷¤W¥«±Ï¤HµL¼Æ¡A¤½¥q»PªÑªFnÁÈ¿ú³o¬O²z©Ò·íµMªº¡A ¦ý¹ï±wªÌ¥Í¬¡«~½è»P®a®x»ùÈ«o»·«Dª÷¿ú¥i¥H¿Å¶qªº¡A¤~¬O²³©Ò´Á¬ßÂùĹªº³Ì¨Îµ²§½ |
|
|
·|û¡G¤p³ì10135960 µoªí®É¶¡:2015/6/12 ¤U¤È 01:35:48²Ä 1253 ½g¦^À³
|
¬üªÑ¥Í§Þ¼ö¡I·s¤½¥q¦¨¥ß¤£¨¬1¦~µLÀò§Q IPOº¤éªÑ»ù¤Wº¦99% ¬üªÑ¥Í§Þ¼ö¼é¥¼¨£°h¿N¡AÃĪ«¶}µo¤½¥q Axovant Sciences (AXON-US) ©P¥| (11¤é) ¥H 15 ¬ü¤¸»ù®æ¡A¦b¯Ã¬ùÃÒ¥æ©Ò IPO¡A¦b¤½¥qÁÙ¨S¦³¥ô¦óÀò§Q¼Æ¦r¤§¤U¡A¦¬½L´Nötº¦¨ì 29.9 ¬ü¤¸¡Aº¦´T°ª¹F 99%¡AªÑ»ù³Ì°ªÁÙ¹F¨ì 31.17 ¬ü¤¸¡C ¡m¯Ã¬ù®É³ø¡n³ø¾É¡AAxovant Âǵۦ¹¦¸ IPO ¨ú±o 31.5 »õ¬ü¤¸¡A§¹¥þ¶W¹L¤½¥q¹w´Á¡C¨Æ¹ê¤W¡A¤µ¦~¬ü°ê¥Í§ÞªÑ¦h®a¤½¥q IPO ¡AªÑ»ù³£¤j´TÃk¤É¡A¥]¬A Aduro Biotech Inc. ¤]¦b¤W¥«²Ä 1 ¤ÑªÑ»ù´N½¿¡A¶Ò±o¸êª÷ 1.19 »õ¬ü¤¸¡CBluePrint Medicines Corp. «h¬O±q 4 ¤ë©³ IPO ¤§«á¡AªÑ»ù±jº¦¤F 80%¡C Axovant ¥Dn¬O¶}µoªü¯÷®üÀq¯gÃĪ«¡A¨Ã¥H 15 ¬ü¤¸q»ù¡AÂX¤jµo¦æ 2100 ¸UªÑ¡A¹F¨ì¤½¥q IPO ³Ì°ª¥Ø¼Ð¡A¨Ã¦¨¬°¾ú¨Ó³Ì¤jªº¥Í§Þ IPO ®×¡C¤½¥qpµe±N¶Ò±o´Ú¶µ¥Î©ó¤½¥q¬ãµo»P¤@¯ë¥ø·~¥Î³~¡C Axovant ¦b¥h¦~ 12 ¤ë¡A¤½¥q¦¨¥ß¤£¨ì 2 Ó¤ë®É¡A¥H 500 ¸U¬ü¤¸ªº«e´Á¶O¥Î¡A¶R¤U¸¯Äõ¯À¥v§J (GlaxoSmithKline PLC) ¥Î©óªvÀøªü¯÷®üÀq¯gªºÃĪ«¡C®Ú¾Ú 2 ´Á¬ã¨sÅã¥Ü¡AÃĪ«ÁöµM¥i´î»´¯gª¬¡A¦ýµLªk¹ê½è§ïÅܯfµ{¡C³o¦¨¬°¤½¥q³Ì«nªºÔ¿ïÃĪ«¡AºÙ¬° RVT-101¡A¤½¥q·Ç³Æ¶}©l«á´Á¶¥¬qªº¸ÕÅç¡C ·sÃĪ«Y¯à¦b¬ü°êÀò³q¹L¡A¸¯Äõ¯À¥v§J±N¥i¦AÀò´Ú 3500 ¸U¬ü¤¸¡A¦pªGÃĪ«¦~¾P°âÃB¨Ó¨ì 12 »õ¬ü¤¸¡A¸¯Äõ¯À¥v§J¥i¦A¨ú±o 8500 ¸U¬ü¤¸¡C¬Û¸û©P¥|¦¬½L«á¡AAxovant ¦ôȤw¨Ó¨ì 22 »õ¬ü¤¸¡A³oµ§¥æ©ö¥Ø«e¬Ý¨Ó¬Û·í¦Eºâ¡C ³o®a·s IPO ªº Axovant¡A¤½¥q CEO Vivek Ramaswamy ¶È 29 ·³¡A¥h¦~¦C¦W Forbes ¡uunder 30¡v³Ì¨Î 30¤H¡C¥L¥ý«e¬O QVT Financial ªº¦X¹Ù¤H¡A©ó¥h¦~ 5 ¤ëÂ÷¶}¡A10 ¤ëµù¥U¦¨¥ß¤½¥q Roivant Sciences¡A¦Aª`¸ê³Ð«Ø¤l¤½¥q Axovant Sciences¡C³o¦¸¦¨¥\ IPO ¤§«á¡A¤½¥qªí¥Ü¡A¥L¦¨¬°¯Ã¬ùÃÒ¥æ©Ò¤W¥«¤½¥q²Ä 2 ¦~»´ªº CEO¡C ®Ú¾Ú Axovant ´£¥æ¤å¥óÅã¥Ü¡ARamaswamy ªº¥À¿ËGeetha ¤Î¥S§Ì Shankar §¡¬°¤½¥qû¤u¡C¤µ¦~ªì Vivek Ramaswamy µ¹ 19 ¦Wû¤uªÑ²¼¿ï¾ÜÅv¡A¥i»{ÁÊ 400 ¸UªÑ¡AGeetha ¤Î Shankar ¦@»{Áʬù 100 ¸UªÑ¡C |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/12 ¤U¤È 12:01:42²Ä 1252 ½g¦^À³
|
²q·Q¤j¤j¡G ¦A¤@¦¸ÁÂÁ±zªº¶O¤ß¡A±Àºâ¬O±z½ç¤©±M·~ª¾ÃѤ£¨¬ªº¦P¨Æ°Ñ¦Ò¬OªÑªFªººÖ®ð¡A¨º¨Óªº»~¸Ñ»P¸o¹L¡I·P®¦¡I |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/12 ¤W¤È 11:54:14²Ä 1251 ½g¦^À³
|
¤ý£«¬Â¤j¤j¡G ½Ð´À§Ú¯¬ºÖ¨ºÇ¦ìªB¤Í¤]½Ð¦oÌ¥[ªo¡K¡K¥i¥Hªº¸Ü±`§iª¾¤j®a¦o̦w¦n¡I ´À§Ú»¡Ó¬G¨Æµ¹¦oÌÅ¥¡K¡K¡i¯ø¡K¡K¡K¡K¨«¤F¡Aè°µ§¹¹ï¦~¤S¢°¢¯¤é¤F¡A°Ñ¥[Á{§É«á¹ï§Ṳ́@®a¤H¦Ó¨¥§Ï©»¦pÀò¦ÜÄ_·P®¦µÐÂÄ¡A·Pı¤H¥Í¤S¨£¨ìÀÆ¥ú¡K¡K¡K¨C¤é¬è«Ý¦o¨Å馳°Æ§@¥Îªº¤ÏÀ³¡K¡K¦ý¤@¤é¤é¹L¥h¤Fµ·²@µ¥¤£¨ì822/821ª`®g«áªº¤ÏÀ³¡K¡K¤ß¤¤¦³¼Æ¡K§¹¤F¡K¬O¤À¨ì¹ï·Ó²Õ¡K¡K¥þ®a¤H¢±«×¶Ë®`ªº§é¿i¬OÃø¥H§Î®e¡K¡K¢³¡A¢´Ó¤ëµ²§ô¤F¡K¡K§Ú¥u¯à»¡822ªº¦¨¥\¹ï§Ú¦Ó¨¥¬OÀH®É§Ñ¤£¤F¦o¡K¡K Âùª¼¨î«×¬O¥²n¦ý¹ï¹ï·Ó²ÕµL½×¬O±wªÌ©Î¬O®aÄݪº¢±«×¶Ë®`¡K¡Kü¡K¾ã¾ã¢³Ó¤ë±q¤Ñ°ó¨C¤é²M·¡ªº´Â¦V¦aº»¨««o¥²¶·¤@ª½¨«¡K¡K¡j³s°µ¹Ú³£·|¹Ú¨ì¦o¨Å馳°Æ§@¥Îªº¤ÏÀ³¡K´¤µÛ¦o¤@ª½¨nµÛ¦o¤âÁu¬Ý¡K¡K¸~¤F²×©ó¸~¤F¡K¡I ¯u¤ß¬èë¯E¹©¥[ªo¡A±i¸³¨Æªø¥[ªo¡IÅý§ó¦h¤H«¨£¤H¥Í¡A«·s¬¡°_¨Ó¡K¡K |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/6/12 ¤W¤È 11:47:02²Ä 1250 ½g¦^À³
|
Jolin¤j ³Ò±zÁ}Ãø¦a§â¼Æ¦r¹ï±o¾ã¾ã»ô»ô ¦Ó¥B¤º®e§óÃø¬Dç¤F¡A¤£¬O¦Ñ¹«·Q¬G·N¬Dç ¦Ñ¹«Ä±±o±zªº±À½×¥tÅPÁÑ®|¡A¤º®e¦Ò¼{¨ìNEDªº³]¡A¤]¦Ò¼{¨ì·s¦¬®×ªº³]¸ê®Æ ȱo¦n¦n¬DçÅý±zªº¨¯W"§¹¬ü§e²{" ¥xÁÞ¤j¦ó®É¦³ªÅ¤]¨Óµoªí°ª¨£¡H |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/6/12 ¤W¤È 11:42:30²Ä 1249 ½g¦^À³
|
¤p³ì¤j ¼í®õ¥þ ¤£ºòªº µuÉ+¤@¦~¤º¨ì´ÁªºªøÉ ³o³¡¤ÀÃöÁä¦b»È¦æn¤£n¦Aµ¹??(µª®×¦Û¤v·Q) §Ú¬O»{¬°¨S°ÝÃDªº ·íµM¥H²Ä¤@©u ³t°Ê¥h¤äÀ³ ¬O¤£°÷ªº ¼í®õ¥þ²Ä¤@©ut¶Å¦ûÁ`¸ê²£¬O27% t¶Å²v¤£°ªªº »È¦æ¤£Äò ¥h¨º°µ¥Í·N°Ú §ÚÁÙ»{¬°"¤½¥q¸ò»È¦æ»¡ §ÚnÉ¿ú°Ê§AÃB«× ´N¬On¶R¯E¹© »È¦æÁÙ·|«Ü°ª¿³ §A²×©ó¤Sn¥ÎÃB«×¤F ¶RÔ£ §A¦Û«K" |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/6/12 ¤W¤È 11:18:25²Ä 1248 ½g¦^À³
|
°ß°ß¤j ¤p§Ìªº·Qªk¦³¨âºØª©¥» ²Ä¤@ºØ:¤ñ¸û¥¿½Tª© ³æ¯Âªº§ë¸ê ¤p§Ì´¿¸g¾ú¹LªÑ»ù160~180¤§¶¡ ¨º®É,¦³³sÄò¦n¤@°}¤l,¤@¤Ñªº¶q¤£¨ì100±i,¦ý¨Ì¬Ý½Lªº¸gÅç,´Nª¾¹D¦³¤H¦b¶R ¥i¬O,ªÑ»ù´N¬O¦b³oÓ»ù¦ìªþªñ¤W¤U½L±Û,³o¼Ë...¬ù¥½6~7Ó¤ë µM«áª½½Ä287,·í®É¤p§Ì©|¥¼¶i¤J°Q½×ª©,©Ò¥H¤]¤£ª¾¹D¬O½Ö¶Rªº,¥uª¾¹D¦³¤HÀqÀq¦b¶R ²{¦b¦^ÀY¬Ý,¤~ª¾¹D¨º¤H«Ü¥i¯à(¯Âºé¤p§Ìªº²q´ú)¬O¤ô¨C¥ý¥Í,¦pªG·í®É¥L¥§¡¶R¦b200,´Nºâ½æªº¬O250,¦]¬°¶q¤j ¤]¤j¼´¤@µ§¤F ©Ò¥HY´N³æ¯Â¨Ó¬Ý,´N¬O§ë¸ê(¦A©¹²`¼h¤@ÂI·Q,¨º...¥LÌ¥´ºâ¦h¤Ö½æ???¨S¦³¤HÄ@·N°µÁ«¥»¥Í·N) ²Ä¤GºØ:¶È¨Ñ°Ñ¦Òª© ¦¬¶°ªÑÅv °e³ø¤j·Q¨ìªº¬O¬Y¤½¥q ¤p§Ì·Q¨ìªº¬O X¶® «¢«¢«¢,³o¹ê¦b¤Ó¨S®Ú¾Ú°Õ,¤j®a¬Ý¬Ý¯º¯º´N¦n ¸É¥R: 1.³oºØ¨Æ±¡°Ý±Û«a¤j©Î»¹«¤jÀ³¸Ó³Ì¦³¸gÅç 2.6¤ë¥÷ªºªÑªFµ²ºcªí¦¤w¥X¨Ó,¦³¿³½ìªº¦Û¤v¥h¬Ý¤@¤U 3.PD229 others37,¦]¬°²Îp¨ì5¤ë,©Ò¦³¤H¬Ò¤w¥Î§¹ÃÄ,©Ò¥H¤p§Ì²q´ú,n¦A¦³°h¥X¹êÅ窺¯f±w¤H¼ÆÀ³¸Ó¬O¤Ö¤§¤S¤Ö¤F ¥H¤W¯ÂÄÝÓ¤H·N´ú,¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¤p³ì10135960 µoªí®É¶¡:2015/6/12 ¤W¤È 11:06:50²Ä 1247 ½g¦^À³
|
¬Ý¤F¼í¥þªºBSªí,³t°Ê¸ê²£³¡¥÷¨ä¹ê¤£¤j,³o¤@°}¤lªá¤Fªñ¤Q»õ¶R¯EX,¥u¯à»¡¤½¥qÀ£«Ü¤j,¦]¬°¨C©uÁÙ»ÝÀvÁÙ´XEªºªø´ÁÉ´Ú |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/12 ¤W¤È 11:02:56²Ä 1246 ½g¦^À³
|
²q·Q¤j¡A ¤p§Ì¸ò±z°Q½×¤@¤U¬Q¤Ñªº¦ôªk¡A ¡y´N¥H5/25ªº¼Æ¾Ú¨Ó¤ÀªR¡@¦ý¥ÎÄYV«O¦uªº¼Ð·Ç¡@¥HCR/LR = 0.9¤ÀªR ¥ÎÃIJաG 233 ¹ï·Ó²Õ¡G 116 °²³]°h¥X¤H¼Æ ¨â²Õ1¡G2¤À°t ¥ÎÃÄ²Õ ¡G12 ¹ï·Ó²Õ¡G 25 ¹ï·Ó²Õ ¥u³Ñ¢´Ó¥¼PD ©Ò¥H ¹ï·Ó²Õ PD¼Æ = 116 ¡V 25 ¡V 5 = 86 CR/LR¥H0.9¤ÀªR Á`PD¼Æ = 229 * 0.9 = 206 ¦]¦¹¥ÎÃIJÕPD¼Æ = 206¡V86 = 120 ¥ÎÃIJթ|¥¼PD¼Æ = 233¡V12¡V120 = 101 ©Ò¥H¥ÎÃIJÕÁ`³]¸ê®Æ¼Æ = 101 + 12 = 113 ¯uªº«ÜÃø²q´ú ¾ãÓ¥ÎÃIJժº±Æ¦Cª¬ªp §ó¦]¬°¥ÎÄYVªº¼Ð·Ç ªí¥ÜÃĮĸû®t ¤´°²³]±Æ¦bÃöÁäA¤§«eªº³]¸ê®Æ¼Æ¤´¬°100Ó(ªí¥Üªø§À¼Æ¤£¦h) ¤]´N¬O»¡¬ù80¤H´c¤Æ ´N¥iºâ±o¤¤¦ìPFS ¥Î·§¦ôªk¦ôºâA¥i¯àµo¥ÍPD©¹«e²¾ªº¤ë¼Æ(¥i¯àÅ޿観¨Ç°ÝÃD) ¨C¤ë¥§¡´c¤Æ¼Æ = (229¡V187 )*0.9 /5 = 7.56 ©Ò¥H ( 120¡V80 ) / 7.56 ¬ù = 5Ó¤ë ¥Î«e¦ôªº19¥[´î2 ¦©°£ 5 Ó¤ë = 14¥[´î2¡z ¥ÎÃIJÕÁ`¦@¦¬233¤H¡A¨Ì·ÓÓ§O±wµÛªºPFS§C°ª¨Ó±Æ§Ç¡AÃöÁäA¤§«eªº³]¸ê®Æ¼Æ100Ó¥H¤ÎÃöÁäA¤§«eªºPD=80ӮɹF¨ì0.5ªº¤ô¥½u¡A³o´NÁô§tµÛ¡A´N¦b³o®ÉÔ·í°µÁ{§É¼Æ¾ÚºI¤î¤éªº¸Ñª¼®É¾÷¡AÃöÁäA¤§«á¦³233-180=53¦ìªø§Àªº±wªÌ¡A³o53¦ì±wªÌ¦³¥i¯àPD¡A¤]¥i¯à¥¼PD¡C ¨Ì·Ó±zªº¦ôºâ¡A¥ÎÃIJթ|¥¼PD¼Æ = 233¡V12¡V120 = 101¡AÃöÁäA¤§«eªº³]¸ê®Æ¼Æ100¦ì¤¤¡A¦³100-12=88¬O«D¤¤³~Â÷¶}ªº¯u¥¿ªº¥¼PD¼Æ¡A©Ò¥HÃöÁäA¤§«áªº¥¼PD ¼Æ=101-88=13¡A¤]´N¬O»¡¡AÃöÁäA¤§«áªºªø§ÀPD ¼Æ=53-13=40¡Aì¨Ó¦b5/25¥ÎÃIJÕPD¼Æ = 206¡V86 = 120¤¤¡A¦³40¦ìªø§ÀªºPD§e²{¦bùØÀY¡A³oªø§ÀªºPD¹ï0.5¤ô¥½u¥H¤Uªº¹Ï«¬¥H¤ÎpºâpȦ³Ãö¡A¦ý¤£¼vÅTM PFS¡A©Ò¥H¡y¥Î·§¦ôªk¦ôºâA¥i¯àµo¥ÍPD©¹«e²¾ªº¤ë¼Æ¡z³oÓpºâ¦¡¤¤¡A±z´N¤£¥Î©¹«e²¾°Ê5Ó¤ë¤F¡C «¢¡A¦³¨S¦³Ä±±o»´ÃP³\¦h¡I ¥t¥~ÃöÁäAªº°_©lÂI¡A¦³¤@Óì«h¡C¥H±zªº¨Ò¤l¬°¨Ò¡AÃöÁäA¤§«eªº³]¸ê®Æ¼Æ100¦ì¤¤¡A¦³100-12=88¬O«D¤¤³~Â÷¶}ªº¯u¥¿ªº¥¼PD¼Æ¡AÃöÁäAªº°_©lÂI¤ë¥÷¤§«á¦Ü¤Ön¦³88¦ì¥ÎÃIJժº¦¬®×±wªÌ¡CÁ|Ó¨Ò¡AY°²³]ÃöÁäAªº°_©lÂI¤ë¥÷¦b2013/12/31¡A¨º»ò2014ªº¥ÎÃIJզ¬®×±wªÌ¤j¬ù60¦ì¡A60¤p©ó88¡AÃöÁäAªº°_©lÂI¤ë¥÷Y³]¦b2013/12¡A³s88¦ì«D¤¤³~Â÷¶}ªº¯u¥¿ªº¥¼PD³]¸ê®Æ³£¤£°÷¡A«ç»ò¯àº¡¨¬¡u³]¸ê®Æ¼Æ100Ó¥H¤ÎÃöÁäA¤§«eªºPD=80ӮɹF¨ì0.5ªº¤ô¥½u¡v³oÓ±ø¥ó©O¡H¦]¦¹ÃöÁäAªº°_©lÂI¤ë¥÷¥²¶·¦A©¹«e±À¡A¦pªG¥ô¤@´Á¶¡ªº¥ÎÃIJդ¤³£¦³¤@©w¤ñ¨Òªº±wªÌµL®Ä¡A©ÎªÌ10%©ÎªÌ15%¡A¨º³o¨Ç±wªÌ¥²¶·ÂkÃþ¨ìÃöÁäA¤§«eªºPD=80¤H¤¤¡An¹F¨ì88¤H³]¸ê®ÆªºÃöÁäAªº°_©lÂI¤ë¥÷´NÁÙ¥i¥H¦A©¹«e±À1~2Ó¤ë¡C ¥H¤W¡A¨Ñ±z°Ñ¦Ò¡C |
|
|
·|û¡G¯EÃvµLÃä10140526 µoªí®É¶¡:2015/6/12 ¤W¤È 11:02:28²Ä 1245 ½g¦^À³
|
¤]²`ªí»{¦P¹ÇÅó±ø¤j©Ò»{¦P¤p©_¤jªº¡y¶R¨Ó©ñµÛ¡A¥H«á·|ÁÈ¿ú¡z" ¦³¨Ç®ÉÔµ¥«Ý´N¬O³Ì¦nªºµ¦²¤ |
|
|
·|û¡G¹ÇÅó±ø10135894 µoªí®É¶¡:2015/6/12 ¤W¤È 11:01:48²Ä 1244 ½g¦^À³
|
¤£¦n·N«ä¡A¥´¿ù¦r¡A¬O¤p©_¤j¤~¬O¡C ¥t¥~§Úµo²{¤½¥q¦bªÑªF·|®É±i¸³«æµÛ°¨¤W¼á²MPD 229,ªí¥Ü¤½¥qÀ³¸Ó¦³¤H¦b¬Ý¥²´Iºô°Q½×°Ï¤º®e §Ú·Q¦pªG¦³¤°»ò»Ýn¤½¥q§ï¶iªº·Qªk¡A¤½¥q·|¬Ý¨ìªº¡A¥u¬O·|¤£·|¦]À³´N¤£±o¦Óª¾¤F ¹³¬OPD/CR/LR...ªÑªF·|¸ÑÄÀ¤F¤@³¡¤À¡A¤£¨ì¤@¤p®É¤S¥^¥^¦£¦£»¡n¥l¶}¸³¨Æ·| ¨îªÑªFµo¨¥ªº®É¶¡»P¹LÂo°ÝÃD¡A³oÂI¨ä¹ê§Ú¤]¬O¦³ÂI¤p¤pªº©ê«è ¤£µM¤j®a¤]¥Î¤£µÛÁÙn¥Î¦UºØ°²³]"²q´ú"¥i¯àªºµ²ªG»P822 M PFS¹w¦ôȤF |
|
|
·|û¡G¹ÇÅó±ø10135894 µoªí®É¶¡:2015/6/12 ¤W¤È 10:32:00²Ä 1243 ½g¦^À³
|
²`ªí¦P·N¤p´Á¤j»¡ªº"´N¬O¡y¶R¨Ó©ñµÛ¡A¥H«á·|ÁÈ¿ú¡z" ÁöµMû¤u³£n»{ÁÊ320, ¤¨¦Ñ¤j¤]¥Î310¶R4200±i¡A ¦ýªÑ»ù¤U¶^¤¤´N¬O¨Æ¹ê¡A¯Q¾~¤jªº¦Ð¤ò¤]°{°{µo«G¡AÅkµM¶Â¦â±Ð¥D ¦n©_ªº¬O¨s³º¬O½Ö¦b½æ¡A¬°¦ó½æ? ²¦³º½æÀ£¤@ª½¦b¡A¨Ò¦p³Í°òªº¯«¯µ¤áÀY¡A¨g½æN¤Ñ¡A ½æ¦b³oÓ»ù¦ì¡A¨s³º¥Øªº¬°¤°»ò? ¦]¬°°£«D³o¨Ç¤H¤£½æ¤F¡A¤£µM¤¨¦Ñ¤j¤]·|±µ¨ì¤â³n ®a¸VªÑ¤w¸g³sÄò¤T¤Ñ©Ôº¦°±¤F¡A©Ç²§¨«ªkÅý¤H«Ü¶Ì²´¡A»¡¨S¦³¤H¦bªÑ¥«¸Ì±°Ê¤â¸}¡A«ÜÃøÅý¤H¬Û«H~~ ¤]³\¯E§b¤Ó¦Ñ¹ê¡A©Ò¥H¤~·Å·Å§]§]¡A¤£¹LºC¤u¥X²Ó¬¡¡A¤£¾å±o8¤ë·|¤£·|¦³§ó¦h¼Æ¦r¥X²{? ÁÙ¬O¦U¦ì¤j¤j¹Ú¹Ò³Ìªñ³£¤w¸g¯B²{¤F? §Ú³£ºÎ¤Ó¨I¡A¤@ª½¹Ú¤£¨ì»¡ |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/12 ¤W¤È 09:58:47²Ä 1242 ½g¦^À³
|
°ß±©¤j ¤p§Ìªº·Qªk«Ü²³æ ´N¬O¡y¶R¨Ó©ñµÛ¡A¥H«á·|ÁÈ¿ú¡z ·íµM¼í®õªº§ë¸ê¨Mµ¦¼h¥i¨S¦³¨º»ò¥Î¥\¦b°lÂܯE¹©ªº°ò¥»± ´N¤¨¦ÑÁ󪺤@¥y¸Ü¡A´N¶R¤F ·íµM¤¨¦ÑÁó¤@©wn°Ý±i¸³¤@¥y¸Ü ¡y³o»ù¦ì¥i¤£¥i¥H¶R¡z ±i¸³»¡¡A¡y¥i¥H¡z¡A´N¶R¤F ¨ä¥¦ªº¤°»òCR¡BLR¡A´N¥æµ¹±M®a´N¦æ¤F ¥t¥~ÁÙ¦³¤@Ó¦Ò¶q¡A û¤uªº²{¼W»{ÁÊ3000±i¡A¦¨¥»¦b320¤¸¤W¤U §OÅýû¤u¤W¯Z¤£¶}¤ß¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/12 ¤W¤È 08:39:18²Ä 1241 ½g¦^À³
|
°ß±©¤j ¦U¦ì¤j¤j ¤¨¦ÑÁó ²´¥ú»· §G§½²` ³ßÅw©ñªø½u³¨¤j³½ ±q¥_¤j¥úµØ¾Ç°| ®M°ª¼h¥æ±¡ ¤S³]¼ú¾Çª÷ ¥¾®Ú°ò¼h ³y´N¥L¤j¼íµo¦b¤¤°ê¤j³°ªºµo®i ³]ð¼ú ¥Í§Þ¼ú¹{µ¹ CCTLA-4 ¤Î PD-1ªºµo²{ªÌ µo´§K¬ÌÀøªk ©ñ²´°ê»Ú ¬°¨ä¥Í§Þ§ë¸ê¾Q¸ô ¥´ª¾¦W«× ³o¦¸§Q¥Î¼í®õ¥þªº¸êª÷ ¶R¶i¯E¹© Ó¤H·Pı ¼í®õ¥þÃþ¦ü±±ªÑ¤½¥qªº©Ê½è ¬°¬°ªÑªF³Ð³y¾÷·| ¥H§G§½¦¨¥÷©~¦h ¥L¥i¯àª¾¹D 822ªº¼Æ¾Ú¤£Y¥H©¹¹w´ÁªºÅåÆA(Ó¤H²q´ú «D¨Æ¹ê) ¦ý¥i¥Î¨ä§@¬°¦æ¾P½m§L «áÄòÁÙ¦³833¡N 858 ¡N868¡N 888µ¥·sÃÄ¥i´Á YÃĮĦp¹w´Á ©Î±N¦¨´N¨ä¥Í§ÞÅQ¥D ²{¦b¶R¤J ¥i¯à¤£µÛ²´©ó²´«e ¬Ýªº¬O¥¼¨Ó¤@¡N¤G¤Q¦~ªº¼ç¤O ²{¦bªº§G§½ Å@½L¬Oªþ±a®ÄÀ³ ¤SÅU¦WÁn ¤S¦wªÑªF¤ß ¤@Á|¦h±o ¥u¬O³oÓ§G§½ ·|©µÄò¦Ü¦ó®É ©¡®ÉªÑ»ù¦p¦ó¨« ©Î¥iÆ[¹î ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/12 ¤W¤È 05:59:12²Ä 1240 ½g¦^À³
|
£«¬Â¤j, «D±`·PÁ±zªº¸ê°T! ¤p§Ì¦A½Ð±Ð±z¤@ӺðÝ, "²{¦b©ñ¼e¦Ü¦Ê¤À¤§¤G¤Q¤", ¬O¤£¬O¥H«e¥Î"¤ñ¤W¦¸¤j10%©Î15%"´N§P©w¸~½F´c¤Æ? ·PÁ±z! ³Â·Ð±z! |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/12 ¤W¤È 02:15:08²Ä 1239 ½g¦^À³
|
°ß°ß¤j: ±z©Ò´£¤Îªº«¬ºA, n¬Ý¥L¦¬Äw½Xªº¥Ø¦a¦Ó·|¦³¤£¦Pªºµ¦²¤, ¨C®a¤½¥qªº±ø¥ó¤£¦P, ªÑ¥»¤£¤@, ¦b¥~¯BÃB³£¤£¦P., ©Ò¥H¦p¦ó¦¬Äw½X, ¦]À³¦Û¨¤Î¹ï¤èªº±ø¥ó³£·|¦³¦UºØª©¥». ¥u¯à»¡¥E¬Ý¬Û¦ü, ¹ê»Ú¤j¤£¦P. ¸êª÷¬y¥ç¦P. (®M¥Î¨ä¥L¤j¤jªº»¡ªk, ³o¬O¹Ú¤¤¯B²{ªº) ¯EX¤jªÑªFªº¤âªk, ¥H§Úªº²L¨£, »PÅ@½LµLÃö. ·Å·ÅºCºC©Î³\»PÁ`¸g¤j¶Õ¦³Ãö. ¦ý³o¨Ç³£¬OÁr´ú¤F. Ó¤¤¥È¾÷, ÀH®É¶¡¦ÛµM·|¤ô¸¨¥Û¥X. ¤j®a³£¦b¬Ý¶R¤è, §ÚˬO¹ï½æ¤è®¼¦n©_ªº. ½Ö¦³³o»ò¦hÄw½X«ùÄò¨ÑÀ³¥X¨Ó ? |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/12 ¤W¤È 12:01:20²Ä 1238 ½g¦^À³
|
°ß±©¤j¡G¨Ì§ÚÓ¤H¸gÅç¦b¥«³õ¥D¤O¥~³ò¡A¤½¥q¥~³ò¤£ºÞ¥Î¦óºØ¤è¦¡¨ä¹ê¥Øªº³£¤£ºÉ¬Û¦P¡A¨C®a¤½¥q¥i¥Îªº¾Þ§@¤âªk¤]¤£¦P¡A¦A¥[¤WªÑ»ù¦ì©ó°ª¦ì©ó§C°ò©ó¦¨¥»ªº°ÝÃDÁÙ¦³¥¼¨ÓÀç¹B¬O¥¿t±ªº¥ýª¾¡Kµ¥µ¥¡A©Ò¥H¯u¤]µLªk¥Î¤@ӧκA¨Ó½×z¡I ¦ýY¥H¯E¹©³æ¤@¦Ó½×¡A§ÚÓ¤H²q·Q¬O¦³¥i¯à¦³¤jªÑªFIPOÁ×µ|ÄÀ¥X¡A¦ý¤S¤£Ä@·NÄw½X¬y¸¨¦b¥~¡A¬Æ¦Ü¬G·N»s³y½æÀ£¶°¤¤¶R¤J¡Aµ¥©ó§Q¥Î®É¶¡¦h¦¬¦b¥~¯BÃB¡I¦ý¤W¥«¤½¥q¤@¯ë³£«Ü§Ò¿Ð¸¨©óª£§@©Ô©ïªÑ»ù¹H¤ÏÃÒ¥æªk¡A©Ò¥H±Ä¨úº¥¶i¦¡¡A¤½¶}¦¡©ó¤½¶}¥«³õ¤½¶}¶R¶iÁ׶}ª£§@ªº¶ûºÃ¡I ¨Æ¹ê¤Wªñ´Á¥H¼í®õ¥þ¶R¶iªº±i¼Æ¤Î¥H³Í°ò½æ¥Xªº±i¼Æ3000-1400=¦h¶W¦¬1600±i¡AµM¦Ó¯E¹©¦]¬°¸Ñª¼®É¶¡¥¼¨ì¡A©Ò¥H¤]¥u±Ä³{§C¶R¤J¥¿±`ªº§ë¸ê¤è¦¡¡A³oÀ³¸Ó¤]¬O¤@ºØÁ׶ûÁת£§@¶ûºÃªº¥¿·í¤è¦¡¡A¥¼¨Ó¯u¦³§Q¦h¨ä¹ê¬OµLªk¥H¤º½u¥æ©ö¥h½×z¡I ²q·Q¤j¡G³Ò±z¶O¤ß¤F¡IÁÂÁ±z¡I§Ú·Q¥ô¦ó¤½¥qªº¥¼¨Ó¡A¤@¤Áªº(®Ú)»P(¥»)³£¬OºÉ¦b¤½¥qªº¸gÀçªk«h¡I¯E¹©¤]¤£·|¨Ò¥~¡I ¸Û¦p¥xÁÞ¤j©Ò»¡ªº¡A§Ú¬Ý¦n¯E¹©°ß¤@ªº²z¥Ñ´N¬O¯Î°|ªøªºÁÞ¤À¤l§Þ³N»P±i¸³¨Æªø¸gÀ窺¸gÅç»P´¼¼z¡I |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/11 ¤U¤È 11:58:50²Ä 1237 ½g¦^À³
|
¦^Âа߰ߤj : ü~ ¤å¦r¦^ÂЫܺC¡A¥B¤£©P¸Ô¡C ¦³¾÷·|(¤U¦¸¯E¹©©Î¤¤¸ÎªÑªF·|)¡A±z¨Ó¥l¶° ¡§µØ¤s½×¼C¡¨ ¡A¥ÎÁ¿ªº¤ñ¸û§Ö°Õ ~ (1)Why ½Õ¬ã¾÷ºcº|±¼ OBI-822 ¡A§Ú©M±z¤@¼Ë¦n©_¤]¡C©Î³\¬O¥¦ªº¬ã¨s¼ÐÃD: ¡§§Y±Nµ²§ôÁ{§É¸ÕÅ窺¥þ²y«½SÃĪ«TOP 15¡¨ ¡A¦ÓOBI-822¨ú±oFDAÃĵý¡A ·|¦b2018¦~2H¤§«á¡A©Ò¥H¬ã½Õ¾÷ºc¨S¦³¬ã¨s¨ì§a ? ¶¶µÛ¦¹¸ÜÃD¡ACancerÃĪ«¡A·íµM¬O¤@¶ô«Ü¤jªº¥«³õ¡A¦ý¤]¦]¬°¦p¦¹¡AÄvª§ªÌ«D±`¦h¡A CancerÃĪ«¬ãµo¡A¦bÁ{§É¸ÕÅ礤ªº¡A§ÚÅ¥¨ì¤@Ó¶W«¶q¯Å¥Í§ÞCEO»¡5000Ó??? (§Ú¦ÕI?) ¦h¤H¦b¤ÞHerceptin PFSµ¥¡A¨ä¹ê§Ú¸ûÃö¤ß¡A¦b¤W±¬ã½Õ¤å³¹«½S«e15¦W¡A±Æ²Ä4¦W ¨ÅÀù·sÃÄ Pfizer ¡APalbociclib¡A( 2013¦~4¤ëFDAµ¹ BDT¡A§K°µIII´N¥i¥H´£¥æ) OBI-822©MPalbociclibªºÄvª§¤O ? (2)Why ¼í®õ ¥ú©ú¥¿¤j¶R¯E¹©? ¡÷ §ÚÌ¥u¯à²q¡A¦U§ç¤w¨£¦Ó¤w§a ~ ~ ¥ý»¡¤@¬q¡A¤§«e ¤ô¨Cô¡A¤j½æ¯E¹©¡A¤¤¸Î¡A ¤]¬O°ó¦Ó¬Ó¤§¡A¨C¤Ñ©T©wªº¸¹¤l¡A¤j¶q½æ¥X¡A Åý¤j®aª¾¹D¤]µL©Ò¿× ( §¹¥þÃn¥ú¡A·|Åý¥Lªº»ù®æ ½æ§C«Ü¦hªº)¡C Why ¥L¤£¥Î ¡§¦Ñ·~¤º§@ªk¡¨ ¡A¨Ò¦p KGIµý ¶R¶i ¡÷ ¶×¨ì ¤¸¤jµý ½æ¥X¡A¥B¡A¦A¤À´² ? ¨é°Óªº¸³¨Æªø¤]©M§Ú°Q½×«Ü¤[¡A¤ô¨Cô³o¬OÔ£ÅÞ¿è ? ·í®É§Ú¦³¤@»¡¡A¸³¨Æªø¯ººÙ¤]¦³¹D²z : (§Ú¨Ó§ä ·í®Éªº line ¹ï¸Ü¶K) ¸³: ¦pªG¥L¥Î½â½æªº¤è¦¡¡An¤£¬O¦¨¥»«Ü§C¡A¤£µM´N¬O¤âÀY«Üºò ? ¼C: «D¤] «D¤] ~ ¨º¬O§ÚÌ "¤p«Ä¤l" ªº²´¬É¡A¤£À´¤jÆs¤âªk¡C ¼C: ¤ô¨Cô(§t¥~³ò¶Ç»¡¦³300~400~500»õ??) «ù¦³¤¤¸Îªº¥«È¬ù6 »õ¡÷ ¥i¯à¦û¸ê²£¤£¨ì2% ? «hÀH«K¥X¡A ¤Ö½æ 20% ¡÷ °^Äm¦^¥LÌÁ`¸ê²£¡A ¤£¨ì¤d¤À¤§4 ( 2% * 20 % = 0.004)¡C ©Ò¥H¡A´N¦VÀç·~û»¡¡A ¤µ¤Ñ½æ400±i¡A »ù¦ì©O? ¡÷ "ÀH«K" !! ¨Ò¦p ¶w¼C§Ú ¦pªGn½æ¥X10¸U¥«ÈªºªÑ²¼¡A§Ú¤]Ãi±o¬Ý ¡÷ ´N¥«»ù ª½±µ½æ±¼¡A ©Î¡A¥sÀç·~û ª½±µ À°§Ú ¥X²M¡C ¸³: ³á~ ¨º©p´N§Ö§Ö¥hªø¤j§a ! ¦A»¡»¡ ¼í®õ³o¦¸¶R¶i¯E¹© : §Úı±o³o¦¸¨S¦³¨º»ò¦hªºÅv¿ÑC~ 2014¦~¬Û·í¦h ¡§±M·~¥Í§Þ§ë¸ê¤H¡¨ ¡A³£Ä±±o¶Wº¦¤Ó¸Ø±i¸¨ì¥~¤ÓªÅ¤F ~ ~ ·í®É§Ú¹ð¦¸µoªí¡A¥Î¥|¤j¶ôÄÄz : (·íµM¬O¦³ÂI¥DÆ[¡A¥B¦³¬Û·íªºÁr´ú¦¨¥÷) (1)under value (2) fair price (3)price-in (4)over shooting ²³±M·~¥Í§Þ§ë¸êªB¤Í³£¦P·N¡A·í®É¤@°ïªº¥Í§ÞªÑ¡A³£»·»·»·¦b (4)over shooting ¥~¤ÓªÅ ¦pªG ¡§¤@P¡¨ »{¬°»·¦b(4)¤§¥~¥~¥~¡A«h´Nºâ¦³¥DÆ[§PÂ_¿ù¡A¤]¤£·|Åܦ¨(2)¶¥¥H¤Uªº¤ß°Ê»ù¡C ¥B¡AÄꨡ¥R¼Æ¤ÓÄY« ! ®ü¤ô°h¥h¡A²{¦b«Ü²M·¡¬Ý¨ì¡A¤@°ï¦bÞóªa !! ¨º²{¦b¯E¹©(510»õ¥«È)¡A¦b¨º¤@Ӧ춥©O ? §Ú¤£prefer¦b¤½¶}ºô¸ô¤W¡Aµoªí ¡§¯S©wªÑ²¼¡¨ ¡§¯S©w»ù¦ì°Ï¶¡¡¨ §Ú¥DÆ[»{¬°¡A¥H¯E¹©¥Ø«eªº¸ê°T¶i«×(¶Ç¨¥)µ¥¡A¥úÃаϨM¹ï¤£·|¦b (4)¡A ¥i¯à¬O¦b (2)~(3) ¤§¶¡§a ?? (·íµM»¡¤FN¦¸¡AÁÙn¦Ò¶q Á`¸g & ¥Í§Þ¦¸Á`¸g) ¯E¹©¦b¦¹»ù¦ì¡A§Ú¦Û¤v¤]¬O³{§C´N¦^¸É¤@ÂIÂI¡A(§Ú¤]¨S°Ê©Àn¤@¤j¤f ±ô«¢) ¹ï·Ó¼í®õ¤]´N¬O ³{§C¶R¤@ÂIÂI¡A ¨â¬Û¹ï·Ó¤§¤U¡A§Úı±o¡A¥H²{¦bªº ¡§»ù¡¨ ¡§¶q¡¨ ¡§¸Ñª¼±ÂÅvÃĵý¡B¡B¡B¡¨ ¡A ¡§ÁÙ¡¨ ¤£»Ýn¥h°µ Åv¿Ñ«ä¦Ò¤] ~ ~ ©å¨£ |
|
|
·|û¡GJOLIN10140555 µoªí®É¶¡:2015/6/11 ¤U¤È 11:02:39²Ä 1236 ½g¦^À³
|
¦^À³¹«¤j (³Ì¨Î¸Ñª¼®É¾÷ÂI)¡K¡K.×¥¿ª©¤G ¼W¥[¾¯¶q/ ÁÙ¦³°w¾¯¨ì9Ó¤ë,¨Ì¦¹Ãþ±À±NPD¤ë¼W¥[4Ó¤ë,¦ý¤´¥H«e15%µL®Äªº¤H¤£ÅÜ,³o¼Ëªº¼Æ¾Ú¸û²Å¦X9510¤j¤jªº¹Ú¹Ò. ¥Ñ¤U¦CӹϪí¥iÃÒ (¹Ïªí¤@)---ÅçÃÒ °Ñ¦Ò²Ä¤@ ´ÁÁ{§É27¤H¹êÅ窺PD/¤ë¼Æ©Ò°µªº2014/12¤ë2-3´Áªº¹êÅç²ÕªºPD¡@ ¡@ PD/¤ë¡K..NED....40....36.....32.....28.....24.....16.......8.......4. PD/¤H¡K¡K.6¡K¡K7¡K..2¡K..2¡K¡K2¡K..1¡K..3¡K¡K2¡K..2 %...............22¡K26¡K7.4¡K.7.4¡K7.4¡K3.7¡K.11¡K7.4¡K7.4 ¦¬®×®É¶¡ ¦~/¤ë ¤H/¤ë¼Æ 2011/7¡K¡K.4¡K2¡K...1¡K¡K1¡K¡K1¡K..1¡K...1¡K¡K1¡K..1 14/42 2012/1¡K¡K4¡K.2¡K¡K1¡K...1¡K¡K1¡K..1¡K¡K2¡K...2¡K..1 18/36 2012/7¡K¡K4¡K.0¡K¡K0¡K...0¡K¡K1¡K¡K1¡K..2¡K...1¡K..1 16/30 2013/1¡K¡K4¡K..0¡K¡K0¡K..0¡K¡K0¡K¡K1¡K..2¡K...2¡K..1 18/24 2013/7¡K...15¡K.0¡K¡K0¡K..0¡K¡K0¡K¡K0¡K..8¡K...5¡K..5 69/18 2014/1¡K¡K0¡K..0¡K¡K0¡K..0¡K¡K0¡K¡K0¡K...3¡K..4¡K..3 50/12 2014/8¡K¡K0¡K..0¡K¡K.0¡K..0¡K¡K0¡K¡K0¡K..0¡K..0¡K..3 48/4 Total:63 NED:31 CR/PD³]©w¹êÅç²Õ°h¥X6¤H+¹ï·Ó²Õ°h¥X20¤Hp26¤H¡A ¹ï·Ó²ÕPD84¤H©|¦³12¤H¥¼´_µo¡A¹êÅç²Õ63-6=57¤H©Ò¥HCR/PD=57+84=141, 141CR/187LR=75.4%(²Å¦X¥¼¹F142¤HCR/PD) (¹Ïªí¤G)--- ÅçÃÒ °Ñ¦Ò²Ä¤@ ´ÁÁ{§É27¤H¹êÅ窺pd/¤ë¼Æ©Ò°µªº2015/5¤ë2-3´Áªº¹êÅç²Õpdªí PD/¤ë¡K..NED....40....36.....32.....28.....24.....16.......8.......4. PD/¤H¡K¡K.6¡K¡K7¡K..2¡K..2¡K¡K2¡K..1¡K..3¡K¡K2¡K..2 %...............22¡K26¡K7.4¡K.7.4¡K7.4¡K3.7¡K.11¡K7.4¡K7.4 ¦¬®×®É¶¡ ¦~/¤ë ¤H/¤ë¼Æ 2011/7¡K¡K.4¡K2¡K...1¡K¡K1¡K¡K1¡K..1¡K...1¡K¡K1¡K..1 14/46 2012/1¡K¡K4¡K.2¡K¡K1¡K...1¡K¡K1¡K..1¡K¡K2¡K...2¡K..1 18/40 2012/7¡K¡K4¡K.0¡K¡K1¡K...1¡K¡K1¡K¡K1¡K..2¡K...1¡K..1 16/34 2013/1¡K¡K4¡K..0¡K¡K0¡K..1¡K¡K1¡K¡K1¡K..2¡K...2¡K..1 18/28 2013/7¡K...15¡K.0¡K¡K0¡K..0¡K¡K5¡K¡K3¡K..8¡K...5¡K..5 69/24 2014/1¡K..11¡K..0¡K¡K0¡K..0¡K¡K0¡K¡K0¡K...6¡K..4¡K..3 50/18 2014/8¡K..11¡K..0¡K¡K.0¡K..0¡K¡K0¡K¡K0¡K..0¡K..4¡K..3 48/10 Total:82¡K¡K¡K.4¡K¡K.3¡K...4¡K...9¡K¡K7.....21.....19¡K.15 NED:53 CR/PD³]©w¹êÅç²Õ°h¥X17¤H+¹ï·Ó²Õ°h¥X20¤Hp37¤H¡A ¹ï·Ó²ÕPD/96¤H¥þ´_µo¡A¹êÅç²Õ82-17=65¤H©Ò¥HCR/PD=65+96=161, 161CR/229LR=70.3%(±µªñ9510¤j¤jªº¹Ú¹Ò15?) (¹Ïªí)¤T:------±Àºt °Ñ¦Ò²Ä¤@ ´ÁÁ{§É27¤H¹êÅ窺pd/¤ë¼Æ©Ò°µªº2015/12¤ë2-3´Áªº¹êÅç²Õpdªí PD/¤ë¡K..NED....40....36.....32.....28.....24.....16.......8.......4. PD/¤H¡K¡K.6¡K¡K7¡K..2¡K..2¡K¡K2¡K..1¡K..3¡K¡K2¡K..2 %...............22¡K26¡K7.4¡K.7.4¡K7.4¡K3.7¡K.11¡K7.4¡K7.4 ¦¬®×®É¶¡ ¦~/¤ë ¤H/¤ë¼Æ 2011/7¡K¡K.4¡K3¡K...1¡K¡K1¡K¡K1¡K..1¡K...1¡K¡K1¡K..1 14/54 2012/1¡K¡K4¡K.5¡K¡K1¡K...1¡K¡K1¡K..1¡K¡K2¡K...2¡K..1 18/48 2012/7¡K¡K4¡K.4¡K¡K1¡K...1¡K¡K1¡K¡K1¡K..2¡K...1¡K..1 16/42 2013/1¡K¡K4¡K..1¡K¡K1¡K..1¡K¡K1¡K¡K1¡K..2¡K...2¡K..1 18/36 2013/7¡K...15¡K.0¡K¡K0¡K..5¡K¡K5¡K¡K3¡K..8¡K...5¡K..5 69/30 2014/1¡K..11¡K..0¡K¡K0¡K..0¡K¡K3¡K¡K2¡K...6¡K..4¡K..3 50/24 2014/8¡K..11¡K..0¡K¡K.0¡K..0¡K¡K0¡K¡K0¡K..5¡K..4¡K..3 48/18 Total:107¡K.0¡K13¡K...4¡K...9¡K..12¡K..9¡K...26....19¡K15 NED:53 CR/PD107+116-37=186 ¹êÅç²Õ°h¥XªÌ¦ô17¤H¹ï·Ó²Õ°h¥X¦ô20¤H NED=53¤H ¹êÅç²ÕCR/PD107-17=90¹ï·Ó²ÕCR/PD116-20=96 ** p°h¥XªÌ¥ç pNED 107-17+53=143 143/ 2 =72,15+19+26+9+12+9-17=73 PFS=32¤ë ** p°h¥XªÌ¤£ pNED 107-17=90 ¤H,90/2=45,15+19+26+9-17=52 ¤¤¦ì¼Æ¤H,90/2=45 ¨ºPFS=24¤ë ©Ò¥H¦~©³¸Ñª¼¬°³Ì¨Î«O¦u®É¾÷ÂI |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/11 ¤U¤È 10:22:41²Ä 1235 ½g¦^À³
|
«¼C¤j ¬°¤°»ò¬ã½Õ¾÷ºc·|º|±¼822?ÁÙ¦³¡A±z¨Spo¥Xªº¥t¤@¥b¤å³¹¬O¤°»ò? ¥i§_©_¤å¦@½à? |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2015/6/11 ¤U¤È 09:50:25²Ä 1234 ½g¦^À³
|
¯E¹©ªÑ»ù§C¼é ¼í®õ¶°¹Î¦A¥[½X 2015/06/11 20:43:35 ¡]¤¤¥¡ªÀ°OªÌ¦¿©ú®Ë2015¦~6¤ë11¤é¹q¡^¥Í§ÞªÑ¯E¹©(4174)ªñ´ÁªÑ»ù¯h³n¡A¼í®õ¶°¹Î«ùÄò¥[½X®Â½ÃªÑ»ù¡A¼í®õ¥þ(2915)¤µ¤Ñ¦A¤½§i5¤ë27¤é¦Ü6¤ë11¤é¶R¶i1075±i¡A¥¸¸ê3.34»õ¤¸¡A¨C³æ¦ì»ù®æ310.79¤¸¡C ¨´¥Ø«e¬°¤î¡A¼í®õ¥þÁ`p«ù¦³¯E¹©¬ù4216±i¡A«ùªÑ¤ñ2.47%¡A«ùªÑª÷ÃB13.74»õ¤¸¡C¼í®õ¥þ¤µ¦~¤w¬O²Ä3¦¸¤½§i¶R¶i¯E¹©¡C ¥Í§ÞªÑ¾D³{½æÀ£¡A·sÃĪѧó¦]º©u°]³øªí²{¤£¨Î¡AªÑ»ù³B©ó§CÀÉ¡A¯E¹©ªÑ»ù¶^¯}300¤¸¤jÃö¡A¤µ¤Ñ¦¬¦b297¤¸¡A¶^´T0.5%¡A¼í®õ¥þ¿n·¥¶R¶i¡A³Qµø¬°¼í®õ¶°¹ÎÁ`µô¤¨l¼ÙÅ@½L¤ß¤Á¡C |
|
|
·|û¡G¤p³ì10135960 µoªí®É¶¡:2015/6/11 ¤U¤È 09:17:30²Ä 1233 ½g¦^À³
|
°ß±©¤j §Ú¦Û¤vªº¬Ýªk¬O,¼íxx¥»¨¹ê½è¤W¤w¬O¤@®a§ë¸ê¤½¥q,¥DnÀò§Q°^Äm³£¨Ó¦Û·~¥~,¨Ò¦p«n¤s,°ªøʪº§ë¸ê¦¬¯q,¤Î³Ìªñªº´¼´Q,§A¥i¥H§â¥¦¦Û¦¨Ãþ¦ü¤Úµá¯SªºBerkshire Hathaway, ¬Ý¦nªº¼ÐªºY¬O¤W¥«Âd,¦pªG¤£¬O¨p¶Ò´N¬On¤½¶}¥«³õ¶R,¯Ex¤~èIPO²{¼W,¨S²z¥Ñ¥h¨p¹õ,¦Ó¥B¨p¶Ò¤j³¡¥÷nÂê¤T¦~,¤£§Q¶i¥X,§ë¸ê¤Hn§â¥¦·í¦¨¥¦¬Ý¦n¯Ex¥h§ë¸ê¤]¥i¥H,¬Ý¦¨nÅ@½L¤]¥i¥H,ºÝ¬Ý§A¥Î¤°»ò¨¤«×¥h¬Ý, ¤£¹Ln·Q·Q¥H¤¨¦ÑÁ󪺧@·,À³¸Ó¤£¦Ü©ó¶R¤@®a¦¨¥\¾÷·|¤pªº¤½¥q,®³ªÑªFªº¿ú¥hÅ@½L,Y¬O¦p¦¹,¥¼¨ÓY¯Ex fail,ªÑªF·|ªÖ©w·|³Q¬¶ÅF,¦WÁn¤]±ÑÃa,»¡¤£©wª÷ºÞ·|¤]·|¥X¤â¥h¬d,§Ú¦Û¤v¹Ú¨ì ¼íX±b¤WÁÙ¦³¬ù40EªºCB¦~©³¨ì´Á,¤@¯ë³£·|©Ô¨ìÂà´«»ù¥H¤WÅýCBÂà´«±¼(§Ú¬Ý¥¦±b¤W²{ª÷À³¸Ó¤£°÷ÁÙ),¦ýªñ¦~¨ÓªÑ»ù¤£®¶,·|¤£·|¤U¥b¦~«Å¥¬¸Ñª¼¤§«á·|¦³§Q¦h??¶¡±µÅý¥¦ªºÉ_¸êÀò§Q¤j¼W??? ¥H¤W¯ÂÄݹڸÜ, ¤j®a¯º¯º´N¦n |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/11 ¤U¤È 09:13:17²Ä 1232 ½g¦^À³
|
©êºp¡A¤U¤å¤Ö¥´¤F¤T¦ì¤]·Q½Ð±Ðªº¤j¤j¡A ²q·Q¤j¡A¤p©_¤j¡A¤j¤á¤j! |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/11 ¤U¤È 08:58:31²Ä 1231 ½g¦^À³
|
¦³¤@°ÝÃD«ä¦Ò¤Fªñ¤@Ó¤ë¡AÁÙ¬O¤£±o¨ä¸Ñ¡A·Q¦b³oùظò´X¦ì¤j¤j½Ð±Ð¤U! «¼C¤j¡A¤¤¹D¤j¡A¥xÁÞ¤j¡AFaith¤j¡ACliff¤j¡Aµ½¤H¤j¡A¯Q¾~¤j¡A°e³ø¤j¡A ¦Ñ¹«¤j¡AÅó±ø±ø¤j¡AChen¤j¡AQQ¤j¡A¤j¤á¤jµ¥ ¦b¸ê¥»¥«³õ¤¤¡A90%¥H¤Wªº¤½¥q¦b¶R¦Û®a©Î¶°¹ÎªÑ²¼¡A ¤£ºÞ¬O¦¬Äw½X©Î·Qª£»ù®æ¡A¤£¥~¨âºØ¤è¦¡¡A ¥Ñ¹Ò¥~¥H¥~¸ê¦W¸q¶×¤J¡A©ÎªÌ¸g¤½¥qªº¹ï¥~¸g±`±b¬y¥X¡A¦A±q¥¦±b¤áÂà¤J¡A °£«D¬On«Å§i®wÂêѡA§_«h³£¬O§C½Õªº°t¦X¥D¤O¤è¡A ¦bµu´Á¤º¥H¨³¹p¤£¤Î±»¦Õªº³t«×¡A¦Y¥ú¥«³õ¤W¬Y»ù¦ì°Ï¶¡Äw½X¡A ¦A¨Ó¤~¬O©Ò¿×¥D¤Oªº¥~³ò¡C ¥~³ò¥§¡·|·j¶°¨ìªº¼Æ¶q¡A ¬ù¬O¥D¤Oªº¤~¤»¿¼Æ¶q¡A¦¹®É¤~·|ºCºCÅý¥«³õ¦Û¥Ñµo»Ã¡C ¥O§Ú¤£¸Ñ¤§³B¬°¡A¬°¤°»ò¯EX¤jªÑªF¬Ý¦ü·Q§C½Õ¦Ó·Å·Åªº¡AºCºCªº¡A «o¤S¥H±ý©ÚÁÙªï¡A±©®£¤Ñ¤U¤£ª¾ªººA«×¦b¦¬ªÑ¼Æ! ¥¿±·N¸q»P¤Ï±·N¸q¨ì©³¬O¤°»ò?©Î¬O¦³¦UºØ¤£¦P±¬Ûªº¸ÑŪ? ·Ð½Ð¦U¦ì¤j¤j½ç±Ð¡A¤£§[·P¿E! P.S.·s¤â¥S¡A¤Ú¥ý¥Í«ù¦³ªºµ´¤£¥u§A»¡ªº³o¨â®a¡AÀH«KÁ|¤@®a4966 ¥h¬Ý¬Ý¤jªÑªF¦³þ´X¦ì? ¦A¡A¶°¤¤¦b¤@°_ªº¬Y´X¦ì¡A²´¥ú·íµM¤£®t¡A¦ý§ó«nªº¬O"¹Îµ²"¤O¶q¤j¡C ¦Ü©ó¬Oþ¤@ºØ»Ýn¦Ó"¹Îµ²"´N¯d«Ý¦Û¤v¸ÑŪ¤F¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/11 ¤U¤È 07:15:31²Ä 1230 ½g¦^À³
|
¦Ñ¹«¤j¤j ±z¤]¤Ó«È®ð¤F Y¤£¬O¤p§Ì(¥i¯à)µêªø±z´X·³ ¥s¤jô¥i¯u¤£´±·í ±zªº¤j¤å ¨¥¤§¦³ª« ¨ã³Ð·s«ä¦Ò ¼W²K«Ü¦h¤p§Ì¥H«e¤£´¿¦³¹Lªº·Qªk ¤S¥H«ÕÀqªºµ§Ä² Ū°_¨Ó§óÅý¤H¤ßÃm¯«©É ¦n¥Í·PÁ§r! ¦Ü©ó±z»¡ §Ú²qªºPFS¬O¦h¤Ö©O¡H ±q¥H«e§Úªº©å¤å ´NÂI¥X©M¤p©_¤jªº®t¤£¦h 19¥[´î2 §a ??? ³o¬O¥H¤½¥qªº»¡ªk ¥Î¬Q¤Ñªº°²³] ÁÙ¦³¨Ì·Óª©¤WªB¤Í»¡¤¸¤ëPD(CR) «Ü±µªñ142³oÓ¼Æ ¨Ã«Ø¥ß¦b±ß¶iªÌPD¼Æ¤£¯à¤Ó¦hªº±¡ªp¤U ºî¦X²q´úªºµ²ªG ? ¤£¹L³oÓ¦ôpªº°_ºâ¦~¤ë ¦Ü¤µ§ÚÁÙ¦b¶Ë¸£µ¬§ÚªºÅÞ¿è¹ï¤£¹ï ¦]¬°Â÷¤Ó»· »~®t·|«Ü¤j ²q´ú³oÓ¤¤¦ìPFS ³Q¤j¤O¥´Áyªº¾÷²v¬O«Ü°ªªº Ó¤H²q´ú ³oÓ¬ï¯}0.5ªº´c¤ÆÃöÁä±wªÌ ¥i¯à¸¨©ó¤µ¦~ 3 ~ 6 ¤ë¶¡? ¸Ñª¼®É¶¡¥i¯à¸¨©ó²Ä¥|©u? ³o¬O°Ñ¦Ò¤p©_¤jªº»¡ªk¨Ó§PÂ_ªº ¶È¨Ñ°Ñ¦Ò ÁÂÁ¦ѹ«¤j¤j ¤]ÁÂÁ¤j®a! ¦Ü©ó¤¤¹D¤jªº¤jÃøÃD --- ¥Î«O¦uªº°ò¦pºâ ¦¤Wªü¬Â¤j¤]´£¨Ñ°T®§ ¡§¨ÅÀù´_µo:¤@¨C¦¸Àˬd¸~½Fn©¹¶V¤p¤è¦Vµo®i©Îéw,¦pªG³o¦¸¤ñ¤W¦¸¤j10%©Î15%(¥L»¡§Ñ¤F)§Y°eLR.¤G²£¥Í·s¯f¥üÈÐ ©Ò¥H¤@©w¬O¦³¼x¥ü¡@Á{§ÉÂå®v¤~·|§P©w¬°¢Þ¢Ò ´N¥H5/25ªº¼Æ¾Ú¨Ó¤ÀªR¡@¦ý¥ÎÄYV«O¦uªº¼Ð·Ç¡@¥HCR/LR = 0.9¤ÀªR ¥ÎÃIJաG 233 ¹ï·Ó²Õ¡G 116 °²³]°h¥X¤H¼Æ ¨â²Õ1¡G2¤À°t ¥ÎÃÄ²Õ ¡G12 ¹ï·Ó²Õ¡G 25 ¹ï·Ó²Õ ¥u³Ñ¢´Ó¥¼PD ©Ò¥H ¹ï·Ó²Õ PD¼Æ = 116 ¡V 25 ¡V 5 = 86 CR/LR¥H0.9¤ÀªR Á`PD¼Æ = 229 * 0.9 = 206 ¦]¦¹¥ÎÃIJÕPD¼Æ = 206 ¡V 86 = 120 ¥ÎÃIJթ|¥¼PD¼Æ = 233 ¡V 12 ¡V 120 = 101 ©Ò¥H¥ÎÃIJÕÁ`³]¸ê®Æ¼Æ = 101 + 12 = 113 ¯uªº«ÜÃø²q´ú ¾ãÓ¥ÎÃIJժº±Æ¦Cª¬ªp §ó¦]¬°¥ÎÄYVªº¼Ð·Ç ªí¥ÜÃĮĸû®t ¤´°²³]±Æ¦bÃöÁäA¤§«eªº³]¸ê®Æ¼Æ¤´¬°100Ó(ªí¥Üªø§À¼Æ¤£¦h) ¤]´N¬O»¡¬ù80¤H´c¤Æ ´N¥iºâ±o¤¤¦ìPFS ¥Î·§¦ôªk¦ôºâA¥i¯àµo¥ÍPD©¹«e²¾ªº¤ë¼Æ(¥i¯àÅ޿観¨Ç°ÝÃD) ¨C¤ë¥§¡´c¤Æ¼Æ = (229 ¡V 187 )*0.9 /5 = 7.56 ©Ò¥H ( 120 ¡V 80 ) / 7.56 ¬ù = 5 Ó¤ë ¥Î«e¦ôªº19¥[´î2 ¦©°£ 5 Ó¤ë = 14¥[´î2 ºâ¨ì³o¸Ì ¶V¨Ó¶V¤ßµê §Ú·Q¥Ñª©¤Wªº°T®§ ±i¸³3/3»¡ªº¤¸¤ëPD(CR)¥¼¹F142 ¦³ªB¤Í»¡³o¬O¤¸¤ë¥H«eªº¼Æ¾Ú Y¬O³o¼Ë ³o²Õ¼Æ¾Ú´NÁÙ¦X²z? ©Î³\¤j®aÀ³µÛ«¦bª¾¹D«ç»òºâ´N¦n ¦]¬°¥u¦³PD(LR)¼Æ¬O¯uªº ¦Ü©ó¤W±¦ôºâPFS¼Æ¦rªº¤j¤p ¬Ý¬Ý´N¦n ¦]¬°¯uªº¤ÓÃø²q·Ç¤F ¹ï¤£°_ ¤¤¹D¤j ¯u¥¿ªº¥ÎÃIJձƧǤ£ª¾ ±À¦ôµ²ªG¥i¯à¤Ñ®t¦a»· ©Ò¥Hª©±³Ì±jªºCliff¤j ±q¨Ó¤£±Àºâ ¤j·§»{¬°µL¤°·N¸q§a! ¤p§Ì²`®£»~¾É¤j®a ¨º¯u¬O¸o¹L ½Ð±z§O§â¼Æ¦r©ñ¦b¤ß¤W ÁÙ¬O½Ð±z¨Ì±zì¨ÓÆ[¹îªº«ÂI¨Ó§PÂ_§ë¸ê ÁÂÁ±z̦h¦ì«e½úªº±Òµo ÁÂÁ±zÌ! ¤p©_¤j ¤Ó¹ï¤£°_¤F! ¤§«e¤£¹î »~·|±zªº·N«ä¤F ¤p§Ì¹ï©ó±z¤ÀªR¨Æ±¡ªº©P¼{ ²`·P·q¨Ø «Ü¦h·Qªk ¸g±z´£¿ô«ü¾É §¹µ½¦h¤F ÁÂÁ±z! |
|
|
·|û¡G¥Í§Þµæ³¾10140600 µoªí®É¶¡:2015/6/11 ¤U¤È 07:07:43²Ä 1229 ½g¦^À³
|
¥_³¡ªº¥xÆW¤Úµá¯S³\¥ý¥Í¡A Å¥»¡Á`«ùªÑ¥u¦³¢±ÀɡЯE¹©¤Î¤¤¸Î¡AÅ¥»¡¦Ü¤Ö³£n©ñ¤¦~¥H¤W¡A¥B¯E¹©¦¨¥»¦b¢²¢°¢¯¥ª¥k¡A §óÅ¥»¡³o¤G¤äªÑ²¼³£ÁÙ¦bÓï§C¤@ª½¥[½X¡C «n³¡ªº®}¥ý¥Í¡A Å¥»¡¬O¤@¦ìªø´Á§ë¸êªÌ¡A±q¤£µu½u¶i¥X¡AÅ¥»¡«ùªÑ¤]¬O¥u¦³¯E¹©©M¤¤¸Î³o¤G¤äªÑ²¼¡A §óÅ¥»¡«ùªÑ¤]¬O·|©ñ¦n´X¦~¡A¦Ó¥B²{¦b¤]¦³¤Ö¶qªº¦b¶R¶i¡C ¤G¦ì§ë¸ê¬Éªº«e½ú¡A©~µM³£¤£¬ù¦Ó¦Pªº¶R¶i¯E¹©¤Î¤¤¸Î¡A¯u¬O¤Ó¥©¦X¤F¡A¤]¤Ó¯«©_¤F¡I ²¦³º¥Í§Þ¤W¥«¡B¤WÂd¡B¿³ÂdªÑ²¼¤Ó¦h¤F¡A¦Ó¥B¿ïªÑÃø«×¬Û·í°ª¡A¦Ó·ÀI¤]«D±`ªº¤j¡A ¦b³o¯E¹©¢±¢±¢¸¤H´_µoªº§QªÅ¤¤¡]À³¸Ó¤£ºâ§QªÅ¡^¥LÌÁÙ¬O«i©ó¥[½X¡A¯u¥Oµæ³¾ªº§Ú¤Ó·P°Ê¤F¡C ¹J§QªÅ´±«i©ó¶R¶i¡A¹J®ü¤ô°h¼é¤~¬Ý¨£¤¨¦ÑªO¡B³\¥ý¥Í¦b»rªa¡AÃø©Ç¥i¥H¦¨¬°¥xÆWªÑ¯«¤Úµá¯S¡A ¯u¬O°£¤F¨ØªÑÁÙ¬O¨ØªA¡C |
|
|
·|û¡GJolin10140555 µoªí®É¶¡:2015/6/11 ¤U¤È 04:05:03²Ä 1228 ½g¦^À³
|
¦^À³ ¹«¤j ¦]¯ó½Z¼Æ¦r¹L¦h¥´¿ù,¤S¨S®Õ¥¿©êºp ¥xÁÞ10138776 µoªí®É¶¡:2015/4/29 ¤U¤È 10:22:29 §A̪º±À½×³£²Å¦XÅÞ¿è,Â÷¯u¥¿¼Æ¦r®t¶ZÀ³¤£¤j,¤@´Á¨S¦³PFS,¦³¤½§i4¦~µL¯e¯f´c¤Æ¦s¬¡´Á¤ñ²v¬O41% , ¹Á¸Õ¥h¬ù²¤±Àºâ¤@´Á¤¤¦ì¼ÆPFS¦b32-36Ó¤ëªþªñ ,¤@´Á¥u°lÂÜ10¦~,À³¦³¤H¬¡¹L10¦~,¥u¯à·í°µ°Ñ¦Ò,¤£¯àÃþ±À , (¦]¾¯¶q»P¬I¥´¦¸¼Æ¤£¦P) OS ,¤H¼Æ ,¦Ê¤Àµ§,¹w¦ô ¤¤¦ì¼Æ PFS ,(Á`¦s¬¡´Á°£¥H3¨Ó¬ù²¤¹w¦ôPFS)(¥HHer2¶§©ÊÂù¼Ð¹vÃĪºOS/3=PFS) 1¦~ 2 6.8% PFS 4 Ó¤ë 2¦~ 2 6.8% PFS 8 Ó¤ë 3¦~ 3 11% PFS 12Ó¤ë 5¦~ 1 3.7% PFS 20Ó¤ë 6¦~ 2 6.8% PFS 24Ó¤ë 7¦~ 2 6.8% PFS 28Ó¤ë 8¦~ 2 6.8% PFS 32Ó¤ë 9¦~ 7 26% PFS 36Ó¤ë 10¦~ 6 22.2% PFS 40Ó¤ë ¤@´Á¦¬®×27¤H,¤¤¦ì¼ÆPFS¬ù²¤¦b32-36Ó¤ë ¨Ì×¥¿¦p¨ì¦~©³PFSÀ³¬°24-28¤ë ¦Ü©ó Áô§tµÛ¥¼´_µoªº³]¸ê®Æ¡A´NK-M¦±½uÆ[ÂI¡A¤j·§¥unPD80¤H´N·|ºN¨ì0.5ªº¦ì¸m¡A©Ò¥H±N16+19+24+10+12=81 §Ú¸û«O¦u 30%PD20Ó¤ë¥H¤U16+19+24+10=69¤H ¦pPD¤H©Î¥[¤WNED¤H¼Æ¹F¨ì69+70=139¥H¤W ¨ºPFS 24Ó¤ë©Î¥H¤W«K¥i¹w´Á ©Ò¥H¦p°µ§¹¥þµ{¤ñ¸û¤@´Á¤¤¦ì¼ÆPFS¦b32-36Ó¤ëªþªñÀ³¥i´Á«Ý |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/11 ¤U¤È 02:27:45²Ä 1227 ½g¦^À³
|
£«¬Â¤jªº¶K¤å: ¨ÅÀù´_µo: ¤@.¨C¦¸Àˬd¸~½Fn©¹¶V¤p¤è¦Vµo®i©Îéw, ¦pªG³o¦¸¤ñ¤W¦¸¤j10%©Î15%(¥L»¡§Ñ¤F)§Y°eLR. ¤G.²£¥Í·s¯f¥ü £«¬Â¤j, ¯à§_³Â·Ð±z¦A¸ß°Ý¤@¦¸, ¨Ã½T©w¬O³o¦¸¤ñ¤W¦¸¤j10%©Î15%©ÎªÌ20%§Y°eLR. 10%©Î15%©ÎªÌ20%, ³oӼƦr«D±`«n, ¦]¬°¥¦Ãö«Y¦U¦aªºÁ{§ÉÂå®v©M¤¤¥¡§PŪ¤¤¤ß¹ï¸~½F´c¤Æªº§P©w¬O§_¤@¼Ë. ¦pªGÁ{§ÉÂå®v¥Î¤j©ó10%©Î15%´N§P©w¸~½F´c¤Æ; ¦Ó¤¤¥¡§PŪ¤¤¤ß¥Î¤j©ó20%§P©w¸~½F´c¤Æ, ¨âªÌ§P©w´c¤Æªº¤H¼Æ´N¤£¤@¼Ë. £«¬Â¤j, «ô°U±z¤F! ·PÁÂ! |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/6/11 ¤U¤È 01:52:50²Ä 1226 ½g¦^À³
|
Jolin¤j ¹ï©ó±zªºpºâ¼Ò¦¡ §Ú¦³¤@ӺðݻP¤@Ó«Øij ºÃ°Ý¡G«ö·ÓOS¦~¼Æ*12/3¨Ópºâ¡APDÀ³¸Ó¬O4ªº¿¼Æ «h±z©Ò¦CPD/¤ë 40 36 32 30 28 24 12 8 4¬O§_À³¬°40 36 32 28 24 20 12 8 4¡H¡]30¤£¬O4ªº¿¼Æ¡^ «Øij¡G±zªºªí¤]Áô§tµÛ¥¼´_µoªº³]¸ê®Æ¡A´NK-M¦±½uÆ[ÂI¡A¤j·§¥unPD80¤H´N·|ºN¨ì0.5ªº¦ì¸m¡A©Ò¥H±N16+19+24+10+12=81 81¤j¬ù¸¨¦b24Ó¤ëªþªñ¡A¦ü¥G¤ñ¸û²Å¦XK-M¦±½u ¤£ª¾±z·N¤U¦p¦ó¡H |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/11 ¤U¤È 01:28:38²Ä 1225 ½g¦^À³
|
«¼C¤jº}«G ³»¦yªº§ë¸ê«äºû»P³W¹º, ¨ØªA! |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/11 ¤U¤È 12:59:37²Ä 1224 ½g¦^À³
|
²q·Q¤j¡A ¥H¤U¤p§Ì¸ò±z°Q½×¤@¤U¡G ¡y§Ú¥Î¨â²Õ¼Æ¾Ú¼ÒÀÀ (¼ÒÀÀ¸Õºâªí¦C©ó«á) A²Õ³]¸ê®Æ¼Æ100 (§Yªø§Àªº¥¼PD¼Æ 56 ) ¥B´X¥G¥H§¡¤Ã¤À¥¬¨Ó¼ÒÀÀpºâ ±o¨ì´c¤Æ¤H¼Æ 80®É «ê¬ï¶V0.5 B²Õ³]¸ê®Æ¼Æ130 (§Yªø§Àªº¥¼PD¼Æ 26 ) ¥B´X¥G¥H§¡¤Ã¤À¥¬¨Ó¼ÒÀÀpºâ ±o¨ì´c¤Æ¤H¼Æ 69 ®É ¤]«ê¬ï¶V0.5¡z °²³]¤½¥q¦b¾A·íªº®É¾÷¸Ñª¼¡A¥´¶}¬Ý¹êÅç²Õªº±Æ§Ç±¡ªp¡A¥HA ²Õ¦Ó¨¥¡A±Æ¦bPFS¤¤¦ì¼Æ¨ºÓ¤H«e±ªº¦³100¦ì³]¸ê®Æ(¥]¬A¤¤³~°h¥X)¡A±Æ¦bPFS¤¤¦ì¼Æ¨ºÓ¤Hªº«á±¦³56¦ì¸ê®Æ¡A±Æ¦bPFS¤¤¦ì¼Æ¨ºÓ¤HªºPFS«á±ªº¼Æ¾Ú(¥BºÙ¤§¬°ªø§À)¦³¥i¯à³£¬O¥¼PD¶Ü¡H¦pªG³£¬O¥¼PD¡A¨ºÁô§tµÛ¤@Ó°²³]¡A´N¬O³oÓÃīܯS®í¡A¥un¯à¶W¹L¤¤¦ì¼ÆPFSªº®É¶¡¥¼´c¤Æªº±wªÌ¡A´N¥i¥H¤@ª½¥¼´c¤Æ¡Aª½¨ì¶}ª¼ªº®É¶¡¡C¹ê»Úªº±¡ªpÀ³¸Ó¬O¡A³o¨Ç¦¦¬®×¤SÃĮĵo´§±o¦nªº±wªÌ¡A¥L̪ºPFS¤w¸g¤ñ50%¥H¤Wªº±wªÌÁÙ°ª¡A°ª¦h¤Ö¡H¦³ªº¦b¸Ñª¼¨º¤@¨è¤§«e¤w¸g½T©w¤F¡A¦³ªº¦b¸Ñª¼¨º¤@¨è¤´µM¨S¦³½T©w¡A³o·|¤ñ¸û±µªñ¯u¹êªº±¡ªp¡CÁ|Ó¨Ò¤l¡A¥ý¥Î¤p§Ì¦ôªºM PFS ¦b20¤W¤U¡A2013¦~1¤ë¦¬ªº¹êÅç²Õ±wªÌ¬ù¦³11¤H¡A¥ý°²³]2015¦~5¤ë¬O¹F¨ì¨M©w0.5¤ô¥½uªº®É¶¡¡A¥H³o®É¶¡·í§@©Ò¦³¼Æ¾Ú¦¬¶°ªººI¤îÂI¡A¥´¶}¬Ýµª®×®É¡A¦³2¦ì2013¦~1¤ëªº±wªÌ¬OÄÝ©óªø§Àªº¡A¤@¦ì¦b¥´¶}¬Ýµª®×®É¥¼PD¡A¤@¦ì¦b¥´¶}¬Ýµª®×®Éè¦n³oÓ¤ëPD¡A³o¨â¦ì³£ÂkÃþ¨ìªø§Àªº56¤H¤¤¡A¦ý¤@¦ì¬O¥¼PD¡A¤@¦ì¬OPD¡APDªº¨º¤@¦ì±wªÌ·Ó²z¤]À³§e²{¦b±zpºâªº¥ÎÃIJÕPD¼Æ = 172¡V95 = 77¤H¤§¤¤¡A¦ý¥L¨Ã¨S¦³¦û¥ÎK-M¨ç¼Æ¤ÀªR©Ò»Ýnªº´c¤Æ¤H¼Æ80¤H¡C¤]´N¬O»¡¡A°²³]ªø§Àªº¦³56¤H¡A¥´¶}¬Ýµª®×¡AÀ³¸Ó¬O¤@³¡¤ÀPD¡A¤@³¡¤À¥¼PD¡A¦ýn¥Î¦h¤Ö¤ñ¨Ò¨Ó¦ôºâ¡A¨ä¹ê¤@ÂI®Ú¾Ú³£¨S¦³¡A¬JµM¨S¦³®Ú¾Ú¡A¤p§Ì´Nª½±µ56¤H¡APD©M¥¼PD¦U1/2¡A¤]´N¬Oªø§ÀªºPD¤]¦³28¤H¡C¨º¦b¦P¼Ëªº¼ÒÀÀ±ø¥ó¤U¡A100¦ì³]¤Î80¦ì´c¤Æ«ê¬ï¶V0.5¤ô¥½u¡A¥i¥H±µ¨üªº¦X²zPD¼Æ¥Ø¬O80+28=108¤H¡A¦]¬°¸ò(233-(37/2))=107³o¼Æ¦r«Ü±µªñ¡A©Ò¥H¦b©Mµ½¤H¤jªº°Q½×¤¤¡A¤p§Ì´Nª½±µ¥Î³o®t¤£¦hªº¼Æ¦r·í°µ¼Æ¾Ú¤w¹F¦¨¼ôªºPD¼Æ¡A107/233=46%ªºPD¼Æ¡A¹ï¤j³¡¤ÀªºÁ{§É¹êÅç¨Ó»¡³£¤w¸gºâ¦¨¼ô¤F¡A¦Aµy·LÂÔ·V¤@ÂI¦hµ¥¤@¨âÓ¤ëµL¥i«p«D¡A¦ý¦pªGÁÙnµ¥¦n´XÓ¤ë¤~¸Ñª¼¡A¤p§Ì´Nı±o¤Ó¹LÂÔ·V¤F¡C ¥t¥~B²Õªº¼ÒÀÀ¡A³]130¡A´c¤Æ69¤H¤]¥i¬ï¹L0.5¡AÁöµM¸Õºâªí¤W¥i¥H¡A¦ý¤p§Ìı±o¬Ý¨ì³o¼Ëªº¼Æ¦r¥i¥HÀ³¸Ó·|¦Aµ¥¤@¨ÇPD¼Æ¦r¥X²{¦A¸Ñª¼¡AÅý¦h¤@¨Ç¤¤±ß´Á¦¬®×ªº±wªÌ¤]§e²{¥L̹ê»ÚªºFP S±¡ªp¡C ¥H¤W¡A¶È¨Ñ°Ñ¦Ò¡C ¥t¥~¡A ±ø¤j¡A±z»¡ ¡y¦pªG§A°Ý§Ú»¡"¤w¸g¬O³]¸ê®Æ¤F¡A¬°¦óÁÙn§â³o¨Ç¦^±À¦^¥h¦ô¦¨PD"? ¥¿¬O¦]¬°·í¦³¤H°h¥X¹êÅç¡A³Ñ¤Uªº¨ü´ú¸ÕªÌ¤H¼Æ´î¤Ö¡A¼W¥[¤@¦ìPD,¬OÅýK-M¦±½u·|¤U§Ö§ó°~¡z ³o¬O¹ïªº¡A²q·Q¤j¤w¸g§â¤¤³~Â÷¶}¤]p¤J100¦ì³]¸ê®Æ¤¤¤F¡A©Ò¥HY¤£pªø§ÀªºPD¡A¥un¦³80¦ìPD´N¥i¥H¨M©w0.5ªº¤ô¥½u¡A¤£»Ý¨ì233/2=117¤H©ÎªÌ(233-(37/2))=107¤H¨º»ò¦h¡C |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/11 ¤U¤È 12:48:39²Ä 1223 ½g¦^À³
|
Palbociclib 2013¦~4¤ë®³¨ì BTD ¡÷ 2015¦~4¤ë®³¨ìÃĵý¡C (¤j¬ù24Ó¤ë) («Ü¦hªB¤Í¥H PfizerªºPabocilib¥u§@§¹ II«K´£¥æFDA°e¼f¡Aª`·N¡A¥¦¬O¦³¥ý®³¨ìBTDªº) TMB-355 2015¦~2¤ë®³¨ìBTD ¡÷ ¦ô2016¦~6¤ë®³Ãĵý¡C(¦ô16Ó¤ë) (µù) TMB-355 IV¦P®É¤S¬O©t¨àÃÄ¡A©Ò¥H¥un°µ30¤HPHASE III¡A ¥BAIDS®ÄªG¬Ý ¡§2wk¡¨ ! primary end pointªº virus¤U° 0.5 log ¡A ªvÀø /µû¦ô ¤ñ°_¨ÅÀùtrial ¡A¤H¼Æ¤Ö ¥B ®Éµ{µu¡C ¦æ¬F¬yµ{¡AÁÙ¯uªº¤£¬O¤j®a·Q±o¨º»ò¨³³t¡C(°£«D«æ¨ì¹³ EBOLA VIRUS ªºª¬ªp) ¥H³Ìªñ°ê¤º°ß¤@ªºCASE¤¤¸Î ( ¥xÆWCASE§Ú̪¾¾å¨ÓÀs¥h¯ß¡A¤ñ¸û¦n»¡) ¤¤¸Î2015/02/24 Àò±oFDAªºBDT»{µý (Å¥»¡¬O°e¥ó®Ö³Æ§Y¥i¥H¶}©l§@ III trail ) ¡÷ ¤õ³t³Æ¸ê®Æ¡A2015/04/22³Æ»ô°eFDA ¡§®Ö³Æ¡¨ ¡÷ 2015/7/21 ¤~¥i¥H ¡§¶}©l¡¨ ¦¬²Ä¤@Ó¯f±w ! (¶Z®Ö³Æ¤w±µªñ3Ó¤ë!) ¡÷ ©Ò©¯ ¥un¦¬ 33¤H¡A¬°¤F³o33¤H¶}¤F ¤G¡B¤T¤Q®aÂå°|¨Ó¦¬ ¡÷ 8¤ë©³¦¬»ô ? ¡÷ ©Ò©¯¥un¥ý¬Ý 2WK«áªºprimary endpoint ¡÷ 9¤ë¤¤¦¯¼Æ¾Ú¥X¨Ó?¡A©Ò©¯ ¾A¥Î ¡§ºu°Ê¼f¬d¡¨ ¡A¶×Á`«á§Y¥i¥H´£¥æ FDA ¡÷ ¡B¡B¡B¡B ¡÷ µ²ªGÁÙ¬O ¡§±H±æ¡¨ 2016¦~®L¤Ñ«e? ( ²q3~5¤ë ????? ) ¤~¦³¾÷·|®³Ãĵý¡C ¦æ¬F¬yµ{¡A¨S¦³¤@¨ÇªB¤Í·Q¹³ªº¨º»ò§Ö°Õ¡C ©Ò¥H§Ú¦Û¤vªº §ë¸ê¤¤¤ß«ä·Q¡A±q¨Ó¨S¦³¦C¤J ¡§¯E¹©2017¦~©³ ¤§«e¥i¥H®³Ãĵý¡¨ May be ¡A2018¦~ 2H ¡A´Nºâ¬O ¡§¸U¨Æ¦p·N¡¨ Åo ~ ~ ¯d¦bµ§°O¥»¡A¤j¬ù¤@¦~«á´N¥iªì¨BÅçµý¤F ¡C (¦pªG¯E¹© ¨³³t¨ú±o BTD¸ê®æ¡A´N·|×¥¿) ¥H¤U¬O ¡§¦Û¤v½s¼@¡¨ ¡A§Úªº§ë¸ê¨Mµ¦¡A ¡§¥Ø«e¡¨ ´N¬O¬[ºc¦b¤U±¤GÓÅÞ¿è¤]¡C ¥ý°²³]¡A¯E¹©OBI-822¼Æ¾Ú ¡§«D±`«GÄR¡¨ 2016/2(?) ¸Ñª¼¡÷ 2016/4 (?) ¶×¾ã¸ê®Æ°e¥Ó½ÐBTD¡÷ 2016/7(?) 3Ӥ먳³t§åã ¡÷ Y¤ñ·Ó Palbociclib§K°µ¤T´Á¡A¦nÃö«YªºPfizer°ê»Ú¤jÃÄ°Ó®³BTD«á24Ó¤ë¡A µ¹¯E¹©¦Pµ¥Àu´f ¡÷ 2018¦~2H ®³Ãĵý¡C ¡÷ Yn§@ ¤p¤T´Á ¡÷¤ñ·Ó¤¤¸Î¬yµ{¡A®³¨ìBTD«á6Ó¤ë¶}©l§@ ? ( 2018/1 ? ) ¡÷ ¦¬¥ó¤H¼Æ¡BªvÀøµ{¡BÆ[¹îµ{ ³£·|¸ûªø ¡÷ 2019/6 (???) ®³Ãĵý¡A´N¬O¸U¨Æ¦p·N¤F¡C |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/11 ¤U¤È 12:37:29²Ä 1222 ½g¦^À³
|
CDK4/6¥«场开启¦b±æ¡X¡XFDAɬ¥ý审¬d辉·ç¨Å¸¢Àù©ú¬P药palbociclib 来·½¡G¥Íª«¨¦ 2014-10-15 10:39 2014¦~10¤ë15¤é讯 /¥Íª«¨¦BIOON/ --导读¡G辉·ç¡]Pfizer¡^¬ð¯}©Ê¨Å¸¢Àù药ª«palbociclib备¨ü业¬É关ª`¡A业¬É¦¹«e预测¡A¦pªG获§å¡A 该药¦~销°â®pÈ将¬ð¯}30亿¬ü¤¸¡A¦b¡m§Y将结§ô临§É试验ªº¥þ²y«½S药ª«TOP 15¡nº]单¤¤¦ì¦C²Ä¥|¡C¦¹«e¡A FDA¤w±Â¤©palbociclib¬ð¯}©Ê疗ªk认©w¡A¦Ó辉·ç¤_2014¦~8¤ë´£¥æ¤W¥«¥Ó请¡Cªñ¤é¡A该药¦b监ºÞ¤è±传来¤F¦n®ø®§¡C FDA将ɬ¥ý审¬dpalbociclib 辉·ç¡]Pfizer¡^ªñ¤é«Å¥¬¡AFDA¤w±µ¨ü审¬dpalbociclib·s药¥Ó请¡]NDA¡^¡A¦P时¤w±Â¤©É¬¥ý审¬d资®æ¡]Priority Review Status¡^¡A¦}¤w«ü©w处¤è药¥Î户¦¬费ªk¡]PDUFA¡^ ¥Ø标¤é´Á为2015¦~4¤ë13¤é¡C ɬ¥ý审¬d资®æ·N¨ý着FDA将¦b6个¤ë内§¹¦¨palbociclib NDAªº审¬d¡A¬Û¤ñ±`规ªº10个¤ë审¬d©P´Á缩µu¤F4个¤ë¡C ¦pªG获§å¡Apalbociclib+¦±Ðü¡]letrozole¡^联¦X疗ªk§@为ER+/HER2-±ß´Á¨Å¸¢Àùªº¤@线疗ªk¡A将为¦¨¤d¤WÉE转²¾©Ê¨Å¸¢Àù±wªÌ´£¨Ñ¤@个«nªº·s选择¡C palbociclib获§åÉó会«Ü¤j ¦¹«e¡A¦³学ªÌ对¤w获±oɬ¥ý审¬d资®æªº药ª«ªº历¥v§åã²v进¦æ¤F统计¡A发现¤F¤@个¦³½ìªº数Õu¡G获±oɬ¥ý审¬d资®æªº药ª«¡A²Ä¤@轮§åã²v为67.9%¡]72/106¡^¡F¦Ó标ã审¬dªº药ª«¤¤¡A这¤@数Õu仅为40.3%¡]79/196¡^¡C¦]¦¹¡A¦³¤ÀªR师预计¡Apalbociclib¦³«Ü¤jªºÉó会¯à获±oFDAªº§åã¡C ªñ¤L¦~来¡A辉·ç¤@ª½¨ü§x¤_µ}²¨ªº¬ã发ºÞ线¡AÌå«×´÷±æ¦¬获¤L个«½S产«~«®¶¶¯风¡C¦¹¦¸¡A辉·ç决©w奋¤O¤@·i¡A ¶È®ÚÕuII´Á临§É试验数Õu«K´£¥æpalbociclib¤W¥«¥Ó请¡C (ª`·N¡A¤§«eFDA¤w¤_2013¦~4¤ë±Â¤©palbociclib¬ð¯}©Ê疗ªk ) ¦Ó竞争对¤â诺华¡]Novartis¡^¤w¤_2013¦~11¤ë将¨äCDK4/6§í¨î剂LEE011±À进¦ÜIII´Á¬ã¨s¡A 预计¦b2016¦~´£¥æ¤W¥«¥Ó请¡A ¦Ó礼来¡]Eli Lilly¡^ªºCDK4/6§í¨î剂LY2835219ªº±À进¬Û对缓ºC¡A¬ã¨s进µ{¸¨¦Z¤_辉·ç©M诺华¡A¥Ø«e¤]¤w进¤JIII´Á¡A预计将¦b2017¦~´£¥æ¤W¥«¥Ó请¡C 辉·ç©Î²v¥ý¼À开CDK4/6¥«场 ¦pªG辉·ç这¤@¤j胆µ¦²¤获±o¦¨¥\¡Apalbociclib将²v¥ý¼À开CDK4/6§í¨î剂¥«场¡ALEE011©MLY2835219则¥u¯à§À随¨ä¦Z¡A该类药ª«将为¨Å¸¢Àùªº临§Éªv疗带来«¤j进¨B¡C palbociclib¬O¤@ÏúCDK4/6§í¨î剂¡A¯à够选择©Ê§í¨î细M©P´Á³J¥Õ¨Ì赖©Ê¿E酶4©M6¡]CDK4/6¡^¡A«ìÎ`细M©P´Á±±¨î¡Aªý断肿½F细M¼W´Þ¡C¦¹«e¡A FDA¤w¤_2013¦~4¤ë±Â¤©palbociclib¬ð¯}©Ê疗ªk¡A 辉·ç¤_2014¦~8¤ë¦VFDA´£¥æ¤F¤W¥«¥Ó请¡A寻¨D§åã¥Î¤_»Û¿E¯À¨üÊ^阳©Ê¡]ER+¡^¡B¤Hªí¥Ö¥Í长¦]¤l¨üÊ^2阴©Ê¡]HER2-¡^±ß´Á¨Å¸¢Àùªº¤@线ªv疗¡C palbociclib NDAªº´£¥æ¡A¬O°ò¤_II´ÁPALOMA-1¬ã¨sªº³ß¤H结ªG¡C数Õuªí©ú¡AÉO标ãªv疗药ª«¦±Ðü¡]letrozole¡^ªv疗组¬Û¤ñ¡Apalbociclib+¦±Ðü联¦X¥Î药组 ¯e¯f无进®i¥Í¦s´Á¡]PFS¡^¨ú±o¤F统计学·N义ªº显µÛ©µ长¡]20.2个¤ëvs 10.2个¤ë¡Ap=0.0004¡^¡A达¨ì¤F¬ã¨sªº¥Dn终点¡C 细M©P´Á¥¢±±¬OÀù¯gªº¤@个标§Ó©Ê¯S©º¡ACDK4/6¦b许¦hÀù¯g¤¤§¡过«×¬¡跃¡A导P细M¼W´Þ¥¢±±¡CCDK4/6¬O细M©P´Áªº关键调节¦]¤l¡A¯à够àD发细M©P´Á从¥Í长´Á¡]G1´Á¡^¦VDNAÎ`¨î´Á¡]S1´Á¡^转变¡C¦b»Û¿E¯À¨üÊ^阳©Ê¡]ER+¡^¨Å¸¢Àù¡]BC¡^¤¤¡ACDK |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/11 ¤W¤È 11:54:00²Ä 1221 ½g¦^À³
|
§Ú¬Ý¦n¯E¹©¬O¦]¬°§Ú¬Û«H¯Î°|ªøªº¬ã¨s±MªøÁÞ¤À¤l·sÃĤίE¹©¹Î¶¤¦b¬ü°êªº¸gÅç¡A§Ú¤]¬Û«HºÖ³ø¨Ó¦Û¼w¡A ³o´X¦~¨Ó§Ú¤@ª½Ãö¤ßÀô«O¡AÃÄ¥i±Ï¤H¡A§ïµ½¦Ã¬V¤]¥i±Ï¤H¡A¦bªÑ»ù¾ã²z´Á¶¡¡A¤£§«¥´¹q¸Üµ¹¦í°Ï¥ß©e¡Aijûªí¹F¹ï¹¦w»PªÅ®ð¦Ã¬V¡A¹D¸ô¦w¥þªºÃöÃh |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2015/6/11 ¤W¤È 11:50:54²Ä 1220 ½g¦^À³
|
¦U¦ìª©¤j¤j:¤p§Ì¬O¨S»{¯uºâ¹L¹w¦ôªºPFS ¦ý¦L¶H¤¤ ¦³¦¸ªÑªF·|±i¸³»¡¹L GLOBA H ¿@«×¦³¤À°ª¤¤§C ¦pªG¸Ñª¼¼Æ¾Ú¥X¨ÓÀ³¸Ó¤]¥i¤ñ¹ï¬O§_©MPD ¦³ÃöÁp ±N¨Ó¬O§_¤]¥i¯à¥ÎµLGLOBA H ¥h°£«á¦Aºëºâ¤@¦¸PFS ©M¬ü°êFDA½Í ¦]¬°¼Ð¹vÃÄ ·íµM´N¬On¹ï¯g¤UÃĪü~ ¦Ü©ó¥xÆWTFDA¼f®ÖÃÄÃҮɵ{§Ú¬O¤ñ¸û¨S«H¤ß ¬Ý³o¦¸OBI-833 INDªº¼f¬d«Kª¾!!¦³°÷ºC~ |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/11 ¤W¤È 11:49:34²Ä 1219 ½g¦^À³
|
¤¤¹D¤j¤j: ·PÁ±z¹ï¸ê¥»¥«³õ²{ª¬ªº¤ÀªR, ¯u¬OºëÅP, ¹é¹é¼Æ»y¹D¯}½L±¥ÍºA. ¨ØªA! ¨ØªA! ±z¹ï¯E¹©ªº·P¨¥, §Ú¤£¥uÅ¥¨ì©P¾Dªº¨cÄÌ, ¦Û¤v§ó¦³¿Ë¨ü. »¡±o¤Ó¦n¤F! ²@µLºÃ°Ýªº, ¯E¹©¬OÃø±oªº¬Ã¶Q¤½¥q, ¯à¦b¥xÆW³o¥«³õ¤W¥«µ¹§ë¸ê¤H§ë¸êªº¾÷·|, ¬O¥xÆW§ë¸ê¤HªººÖ®ð (·íµM³o¥u¬O§Úªº²L¨£). ¦ý¥¿¦p±z©Ò³¯z, ¥Í§Þ¥ÍÂ媺¥ÍºA»PªÑ²¼¥«³õªº¥ÍºA¬OºIµM¤£¦Pªº¥ÍºA, ¦b¸gÀç¤W¤]n¦³¤£¦Pªº«ä±©¤~¯à¦b¤£¦Pªº¥«³õ³£¯à¦¨¥\. ¥u¦³³o¼Ë, ¤~¯à¯u¥¿±a°Ê¥xÆWªº¥Í§Þ²£·~ÁÚ¦V¨}©Ê¥¿±ªº´`Àô. °µ¬°»âÀY¦Ï, ³oÀ³¬O¯E¹©³dµL®Ç¶Uªº¨Ï©R§a? ¥ô¦óªº¤½¥q, ¶ÆºC³£¬OP©R¶Ë, ¤£½×³o¶ÆºC¬O´Â¦V¨º£¸±¦V. ±z¹ï¯E¹©¤½¥qªº´£¿ô, ¯u¬O»y«¤ßªø, ´Á³\²`²`. °µ¬°¯E¹©ªºªø´ÁªÑªF(¥i¯à±z¤]¬O§a?), ¦V±zP·q. §Ú¤]§Æ±æ¦³¤½¥qªº¤H¯à¬Ý¨ì, ¯à¶Ç¹F. ÂIÂIºwºwªº´Á³\, ³£¬O¦ñÀH¤½¥qÁÚ¦V°ê»Ú¯Å¦Ê¦~¤j¤½¥qªº²Ö¿n. ¦P°ß°ß¤j¤@¼Ë, §Ú¤]¦Û¥»ª©ªºÆ[ªÌ§Ô¤£¦í¶}©lµo¤å, ¤@¬O¦]¨ü¯q¨}¦h, ¦P®É³Q¦U¦ì¤j¤jªº»{¯u§V¤O²`²`·P°Ê. ªÑ»ùªº°ÊÀúÃø§K, ¯u¥¿ªº¦n¤½¥q¥Ã»··|§e²{¥¦¯u¥¿ªº»ùÈ. °ÝÃD¬O, ¦h¤[§e²{ ? ¥b¦~? £¸¦~? ¤T¦~? ¤¦~? §e²{«á¤S¦p¦ó¯à«ùÄò ºû«ù¨ä»ùȩ󤣼Y ? ¥«³õ¤¤¤H¤H¤ß¤¤¤@§â¤Ø, ·í¤½¥q¦b¥«³õ¤Wªº¡¨«~µP¡¨¥X¨Ó¤§«á, ³o§â¤Ø´N·|§ä¨ìµû¶qªº°ò·Ç. §Æ±æ¦b¯E¤Í̪ººÊ·þ¤U, ¯E¹©¯à³v¨B«Ø¥ß¥X¦b¥«³õ¤Wªº¤f¸O, ±q¦Ó¦¨¬°£¸¸ê¥»¥«³õ¤W±j¦Ó¦³¤Oªº«~µP. ¦U¦ì¤j¤j, ¤j®a¥[ªo ! |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/11 ¤W¤È 11:37:40²Ä 1218 ½g¦^À³
|
¥xÁÞ¤j¡G ÁÂÁ«ü¾É¡A¦b³oºô¯¸¸g±`«ôŪ±zªº«ü¾É¤]²`¨ü¨äÀò§óª¾¯E¤Í·|¤w¦s¦b¦U¤èºë^¡K Ó¤H¤~²¨¾Ç²LP O¤å¥u¬O²¤ºÉ¤ß·N´£¿ô¤½¥q¸gÀç¸ê¥»¥«³õ¥i¥H°Ñ¦Òªº¦Ò¶q¡K¨£¯º¤]¨£½Ì¤F¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/11 ¤W¤È 11:25:06²Ä 1217 ½g¦^À³
|
¤¤¹D¤j «O¦u¦ôp§Ú¤ñ¸û»{¦P¤é²±¤ÀªR¤Î¥»ª©¦³«Ü¦h«e½úªº¤ÀªR¡A²Îp±À¦ô³o³¡¤À«D§Úªº±Mªø¡A¥H«e¦³¤ÀªR¤@´ÁÁ`¦s¬¡´Á¤ñ¨Ò¡A¦ý¦]¤H¼Æ¥u¦³27¤H¡A°Ñ¦Ò´N¦n¡A¦Ü©ó¤é²±»{¬°NED·|¦C¤JPFSpºâ¤Î¹êÅç²Õ¦¬®×®É¶¡³]©w2014¦~¤K¤ë¡A³o¨âÂIÀ³¦³¾÷·|§â«O¦u¦ôpÈ´£°ª¡A ·|´£°ª¦h¤Ö¡A¥u¦³¤W¤Ñ¤~ª¾¹D |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/11 ¤W¤È 11:23:08²Ä 1216 ½g¦^À³
|
§Y±Nµ²§ôÁ{§É¸ÕÅ窺¥þ²y«½SÃĪ«TOP 15 ±Æ¦W ÃĪ« ¤½¥q ¶i«× ¤ÀÃþ 2020¾P(»õ¬üª÷) ²b²{ÈNPV(»õ¬üª÷) 1¡B Nivolumab Bristol-Myers / BMS III´Á §ÜPD-1³æ§Ü 60 231 2¡B MK-3475 Merck ¤w´£¥æ §ÜPD-1³æ§Ü 41 167 3¡B Obeticholic acid Intercept¨îÃÄ III´Á FXR¿E°Ê¾¯ 30 114 4¡B Palbociclib Pfizer III´Á CDK4/6§í¨î¾¯ 30 79 5¡B RG7446 Roche III´Á §ÜPD-L1³æ§Ü 29 156 6¡B Ledipasvir/Sovaldi Gilead ¤w´£¥æ C¨xNS5A&NS5B 28 98 7¡BDCVax-L Northwest Bio III´Á Àù¯g¬Ì] 20 55 8¡BVX-809+ivacaftor Vertex¨îÃÄ III´Á CFTR½Õ¸`¾¯ 19 50 9¡BLCZ696 Novartis III´Á ARNI§í¨î¾¯ 13 30 10¡BLampalizumab Roche II´Á §Ü¸ÉÅé¦]¤l-D-³æ§Ü 11 45 11¡BEvolocumab Amgen III´Á §ÜPCSK9³æ§Ü 11 35 12¡BAlirocimab Sanofi III´Á §ÜPCSK9³æ§Ü 11 30 13¡BPlegridy Biogen ¤w´£¥æ ¤zÂZ¯À-beta 10 29 14¡BSecukinumab Novartis ¤w´£¥æ §ÜIL-17 ³æ§Ü 10 27 15¡BMEDI4736 Astrazeneca / AZN III´Á §ÜPD-L1³æ§Ü 10 47 ½Õ¬ã¾÷ºc¡A¤£°÷¥Î¥\¡A©Ò¥H¸¨±¼¤F ¯E¹©OBI-822 ?? |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/11 ¤W¤È 11:02:41²Ä 1215 ½g¦^À³
|
²q·Q¤j¡G½Ð±Ð±z¨Ì±z²{¥Î«O¦uªº°ò¦pºâ¤¤¦ìPSF¦³¾÷·|¸¨¦b¢°¢±¡ã¢°¢´Ó¤ë¶Ü¡HÁÂÁ«ü¾É¡I ¥xÁÞ¤j¡A¥ò´º¤j¬O§_¤]¯àÀµ½Ð±zÌ´£¨Ñ«O¦u±À¦ô¥XªºP F Sªº¤¤¦ì¼Æ¦³¾÷·|¸¨¦b¦h¤Ö¤ë¼Æ¡H¡HÁÂÁ¡I |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/11 ¤W¤È 10:51:53²Ä 1214 ½g¦^À³
|
¦ÛPO¤å³Í°ò¬O¦¹¬q¶^¶Õªº³Ì¤j¶°¤¤½æ½L«á¹j¤é´N¥¼¦A¶°¤¤½æ¥X¡yÀ³¸Ó¬O¥©¦X§a¡I¡z¡A¦ý¤u»È¡A¤¤«H«ùÄò¶R¤J¡K¼í®õ¥þÀ³¸Ó¦³¾÷·|©ó¥»¶g¤Sn¤½§i¦A¶R¤Jªñ¤d±i¯E¹©¤F |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/11 ¤W¤È 10:51:11²Ä 1213 ½g¦^À³
|
¥«³õ¥»¨Ó´N¬O³B©ó¤@Ó·¥«×¤£³z©úªºª¬ºA,¥x¿n¹q¬O¤½¥qªv²z«D±`³z©úªº¤@®a°ê»Ú¯Å¤½¥q,§A°Ý¥L¥¼¨Ó¨â©uªº¤½¥q¤º³¡q³æ¥X³f¤ñ,¥L·|§i¶D§A¶Ü?©Î¬OÄ«ªGA9ªºq³æ±µ¨ì¤F¦h¤Ö%? ¤½¥q¤¤·|¦³¤H¤£ª¾¹D¶Ü?¨ä¹ê«Ü¦h§Ú̹綠¥q·Qnªº¸ê°T,¤½¥q¤£¬O¨S¦³,¬O¥Ln¤£n´¦ÅS,³o¦³ªk³W¸ò«È¤á¤§¶¡«O±K¨ó©wµ¥µ¥ªº°ÝÃD,¦]¦¹«Ü¦h¹ï¤½¥qªºµû¦ô³£¥u¯à±q¤j¤è¦V©Î¬O¤W¤U´åªº¼t°Ó¨ÓµÛ¤â. ¥~¸ê¶R¤F¤@¬û¤lªº¥x¿n¹q,¥L̪ººÞ¹D¦³¦h¤Ö?¤j®aÀ³¸ÓÅ¥¹L¤@Ó¬ü°êÁ×ÀI°òª÷ªº¤j©@¦]¬°¤º½u¥æ©ö³Q»@¥¨´Ú,¤U±¤@Ó¬ã¨sû¬°¤F±oª¾¤@®aÃļtªºÃÄ·|¤£·|³q¹L,²V¶i¤FÁ{§ÉÂå®vªºªÀ¥æ°é,·íµM³Ì«á³£¬O³Q»@¥¨´Ú¸ò°µ¨c.Á|¤Z¦¹¨Ò¤£³ÓªTÁ|. ¸Ü¤S»¡¦^¨Ó¤F,´Á®ÉªÑ»ùªº±À°Ê´N¬OÄw½Xªºª§¹Ü¾Ô.´²¤á¥Ã»·³£¬O³Ì®z¶Õªº¤@¤è.¦]¦¹§ÚÓ¤H¤£³ßÅw¬Ý¨ì¤½¶}´CÅé¤@Pªº¼ÖÆ[, ¦]¬°³o¼Ë·|§l¤Þ´²¤áªº¶i¤J,¥t¤@¤è±´N¬OÄw½X¶]¨ì¤F´²¤á.¤Ï¤§,¬Ý¨ì¤F¸û¬°´dÆ[©Î¬O§QªÅ.§QªÅ¥i¯à¬O®ø®§±¤]¥i¯à¬O§Þ³N½u«¬¤Wªº,³o¤]³\´N¬O¦n®ø®§¤F. ¥Í§ÞÃþªÑªº¯S©Ê¸ò¹q¤l¬Û®t«Ü¤j,¹q¤lªÑÁÙ¦³¤W¤U¦³¼t°Ó¥i¥Hcheck,¥Í§ÞªÑ¨S¦³¶}µP«e´X¥G¬O¤@¤ùªº°g¯í,¦³¤ß¤H¤Ó®e©ö¥i¥H¥Î¦UºØªº¤èªk¨Ó¾Þ§Ë.¨ÏÄw½X¬y¦V¥L·Qnªº¦a¤è.¦]¬°¤j³¡¤Àªº¤H³£¬O¨S¦³¥ô¦óªº¤è¦V,°ß¤@µ¹§Aªº¤è¦V´N¬OªÑ»ù.¥un¦b³o¸Ì°Ê°Ê¤â¸},´X¥G«Ü¤Ö¦³¤H¤£³Q¼vÅT.¦A¥[¤W²{¦b´CÅ骺µo¹F.¦P·~lineªº¸s²Õ¥[¤W³ø³¹´CÅ餣¥I³d¥ôªº³ø¾É.´²¤á´X¥G´N¬O³½¦×. ¦]¦¹§Ú±j½Õªº¬O°ò¥»±»PÄw½X±´X¥G¦P¼Ëªº«n. ¼g³oªº¦P®É,ÂûÀnº¦°±,130-140¥«³õ³£¦b¶Ç¥LÃÄ¥¢±Ñ¤F.¯uªº¥¢±Ñ¤F¶Ü?§Ú¤]·d¤£À´,«e´X¤Ñªº¨«¶Õ¬Ý°_¨Ó¯uªº¹³¬O¥¢±Ñ¤F.¦ý¬O¥L¯uªº¥¢±Ñ¤F¶Ü?¦pªG¦¨¥\¤F©O?§Ú¬Û«H¤j®aÀ³¸Ó³£¨S¦³µª®×,¦pªGª¾¹Dµª®×ªº,²{¦b´X¥G¥i¥H¦bµª®×¤½§G«e±q®e¥¬§½.³o¸ÌÁÙ¬O«Ü·PÁ¹L¥h¹ï°ò¥»±©M§Þ³N±©Î¬O®ø®§±°^Äm¤j¶q¤ß¤Oªº¯E¤ÍÌ.ÁÂÁ§A̪º¥I¥X. |
|
|
·|û¡G¯EÃvµLÃä10140526 µoªí®É¶¡:2015/6/11 ¤W¤È 10:29:30²Ä 1212 ½g¦^À³
|
¦Û¤vªº¤ú³£¯à«r¨ì¦Û¤vªº¦Þ,¦³¨Ç¨Æ¦Û¤v®a¤H³£¤£¤@©w¯àÅ¥§Aªº, ¦A¥«³õ¸Ì¨CÓ¤H¦U¦Û¦³·Qªk ¤]µL¶·½Ö´£¿ô½Ön«ç¼Ë, §Ú·Q¥»ª©¤j¤j³£¼ö¤ßªº§â¥L¹ï822§óÁͪñµ²ªG§@¤ÀªR ¹ï§Ú¦Ó¨¥³o¤~¬O«ÂI ¦Ü©ó·|¶^¨ì¦h¤Ö¤~¶R ¤j¤á¥X1/3...¨º´N´±§Ö½æ¥H«á¦A¶R§a! ¦pªG§A¦Û¤v¬Û«H§A¬O¯«ªº¸Ü~ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/11 ¤W¤È 10:25:31²Ä 1211 ½g¦^À³
|
¤p¯E¤j: ok,°²³]±z»¡±o³£¹ï,¦æ¾P¥i¥H±j¨ì·m¤Uherceptin¤@¥b¥«³õ,eps6~7´N¬O²Ä¤@ӥؼР¥»¯q¤ñµ¹³Ì°ª30¿,ªÑ»ùªì¨B¤ä¼µ¬°180-210¤¸? |
|
|
·|û¡G¤p¯E10135877 µoªí®É¶¡:2015/6/11 ¤W¤È 10:19:05²Ä 1210 ½g¦^À³
|
¥h¦~¶PÀù¥¥xÆW½æ¥X¬ù20»õ,Y¥xÆWÃÄÃүள¨ì,¹w¦ô¥i·m¤U¤@¥b¥«³õ10»õ,¥t¥~¥[¤W¤T³±©Ê¨ÅÀù¥i¬ù10»õ,YÀç§Q²v§ì¤@¥b¬ù¥i¬°eps6~7¤¸,ªp¥B¤£¥]¬A¸¨Ó¥xÆWªvÀøªº¯f±w, ²³ø¤¤2016¦³topline¤]«Ü¥i¯à«üÀ禬 |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/11 ¤W¤È 10:17:28²Ä 1209 ½g¦^À³
|
º¥ý§Ú¦b¦¹²`²`ªº¤@Áù°`¡G¡iª©¥DÁÂÁ±z¡j¡ã¥\¼wµL¶q¡I ½t¡Aµ½½t¡AºÖ®ð»P¬Ã¶Qªº¯E¤ÍªÑªFÌ¡A¸Û¼°ªºÁÂÁ¤j®aªº±M·~pºâ»P¸gÅçµL¨pªº¤À¨É¡A±aµ¹§Ú¦b¸ê¥»¥«³õ¼i¾ú¼Æ¬B¦~¨Ó§Ú±q¨Ó¥¼¦³ªº·P°Ê¡KÁÂÁ¡KÁÂÁ¤j®a±a¨Óªº¤@¤Á·Å·x¡I °ß±©¤j¡A¥xÁÞ¤j¡A¥ò´º¤j¡A²q·Q¤j¡K¤Î¨ä¥L¤j¤j¦P¨ÆªÑªF¹ï±z̪º´L·q¤@¤Á©ó¤ß¡A¦b¦¹´N¤]¤£¨£¥~«È®M¤F¡I¡y¼e½Ì¡z¡I §Ú¬Û«H¦b¦¹°Q½×ªº¯E¤Í³£¬O¯E¹©ªºªÑªF¤]¦p°ß±©¤j¯ë³£¬O¼ÖÆ[¬Ý«Ý¢·¢±¢±ªº¥¼¨Óµo®i¡I ¦A¦¹¤]¨Ì¸gÅç©IÆ~¤½¥q¸gÀçªÌ¡y¯u§Æ±æ³o¬O¤½¥q³]ªº±MÄݺôx¡z¡K»P¥þÅé¡i«i´±¡jªºªÑªFÌ«µø¡m°ß±©¤j¡nW¤ßªº´£¿ô¡K¡I ¨Ì§ÚÓ¤Hªº²L¨£±N¸gÅ礧½Í´£¥X¦p¤U¡G¤]¬ß¤£§[½ç±Ð«ü¥¿¡I µL½×¥ô¦ó¥ø·~¡A°Ó«~¡AÃĪ«¬Æ¦Ü§ë¸ê¥«³õ§Ú·Q³£Áפ£¶}¤@¤j·Ç«h¡A¨º´N¬O¡i¥«³õ¥Ã»·¬O¹ïªº¡j¡I¤]¸Û¦p°ß±©¤j©Ò¨¥¡m¥«³õ¥Ã»·¥u¦³§Ṳ́£ª¾¹Dªº¡A¦Ó¤£·|¦³§Ú̪¾¹D¦Ó§O¤H¤£ª¾¹Dªº¡n¡I¤×¨ä¬O¸ê¥»¥«³õ§ó¬O³B³B¦p¦¹¤]§ó¬O¬ðÅã§Ú̯E¤ÍªÑªF¶°«ä¼s¯qªº¬Ã¶Q»ùÈ¡C ©Ò¥H¨ä¹ê¯u¥¿²z©Ê¦³¸gÅ窺¸êª÷¤×¨ä¬O°òª÷¡Aªk¤H³£·|¯S§O«µø¤@®a¤½¥qªº³z©ú¡A¤½¶}¡A¤½¥ªº¸Û«H»P¹ï§ë¸êªÌªººA«×¡A¦]¬°³o¤]´N¬O¥ý¾Ü¸gÀçªÌªº¤å¤Æ¡A¤å©ú¼h¦¸¡K¤×¨ä¬Oµ½©óªø§ëªº°òª÷³æ¦ì¡I ¥«³õ¤¤ªº¤@¥y¸gÅçªk«h¡yµu¦h¤£¦º¤j½L¶^¶Õ¤£¤î¡AӪѷí¨R¤£Â_º¦¶Õ©ö¤¤Â_¡z¡A¦ý²{¤µªº¸ê¥»¥«³õ¦b¬Fµ¦»P¨î«×¤U¤j¶q¶}©ñ¹ªÀy·í¨R±N¡y¸ê¥»¥«³õ¡zÅܬۧᦱ¦¨¡y§ë¾÷¥«³õ¡z¤]´N¬Oµ¥©ó»s³y¤F¤j¶qªºµu¦h¡A©Ò¥H¯u¥¿ªº§ë¸ê¸êª÷¤j¶qªº©âÂ÷¥«³õ¨ä¦]¬OªÑ²¼¦A¤]¤£©ö»ôº¦»ô¶^¡A¯u¥¿n©Ô©ï¤]¤£©ö¡A¹ªÀy·í¨Rµ¥©ó¨C®a¤½¥qÄw½XµL¡I¦]¦¹ªø½u¸êª÷·|¥u¶°¤¤¦b³Ì¦n³ÌÀu¨qªº¤½¥q¡I¨ä¥L¤½¥q³£·|¥¢¦å¦Óº¥º¥¦¨¤U¶^ÁͶեu¬O®É¶¡½ü´À¦Ó¤w¡I ¦b¸êª÷»PÄw½Xªº¨Ñ»ÝÃö«Y¤W¡K¦b¥[Åv¥§¡ªÑ¥»»P²{¥«³õºD©Êªº¦¨¥æȤW³£¥i¥H§PÂ_¥X¨ä¨Ñ»Ýªº¥¢¿Å¡K©Ò¥H¤@®a¤½¥qªº³z©ú¡A¤½¶}»P¸Û«H¡A¹ïªÑªFªººA«×¤w¸g¬O¤½¥q»P¥þÅéªÑªF¥²¶·«µøªºªø½u¸gÀç°ÝÃD¡I¤]ª½±µÃö«Y¨ì¥«³õªk¤H³ø§iÄ@µ¹ªº¥»¯q¤ñªº°ª§C¡I §Ú·Q§ë¸ê¯E¹©ªºªÑªF³£¬O¡i«i´±¡jªºªÑªF¡F¤]·|²`²`ªº¬è¬ß¸gÀçªÌ¬O°ª¤å¤Æ¡A¤å©ú¼h¦¸ªº»â¾ÉªÌÅý¸ê¥»¥«³õªº§ë¸ê¤HªÖ©w¦Ó«H¥ô¡I¶i¦Ó¬ÛÄ~§ë¸ê¡I ¦ý¬O¡K¡K¡K¦b§Ú¸g¾ú¤¤½T¹ê¬O¸I¨ì«Ü¦hÀ´²£·~¸gÀç«o¤£À´¸ê¥»¥«³õ¸gÀ窺¤½¥q¡A¸gÀçªÌ¡m¹j¦æ¦p¹j¤s¡n¤Ñ¤ÑW¹ÄªÑ»ù©e©}¤]¤é¥HÄ~©]ÅýªÑªF³d½|«o¤£ª¾°ÝÃD¥X¦b¨º¡K¡K¡H¡H¡H¡H¡H¡H ¬Æ¦Ü¶R¦A¦hªº®wÂêѤ]µLªk¤Þ°_¥«³õ»{¦P§ó§O»¡¬O¦@»ï¤F¡K¡I §ÚÓ¤H»{¬°¦b½Ñ¦h±M·~¤S²Ó¤ßªº¯E¤ÍªÑªF¤j¤jpºâ¥X¨Óªº¤¤¦ìP F SµL½×¬O¢°¢±¡F¢°¢´¡F¢±¢¯¹ï¯E¹©ªºªø½u¥¼¨Ó³£¬O¥ú©ú«e´º¡A¤]¬O¦b¥xÆW²LºÐ«¬¸ê¥»¥«³õ¤¤µ}¤Öªº§ë¸ê¾÷·|¡I ¦]¬°¦³¢·¢±¢±ªºÁÞ¤À¤l²z½×Á{§É¦¨¥\¦ÛµM¢·¢²¢²ªº©µÄòµo®i´N©ö§Ö¦ÓÂE¹Ï¤j®i¡K¤Ï¤§¡K¨ä¥L¡K¡K¡H¦A»¡°Õ¡I §ÚÓ¤H¬O«Ü§Æ±æ¦b³o¯E¤Í·|¤¤¬O¼çÂõۦ³¯E¹©¤½¥qªº¥DºÞ¶¥¼h¡K§Æ±æ¥L̯à¬Ý¨ì§ë¸êªÑªF¦]µLª¾¦Ó·Î¼õ¡A¦ý«o¹Îµ²»P¤ä«ù¤½¥qªººA«×¡I ¦b³o¼Æ¤ë¤¤¤½¥q½T¹ê³ÐÁ|¤F«Ü¦h¥O¤½¥q«Ü©öªø´Á¨ü¶Ë®`ªº¨Æ¹ê¦p¦A¤£¥[ªo½T¹ê¬O¦³¾÷·|³y¦¨¥þÅéªÑªF»P¤u§@¦P¨Æ¦P¤¯ªº§Q¯q¶Ë®`¡I «Ø¨¥¦p¤U¡G ¢°¡n¡GÁÙµ¹ªÑªF¥¿¦W¡y¥þ¥«³õ½|½¤Ñ¡z¡ã ªÑ²¼¥«³õ¥¿¦W¬O¡y¸ê¥»¥D¸q¤Uªº¸ê¥»¥«³õ¡z ¥u¦³¸gÀçªÌ»P§ë¸ê¤H¡A¦ó¨Ó¤§¡y§g¡A¥Á¡z¤§ºÙ¡I³o¬O½ÇÁÙ¬O¶S¡A¯u¬OӶƺCªº³ÐÁ|¤§ºÙ¡I ¯E¹©¦¨¥\¦¨¬°¯E¹©°ê¤F¶Ü¡H ¥H¦¹ºÙ©I¥Ø«e¡m«i´±¡n«ùªÑªÑªF¬O´L«¶Ü¡H¬O¤½¥¶Ü¡H§Ú·Q¥u¬O¬ðÅ㤽¥q¸gÀçªÌªº´L¶Q¤F§a¡I½Ö¦³¹ê§Q¡I¡y¥«³õ¹ê¤á°òª÷¸g²z¤H´±«ã¤£´±¨¥¡z¡I©ó¤½¥q¬O¥¿±§Î¶H¶Ü¡H ªÑ¤ý¡AªÑ¦Z¡A¥x¿n¹q¦³¦p¦¹¶ÆºC¶Ü¡H ¢±¡n¡G¤½¥q¦P¤¯¨¯W§V¤Oº¥¨£¦¨ªG¡A¤½¥q¥X¸ê¹Î¹C·íµM¬O²z©Ò·íµM¤]³dµL®Ç¶UªººÖ§Q¡A¦ý¦b«Dªø°²¤é©~µM±N¤½¥q©ñªÅ«°¥u¯d´X¦ì¯d¦u¡A³sÁ`¾÷³£µL¤H±µÅ¥¬O§_¦³¦Ò¼{ªÑªF§ë¸êªº·ÀI¡y¤Ñ¨a¤Hº×¤£¥i´ú¡z¦³Ó¸U¤@½Ö¦¬¬B»Pµ½«á¡A¤½¥q¦p¦ó¦A¸gÀç¤U¥h¡K¡K³o¹ïªÑªFt³d¶Ü¡HªÑªF¯à¦w¤ß¶Ü¡H¡I¡i³o¤]¬O¤W¥«¤½¥qªº³ÐÁ|¡z¡I ¢²¡n¡Gµo¨¥Åé¨tªº´²º©»P¶ÆºC¡Kµo¨¥¤HªººA«×»P¨¥Ãã¥H¤Î¹ïªÑªFªº½Ð¯q¯u¬O¤Ö¨£ªº¼Ål§ó±`§_»{¸gÀ綥¼h©Ò¨¥ªº¨Æ¹ê©Î¡K¡Knª¾¤½¥qªº¤å¤Æ¼h¦¸»P¥«³õªº»{¦P«×¡Aµ¹¤©ªº¥»¯q¤ñ°ª§C¬O»Pµo¨¥¤H®§®§¬ÛÃöªº¡K¡I ¦A¤@¦¸ªº·PÁ¦U¦ì¤j¤jªº¦@¨Æ¦@·~¡I¸ÛÀµ©IÆ~¤j®a¥[ªo¦@³Ð¥Í§Þ§ë¸ê©_ÂÝ¡I §ó¬è¬ß¡y¯E¹©¤½¥q¸gÀçªÌ¡z¬°¦Û¤v¬°ªÑªF¯à¬Ã±¤¤]¸ÛÀµªº¹ï«Ý§Ú̳o¸s¡y«i´±¡zªºªÑªF¡I ¤]¦b¦¹©IÆ~¤½¥q¸gÀçªÌÅé½ÌªÑªFªº±M·~¤£¨¬¦b¥i¥Hªº½d³ò¤ººÉ¶q´£¨ÑªÑªF©ú½Tªº¶i«×¡A¼Æ¦r»P«ü¾É¦Ó«Dµª«D©Ò°ÝªºµLºÉ§é¿i»PªÑªF¤£¦w¤ßªº²q´ú¡I¡iÅýªÑªF¦w¤ßÅý¥«³õ¨ä¥L¥¼§ë¸êªº¥«³õ§ë¸ê¤H»{¦P¤½¥qªº«~¼w¡AÀ³¸Ó¬Oµ´¹ï¥¿½Tªº§Q¤H§Q¤v¤§µ½¦æ¡j¡I |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/11 ¤W¤È 10:14:04²Ä 1208 ½g¦^À³
|
¤p¯E¤j,or¼Ú¤j,or¤po¤j ±z¥i¥H¥h°Ý¤@¤U¾Ç¹L²Îpªº¤H ¨S¦³¹ï·Ó²Õªº¸Ü "6","7","8"³o¤TӼƦr¹ï¥L̬ݰ_¨Ó¦³¨S¦³®t²§ |
|
|
·|û¡G¤p¯E10135877 µoªí®É¶¡:2015/6/11 ¤W¤È 10:07:27²Ä 1207 ½g¦^À³
|
¨S¿ìªk»¡ªA¬O¦³¦¨¨£ªÌªº¨Æ§a,¥i¥H»¡ªA¯f±w±Ï©R¬O¥Lªº¨Æ§a,¦pªG¥»¨Ó´N¦³¦¨¨£¦p¦ó»¡ªA©O, |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/11 ¤W¤È 10:06:56²Ä 1206 ½g¦^À³
|
Bravo ! °ß°ß¤j »¡ªº¦n¡C¤@Å¥«Kª¾¬O§Ú½ú¤¤¤H ¡C ¡§¥þ±©Ê¬ì¾Ç¡¨ ¡A¤£¬O¥u¦³°Q½× ¡§PFS¡¨ ¡§PD229¡¨ ¡FÁÙn¥]¬A¡G ¡§Á`¸g¡¨ ¡÷ ª÷¿Ä®ü¼S¨Ó®É¡A¦A¤jªº«Ø¿v¤]¬OºR¬\©Ô¦´¡C (¤ñ¯q¤ñn20¿? 15¿? 10¿? ¡÷ ¬Ý·í®Éªº Á`¸gÀô¹Ò°Õ) ¡§¦¸Á`¸g¡¨ ¡÷ ¥Í§Þ±Ú¸s¹L¼ö«á°h¿N¡A¥þ±©Ê¸êª÷²¾°Ê¡C ¤§«eªº¹L¼ö¡A¤w±q¤W¥«Âd ¡÷¿³Âd ¡÷ ¿³Âd«e©Ó¾P°Ó·m®×¶Ã¶}»ù ¡÷·s³]¥ß¤½¥q ³Ð§ë¶Ã¶}»ù ¶Ã¶HÂO¥Í~ Äꨡ¥R¼Æ~ ¡§Ó¸g(¤@) ¡¨ ¡÷ ©h¥B¦W¤§¤ê: ¾Ç³N°ò¥»±¡C´N¬OPSF¡BPD229¡A¥þ²y«½SÃÄ¥«³õ¡A Cancer¥ÎÃÄI¡BII¡BIII´ÁªºÄvª§ªÌ¡B¡B¡B¡B¡B¡B ¡§Ó¸g(¤G) ¡÷ ©h¥B¦W¤§¤ê:ªÑ²¼¥«³õ°ò¥»±¡C´N¬OÄw½X¡B¸êª÷(¤j½L¡B¥Í§Þ)¡B®Éµ{¡B¡B¡B¡B ¤S¡A§Úµ½·N´£¿ô¡A·íµM«Ü¦h¤H·|»¡ : ¡§¦pªG§ë¸ê·sÃÄ¥¢±Ñ¡A´N·í¦¨°µ¥\¼w¡¨ ªì°J¤ß©À¤W§¹¥þ¦P·N¡C·íªì§^¥ç¦p¬O¡C¬G¦³¦hÀɤḹ¡A¬O¦b100¸¹¤§¤º¤º¤º¡C ¦ý¬O¥t¤@Ó·Qªk : ¤@½XÂk¤@½X¡A§ë¸ê´N¬O§V¤O¬ã¨s§ë¸êÁÈ¿ú¡A¥\¼w´N¬O§V¤OÀ°¤H¾A·í®½´Ú ¡C §â¤GªÌ·d¦b¤@°_¡A¦Û¤vªºÅÞ¿è¤GÃä¸õ¨Ó¸õ¥h¡A¤]¤£¨£±o¦n ? ? ~ ~ ~ («ÝÄò) «¢~ ¨ü°ß°ß¤j ·P¥l¡A¼g¤F¤@¤j°ï¡A «á¨Óµoı¡AÁ¿¤Ó¦h¤F¡A¥ý¶K¤@¥b ~ ~ ~ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/11 ¤W¤È 10:02:16²Ä 1205 ½g¦^À³
|
°ò¥»¤W³oÓphase 2/3 study¨Ã¨S¦³®³herceptin·í¹ï·Ó²Õ ©Ò¥H9Ó¤ë>PFS>6Ӥ몺¸Ü,¼Æ¾ÚµLªk»¡ªA§Ú¨äÀø®Ä¤ñherceptin¦n |
|
|
·|û¡G¤p¯E10135877 µoªí®É¶¡:2015/6/11 ¤W¤È 09:54:15²Ä 1204 ½g¦^À³
|
±i¸³¤@¦A±j½Õ»P¶PÀù¥ªºpfs 6Ӥ밵¤ñ¸û,¥Ø¼Ð¬O¨ì9Ó¤ë, ©Ò¥H¤½¥qªº§C¼Ð¬O6Ó¤ë,°ª¼Ð¬O9Ó¤ë,¥un9Ó¤ë>psf>6Ó¤ë,¤´Ä¹¹L¶PÀù¥,¥xÆWÁÙ¬O·|µ¹¤©ÃÄÃÒ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/11 ¤W¤È 09:43:32²Ä 1203 ½g¦^À³
|
¨ä¹êpfs>= 15Ӥ볣ºâ¬O¼ÖÆ[ªº¼Æ¾Ú,¥i¬OÅܼƤӦh,À³¸Ón°Q½×¤@¤U´dÆ[ªº¼Æ¾Ú,¤~ª¾¹D©³¥i¯à¦bþ ´dÆ[ªº¼Æ¾Ú¦³¨âºØ1. pfs¤¶©ó9-15 months¤§¶¡; 2. pfs< 9 months, «áªÌ=ÂûÀn¨«¶Õ¤£¥Î¦A´£, ¦pªGobi822¨ÅÀù¥ÎÃÄpfs¤¶©ó9-15 months¤§¶¡(§Ú·Q³o¤]¬O¤½¥q©Òqªº§C¼Ð) ³oÓÃÄÁٯন¬°blockbuster¶Ü? ³o®a¤½¥qªº»ùȤj·§·|¬O¦p¦ó? §Ú·Q³oÀ³¸Óȱo±´°Q§a! |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/6/11 ¤W¤È 09:23:30²Ä 1202 ½g¦^À³
|
·PÁ²q·Q¤j¡BJolin¤jªº«ü¾É ²q·Q¤jô±z¹ê¦b¤ÓÁ¾µê¤Ó«È®ð¤F¡A¤p§Ì«ôªA ª¾¹D¦U¦ì¤jªº"³]©w±ø¥ó"¤§«á ¦Ñ¹«¥¿¦b½Ð¥Ü¯«©ú¦p¦ó±N¦U¦ì¤jôªº°²³]·f«Ø¾ô¼Ù ¨Ò¦p±N10130510¤jªº¹Ú¹Ò©ñ¶i¥h¡A«hK-M¥i¯àÁÙn´XÓ¤ë¤~·|IJ¨ì0.5¡H Y¦pJolin¤j°²³]¡A²{¦b¥i¯à³£¬OGLOBO-ªº¥X²{´c¤Æ¡A ¦ý¥un¬OGLOBO+¡APFS´N·|©Ô«Üªø¡A¤]´N¬O¥¼¨Ó´XÓ¤ë¹êÅç²Õ¨C¤ë·s¼WPDÀ³¸Ó·|«Ü¤Ö ¦bPD<160ªº±¡ªp¤U¡APFS¥i±æ©µªø....... ²q·Q¤jô»¡ªº¹ï¡G²q²q²q ¤@¤Á³£¬O²q ¶È¨Ñ°Ñ¦Ò¡]²q·Q¤jô±z²qªºPFS¬O¦h¤Ö©O¡H¡^ ¦p¤p©_¤jªºpºâ¡Gºâ¬O3¤ë¤w¹F¨ì0.5ªº¤ô¥½u¡AM PFS ¤]·|¦³19Ó¤ë ¦Ñ¹«·Q°_rabbit¤j»¡ªº(2015/2/6¤U¤È02:20:50 ) ¨S¦³Àø®Ä¡Aµ´¹ï¨S¦³¥«³õ¡A ¦ý¦³Àø®Ä¡A¤£¤@©w¦³¥«³õ¡C ¤×¨ä¬O¦b¬ü°ê¡C ÃĮijQÃÒ©ú¤FÀø®Ä¡A«á±´N¬O³q¸ô¦æ¾Pªº°ÝÃD¡C ®³°²©w¥¼¨ÓY¬O©MRoche¦X§@¡A¥ú¨Ï¥ÎHerceptinªºÂå®v©MÁ{§É¬ã¨s¾÷ºc´N¬O³Ì¤jªº³q¸ô(2015/2/6¤W¤È10:13:41 ) ¦ÛÀç¡A¨º®É¶¡±N·|©ì±o«Üªø¡A³q©¹ EPS 200 ¶ôªº¸ô³~¤]±N§ó»»»·§óÁ}¨¯¡A¬Æ¦Ü¾÷²v§C Ó¤H»{©w¦ÛÀ窺¾÷²v´X¥G¬O¹s¡A©Ò¥H±i¸³»P Merck ªº®¦«è±¡¤³¡A¥¼¨Ó±NÁÙ¬O¦³¾÷·|¦¨¬°¯ù¾l¶º«áªº¤K¨ö¶¢²á XD ¦Ó¥B¦ÛÀ窺»{©w¦³ªk«ß°ÝÃD(¨Ò¦p¬ü°ê OBI ¤l¤½¥qºâ¤£ºâ²Ä¤TªÌ)¡A©¡®É Merck ¾÷¨®ªº¾ú¥v§Ú¥i¤£Ä@¥¦µo¥Í¦b OBI-822 ¤W¡C ¦pªG822¦³30Ó¤ë¥H¤W¡A¤½¥q¥i¯à·|¦³«Ü±jªº¥ø¹Ï¤ßn¦Û¤v¸gÀç¬ü°ê¥«³õ ¦pªG822"¥u¦³"19Ó¤ë¥H¤W¡A¤½¥q¬ü°ê¦ÛÀ窺¥ø¹Ï¤ß·|¤£·|µy·L°¤@¨Ç¡H ¹ï©óè¦bPD-1¨ú±o»â¥ýªºMERCK·|«ç»ò·Q¡H·|¤£·|©ñµÛfirst right of refusal¤£¥Î¡H ¥H«eOBIÄÀ¥Xªº°T®§³£¬On¦ÛÀç¬ü°ê ªÑªF·|¤WºA«×¨S³o»ò°í«ù¤F ·R«}"¼È©w¤j¤¤°ê°ÏÁÙ¦³¬ü°ê§Ú̧Ʊæ¥i¥H¦Û¤v¥h¸gÀç¡A¦ý¬O³o¤£¬O¦ºªº¡A¥H¹ïªÑªF³Ì¤j§Q¯q¥h±Ä¨ú§Ú̪ºµ¦²¤" ÁÚ¥i±µµÛ¸É¥R"§Ú̸ò¤j¤½¥q¤¤¶¡ªº·¾³q¬O¤@ª½¦b¶i¦æªº¡AMerck¹ï822ªº²£«~¦³first right of refusal¡A¥L¦³Àu¥ý¨Ó¸ò§ÚÌ°Ó°Q±N¨Óªº¦@¦P¶}µo¤]¦n¡A±ÂÅv¤]¦n¡A¤£¹L¥Lªº±ø¥ó¤@©wn³Ì¦nªº" PFS¥¼¹F30~40Ó¤ë¥P¤¦µ¥¯Å©Î³\Åý¤£¤Ö¤jô¥¢±æ¤F ¦ýmaybe«P¦¨Àq¨FªF»POBI¦X§@ ¥¢¤§®á·®¦¬¤§ªF¶¨ ³o¬O¦Ñ¹«¤p¤p¸£³U¤Uªº²q´ú |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/11 ¤W¤È 08:42:38²Ä 1201 ½g¦^À³
|
·PÁ¦¹ª©¤¤ªº²{¦³°ª¤â¤À¨É¬Ýªk»P¤ÀªR¡A §ó§Æ±æ¯àÂǦ¹©ß¿j¤Þ¥É¡A¨Ï§ó¦hªºª×Às/»ñÂú/Ãe²Î/Ĭ¯³µ¥½ú¥X¤s¡A ´£¨ÑÄ_¶Qªº·N¨£¨Ñ¨ä©Ò¦³§ë¸ê°Ñ¦Ò¡A ¾®»E¥¿±¤O¶q©M®e¯Ç¥¿¤Ï¨â¤è¸ê°T¡A¸Ô¥[©âµ·éõ¡A ڨϤK¤è·«B¶×¤¤¦{¡A¨}¹ôºCºCªº³v¥«³õ¤¤¦H¹ô! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/11 ¤W¤È 08:22:38²Ä 1200 ½g¦^À³
|
´²¤á¤j ±z¦n¥Î¥\§r! °ò¥»¤W ±z»¡ªº ¡§§Ú±N§Aªþªº¸ê®Æ¥Îexcel««Ø¹L¤§«á¡Aµo²{¦pªG³]¸ê®ÆÁ`¼Æ100(±¡ªpA)¤£ÅÜ¡A ¦ý±N¨ä¤À§G§ïÅܤ@¤U¡A«hµ²ªG±N¦³¤£¦P¡C¡¨¬O¨S¿ùªº ±N³]¸ê®Æ(¦b¬Û¦P¼Æ¶q¤U)¸m©ó«e ¨ä¹F¨ì0.5©Ò»Ýªº´c¤Æ¤H¼Æ±N·|´î¤Ö ¤Ï¤§¥çµM ©Ò¥H¤p§Ì¥Î¤F¤@Ó«e´£ ¡§ ¥B´X¥G¥H§¡¤Ã¤À¥¬¨Ó¼ÒÀÀpºâ ¡¨ ¦ý¨Æ¹ê¤W¤£¥i¯à³o¼Ë§¡¤Ã±Æ¦C ©Ò¥H·|¦³»~®t ±zªº²Ä¤GÓ°ÝÃD ²³æ»¡À³¬O¤£ª¾PD®É¶¡ªº¼Æ¾Ú §¡ºÙ¬°³]¸ê®Æ ¦b¬Y¤@®ÉÂI(¦p¸Ñª¼(°²³]2015.10¤ë)®É ³o®É¥þ³¡¸ê®Æ¤~·|½µP) §ÚÌnpºâ¥ÎÃIJժº¤¤¦ìPFS ¨º´N§â¥ÎÃIJժº±wªÌ ¤£ºÞ¬O¤wPD ©Î¥¼PD §¡¨Ì¨ä®É¶¡ªøµu«ö§Ç²VÂø±Æ¦C °h¥XªÌ¤]¨Ì¨ä°h¥X®É¶¡ªºªø«× ¥H³]¸ê®Æ±Æ¦C¨ä¤¤ ³o®É §ÚÌ·|¦³Ãþ¦üªþªí©Ò¥Üªºªí®æ ¥u¬O«eÀY¦h¥[¤F¤@Ó¤wPDªº®É¶¡ ©Î¥¼PDªº®É¶¡ ¥Îªþªí©Ò¥Üªººâªk §ÚÌ·|±o¨ì¤@ÓÁ`¥Í¦s¾÷²v¶^¯}0.5ªº´c¤ÆÃöÁä¤H(²ºÙ¬°A) Aªº´c¤ÆPD®É¶¡ªø«× ´N¬O¥ÎÃIJժº¤¤¦ìPFS ¦b±Æ§Ç¤¤ Aªº«e«áÀ³¸Ó§¡¦³¤wPD©M¥¼PDªº¼Æ¾Ú ©Ò¥H ¦b¥¼¸Ñª¼¤§«e ¤@¤Á¥u¯à°µ¦X²zªº²q´ú ¦]¬°§Ú̮ڥ»¤£ª¾³oӱƧǪø±o«ç¼Ë §ÚÌ¥u¯à¥ÎPD229ªº¼Æ¾Ú¥h²q´ú ´c¤Æ¤H¼Æ¥i¯à±µªñ¥i¥H¬ï¶V0.5ªº©Ò»Ý¤H¼Æ ¤]´N¬O»¡¤¤¦ìPFS§Ön©³©w¤F ±zªº²Ä¤TÓ°ÝÃD ¤p§Ì¤£¤Ó¤F¸Ñ ª½±µ¥ÎCR/LR¤ñÈ ¤ñ¸û®e©öºâ Yn¥Î¯u¥¿«e¤@®ÉÂIªºCR ¡NLR ¨Ó±Àºâ¤U¤@®ÉÂIªºCRÈ ¤@¨Ó¯u¥¿CR¨ú±o¤£©ö ¤G¨ÓY¥Î¦¹ªk±Àl¤U¤@®ÉÂIªºCRÈ·|Åã±o¹L¤j(¯ÂºéÓ¤H·Pı ¤£ª¾¦óªÌ¬°¹ï?) ¦P®É¹w¦ôªº¤¤¦ìPFS·|§ó«O¦u ¥H¤W¬O¤p§Ì²³æ»¡©ú ¤£¹ï¤§³B ½Ð¤j®a«ü±Ð ÁÂÁÂ! ¬Ý¤F«Ü¦h«e½ú©Ò¨¥Àò§Q»á¦h ·PÁ±zÌ! ¥i¯à«e½ú̦ì©~°ª¬z ¨£¦hÃѼs ¬Ýªk¦ÛµM¤£¦P©ó«á½ú ·íµM¨C¤@¥ó¨Æ±¡ ³£n¬Ý¦¨°Ê¾÷½× ¤p§Ìı±o³o¼Ë¤H¥Í¤Ó¨¯W¤F ©Î³\¤p§Ì³Ìªñªº¬Ýªk¦³¨Ç°¾«O¦u ¤]·|³Q¤Hµø¬°¦³°Ê¾÷ ¤£ºÞ±z«ç»ò¬Ý ¤p§Ì³£¸ÛÀµ±µ¨ü ²¦³º¸Ü¬O¦Û¤vÁ¿ªº ¦b¤p§Ì¬Ý¨Ó §Ú̦b³o¸Ì»¡¦hªÅ ®Ú¥»´N¼vÅT¤£¤FªÑ»ù ³Ì¦n¬O§â°ò¥»±§Ë²M·¡ Åý¦Û¤v¤ß¸Ì¦³Ó¦]À³©³®× ©Ò¥H¹ï©ó¦³¼Æ¾Úªº¬ì¾Ç¤ÀªR §Ú´±Á¿ ¤£ºÞ¦nÃa (¨Æ¹ê¤W ¦n»PÃaªº§PÂ_¤]¬O¨CÓ¤H¥DÆ[ªº·Pı) ÁöµM¤j®a¦³®É·N¨£¤£¤@ ¦ý¹ï¦æ¤§¦³¦~ªº¤ÀªR¤èªk ¥u·|¶VÅG¶V©ú ¶V®e©ö²M·¡¤º²[ ¤p§Ì¹ï¦³¨Ì¾Úªº¤£¦P·N¨£ Á`¯S§O³ßÅw ³o·|§ïÅܧڪººD©Ê«äºû ²`«ä¦Û¤vªº¹ï¿ù °²¦p³Ìªñ´X¤Ñªº¨¥½× YÅý±z¤£´r§Ö ¤p§Ì¹Dºp ¦ý¤]½Ð¦h·Q·Q ¨Ã«ü¥X¤p§Ìªº¤£¬O Åý¤p§Ì¦h¾Ç¤@¨Ç ¤p§Ì«D±`Åwªï ª¾ÃÑ ¸gÅç «H¤ß @¤ß ³£¬O»Ýn§Ú̦b§ë¸ê¸ô¤WºCºC¥h²Ö¿nªº ¦ý¦bºô¸ô¤W ´N¸Û¦p¥xÁÞ¤j»¡ªº ±z¤~¬O±z¦Û¤vªº¥D®_ Å¥¤£Å¥ «H¤£«H ³£¦b©ó±z¦Û¤v °¸¦Óªº¥¢»~©w·|¦³ ¤jªº¿ù»~¤j¶q¸êª÷·l¥¢ «hnÁקK ¤jÁȤp½ß ¤~¯àªøªø¤[¤[¦a²Ö¿n°]´I ¶È¨Ñ°Ñ¦Ò³á »¡¦Ñ¹ê¸Ü §Ú³Ì¤£³ßÅw¼g³o´XÓ¦r ¦n¹³¼g¤F´N¥i¥HÀH«K»¡»¡¦üªº ¸ÜÁö¦p¦¹ ÁÙ¬O±o¼g°Õ ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/6/10 ¤U¤È 11:12:02²Ä 1199 ½g¦^À³
|
Á|Ó·sªº¨Ò¤l,³Ìªñ¥Xªº"¤â¾÷"¨Æ¥ó ¥ý¥Ó©ú §Ú½Íªº ¤½¥q¤è±³B²zªº¤âªk º¥ý ³o¬µ¼u ¥¼n¹ï¥~¬É¤½¶}®É ¦b¤½¥qªº°ª¼h¤Î°ª¶¥°]°È¤Hû ¤@©wª¾±¡ ©Òª¾±¡¤£³æ³æ¬O³o"¬µ¼u" ¤]³£«Ü²M·¡ªº¬ÛÃö³W©wn¨D ¦ý¬O¤½¥q±¤@©wÁÙ¬O¯¸¦b¤½¥q¤è±¤Î¤½¥q°ª¼hªº»Ýn¶i¦æ³B²z ³o²{¶H §Ú¤£´±»¡©Ò¦³¤½¥q³£¬O ¦ý¬O¦b¥xÆWªº¦³¤£¤Ö¤½¥q¬O §Ú¦Y¤½¥q¶º §A»¡¶·¥ýÅU¤Î½Ö °t¦X½Ö°Ú °ß°ß¤j ¤¤¹D¤j ©Ò¨¥ªº ¥HÓ¤H±q¨Æªº°]°È¤u§@¨¤«× «Øij¬O¥²¶·°Ñ¦Ò¤U ¦U¦ì¤j¤jªºpºâ°²³] ³o¨Ç¬O¯Â¬ì¾Ç ¯u¬O¤Ó¼F®` ¤Ó±M·~¤F ¦b³o¨ü¯q¤Ó¦h¤F ¤]¬O¦]¬°³o¼Ë §Ú¦³¶R¤Fôô ¦ý¬O ¯A¤Î¨ì"¤H" ¨º´N¤£¬O¯Â¬ì¾Ç ¥i¥H¨Ó... ¦óªp¤S¯A¤Î¨ì§Q¯q¤Wªº¨Æ °ß°ß¤j ¤¤¹D¤j©Òpo ¬O¦hÓªº±¦Vªº°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/10 ¤U¤È 11:09:39²Ä 1198 ½g¦^À³
|
°ß±©¤j §Aªº¶K¤å«Ü¦³²`«×¡A§Ú¤Sµo²{¤@¦ì¥þ¤è«ä¦Òªº¯E¤Í |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/10 ¤U¤È 10:51:48²Ä 1197 ½g¦^À³
|
¥xÁÞ¤j¦³½ì¤S¬ì¾Çªº±À½×! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/10 ¤U¤È 10:43:43²Ä 1196 ½g¦^À³
|
¨CÓ¤H¦s¦b³£¬O¿W¤@µL¤Gªº¡A°ß¦³¸g¹L«ä¦Ò¡A¤ÀªR¡Aºî¦X¤~¯à¹ï§ë¸ê¼Ðªº°µ¥XµûŲ¡A³o¬O¤@ÓÁ}¨¯ªº¤ß¸ô¾úµ{¡A¤£½×ª©¤Wªº¯E¤Í¬O«O¦u«¬¡A¤¤©Ê«¬©Î¬O¼ÖÆ[«¬ ªº½×z³£«ÜÃøâ¾r¿W¯Sªº§A©p¡A¦Û¤v¤~¬O§ë¸ê¨Mµ¦ªº¥D®_ªÌ¡A¦pªG¤£ª¾¬Û«H½Ö¡A«Øij±q³Ì§C±À¦ôȱƦC¨ì³Ì°ª±À¦ôȫᥧ¡±o¨ì¤@Ó¥§¡È¡A¥H¦¹¬°¼Ð¬ñ¡A¦pªG¶W¹Lºâ¬OºÖ³ø¡C |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/10 ¤U¤È 09:59:03²Ä 1195 ½g¦^À³
|
¤¤¹D¤j±z¦n¡AÁÂÁ«ü±Ð! ¨ä¹ê§Ú¬Ý¦¹ª©¤w¸g¦³¬Û·í¬Û·íªøªº®É¶¡¡A¦bªñ´Á·|W¤f±C¤ßªºz»¡µÛÓ¤H·Qªk¡A ¨Ã«D§Ú¬Ý®t822¦¹ÃÄ¥¼¨Óµo®i¡A¬Û¤Ï¡A§Ú¤Ï¦Ó¼ÖÆ[¬Ý«Ý¡A ¬Æ¦Ü«ù¦³ªºªÑ¼Æ¡A¥i¯à¹ï¤@¯ë¤H¨Ó»¡¡A¤£ºâ¤Ö¡C ¦ý¬°¤°»ò·|±q¬O¬Ý«Èªº¨¤«×¡AÅܬ°¶}©lµo¤å? ì¦]¬é¦³¤@Ó¡A´N¬O¤£§Æ±æ¦¹ª©«Ü¦h¨}µ½ªº§ë¸ê¤H¨ü¶Ë¡C ¹L©¹¡AÓ¤H´¿Á`¸g¹L¤@®a«Üª¾¦Wªº¥@¬É¯Å¸ó°ê¥ø·~¶°¹Î¡A ©Ò¥H¬Û·íÁA¸Ñ¥ø·~¤ºªº¥ô¦ó²Ó·L¿ß¿°»P¸ê¥»¾Þ§@¡A¥]¬A©Ò¦³°]°Èºb±ìÄw¸ê¡A¤°·h¹Bµ¥¡C ¨â¦~¦b¦¹¾\Ū¹L«Ü¦h¸ê®Æ¡A§Úµo²{¨ì¦¹ª©¤£¥F±M·~¡A¦Ó¥B¥§¡¦~ÄÖÀ³¸Ó³£¤£·|¤Ó¤j ¬°¤°»ò³o»ò»¡¡A§Ú·Q............¤¤¹D¤j¥i¯à¤]µo²{¨ì¡A ³o¸Ìªº¤£¤Ö¤H¥i¯à¾Ç¾ú«Ü¦n¡A¦ý¸g¾ú»P¾\¾ú°²¥H®É¤é¡A¥i¯à·|§ó«ÈÆ[»P¤j«×¡C Á|¨Ò¨Ó»¡: ¬°¤°»ò°Q½×Äw½X¥²¶·n¦b¥t¤@ª©?§Ú±q¨S§ËÀ´¹L¡C ¬O¦]¬°¦b³o¸Ì«ÜÀ´pºâ©M²Îp»P©Ò¿×ªº±M®a¡A³£¤£¦b¥GªÑ»ù? ÁÙ¬Oı±o¦Û¤v°ª©|¡A¤£¹¤H¶¡·Ï¤õ¡A¥ç©Î¬Oı±oª±µu½uªº³£¬Oª¾ÃѤô·Ç§CªÌ? ´Nºâ¬O«Ü·Q©êªø¡AÃø¹D´N¬O¤H¤W¤H? ³o¼Ë»¡¨Ó¡Aªñ´Á¬Y¤½¥q¨º¦ì·Q©ê¨ì249X¦^1000ªº·Ý·Ý¯ÅªÑ¥Á¡A ¬O¤£¬O¸ÓÅý¦¹·Qªk¤§¬y¨Ñ»¼¯«ô! ¦A¨Ó¡Apºâ¬O¬°¤F¤°¤\?ºâ²nªº?ºâ¦Û¤v¤ß¦wªº?ÁÙ¬Oºâ°ê®õ¥Á¦w? Ãø¹D¬O¤½¥q¬£ªº±MÄݺôx? ¦pªG¯u¬O°ª¹Ò¬É~~~ µÐ´£¥»µL¾ð ©úÃè¥ç«D¥x ¥»¨ÓµL¤@ª« ¦ó³B·S¹Ð®J ...................¨ºÁÙ¶·nºâ¥b¤Ñ¦A°Q½×¥b¤Ñ¶Ü? ¬O¸Ó²q´ú»P¹w´ú¡A¦ý§ó¤£¯à©¿²¤¥þ±©Ê¬ì¾Ç¡A ªñ´ÁªÑ»ù¤j¶^¡A¤¤¹D¤j»¡ªºµ´¹ï¥¿½T¡A©Ò¿×ªº229®Ú¥»¬O¤£ºâ°ÝÃDªº°ÝÃD¡C ¦AÁ|¤@¨Ò °²³]¡A¥»¨Ó¥H1USD«ù¦³¥|¦¨¦hªÑ¥»ªº¤H¡A½æ¤F¤@¦¨«ùªÑ¡A§¡»ù¬°335NT, ¦^¥»¦h¤Ö? ³Ñ¤Uªº¤T¦¨«ùªÑ¡A¦¨¥»Åܬ°¦h¤Ö? ©Ò¥H¶}ª¼¦n¸òÃaªº¼vÅT?·|¶^¨ì¥Lªº¦¨¥»? ½Ð±Ð¡A¦³¨S¦³¦ÛàH·|²Îpªº¤Hºâ¹L³oÃD?¦¹ÃD«nªºµ{«×·|¤ñ¶È¤@Ó822§C¶Ü? §ÚÁÙ¬O«Ü¬Ý¦n822´N¡A§Y«K¬OPFS¶È¯à¨ì15¡A ³£»{©w·|¤j½æ¡AªÑ»ù¤]¤£·|¤Ó®t¡A¦ý¤£¬O³o¤TÓ¤ë¡C ¦]¬°¥¦¨ã¥xÆW¬ãµoªº·sÃÄ«ü¼Ð©Ê»P°Æ§@¥Î¤p¡AÁÙ¥i¥HÅý¤@³¡¤À¤H¬¡ªº§óªø¡C §ó§ó§ó«ÂI¦b¡AÁöµM¥u¦³¥|¦¨¦³¾÷·|¥i¥H¬¡±oªø¡A ¦ý...........¥H«eªÀ·|¤j®a§¡½a¡A¦n¦º¤£¦p¿à¬¡¡A ²{¦bªºªÀ·|¡A ¬¡±o«ÜµhW¥B©ì²Ö¨Ãä¤H¡A¸ò¬¡±o¦³´LÄY¡AÁÙ¯à¸@¸U¤@§Ö¼Öªº¬¡¨ì§ó¦³®ÄÃÄ¥X²{¡A ¬O§Aªº¸Ü¡A§A¿ïþ¤@ºØ¤è¦¡? ·í¦³¿ï¾Ü¥X²{¡A´N¬O°Ó¾÷ªºµo¥Í! §A»{¬°¬¡ªº´LÄYªº»ùȸӬO¦h¤Ö? §Æ±æ¤½¥q¤£n¦]¬°§Ö¥X²{§Æ±æ¦Ó³vº¥¦a¶ÆºC¡A §ó´Á«Ý¬ãµo±Ï¤H·sÃĪº¤½¥q¡A¤£nÅý§ë¸ê¤j²³¶¼¾}¤î´÷¡A ³Ì«á¡A¤j®anª`·N¤@ÂI¡A §Ú̳£²`¿Ú¾³õ¤W¥Í¦s¤§¹D......¦ÑÁó¯u¥¿·Qªí¹Fªº¡A³£¬O¨S»¡¥X¤fªº¨º¤@¥b! |
|
|
·|û¡G¤p´²¤á10134411 µoªí®É¶¡:2015/6/10 ¤U¤È 09:31:46²Ä 1194 ½g¦^À³
|
¤£¦n·N«ä¡A²q·Q¤j¡A §Ú·Q§A¯º¯º´N¥i¥H¤F¡C³]¸ê®Æ¼Æ¨º¤@Äæ¦pªGªí¥Üªº¬O³]¸ê®Æ¼W¥[¼Æ¨º§Ú´NÁA¸Ñ¤F¡C |
|
|
·|û¡G¤p´²¤á10134411 µoªí®É¶¡:2015/6/10 ¤U¤È 08:57:59²Ä 1193 ½g¦^À³
|
²q·Q¤j¡A §Ú±N§Aªþªº¸ê®Æ¥Îexcel««Ø¹L¤§«á¡Aµo²{¦pªG³]¸ê®ÆÁ`¼Æ100(±¡ªpA)¤£ÅÜ¡A ¦ý±N¨ä¤À§G§ïÅܤ@¤U¡A«hµ²ªG±N¦³¤£¦P¡C ¥Ñ©ó§Ú¹ï³]¸ê®Æªº©w¸q¤£²M·¡¡A¦]¦¹¡A´N¨ä¦r±·N¸q§Ú²q¤@¤U¡G °²³]¬Y¥Ò¨ü¸Õ¤w¹F10Ó¤ë¡A¥B©|¥¼PD¡C ´N¦b³oÓ®ÉÔ¡A§Ų́ӻs§@¥»ªí¡C¥»ªí«e10Ӥ몺¸ê®Æ³¡¥÷¡A ¥Ñ©ó¬Y¥Ò½T¹êPFS¤w¹F10Ó¤ë¡A¦]¦¹¡A¨ä¤£ÄÝ©ó³]¸ê®Æ¡F µM»s§@¥»ªí11Ó¤ë¥H¤Wªº¸ê®Æ®É¡A¥Ñ©ó¤£¯à½T©w¬Y¥ÒPFS¬O§_ ¯à¹F11Ó¤ë¥H¤W¡A¦]¦¹¡A¬Y¥Ò¦b³o¤@³¡¥÷¬ÒÄݳ]¸ê®Æ¡C¦]¦¹¡A °²³]¥»ªí¦@»s§@¤F25Ó¤ë¡A«h¬Y¥Ò¥Ñ11¦Ü25¤ë¬ÒÄݳ]¸ê®Æ¡A ¬Y¥Ò¤@Ó¤H´N°^Äm¤F15ÓȤF¡C ¦pªG§Ú²q¿ù¤F³]¸ê®Æªº·N¸q¡A½Ð¤j¤H¤j¶q¡A¯º¯º´N¦n¡C ¦pªG²q¹ïªº¸Ü¡A«h¸ê®Æ¥i¯àn×¥¿¤@¤U¡C ¥t¥~¡A«e¦¸§A´£¤Î¤@Ó°ÝÃD¡A§YLR¸gCR½T»{¹L«á¡A ¬O§_·|¦^ÀY¥h×¥¿LRªº¸ê®Æ¡C½Ð°Ý§A¦³µª®×¤F¶Ü¡H ¨Ò¦p¡G¤W¤WÓ¤ëLR=100, CR=100;¤WÓ¤ëLR¦h¤F20¡A«h¤W¤ëLR=120, CR=100; ¦ý¦¹¦h¥X¨Óªº20Ó¸gÅçµý¥u¦³15Ó¬O¯uªºPD¡A«h¦¹®ÉCR=115¡ALR=120ÁÙ¬O115¡H ±q§Aªºpºâ¤¤§Ú·Pı§A¤w¸g±ÄpLR»~®t²Öp¤£×¥¿ªºÆ[ÂI¡H |
|
|
·|û¡GJOLIN10140555 µoªí®É¶¡:2015/6/10 ¤U¤È 08:30:25²Ä 1192 ½g¦^À³
|
¦^À³ ¹«¤j §Ú©Ò°µªº¼Æ¾Ú¬O¨ÌÁ{§É¤@´Áªºµ²ªG¬°¨Ì¾Ú 1.Á{§É¤@´ÁªºPD¤ëµLªk¥¿½T±oª¾¡A¥u¯à©Ôªø±qOS/3ªñ¦üPD¤ë¨Ó±À¦ô(¦¹¤D ¥xÁÞ¤j©Ò´£¨Ñ¸ê®Æ)¡A¨Ì¦¹©Ò¦C¥Xªºªí¡A·íµM·|¦³»~®t¡A¦ýÓ¤H»{¬°¦¹¬°¹ê»ÚÁ{§Éªº¼Æ¾Ú¡A¦bÀù¯g¯f±w»PÃĮĪº±ø¥ó¤£ÅܤU©Ò°µ¥X¨ÓªºPD¤ë¥÷ªíÀ³¦³«Ü°ªªººë½T«×¡C 2.¨ÌGLOBO H,SSEA3,SSEA4¦s¦b©ó¨ÅÀù¯f±w³Ì°ªªí²{74%¡A©Ò¥H¨Ì¤W¦¸©ÒPOªºªí¡A¨ä¤¤PD 4¤ë(7.4%) / 8¤ë(7.4%) / 12¤ë(11%) ¦Xp26% À³ÄݹïÁÞ¨t¦CµL®Ä¤ÏÀ³ªÌ¡A¦A¥[¤W24¤ë(3.7%)ÄÝ©ó¦ÛÅé§K¬Ì¨t²Î¤£¨}(©Ò¥H¤~·|µo®i888)¡A¥h°£¤Wz¬ù3 ¦¨¥~¡A¨ä¥¦7¦¨ªº¤H¬Ò¬°¦³®Ä¥ÎÃÄ¡APDȳ£¥i¹F¨ì20-40¤ë¡C 3.¬°¦ón¼W¥[¾¯¶q/ ÁÙ¦³°w¾¯¨ì9Ó¤ë ¡H ¦]¬°¥i¥HÅýIGM/IGGªº®Ä¯à¹F¨ì12¤ë¥H¤W¡A¨º¼Æ¾Ú´N·|¤ñÁ{§É¤@ªí¦n¤W4Ó¤ë¥H¤W¡A¬Æ¦Ü¥i¥HÅý§ó¦h¤H¹F¨ìCR/PR/SD¡A©Ò¥H±i¸³¤@ª½§Æ±æ¼W¥[¾¯¶q¯àÅýÃĮĹF¨ì90%¡C ** ¤£¦PÀù¯g¯f±w©Ò¾Ö¦³ªºGLOBO§Üì¤ñ¨Ò¤£¤@¡A¨Ò¦p§Z±_Àù89%¡AÀù¯g ¬r©Ê°ª ¡A©Ò¥H¯f±w§K¬Ì¨t²Î¦ÛµM¤ñ¨ÅÀù±wªÌ§C¬G¤£¯à¥Î¦P¼ËªºPDy¸ñ¨Ó±À¡C 4.Àù¯g¬ODNA¯fÅÜ¡A822ªº¥Øªº¬O¬r±þÀù²ÓM¨Ã«D§ïÅÜDNA¡APD«á¥i¦A¥´ÃÄ´N¹³¬y·P¦YÃÄ¥´°w ¤@ ¼Ë¡A©Ò¥H¥¦¨Ã«D¤HÃþ¤ß·Qªº¥P¤¦¡A¥´§¹9Ӥ몺Àøµ{«áÁٯ༵1-2¦~¯à¤£¥´ÃÄ¡A©Ò¥H»¡: ¥P¤¦«D ¥P¤¦¬O¥P¤¦¡C «Øij¦Û¤v¨ÌÁ{§É¤@´Áªºµ²ªG°µªíºtºâ¡A´N¤£·|³Q229À~¦º¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/10 ¤U¤È 04:59:28²Ä 1191 ½g¦^À³
|
¤j®a¦n! ¥»¨Ó¤£·Q¦A¦h»¡¸Ü¤F ¦ý¤p§Ì»{¬°¦³¥²n§â¬Q¤Ñªº¤@¬q¸Ü¦A¸ÑÄÀ²M·¡¤@ÂI ¡§ ¦b¤½¥q¤½§G 5/25 ªº PD 229¡F OTHERS 37 ³oӼƦr¥X¨Ó¤§«á »¡¦Ñ¹ê¸Ü §Úº¡¥¢±æªº ¤ß¥Ø¤¤ªº30 ¬Ý¨Ó¤wº¥¦æº¥»·¤F? (³o¬O¤p§Ì¦Û¦æªºµû¦ô ©|«Ý¸Ñª¼½T©w¹ê»Ú¼Æ¦r) ³o¬O§Ú¥»¨Ó¹w´Á822¯à»´ÃP½æ¥B¤j½æ Ó¤Hµ¹ªº´Á³\ ·íµM¨CÓ¤H¹ï©óCR/LR ªº°²³]Ȥ£¤@ ·|³y¦¨°ª§C¬Û®t»á¤jªº¤¤¦ìPFS §Ú¤ß¸Ìªº¦ôºâ ©M¤p©_¤jªº®t¤£¦h Ó¤H¬O¨Ì¾Ú¤½¥qªº»¡ªk »{¬°0.75 ~ 0.8¬O¤¤ªÖªºCR/LRÈ ³o¼Ëªº¦ôªk Ó¤H»{¬°5/25¤w¸g«Ü±µªñ(©Î¤w¥i¬ï¶V)K-M¥Í¦s¦±½u0.5ªº®ÉÂI §Ú²q ¤½¥q©Î³\¤]¤w·NÃѨì³oÂI ©Ò¥H¿ï©w½T»{ªºPD È¥XÄl«á ¦b8¤ë¥l¶}¸Ñª¼»P§_ªº·|ij ¡§ ¥H5/25ªº¼Æ¾Ú¨Ó¤ÀªR ¥ÎÃIJաG 233 ¹ï·Ó²Õ¡G 116 °²³]°h¥X¤H¼Æ ¨â²Õ¦U¥b ¥ÎÃÄ²Õ ¡G18 ¹ï·Ó²Õ¡G 19 °²³]¹ï·Ó²Õ´X¥GPD ¥u³Ñ2Ó¥¼PD ©Ò¥H ¹ï·Ó²Õ PD¼Æ = 116 ¡V 19 ¡V 2 = 95 CR/LR¥H0.75¤ÀªR Á`PD¼Æ = 229 * 0.75 = 172 ¦]¦¹¥ÎÃIJÕPD¼Æ = 172 ¡V 95 = 77 ¥ÎÃIJթ|¥¼PD¼Æ = 233 ¡V 18 ¡V 77 = 138 ©Ò¥H¥ÎÃIJÕÁ`³]¸ê®Æ¼Æ = 138 + 18 = 156 §Ṳ́£ª¾ªø§Àªº¥¼PD¼Æ(¤£·|¼vÅTpºâ¤¤¦ìPFS ¦ý·|¼vÅTPÈpºâ)¦³¦h¤Ö §Ú¥Î¨â²Õ¼Æ¾Ú¼ÒÀÀ (¼ÒÀÀ¸Õºâªí¦C©ó«á) A²Õ³]¸ê®Æ¼Æ100 (§Yªø§Àªº¥¼PD¼Æ 56 ) ¥B´X¥G¥H§¡¤Ã¤À¥¬¨Ó¼ÒÀÀpºâ ±o¨ì´c¤Æ¤H¼Æ 80®É «ê¬ï¶V0.5 B²Õ³]¸ê®Æ¼Æ130 (§Yªø§Àªº¥¼PD¼Æ 26 ) ¥B´X¥G¥H§¡¤Ã¤À¥¬¨Ó¼ÒÀÀpºâ ±o¨ì´c¤Æ¤H¼Æ 69 ®É ¤]«ê¬ï¶V0.5 ¦p«e CR/LR¥H0.75¤ÀªRªº¥ÎÃIJÕPD¼Æ¬° 77 ¦bA²Õ ¤w«Ü±µªñ¬ï¶V¼Æ ¦bB²Õ ¤w¥iºâ±o¤¤¦ìPFS Y¥Î CR/LR= 0.8 ¨Ó¦ô «h¨â²Õ§¡¥iºâ±o¤¤¦ìPFS °£«Dªø§Àªº¥¼PD¼Æ¤ñ¤W¦C°²³]¦h«Ü¦h Åý¬ï¶V0.5ªº´c¤Æ¤H¼Æ¥i©¹117±À¶i¤£¤Ö ¤£µM¤¤¦ìPFSÀ³¤jP©³©w¤F ? ½Ð¤j®a¤£n»~»{ nºâ±o¤¤¦ìPFS ¥ÎÃIJժº´c¤Æ¤H¼Æ¤@©wn¹F117 ¤H ©Ò¥H77¶ZÂ÷117ÁÙ«Ü»· ¤¤¦ìPFSÁÙ¥i©Ô±o«Üªø ³o¬O¿ù»~ªº °²¦p¥Î¤p©_¤jªº¤è¦¡¦ô¥ÎÃIJժº´c¤Æ¤H¼Æ ¨º»ò¤¤¦ìPFS¥i¯àÁÙn¤Ö¤W¦n´XÓ¤ë? ¨º¥i¯à¬O³Ì«O¦uªº¦ôªk¤F ¨Æ¹ê¤W DSMBªº¦¨û¬Oª¾¹D¾ãÓ¸ÕÅç¼Æ¾Úªº ¦p¦P¸Ñª¼¯ë ¤£²M·¡¤½¥q´x´¤¦h¤Ö²Ó¸` ¦p¦Ñ¹«¤j©Ò¨¥ ¡§«ç»ò¦Û±q5/25 LR=229¤§«á¡A³\¦h¤j¤j×¥¿¼ÖÆ[ªººA«×¡H¡¨ ¤p§Ì²q´ú ¥¼¤½§G«e30«Ü¦³¾÷·| ¬Æ¦Ü¥i¥H¬D¾Ô§ó°ª ¦ý¤½§G³o²Õ¼Æ¾Ú«á ½Ä«Ü°ª¥i¯à¦³? §C¤]¦³¥i¯à? ¨ã°ª«×¤£½T©w©Ê ¸U¤@¯uªº¨S¦³«Ü°ª ¦æ¾P¥i¯à´N·|¦³Ãø«× ©Ò¥HÅܱo«O¦u ³o¬O¤p§Ì¦Û¤vªº¬Ýªk ¥i¯à¤]¬O³¡¤À§ë¸ê¤Hªº¬Ýªk ¦ý³Ì«áµ²ªG¦p¦ó ¤]¬O±o«Ý¸Ñª¼¨Ó¤½§G¸Ñµª ²q²q²q ¤@¤Á³£¬O²q ¶È¨Ñ°Ñ¦Ò ¯¬ºÖ¤j®a³£²q¹ïÃä ¤jÁÈ ÁÂÁ¤j®a! ªþµù ¡G ²Ä 1 ¦æ ¡G³]¸ê®Æ¼Æ ²Ä 2 ¦æ ¡Gn( i ) n at risk ²Ä 3 ¦æ ¡Gd( i ) ¦U®É¬q´c¤Æ¼Æ ²Ä 4 ¦æ ¡G1 - d(i)/n(i) ¶¥¬q¦s¬¡¾÷²v ²Ä 5 ¦æ ¡GS(t) Á`¦s¬¡¾÷²v A²Õ ¡G 233 0 1.00000 1.00000 2 233 1 0.99571 0.99571 2 230 1 0.99565 0.99138 2 227 1 0.99559 0.98701 2 224 1 0.99554 0.98261 2 221 1 0.99548 0.97816 2 218 1 0.99541 0.97367 2 215 1 0.99535 0.96914 2 212 1 0.99528 0.96457 2 209 1 0.99522 0.95996 2 206 1 0.99515 0.95530 2 203 1 0.99507 0.95059 2 200 1 0.99500 0.94584 2 197 1 0.99492 0.94104 2 194 1 0.99485 0.93619 2 191 1 0.99476 0.93128 2 188 1 0.99468 0.92633 2 185 1 0.99459 0.92132 2 182 1 0.99451 0.91626 2 179 1 0.99441 0.91114 2 176 1 0.99432 0.90597 2 173 1 0.99422 0.90073 1 170 1 0.99412 0.89543 1 168 1 0.99405 0.89010 1 166 1 0.99398 0.88474 1 164 1 0.99390 0.87934 1 162 1 0.99383 0.87392 1 160 1 0.99375 0.86845 1 158 1 0.99367 0.86296 1 156 1 0.99359 0.85743 1 154 1 0.99351 0.85186 1 152 1 0.99342 0.84625 1 150 1 0.99333 0.84061 1 148 1 0.99324 0.83493 1 146 1 0.99315 0.82921 1 144 1 0.99306 0.82345 1 142 1 0.99296 0.81766 1 140 1 0.99286 0.81182 1 138 1 0.99275 0.80593 1 136 1 0.99265 0.80001 1 134 1 0.99254 0.79404 1 132 1 0.99242 0.78802 1 130 1 0.99231 0.78196 1 128 1 0.99219 0.77585 1 126 1 0.99206 0.76969 1 124 1 0.99194 0.76349 1 122 1 0.99180 0.75723 1 120 1 0.99167 0.75092 1 118 1 0.99153 0.74455 1 116 1 0.99138 0.73814 1 114 1 0.99123 0.73166 1 112 1 0.99107 0.72513 1 110 1 0.99091 0.71854 1 108 1 0.99074 0.71188 1 106 1 0.99057 0.70517 1 104 1 0.99038 0.69839 1 102 1 0.99020 0.69154 1 100 1 0.99000 0.68462 1 98 1 0.98980 0.67764 1 96 1 0.98958 0.67058 1 94 1 0.98936 0.66345 1 92 1 0.98913 0.65623 1 90 1 0.98889 0.64894 1 88 1 0.98864 0.64157 1 86 1 0.98837 0.63411 1 84 1 0.98810 0.62656 |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/10 ¤U¤È 03:57:42²Ä 1190 ½g¦^À³
|
¦pªG¼Ú¬üªº·sÃĤ½¥q,¦³±`§âLR,CR¤½§Gªº½Ð¯E¹©¤ñ·Ó¿ì²z,°ÝÃD¬O¤Ö¤§¤S¤Ö,±`¨£ªº¬O¼Ú¬üªº·sÃĤ½¥q¤]¬O¤£¤½¶}¤£³z©úªº,¥u¦³¦b¸Ñª¼®É¤~¤½§G¼Æ¾Ú,¹j¤Ñ¤jº¦¤@¿¦³¤§, «Ü¦h¨Æ±¡¨Æ¯A°Ó·~¾÷±K,¤]µL»Ýµ¹¹ï¤âª¾¹D |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/10 ¤U¤È 03:43:43²Ä 1189 ½g¦^À³
|
°ß±©¤j¡G¨ØªA±zªº¨£¸Ñ»P¤å¤~¡A¥H§Ú¦b¸ê¥»¥«³õ¢²¢¯¦~§ë¸êªº»{ª¾¡A±z©Ò´£¿ô¤j®aªº¡i¥þ±©Ê°ò¥»±¡j©¹©¹¤~¬O³o®a¤½¥q¥¼¨Ó¬O§_¬O¯uÁZÀu¤½¥qªº»ùÈ«ü¼Ð¡I ¡y¹ð¸Õ¤£²n¡z¡I ¯E¹©°ª¼h¸g¾ú¹ï·sÃĪº´¼¼z»P§V¤O¬OµL±e¸mºÃ¦ý¦b¹ï¸ê¥»¥«³õªÑªFªº¤½¶}¡B³z©ú»P´L«©e¹êÅý§Ú¤Î«Ü¦h§ë¸êªB¤Í¥¢±æ¡I¥H§ÚÓ¤H²L¨£³o¤~¬O¦¹ªiªÑ»ù¶^ªº«Ü¥ûªº¥D¦]¡K¡I ¸Õ·Q¤@®a¥¼¦¨¥\ªº¤½¥q¹ïªÑªF´N¤]¦p¦¹¸gÀç¹ï«Ý¡A¤é«áÃįu¦¨¥\¤W¥««á¨ºªÑªF¯u·|¬O¦¨¬°ªÑ¥ÁµM«á©O¡K¡K¡y½âX¡z¶Ü¡H ¡yªÑ¥ÁÀ³¸Ó¬O¸ê¥»¥«³õ©Ò¦³ªº§ë¸ê¤H¡z ¡y«ù¦³¤½¥qªÑ²¼ªÌÀ³¸Ó¬OªÑªF§a¡z¡I Ó¤Hªº²L¨£¡A¦pªG¤£¬O¥xÁÞ¤j¡A¹ÇÅó±ø¤j¡A¥ò´º¤j¡K¡Kµ¥¤j¤j¨¯W¤S¼ö¤ßªº´£¨Ñ¤j®a¤ÀªR°Ñ¦Ò»P¨ó§U²z¸Ñ¤½¥qªº¶i«×»Ppºâ¡A¨º²{ªÑ»ùªº¶^´T®£¤£¤î¦p¦¹¡I ¤½¥q¦n¹³¤£²z¸Ñ¦bÃÄ«~¥¼±À¥X¥«³õ«e´N¤w¸g±À¥X¡mªÑ²¼°Ó«~¡n¦b¤½¶}¥«³õ¾P°â¤F¡Iµo¨¥¤H§ó¬O³B³B°{Ã{ªÑªFªº½Ð¯q¬Æ¦Ü±`¥Î»y¬O¡m§ÚµL®É¶¡¹ï¨C¦ìªÑªF¦^µª°ÝÃD¡n¡I¡I ³o¯u¬O¤W¥«Âd¤½¥qµo¨¥¤Hªº³ÐÁ|¡K¯u´Á«Ý¯E¹©ªº822/821ªº¬Ì]¤]¯à¦¨¬°¥@¬É·sªvÀùÃĪº³ÐÁ|¡I §Ú¯uªº«ÜºÃ´bµL½×¬OL R /C R³£¥u¬OÓ½T¹êªº¤wª¾¼Æ¤]¥¼¥²µ¥©ó¸Ñª¼©ÎÃÄÃÒ³q¹L¡A¦p¦P¨ä¥L¤W¥«Âd¤½¥q¨C¤ëÀ禬¨Ã¤£µ¥©ó°]´ú»P¦~«×ªºE P S¥u¬OÅýªÑªFÁA¸Ñ¹ê»ÚÁ{§É¶i«×ªºª¬ªp»Ýn¦p¦¹¤£¤½¶}¤£³z©ú¶Ü¡H ¥i¥H²³æ¦^µªªÑªFÅv¯qªºµª®×Á`¬O©äÅs¦Ó§t½kªºÅýªÑªF¶OºÉ¸£¤O¦ÒÅçªÑªFªº±M·~ª¾ÃÑ»P²q´ú¡A³o¯uªºÈ±o¤j®a¬Ù«ä»P·þ¾É¤F¡K¡I ¸Õ·Q¦³¦h¤Ö¡yªÑ¥Á¡z·|¯u´±§ë¸ê¦b¤@®a³s¶i«×¼Æ¾Ú½T¹êª¬ªp³£¤£´±»¡ªº¤½¥q¡I¯u¤£ª¾n¾Ì¦óºØ¨Ì¾Ú¨Ó§PÂ_¬O§_¯à§ë¸ê¡I 2015/4/13¸gÀÙ¤é³ø ±i¸³¨Æªø©Ò¨¥¡G ¡y°ò¨È±ø´Ú¡zÀ³¸Ó±q¥DºÞ¾÷Ãöªº¤ß¤¤®³±¼¡A³o±ø´ÚÁöµM¨S¦³§Î½Ñ¤å¦r¡A¦ý¤w¸g¦¨¬°¦U¥DºÞ¾÷Ãöªº¤@¹DÂê¡A¹ï¤½¥q¸ê°T´¦ÅS¬O¤@¤j»Ùê¡A¹ï²£·~µo®i¹ú¤j©ó§Q¡K ¯Î°|ªø¤]±`¦³¦¹½×z¡K¬O§_¦³¨º¦ì¤j¤j¯à´£¿ô¤½¥q°ª¼h»Pµo¨¥¤H¡K¯u¥¿Âê¦í¦U¶µ¶i«×¼Æ¾Ú´£¨ÑªÑªF°Ñ¦Òªº¬O½Ö¡K¡K¡H¥DºÞ¾÷Ãö¬O«ü¯u¹ê¼Æ¦r¤£¯à´¦ÅS¶Ü¡H¡H¡H ¨º¨ä¥L¤½¥q¨C¤ëÀ禬¤]³£À³¸Ó¤£¯à´¦ÅS¤F¡K¡I |
|
|
·|û¡G¹ÇÅó±ø10135894 µoªí®É¶¡:2015/6/10 ¤U¤È 03:37:06²Ä 1188 ½g¦^À³
|
¦h¦h¤j¡AÁÂÁÂ~~ ±zªº³oÓ³sµ²¸ê®Æ§Ú¤]¦³¬Ý¹L¡A§Ú¬O¥Î³Ì´dÆ[ªººâªkºâ¥X¨Ó822 M PFS=15¡A ·íªìpºâªº¥Øªº¬O¦b©óÓ¤Hªº·ÀI±±ºÞ¡A¥H§Q³]©w³Ì¤j®e§Ôªº°±·lÂI ¤£¹L·íª¾¹D³Ì®t¤]¦³15®É¡A´N©ñ¤ß¤F¡A¤]µL»Ý¦b¥GªÑ»ù¤U¶^»P³]°±·l¤F ¦]¬°´Nºâ15, ªÑ»ù¤]¬OÃ÷|¶W¹L300 §Ú¬O»{¬°³Ì¥i¯àªºPFS·|¦b18~20¥ª¥k°Õ¡A©Ò¥H¤d¤¸¥H¤W¬O«Ü¥i¥H´Á«Ýªº»ù¦ì ·íµM¨CÓ¤H³£¦³¤£¦Pºâªk¡ACR VS LRªº®t²§È¼vÅT§ó¤j¡A©Ò¥H¦pªG¯u¯à°÷CR¤p©óLR 30%ªº¸Ü¡A 822 M PFS>25 ¤]¤£µL¥i¯à¡A©Ò¥H¨C¦ì¤j¤jºâªk³£¦³¹D²z¡A¼f·V¼ÖÆ[ªï±µ¸Ñª¼µ²ªGÀ³¸Ó¬O¤£·|¿ùªº ¥H¤W¯ÂÄÝÓ¤H·N¨£¡A¥¿½T»P§_¥Ø«e·íµM¤]µL±qÃÒ¹ê~~ |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2015/6/10 ¤U¤È 03:13:47²Ä 1187 ½g¦^À³
|
½Ð°Ý¹ÇÅó±ø¤j¤j ³]¸ê®Æ °h¥X¤@©wºâPD? ±z¬O¥H³Ì´dÆ[ªº±¡¹Ò¦ôºâ§a?!ºô¸ô¤W¦³¤@±Ð¾Ç ·Pı¦UºØª¬ªp«Ü½ÆÂø ³£¦³¥i¯à¥X²{?! http://www2.cmu.edu.tw/~biostat/online/teaching_corner_051-4.pdf |
|
|
·|û¡G¹ÇÅó±ø10135894 µoªí®É¶¡:2015/6/10 ¤U¤È 02:56:50²Ä 1186 ½g¦^À³
|
ªÑªF·|«á¡AªÑ»ù½T¹ê±q340ºL¨ì300, ·Æ¤@¸ø ³\¦h¤j¤j¦b¦ôºâ822 M PFS®É¡A¤£ºÞ¬O¥ÎPD/LR/CR®É¤]³£§Ñ¤FOthers 37³o³¡¤À³]¸ê®Æ ¥H2015/5/25 PD 229/Others 37¨Ó¬Ý¡A¦pªG§â³o37¤H¥[¤J¦bPD¼Æ¡A ´Nºâ¥u¥Î229/349=66%¤ñ¨Ò¤]n¦^±À¦^¥hPDn¥[¤W24¤H(37x229/329=24) ¦pªG§A°Ý§Ú»¡"¤w¸g¬O³]¸ê®Æ¤F¡A¬°¦óÁÙn§â³o¨Ç¦^±À¦^¥h¦ô¦¨PD"? ¥¿¬O¦]¬°·í¦³¤H°h¥X¹êÅç¡A³Ñ¤Uªº¨ü´ú¸ÕªÌ¤H¼Æ´î¤Ö¡A¼W¥[¤@¦ìPD,¬OÅýK-M¦±½u·|¤U¶^§ó§Ö§ó°~ ©ÎªÌ¥Î¥t¤@ºØ¤è¦¡¨Ó«ä¦Ò¡A´N¬OÁ`¸ÕÅç¤H¼Æ349-37=312¤H¡A¹êÅç²Õ¥Î208,¹ï·Ó²Õ¥Î104¤H ¦ÓPDÁÙ¬O¥Î229 ¥H¤W³o¨âºØºâªk³£¦³¦Ò¼{¨ìOthers 37,¤£ºÞþºØºâªk¡A822 M PFS¤@©w¤ñ¦U¦ì¤j¤j¦ôpªºÁÙ·|¤p´XÓ¤ë §Ú¦b·Q³o¤]¬OPD 229¨ä¹ê±þ¶Ë¤O¨Ã¤£±j¡A¦]¬°822 M PFS©Î³\¦³20+ ¦ý¬OY¦Ò¼{¨ìOthers 37³oÓ³¡¤À¡A822 M PFS¥i¯àn¥Î15+ªº«äºû¨ÓÀ³¹ï ¥H¤W²Ê²L¬Ýªk¡A§Úª¾¹DÁö¤£§¹¥þ¥¿½T¡A¦ý©Î³\¤]¥i¥H°Ñ¦Ò¤@¤U |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/6/10 ¤U¤È 02:29:22²Ä 1185 ½g¦^À³
|
½Ð±ÐJOLIN¤j ¦Ñ¹«´¼°Ó¤£¤Ó°÷«o¹ï±zªº¤ÀªR«Ü¦³¿³½ì ¯à§_°w¹ï¤@´ÁPDªí°µ§ó¸Ô²Ó»¡©ú¡H §Ú¬Ý¨ìªºPD®É¶¡ ¦³1ÓNED«á´c¤Æ¦º¤` ¦³4ÓNED¦b85~153¶gPD(¤¤¦ì107.5¶g) ¦³3ÓSD¦b21~24¶gPD ¦³4ÓSD¦b61~152¶gPD(¤¤¦ì111¶g) ¦ý§ÚµLªk©M§A»¡ªº·f¦b¤@¶ô «ô°U¤F |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/10 ¤U¤È 01:04:13²Ä 1184 ½g¦^À³
|
¤p©_¤j, «D±`·PÁ±z¦X²z¤SºëÅPªº¸ÑªR. §Úªº·Qªk©M±zªº·Qªk«Ü±µªñ, ¸Ñª¼ªº®É¶¡ÂI¬ù¦b¸ÕÅç²Õ´c¤Æ¤H¼Æ¹L¥b«áªº3Ó¤ë, ¤~¯à±o¨ì¤ñ¸û¦¨¼ô·Ç½Tªº¼Æ¾Ú. ¥un822ªºmedian PFS¦³20Ó¤ë¥H¤W, ÃÄ»ù¤S¤ñIbrance, Herceptin«K©y¤@ÂI, ¦b¥½´Á¨ÅÀù¥«³õ´N¦³Ävª§¤O. |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/10 ¤U¤È 12:26:28²Ä 1183 ½g¦^À³
|
·PÁºa®¦¤j¤j Á`ºâ... ÁÂÁ |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/10 ¤U¤È 12:19:38²Ä 1182 ½g¦^À³
|
µ½¤H¤j¡A ¡y¦pªGmedian PFS¥u¦³9Ó¤ë©Î16.5Ó¤ë, ¸ÕÅç²Õ´c¤Æªº¤H¼Æ¬O¤£¬O¦b2014¦~¦~©³«e¤w¸g¹L¥b?¡z ¥H¤W½×z¦¨¥ß¡A¦ý§â¡u¸ÕÅç²Õ´c¤Æªº¤H¼Æ¹L¥b¡v§ï¦¨¡u¸ÕÅç²Õ´c¤Æªº¤H¼Æ¹F¨ìK-M¨ç¼Æ¥i¥H¹F¨ì0.5ªº¤ô¥½u¡v·|§óºë½T ¸ÕÅç²Õ´c¤Æ¤H¼Æ¹L¥b¦³¨âӼƦr 233/2=117 (233-(37/2))=107 ¥Î107³o¼Æ¦r¤ñ¸û¦n¡A ¦]¬°²q·Q¤j¦³¥Î¸Õºâªí¼Ò¼Ë¹L(¤p§Ì¤]»{¦P)¡A100¦ì³]¸ê®Æ(§t¤¤³~Â÷¶}©M±ß¦¬®×¥¼´c¤Æ±wªÌ)¡A»P80¦ì´c¤Æ±wªÌ¡A´N¥i¥H«ê«ê¬ï¹L0.5ªº¤ô¥½u¡A¦ý¬°¦ó¥Î107©O¡H¦]¬°ÁÙ·|¦³20´X¦ìªºªø§À±wªÌ(¦´Á¦¬®×¦ý¶W¹LM PFSªº®É¶¡¤~´c¤Æªº±wªÌ)¡A³o¨Çªø§À±wªÌ¹ïM PFS¤w°µ¥X·¥¤jªº°^Äm¡A¦ýM PFS¤£¬O¥Ñ¥L̨M©wªº¡A¥LÌ¥u¼vÅTK-M¨ç¼Æ¦b0.5¤ô¥½u¥H¤Uªº¹Ï«¬ªø¬Û¡C³o¨Çªø§À¤w´c¤Æ±wªÌ»Pªø§À¥¼´c¤Æ±wªÌ¨âÓ¥[°_¨Ó´N¬OK-M¨ç¼Æ¹Ï«¬¤W¶V¹LM PFS ¥H«áªºn at risk ¡C ¡y2014-12-31 Local Read: PD 187 / Others 26. ¥H§Úªº°²³]©M¦ôºâ, ¸ÕÅç²Õ´c¤Æªº¤H¼ÆÁÙ¨S¹L¥b. 2015-05-24 Local Read: PD 229 / Others 37. ¥H§Úªº°²³]©M¦ôºâ, ¸ÕÅç²Õ´c¤Æªº¤H¼Æ¤w¸g¹L¥b. ©Ò¥H¸ÕÅç²Õ´c¤Æ¤H¼Æ¹L¥bªº®É¶¡¥i¯à¦b2015¦~2¤ë©Î3¤ëµo¥Í, ¥H¦¹±Àºâmedian PFSÀ³¸Ó¤j©ó16.5Ó¤ë? ¦³20Ӥ륪¥k§a? ¦]¬°CRªº´c¤Æ¤H¼Æ¥i¯à¤ñLR¤Ö20%, ¦pªG¬O, ¸ÕÅç²Õ´c¤Æ¤H¼Æ¹L¥bªº®É¶¡¥i¯à¦b2015¦~5¤ë¥H«á¡z °ò¥»¤W2014/12ªºLR=187 »P2015/5ªºLR=229¡A³o¨âӼƦr¤w¤jP¨M©w¤F¹êÅç²ÕªºM PFS¤@Ó¤j·§ªº½d³ò¡A·|¦³¤ñ¸û¤jªº®t²§©|«Ý¤½¥q¶i¤@¨B¸ê°T½T»{ªº´N¬O¡ACR/LRªº¤ñ¨Ò¦b¤£¦Pªº®É¶¡ÂI¨ì©³¬O¦h¤Ö¡H¦ý¤p§ÌÁÙ¬Oı±o¡ACR»PLRªº»~®tÀ³¸Ó¥u¾A¥Î¦b¹êÅç²Õ¡A´Nºâ¹ï·Ó²Õ2014/12ªº¼Æ¾Ú¦bCR»PLR¦³»~®t¡A2014/12¨ì2015/5¸g¹L¤F5Ó¤ë¡A¹ï·Ó²ÕªºCR·|´X¥Gµ¥©óLR¡A¦]¦¹¦ôºâ2015/5ªºCR®É¡A¤p§Ì¬O§â229¥ý¦©±¼¹ï·Ó²ÕªºLR=CR=100¡A§Y229-100=129¤§«á¦A¥Î¤@Ó¤ñ²v¨Ó¦ôºâ¹êÅç²ÕªºCR¡A¥Î10%©Î20%©Î30%©Î40%³£¦æ¡AÀHÓ¤Hªº«O¦u©Î¼ÖÆ[ªº¤ßºA¡A¤Ï¥¿³Ì«án¤½¥¬¸Ñª¼«e¡A¤½¥qÀ³¸Ó·|¤½§iÁ{§É¼Æ¾ÚºI¤î¤éªºCR¬O¦h¤Ö¡A©¡®É¦A¨Ó«·s½Õ¾ã¡C ¤p§Ì¿ï¥Î20%ªº»~®t²v¡ACR=103¡A¤w¸g±µªñ107¤F¡A0.5ªº¤ô¥½u5¤ë®t¤£¦h¥i¥H¨M©w¤F¡A´Nºâ¥Î«O¦uªº10%»~®t²v¡ACR=116¡A¨º¤]¤£¹L´£¦2Ó¤ë«e¨M©wªº¡A´Nºâ¬O3¤ë¤w¹F¨ì0.5ªº¤ô¥½u¡AM PFS ¤]·|¦³19Ó¤ë¡A©Ò¥H19Ó¤ë¤j©ó16.5Ó¤ë¡C ¦]¬°¹F¨ì0.5¤ô¥½uªºÃöÁä¤H¼Æ·¥¥i¯à¦b5¤ë«e«á2¡B3Ó¤ë¥X²{¡A8¤ë®É®³¨ì5¤ëªºCR¥i¥H§ó¥[½T©w¡AY8¤ë®³¨ìªº5¤ë®ÉªºCR¤w¸gÃÒ¹ê¤F®t¤£¦h¹F¨ì0.5ªº¤ô¥½u¡A¨ì11¤ë®É¥i¥H¤S®³¨ì8¤ëªºCR¡A¦h¤F3Ӥ몺®É¶¡¡A¼Æ¾Ú¤w¸g¬Û·í¦¨¼ô¤F¡A¦~©³©Î©ú¦~ªì¸Ñª¼¤£ºâ®ö¶O®É¶¡¡C ¥H¤W¨Ñ°Ñ¦Ò¡A¹ê»Ú¼Æ¦r¥H¤½¥q¤½§G¬°·Ç¡C |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/6/10 ¤W¤È 11:24:15²Ä 1181 ½g¦^À³
|
10130510«e½ú:2015/6/5¤U¤È02:54:12«üÂITykerb ²Ä18¶ªºstudy¡A97% had stage IV breast cancer.Approximately 95% of patients had prior treatment with anthracyclines, taxanes, and trastuzumab. Independent Assessment¹êÅç²ÕTTP events=82¡A¹ï·Ó²ÕTTP events=102 Investigator Assessment¹êÅç²ÕTTP events=121¡A¹ï·Ó²ÕTTP events=126 (121-82)/121=0.322¡X¹êÅç²ÕCR&LRªº»~®tÈ¡]T cell®û¼í·|¤£·|§ó°ª¡H¡^ (126-102)/126=0.190¡X¹ï·Ó²ÕCR&LRªº»~®tÈ (121+126-82-102)/(121+126)=0.255--¾ãÓÁ{§ÉCR&LRªº»~®tÈ TYKERB is indicated in combination with: 1. capecitabine for the treatment of pa-tients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. Limitation of Use: Patients should have disease progression on trastuzumab prior to initiation of treatment with TYKERB in combination with capecitabine. 2. letrozole for the treatment of postmenopausal women with hormone receptor-positive metastatic breast cancer that overexpresses the HER2 receptor for whom hormonal therapy is indicated PRESCRIBING INFORMATION¥Dn»¡©ú¨âÓstudy¡A¦ý¥t¦³¤å¦r»¡©ú¥t¥~¨âÓTYKERB©M¶PÀù¥ªºÁ{§É¤ñ¸û¡A1. TYKERB+capecitabine(6.6Ó¤ë)¿éµ¹¶PÀù¥+capecitabine(8Ó¤ë)¡A2. TYKERB+µµ§ü¾J(9Ó¤ë)¤]¿éµ¹¶PÀù¥+µµ§ü¾J(11.3Ó¤ë)¡C |
|
|
·|û¡Gºa®¦10139955 µoªí®É¶¡:2015/6/10 ¤W¤È 11:22:35²Ä 1180 ½g¦^À³
|
QQ¤j O1: enrollment O2: dilemma |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/10 ¤W¤È 11:16:23²Ä 1179 ½g¦^À³
|
¦Ñ¹«¤j¡A¤p§Ì©M±z¤@¼Ë¼ÖÆ[¡A¥u¤£¹L§ÚºÉ¶q¸m©ñ¦b¤ß¸Ì¡A¼ÖÆ[¨¥½×¦h¤F¡AªÑ»ù«o§e²{¤£Â_¯}©³ªº¼Ë»ª¡A¦ÛµM·S¨Ó«èïÈ¡Cº¦®É¬Ýº¦¡A¶^®É¬Ý¶^¥»ÄݤH¤§¤Ñ©Ê¡A¤×¨äPD229ª§Ä³µÛ¹ê¼å¤F²³¤H¤@½L§N¤ô¡A¼ÖÆ[ªº¨¥½×¦¹®É¬Ý¨Ó¦³¨Ç³\¿Ø¨ë¡A¥[¤W³\¦h¤H©^ªÑ»ù¦Ü¤W¬°¯u²z¡A½èºÃÁn®ö¤£Â_¡A¬Æ¦Ü¶}©lÃhºÃ¤½¥q¸Û«H¡A§ÚÁÙ¤£¦Û¶q¤O¶]¥X¨Ó±µ¤l¼u¡C¨ä¹ê®É¦Ü¤µ¤é¡A´c¤Æ°ª®p´Á¤w¹L¡A±µ¤U¨Ó¥b¦~µo®i¤~¬O¦Ü¬°ÃöÁä¡A´c¤Æ¤H¼Æ¬O§_§e²{»¼´îª¬ºA¡A©¡®É¥iÀ³ÃÒ¼ÖÆ[¤ßºA¬O§_ȱo«ùÄò¡C |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/10 ¤W¤È 11:07:30²Ä 1178 ½g¦^À³
|
¥xÁÞ¤j¡B½Ñ¦ì¤j¡G ·PÁ§Aªº¼Æ¾Ú¡A¦ý¤£ª¾¦³¨S¦³¤ÆÀøÃijv¦~ªº´c¤Æ¼Æ¾Ú¡H «e±¡@¢°¢¯¡G¢±¢¶ªº¶K¤å¡@§Ñ¤F¼g¤@¥y³Ì«nªº¸Ü¡G "¦pªGµû¦ô¢Ù¡Ä¢Û¦±½u·|¤@¶}©l´N¤À¶}«Ü¤j¡A¨º´N¥i«i©ó´£«e¶}ª¼" |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/10 ¤W¤È 11:02:35²Ä 1177 ½g¦^À³
|
¦U¦ì¤j¤j: ½Ð°ÝªÑªF·|®É¶ÀÁ`¦b°w¹ï¤¤°êÁ{§É®É©Ò»¡ªº ¡§¡K¡K¡K. ¤]¨S¦³·Q¨ì§Ú̪º ?? ¡³1 ·|³o»ò§Ö ¡K¡K¡K¡K¡K ¡K¡K¡K¡K¡K¡K¡K.. ±Æ¹ï±Æ¨ì¤F, ²{¦b¬O²Ä¤C¦ì, ¦ýµo¥Í¤F£¸Ó²{¶H´N¬OÁ{§É¸ÕÅ窺 ?? ¡³1 °µ§¹¤F, ©Ò¥H²{¦b¥X²{¤F£¸Ó ??? ¡³2 ¡K¡K¡K¡K..¡¨ ³o¨âÓ^¤å¦r¡³1 ¡³2§Ú£¸ª½µL¸Ñ, Àµ½Ðþ¦ì°ª¤H¤j¤j«üÂI§iª¾. ·PÁÂ, ·PÁÂ. ¤¶²Ð§Ú¬Ý¦¹ª©ªº¦Ñ¥ýıªí¹F ¡§¤½¥qªºµo¨¥¤H¬O¥Nªí¤½¥qµo¨¥, ¤£¬O´À¦o¦Û¤vµo¨¥, ¤]¤£¬O´À¥ô¦ó¤½¥q¤¤ªº¥ô¦ó£¸¦ìµo¨¥. ¦]¬°¤½¥q¬O¤½¶}¤W¥«¤½¥q, ¯¸¦b¤½¥qªº¥ß³õ, ·í§ë¸ê¤H/ªÑªF¦³ºÃ¦³´b®É, ¤½¶}, ³z©ú, ¤½¥¿ªº±N¤½¥qªº¦UºØ¤£¯A¤Î«O±K±ø´Ú©Î°Ó·~¾÷±Kªº°T®§§iª¾§ë¸ê¤H/ªÑªF. ³o¬O¤½¥qªv²z¤¤«Ü«nªº£¸Àô.¡¨ ±Í¤H²`ı¦³²z, ¬G¦P®É¶K¤W¶È¨Ñª©¤Í°Ñ¦Ò. Y¦³±o¸o¥ô¦óª©¤Í¤j¤j, ½Ð®ü²[. ¦Ñ¹«¤j, «D±`¦P·N±zªº¨£¸Ñ. ¥xÁÞ¤j, ¥ò´º¤j, ·PÁ§A̵L¨pªº¤À¨É. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/10 ¤W¤È 10:42:55²Ä 1176 ½g¦^À³
|
¥ò´º¤j ¨ÅÀù¨}ÃĦó³B´M,¥H¤U´£¨ÑHerceptin@ »Pcyclophosphamide Àù¼w¬Pª`®g¾¯ ªºMedian Time to progression ¨Ñ§A»P¦U¦ì¤j¤j¬ã¨s°Ñ¦Ò FDA Clinical Review of BLA 98-0369 ( Biologic License Application) Herceptin@ Trastuzumab Date of Submission: May 4, 1998 Date of Approval: September 25, 1998 ( ¥Ó½ÐÃÄÃÒ¨ì®Öã141¤Ñ) Sponsor: Genentech, In A²Õ ¤ÆÀøÃÄ»P Herceptin (235¤H) ¤ÆÀø+Herceptin, Median Time to progression (months)7.6Ó¤ë (234¤H) ¤ÆÀø Median Time to progression (months)4.6Ó¤ë B²Õ ´¿±µ¨ü¹LAnthracyclineÃþ§ÜÀùÃÄ (143¤H) AC+ Herceptin Median Time to progression 8.1Ó¤ë, (138¤H) AC Median Time to progression 6.1Ó¤ë AC: Adriamycin¤p¬õ²ù + cyclophosphamide Àù¼w¬Pª`®g¾¯. C²Õ ¯f±w¥H©¹´¿±µ¨ü¹LAnthracyclineÃþ§ÜÀùÃÄ( Adriamycin«UºÙ¤p¬õ²ùDoxorubicin)¡A±`¥Î©óÀù¯g¤§¤Æ¾ÇªvÀø (92¤H) ¤Ó¥¬vµµ§ü¾Jpaclitaxel + Herceptin Median Time to progression 6.9Ó¤ë, (96¤H) paclitaxel Median Time to progression 3Ó¤ë |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/10 ¤W¤È 10:33:18²Ä 1175 ½g¦^À³
|
¦Ñ¹«¤j µ½¤H¤j 1§¹¥þ¦P·N§A̪º¨£¸Ñ»P¸ÑŪ 2§Ú¥u¬O»¡²Ä¤@ºØ±¡¹Ò¹F¦¨¾÷²v¼W¥[ ( ¤½¥q¦³¤F©ú½T¤è¦V¤Î¨º¨Ç¼Æ¦r¦b¦X²z½d³ò),·íµM«e´£¬O¸Ñª¼¼Æ¾ÚnRobust 3§Ú¿ï¾Ü¬Û«H¤½¥qªº±M·~,ÅU°Ý¹Î¶¤ªº±M·~,¦b°µ¦n·ÀIºÞ²zªº«eÃD¤UÀRÀRªºµ¥«Ý |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/10 ¤W¤È 10:27:16²Ä 1174 ½g¦^À³
|
½Ñ¦ì¤j¤j: ¥i§_¦³¯E¤Í¯à´£¨Ñ ¯E¹©822 ¬I¥´«e ©Ò¥Î¤ÆÀøÃÄ ªº PFS »POS È ¥H¤Î ³o¤ÆÀøÃÄ Åý±wªÌ´c¤Æªº®É¶¡¤À¥¬ ? ¥ç§Y Ó¤H·Qª¾¹D ¡§¥½´Á±wªÌ ¡§¬I¥Î¤ÆÀøÃĪ««á 1¦~¤º´c¤Æ¡B2¦~¤º´c¤Æ¡B3¦~¤º´c¤Æªº¦Ê¤À¤ñ ¦U¦³¦h¤Ö? ¦p¦³¦h²Õ¼Æ¾Ú , «h´c¤Æ®É¶¡©ì©µ³Ì¤[ªº¨º²Õ¼Æ¾Ú³Ì«n¡C ¡]¦n¹³¥H«e¦³¯E¤Í¶K¤å¹L¡A¬O§_¥i«¶K¤@¦¸¡H¡^ ¥Øªº¡G·Qµû¦ô¯E¹©ÃĪ«´£«e¶}ª¼ªº¥i¯à©Ê¡H¡@¥H¤Î¬ù¦b¦ó®É¥i±æ´£«e¶}ª¼¡H ½Ð¤Í¤H¸ò¬Y°ê»Ú¯Å±M®a½Ð±Ð«áªºµ²½×¡ã¦p¤U¡G ¢°¡Ö¢Û¡@¢Þ¢Ô¢áȬO¥Î¤@ӼƦr¥Nªí¤@±ø½u¡@¡@¥Nªí¤@¾ã²Õ¼Æ¦rªº¤À¥¬ ¡@¡@¦pªG¡@¢Ù¡Ä¢Û¦±½u¤@¶}©l´N¤À¶}«Ü¤j¡D ¡@¡@¨º»ò¡@´£«e¶}ª¼«á¡A´N¥u¬O¥Î¢Ù¡Ä¢Û¦±½uªí¥Ü¡A¦Ó«D¥H¢Û¡@¢Þ¢Ô¢áªí¥Ü¡@¡]¦]¬°¨º®É¨S¦³²£¥Í¢Û¡@¢Þ¢Ô¢á¡^¡C ¢±¡n¦óºØ±¡ªp¥iºÙ¤§¬°¡@"¢Ù¡Ä¢Û¦±½u¤@¶}©l´N¤À¶}«Ü¤j"¡H ¡@¡@Âùª¼³]p®É¡A°²³]¹êÅç²Õ¢±¢¯¢¯¤H¡A¹ï·Ó²Õ¢°¢¯¢¯¤H¡AÁ{§É®É¶¡¸ò¯E¹©¬Û¦P¡A Y©ó¢±¢¯¢°¢³¡þ¢°¢±´c¤Æ¤H¼Æ¹F¨ì¢°¢²¢¯¤H¡A¨ä¤¤¡A¹êÅç²Õ¦û¢²¢¯¢H¡A¹ï·Ó²Õ¢¶¢¯¢H¡A¨º»ò¡A ¹ê»Ú¸Ñª¼«á¡A¨ä¢Ù¡Ä¢Û¦±½u´Nºâ¬O¤@¶}©l¤À¶}«Ü¤j¤F ¢²¡Ö¦]¦¹¡A¢±¢¯¢°¢´¡þ¢·¯E¹©ªº±M®a·|ij¡A¤@©w·|¦³±M®a®M¥Î¹L¥h¤ÆÀøÃĪ«ªº´c¤Æ¹Lµ{¡A ±À¦ô¢·¢±¢±¦b¢±¢¯¢°¢³¡þ¢°¢±¡@¤Î¢±¢¯¢°¢´¡þ¢µªº´c¤Æ¤H¼Æ¥e¤ñ¡AY¥e¤ñ¡Õ¢²¢¯¢H¡A ·|«Øij¯E¹©¢¸¤ë¶}ª¼¡A·íµM¦³ªº·|«Øij¢°¢±¤ë¡C ¢³¡Ö¦Ü¤µ¥H¡@¢Û¢Þ¢Ô¢áªí¹FªºÃĪ«¤ñ¨Ò¡A¬ù¥eªñ¤E¦¨¡A¨Ã«D¢°¢¯¢¯¢H¡A¦]¦¹¡A¥H¢·¢±¢±¤§°ª¤ô·Ç¡AÀ³¸Ó¬O´£«e¶}ª¼¡C |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/6/10 ¤W¤È 10:18:36²Ä 1173 ½g¦^À³
|
¤p§Ì¤£¸Ñ «ç»ò¦Û±q5/25 LR=229¤§«á¡A³\¦h¤j¤j×¥¿¼ÖÆ[ªººA«×¡H °O±o3/3ªk»¡«e¡A¤j®aÁÙ¦b²q´ú´Á¤¤¤ÀªR¬O142©Î176¡A´Nºâ¬O176¡A¤j®a³£ÁÙ«D±`¼ÖÆ[ ·í3/3½T©w´Á¤¤¤ÀªR¬O142¤H¡A¤j®a³£«Ü¶}¤ß´_µo¤ñ¹w´Á¤Ö¡APFSªº¼ÖÆ[¼Æ¦r³°Äò¤W³õ ²{¦b±i¸³§ó©ú½T»¡12/31ªºLR=187¡A5/25ªºLR=229 ³s³]¼Æ¦r³£§i¶D¤j®a¤F ¤j®a¤Ï¦Ó´dÆ[°_¨Ó¡H¦Ñ¹«¿ù¹LþÓÀô¸`¨S¸ò¤W¡HþӼƦr¥X²{²§±`Åý¦U¦ìÅÜ«O¦u¡H 2¤ë®ÉÔ¤j®a´¿°Q½×Àô²y¥Í§Þ¤ë¥Z´_µo¼Æ¦r ¥h¦~7¤ë91¤H¡A10¤ë110¤H ²{¦bª¾¹D12/31¤£¨ì142¤H¡A10139510¤j¤j¹Ú¨ì13X(©Ò¥HCR=0.75LR) 5/25±qLR¨Ó±ÀCR¤j¬ù170¤H¡AþӼƦr¦³²§±`¡H ¦Ñ¹«¬Ý¨ìªº¬O«Üéwªº¼Æ¦r¡A«Ü¤£¿ùªº¼Æ¦r 10139510¤j¤j·|«á¦³°Ý¶ÀÁ`ÃÒ¹ê¬O»¼´îªº ¦Ñ¹«¿ù¹LþÓÀô¸`¨S¸ò¤W¡H ¥ò´º¤j¡BJolin¤j ²{¦b¦n¹³´N§ÚÌ´XÓ¤@¼Ëºû«ù¼ÖÆ[¡ã¡ã¡ã ¦Ñ¹«²´¤¤25Ó¤ë´N¬O¥P¤¦¤F¡A28Ó¤ë©Î40Ӥ볣¬O¤W»aµ¹ªº·N¥~¤§³ß¡A¤£ª¾ÁÙ¦³þ´X¦ì¤j¤j©M¦Ñ¹«¤@¼Ë¼ÖÆ[¡H |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/10 ¤W¤È 08:55:46²Ä 1172 ½g¦^À³
|
¤p©_¤j, ¦pªGmedian PFS¥u¦³9Ó¤ë©Î16.5Ó¤ë, ¸ÕÅç²Õ´c¤Æªº¤H¼Æ¬O¤£¬O¦b2014¦~¦~©³«e¤w¸g¹L¥b? ¦pªG¬O, ¦b¤µ¦~5¤ë©Ò¦³¸ÕÅçªÌ§¹¦¨Àøµ{«á, ¬O¤£¬O´N¥i¥H¸Ñª¼¤F? ¦ó¥²®ö¶O®É¶¡©M¸ê·½Ä~Äò°µÁ{§É¸ÕÅç? ¤½¥q¥t¦³¨ä¥L¦Ò¶q¶Ü? 2014-12-31 Local Read: PD 187 / Others 26. ¥H§Úªº°²³]©M¦ôºâ, ¸ÕÅç²Õ´c¤Æªº¤H¼ÆÁÙ¨S¹L¥b. 2015-05-24 Local Read: PD 229 / Others 37. ¥H§Úªº°²³]©M¦ôºâ, ¸ÕÅç²Õ´c¤Æªº¤H¼Æ¤w¸g¹L¥b. ©Ò¥H¸ÕÅç²Õ´c¤Æ¤H¼Æ¹L¥bªº®É¶¡¥i¯à¦b2015¦~2¤ë©Î3¤ëµo¥Í, ¥H¦¹±Àºâmedian PFSÀ³¸Ó¤j©ó16.5Ó¤ë? ¦³20Ӥ륪¥k§a? ¦]¬°CRªº´c¤Æ¤H¼Æ¥i¯à¤ñLR¤Ö20%, ¦pªG¬O, ¸ÕÅç²Õ´c¤Æ¤H¼Æ¹L¥bªº®É¶¡¥i¯à¦b2015¦~5¤ë¥H«á, ©Ò¥H¤½¥q¤~nµ¥¼Æ¾Ú¦¨¼ô, ¦b8¤ë¶}±M®a·|ij«á¦b¨M©w¸Ñª¼ªº®É¾÷. ¤W¥«Âd¥ÍÂåªÑ¦¨¬°9¤é¤U¶^ªº«¤ß¤§¤@, ¤W¥«Âd¥ÍÂåªÑ¦¬½LÁ`¦@¦³15®a¶^°±, ÁÙ¦³´X®a±µªñ¶^°±, °£¤F°ò¨È ÁÞÁp¨S¦³¿Ä¸ê¨é¥~, ¨ä¥Lªº³£±Á{¿Ä¸ê°lú©ÎÂ_ÀYªºÀ£¤O. ¿Ä¸ê±þ½L¥i¯àÁÙ¦³´X¤Ñ, ¯E¹©¤]±N³Q©ì²Ö, ¤]¬O¦ÒÅç«ùªÑªÌªº«H¤ß©M@¤ßªº®É´Á. ¨S¦³«H¤ß@¤ßªÌÁÙ¬O¦ÂI¥X³õ, §K°£Ä~Äò¤U¶^·Î¼õªºÀ£¤O. |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/10 ¤W¤È 12:00:02²Ä 1171 ½g¦^À³
|
Cliff¤j , ¥xÁÞ¤j : ½T©w¤F, FDA ¦Ü¤µ¤´¤¹³\ ¬Y¨Ç±¡ªp¤U¥i¥Î LR ¼Æ¦r°µ§P°µ§PŪ¼Ð·Ç: Clinical Trial Imaging Endpoint Process Standards Guidance for Industry ¦Ü2015 3¤ë¤´¬O¯ó½Z¡A¸Ô¦p¤U¤å¡C ¸Ó¯ó½Z¤¹³\¦b¬Y¨Ç±¡ªp¤U¥i¥Îsite-based imaging interpretations refer to line 234, please Nevertheless, the overarching trial design features and 234 the other previously described features may justify the use of site-based imaging interpretations 235 even in large phase 3 multicenter clinical trials, so long as blinding of image interpretation to 236 treatment can be assured or bias is otherwise controlled. |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/9 ¤U¤È 11:13:51²Ä 1170 ½g¦^À³
|
°ò¥»¤W¡A¯E¹©´N¥Ø«eªº°ò¥»±»P822¬O©|ºâ°·±d¡A´Â¥¿±µo®i¡A ªÑ»ùªº×¥¿¦³¥i¯à¶Õ©ÒÃø§K¡C ²¦³º¡A§Ṳ́£n§Ñ¤F¡A¨º¬O¦]¬°¬F©²¦b¤j¤O§ß´Ó¥Í§Þ²£·~¡A©Ò¥H³o´X¦~¤~¦³°w¹ï¥Í§Þ·~³B¤_Á«·l¡A¦ý©|¥i¤W¥«Äw¸êªº²{¹³µo¥Í¡C ¥Í§Þ²£·~¥i¯à¬O¥xÆWªº¥¼¨Ó¡A³o¬O¬Fµ¦µo®i«Ü©ú½Tªº¤è¦V¡A¥i¤j®a¤£n§Ñ¤F¡A ¬F©²¯S³\Á«·l¤½¥q¤W¥«¡A¬Æ¦Ü©ó°ê¦w°òª÷¤JªÑµ¥¡A ¦b¦bªº§â·ÀI¶Éª`©ó¤@¯ë§ë¸êªÌ¨¤W¡A¦]¬°§Ų́S¦³¬F©²¸êª÷¾Ö¦³ªºÀu¶Õ ¥Ã»·¤ñ§A¦ª¾¹D/¥Ã»·¤ñ§A¯à¥ª¥k¤½¥q¬Fµ¦/¥Ã»·¦¨¥»¤ñ§A§C¤Ó¦h........ ¤@°ï¤£¹ï¯¯ªº¥Ã»·......... ¦^Âk²{¹ê± ¤@°ïªº¤£¤½¥«á¡A§ë¸ê¤H¤´Ä@·N±µ¨ü¡A¥B¤ß¥Ì±¡Ä@¤@¸ô¬ÛÀH¡A¬°¤F¤°»ò........ ¶ê¤@Ó¹Ú! ¥i¬O·í¬Y¨Ç©Ç²{¶H¥X²{«á¡A©Îµu´Á¤º¥X²{¹L«×¤£Ã©w¤U ÁÙ¬O±o·Q²M·¡¡A¤â¤W´¤¦³ªº¬O§_¬°¯u¥¿¦X²z»ù¦ì?ÁÙ¬O³oөҿתº¦X²z»ù¦ì¡A ¬O§â¦Û¤vªº¹Ú·Q¥[½Ñ¦b¤W±? |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/9 ¤U¤È 10:14:08²Ä 1169 ½g¦^À³
|
Cliff ¤j: ½Ð±Ð¤½¥q¦³Ãö ¬O§_ FDA¤w§óªk³W ,§ï¬° protocol ¥²¶·¥ÎCR ªº§PŪ¼Æ¾Ú¬°·Ç ? ¤½¥q»¡ªk¦p¤U: ¡§§Ú¨S¦³¬Ý¨ì³o¼Ëªº³W©w¡A©Î³\¬O¤~²¨¾Ç²L¡AÁٽЧiª¾¬Oþ¤@Óguidance¡C ¦pªG¥J²Ó¬Ý¬ü°êªºFDA guidance, ·|µo²{FDA±j½Õguidance¥u¬Oì«h©Êªº³W½d¡C¡¨ ¤p§Ì¬Ý§Aªºì¤å¶K¤å ( ¤p§Ì^¤å¤£¦n, ±`»~¸Ñ¨ä·N) ,¦ü¥G¤]«D±j¨î©Ê³W½d, ¦Ó¬O¤½¥q©ÒºÙªº guidance ¥u¬Oì«h©Êªº³W½d ? |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/9 ¤U¤È 09:30:08²Ä 1168 ½g¦^À³
|
²q·Q¤j¡A¥[ªo¡I§Ú¥u¯à»¡¤µ¦~2Q©M3QªÑ»ù«Ü¤¿ÀI¡A¦³¤ß¤Hªº¨è·N¾Þ±±¡A³Í°òÃÒ¨é¬O½Ö¦b¥X¡A¦ý4Q¤@¤Á²×±N©ú®Ô¡A¦Ü©óPFS30ªº¬K¬î¤j¹Ú¡A§ÚÁÙ¦s¦³¤@µ·µ·§Æ±æ¡A«e´£¬O¸Ñª¼¤é´Á±oµ¥¨ì©ú¦~2¤ë¥H«á... |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/6/9 ¤U¤È 09:12:33²Ä 1167 ½g¦^À³
|
³oÓ¤j½L¦n®z ¦n¹³¤j®a³£¦b°kÃø ¥~(³°)¸ê¨g¬å ¬O¦b¤ÏÀ³¤°»ò? ¼Ú¬üªÑ¥«¦b°ªÀÉ ¹ð§ð¤£¤W? ÁÙ¬O¤j®a¹w´Á§Y±N§ï´Â´«¥N ¥ý¤U¨®¥ýĹ? ÁÙ¬O³°¸ê·o³J ? §Ú¤@ª½¦A·Q¤@Ó°ÝÃD ¦Û¤v¯à§_¦A¤@¦¸©Ó¨ü±o¦íª÷¿Ä®ü¼S¯ëªºÅ§À»¤Î·l¥¢ ¦b·«BÄÆ·nªº®É¨è ±±¨î¦Û¤vªº³¡¦ì ¬Û«H¤~¬O«OÅ@¦Û¤v³Ì«nªk«h ªñ¤é«Ü¬õªº¤ý¦ÑªO ¸gÀç¤W§ÚµLªk¸m³ñ ¦ý¦o³Ì¤jªº±Ñµ§ ©Î³\¬O°ò©ó¦n·N ¤@¦Aµ¹ªÑªF§Æ±æ ¦ý§Æ±æ«o¤@¦A¸¨ªÅ ¾ÉPªÑ»ù²_¸¨¦Ü¦¹ ¦ý¯E¹©À³¤£·|³o¼Ë §Y¨Ï822¤£Y¥H©¹©Ò·Q(Ó¤H¬Ýªk ÁÙ¤£¬O¨Æ¹ê) «áÄò¤]ÁÙ¦³¤£¤Ö¬ãµo¤¤ªº·sÃÄ ¥u¬O®É¶¡·|©¹«á±À ¦b¤½¥q¤½§G 5/25 ªº PD 229¡F OTHERS 37 ³oӼƦr¥X¨Ó¤§«á »¡¦Ñ¹ê¸Ü §Úº¡¥¢±æªº ¤ß¥Ø¤¤ªº30 ¬Ý¨Ó¤wº¥¦æº¥»·¤F? (³o¬O¤p§Ì¦Û¦æªºµû¦ô ©|«Ý¸Ñª¼½T©w¹ê»Ú¼Æ¦r) ³o¬O§Ú¥»¨Ó¹w´Á822¯à»´ÃP½æ¥B¤j½æ Ó¤Hµ¹ªº´Á³\ ·íµM¨CÓ¤H¹ï©óCR/LR ªº°²³]Ȥ£¤@ ·|³y¦¨°ª§C¬Û®t»á¤jªº¤¤¦ìPFS §Ú¤ß¸Ìªº¦ôºâ ©M¤p©_¤jªº®t¤£¦h Ó¤H¬O¨Ì¾Ú¤½¥qªº»¡ªk »{¬°0.75 ~ 0.8¬O¤¤ªÖªºCR/LRÈ ³o¼Ëªº¦ôªk Ó¤H»{¬°5/25¤w¸g«Ü±µªñ(©Î¤w¥i¬ï¶V)K-M¥Í¦s¦±½u0.5ªº®ÉÂI §Ú²q ¤½¥q©Î³\¤]¤w·NÃѨì³oÂI ©Ò¥H¿ï©w½T»{ªºPD È¥XÄl«á ¦b8¤ë¥l¶}¸Ñª¼»P§_ªº·|ij ¨CÓ¤Hªº¦ôºâ Ãö¥G¦Û¤vªº§ë¸ê¨Mµ¦ ¦Ó¦ôºâ¤S»PÓ¤Hªºª¾ÃÑ ¸gÅç °T®§ ®§®§¬ÛÃö ¦A¥[¤W¦U¦Û´Á±æ¤£¦P §Î¦¨¤£¦Pªº³¡¦ìµ¦²¤ ¤£ºÞ¥L¤H·N¨£¦p¦ó ¦Û¤v±¡ªp¦Û¤v³Ì¤F¸Ñ ¬Û«H¦Û¤v´N¬O³Ì¦nªº ¦Û¤vªº§ë¸ê ¤£½×¦¨±Ñ ¦Û¤vt³d¨Ã²`¥[ÀË°Q ¤~¯à¦bÄAð§ë¸êªº¸ô¤W ²Ö¿n°]´I ¯¬ºÖ¤j®a³£¤jÁÈ! ÁÂÁ¤j®a! |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/9 ¤U¤È 08:47:46²Ä 1166 ½g¦^À³
|
½Ð±Ð¦U¦ì¤j¤j¡G¦pªG¤½¥q±q¥¼¦³CRªº¸ê®Æ¡A¨º3¤ëªk»¡·|¸³¨Æªø»¡ªº¥¼¹F142¤H¬O¨Ì¾Ú¬Æ»ò¦Ó¨Ó...¡H ªk»¡·|®É¤£´£LR 187¤H¡A°ê¥~ªk»¡·|®É«o¥D°Ê¤W¶Ç¤H¼Æ229¤H...¡H¡H¡H °Æ¸³¨Æªø©Ò¨¥¡G¹L¥h§PŪ¨Ó¦^4Ó¤ë²{¤w¸gÁYµu¨ì2.5Ó¤ë¦pªG¤£¬O³£¦³CR¤H¼Æ°lÂܧPŪ¡A¨º³o¥y¸Ü¬O¤°»ò·N«ä¡H¦nºÃ´b³á¡Hµo¨¥¤HÁ¿ªº¨S°µ¹LCR¡H¨º¦U¦ì¤j¤j±À²zªºPFSªº¨Ì¾ÚÁÙ¬O¯à¥H20%ªº®t¶Z¬°°ò¦¶Ü¡H TO¡G¹Ç§AÅó±ø±ø¡A±zªº¤£¸Ñ§Ú«D±`ªº»{¦P¡A¦ý³oªi¤U¶^¬O³Í°ò©ó10¤Ñ¶°¤¤½æ¤F1000¦h±i¡I¦³³o»ò¦h«ùªÑªº¤H«ç»ò·|¦b³o»ù¦ì¤@ª½½æ¡H·|¬OÓ¤HÂà½æµ¹¼í®õ¥þ¥h®M¦Û¤vªº¨p§Q¡H¤j®aÁÙ¬On¦h·Q·Q¡I¡H ÁÙ¬O½Ð¤j®a´À¦Û¤vªº§ë¸ê¦h·þ¾É«ü¾Éµo¨¥¤Hªºµo¨¥@¤ß»P¤º®e§a¡I ¡i§¹¥þ¸ò¸³¨Æªø©Ò»¡ªº¤½¶}¡B³z©úIÂ÷¡j¡I §Ú̸Ӭ۫H½Ö»¡ªº¸Ü©O¡H |
|
|
·|û¡G¤¤¹D10140581 µoªí®É¶¡:2015/6/9 ¤U¤È 08:30:16²Ä 1165 ½g¦^À³
|
µL½×¸Ñª¼µ²ªG¦p¦ó¡H·í¯E¤Í¯uªº¨ÆºÖ®ð¡A¤Í¦U¤è¤j¤jªº«ü¾É¤Ó©¯ºÖ¤F¡IQQ¤j»¡ªº¨S¿ù¡A¸³¨ÆªøªÑªF·|½T¹ê¦³»¡¡G¤½¥qªv²z¤@©w¸Õ¤½¥¡A¤½¶}¡A³z©ú¤]n¨DªÑªF·þ¾É¤½¥q¡I ¨Ì§Ú¦Û¤v½Ð¯qµo¨¥¤H§õ¤p©jªº¸gÅç...¦o¯u¸Ó¥[ªo¤F¡I ¨Æ¹ê¤W¤½¥q¬O§_¯àÅý¸ê¥»¥«³õ§ë¸ê¤H»{¦Pµo¨¥ªººA«×»P¨¥½Í¬O¬Û·í«nªº¡I |
|
|
·|û¡G¤p¯E10135877 µoªí®É¶¡:2015/6/9 ¤U¤È 07:34:16²Ä 1164 ½g¦^À³
|
¯E¹©»P°ò¨È¤£¦P¦b©ó,°ò¨È¥u³æ½ä¤@ÃÄ, ¯E¹© Y¤j®a¾á¤ß822ªºpfs,«á±ÁÙ¦³§ó±j§ó¤[pfsªº833,ÁÙ¦³ÁÞ´¹¤ù,Y³£¤£¦æ,ÁÙ¦³¦×¬r±ìµß,Y³£¤£¦æ,´N¥u¯à·í§@¬O°µ¥\¼w¤F. |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/9 ¤U¤È 06:19:41²Ä 1163 ½g¦^À³
|
ÁÂÁ±۫a¤j¤j: §Ú·Q³o°ÝÃD¤wµL¸Ñ. ¥u¯à©ñ¤U¤F. ÁÙ¦n¦¹ª©¤W¦³¦U¦ì¤j¤j´£¨ÑªººëÅP¸ê®Æ¥i¥H°Ñ¦Ò. ¯u¬O¤Ó©¯ºÖ¤F. |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/9 ¤U¤È 06:11:09²Ä 1162 ½g¦^À³
|
Binwin ¤j¤j: §ÚÁ|Âù¤âÃÙ¦¨§Aªº·N¨£, ¦]¬°¦³¨Çµo¨¥¤H¹ï¤½¥qªº¤F¸Ñ¥i¯à¤£¬O¯uªº¨º»ò²`¤J, ¦b³oºØª¬ªp¤UÀ³¸Ó±N°ÝÃD°O¤U¨Ó, ¦ý¦b±o¨ì½T¹êªºµª®×«á, À³¸Ó§i¶DªÑªF©Î§ë¸ê¤Hªº´N¦^ÂÐ, ¤£¯à»¡ªº¤]n»¡©ú¤£¯à»¡ªºì¦]. ²¦³º, ·|¥h°Ýªº, ³£¬OÃö¤ß¤½¥qªº. §Ú¦Û¤vªº¸gÅç´N¦³«D±`¦hªº¤W¥«¤½¥q, ¤½¶}, ¤½¥¿, ¤£¹½¨ä·ÐªºÅýªÑªF©Î§ë¸ê¤H¤F¸Ñ¤½¥q, ¸ÑµªºÃ´b. ªÑ¤ý, ªÑ¦Z¤]¬O¦p¦¹ («e´£¬On¯à§ä¨ì¤H). ³oºØ¤è¦¡, ªø¤[¤§«á, ·|¯u¥¿±o¨ì¥«³õªº»{¦P. ³o¤]¬O«Ü¦h¤½¥q³]¦³¥N²zµo¨¥¤H, ¦]¬°µo¨¥¤H¤Ó¦£¤F, ¸g±`§ä¤£¨ì¤H. ³o¦¸ªÑªF·|¤¤, ¤½¥qªº°ª¼h±j½Õ³z©ú, ¤½¶}. ³o¹ï¯E¹©¬Oµ´¹ïªº¦n¨Æ. ¤]¤¶²Ð§õ¤p©j¸ò¤j®a»{ÃÑ, ¦³°ÝÃD¥i¥H½Ð±Ð¦o. ³o¤]¬Oµo¨¥¤Hªº¥\¯à¤§£¸. ©Ò¥H¥ô¦ó¤½¥q¹ïµo¨¥¤Hªº¿î¿ï¬O«D±`«nªº, ¦]¬°ª½±µ±¹ï¥«³õ, ·íµM·|¦³¬D¾Ô. ¥¿¬£ªº¤½¥q¤£·|¬ÈÁY. ¤½¶}, ³z©ú, ¸Û«H., ¹ï¥ô¦ó¤½¥q³£¥u¦³¥[¤À. ¦ý§Î¶Hªº«Ø¥ß¤£¬O£¸®É, n¾a®É¶¡¥h°ïÅ|²Ö¿n. ¤[¤F¤~¯à§e²{. ¦Ü©ó¦bºô¸ô¥@¬Éµo»Ã, §Ú·Q, ³o¤]¬O¨â±¤bªº°ÝÃD. «ÂI¬O¤½¶}, ³z©ú, ¸Û«H., ´N¦p 822, ®É¶¡¤[¤F, ¦ÛµM·|¦LÃÒ¥¦ªº»ùÈ. |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/9 ¤U¤È 05:03:10²Ä 1161 ½g¦^À³
|
Faith¤j ·PÁ±z¤£¦]"¾~"¼o¨¥ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/9 ¤U¤È 05:01:20²Ä 1160 ½g¦^À³
|
§Ú¤@¼Ë¬O°Ý¨ì§õ¤p©j¡A¦ý§Ú¤£ª¾QQ¤j°Ý¦o®Éªº°ÝÃD¬O¤°»ò¡H¦pªG§Ú¬Oµo¨¥¤H¡A¦³¤H°Ý§Ú¤½¥q¦³¨S¦³¦¬¨ìCRªºdata¡A§Ú·|¦^µª¨S¦³¡A¦]¬°¯uªº¨S¦¬¨ì¹L¡A¦Ü©ó¤½¥qªºCEOµ¥°ª¼h¦³¨S¦³¦¬¨ì·¥¾÷±K¤å¥ó¡A§Ú¤]·|¦^µª¤£²M·¡¡A¨Sªk¥N´À°ª¼hµo¨¥C¡I¦ý¦pªG¦³¤H°Ý§Ú¡A±i¸³ªº¼Æ¾Ú¬OLRªº¸ê°T¶Ü¡H§Ú·|»¡¡A±i¸³ªº©Ò¦³¼Æ¾Ú³£¬O¨Ì¾ÚCRªº§PŪ¦Ó¨Ó¡A¦Ó«D³ÌªìªºLR¼Æ¾Ú¡C |
|
|
·|û¡GBiwin10140217 µoªí®É¶¡:2015/6/9 ¤U¤È 04:53:40²Ä 1159 ½g¦^À³
|
§Ún¬O¯E¹©ºÞ²z¶¥¼h¡A§Ú¤@©wn¨Dµo¨¥¤H¤£±o¾Õ¦Û¹ï¥~µo¨¥»P¦^µª§ë¸ê¤Hªº°ÝÃD¡C ©Ò¦³°ÝÃD°Oºñ¤U¨Ó¡A§ä®É¶¡¦^ÂСI ¬ì§Þªº¦æ·~¡A¦³¥²n´£°ªÄµÄ±©Ê¨Ó³B²z¥~¬Éªº´£°Ý¡A¦Ó¤£¬O¤@³q¹q¸Ü´NÀH¤f»¡¥X¡AµM«á¤U¤@¬í´N¦bºô¸ô¥@¬Éµo»Ã¡I |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/6/9 ¤U¤È 04:53:05²Ä 1158 ½g¦^À³
|
¤p©_¤j Ãö©ó±z°Ý¨ì¤p§Ì "©M¤é²±±i¥ý¥Íªº°²³]°ò¦¦³»á¤jªº®t²§¡A·|±o¨ìªñ¦üªºµ²½×¶Ü¡H" ¨ä¹ê¤p§Ì¯uªº¤£ª¾¹D ¦A¥[¤W¤p¤j§Ì¤~²¨¾Ç²L,¬O¥Î³Ì²Âªº¤èªkºâ¥Xªº,¦Ó¥B´c¤Æ¯f¤H¥²¶·¦b "¨Ì§Ç´c¤Æ" ªº«e´£¤§¤U,¤p§Ìªº°²³]¤~¯à¦¨¥ß (ÁöµM»PÅó±ø±ø¤jªººâªk¤£§¹¥þ¬Û¦P,¦ý§Ú̱o¨ìªºµ²½×¥Ø«e¬O¤@¼Ëªº...§Úºâ¨ì5¤ë) ¤p§ÌËı±o¤é²±±i¥ý¥Í½×z»P¤p§Ì¬Û¤ñ,¸û¨ã°Ñ¦Ò¤O ¯E¤ÍÌ ¸g¾ú¦¹¦¸PD229¤§¨Æ¥ó«á,¤p§Ì«D±`ÃÙ¦P«¼C¤j©Ò¨¥(«Øij§â«¼C¤j6¤ë6¤é ¤U¤È10ÂI¤§¶K¤å¦AŪ¤@¦¸) «¼C¤j¦³³\¦hW¤f±C¤ß¤§³B,¥ç¬O¤p§Ìªº¬Ýªk ª½¥Õ»¡,¸g¾ú³o¦¸«á §ÚÌn¥Î³ÌÄYÂÔ.³Ì«O¦uªººâªk¨ÓºâPFS»PpÈ §â¼ÖÆ[¯d¦b¸Ñª¼«á§a ¦Ü©óªÑ»ù,®É¶¡¦ÛµM¯à¦^ÂkªÑ»ù¸Ó¦³ªº»ù¦ì,ÁȦhÁȤ֨ä¹ê¤]µù©w¦n¤F°Õ(«¢«¢«¢~¼g³o¥y«Ü©È³QRabbit¤j°á) ¸É¥R ¯Q¾~¤j,¨ä¹ê±z¦³´X¦¸ªºµo¨¥¤p§ÌÁÙÆZÃÙ¦Pªº,ÁÂÁ±zÄ@·N´£¥X»P¤j®a¤À¨É |
|
|
·|û¡G¹ÇÅó±ø10135894 µoªí®É¶¡:2015/6/9 ¤U¤È 04:48:07²Ä 1157 ½g¦^À³
|
¦U¦ì¤j¤j¡A ¸Ñª¼±ø¥ó¥H«eÅ¥¨ìªº¡A¬O§_¤´¬O"´_µo¤H¼Æ(PD CR)¨ì¹F"284"¤H Y¬Oªº¸Ü¡A«h¦]¬°¥Ø«eCR¤H¼Æ©|¥¼¹F¨ì¡A©Ò¥H¤´¦bµ¥´_µo¤H¼Æ¨ì284¤H? |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/9 ¤U¤È 04:37:29²Ä 1156 ½g¦^À³
|
±Û«a¤j¤j: ÁÂÁ§A¸Ñ´b. ¥i¯à§Ú¬O°Ý¿ù¤H¤F, ½Ð°Ý§A¤W¦¸¬O°Ýµo¨¥³æ¦ìªºþ¤@¦ì¤è«K³zÅS¶Ü? ¨º§õ¤p©jªº¦^ÂÐ¥u¬O³y¦¨§Ú§ó¦hªº¿ù´j¤ÎºÃ´b. §Æ±æ¯à§ä¨ì¯à¸Ñ´bªº¤H. §Ú¨Ã¤£n¨DCR¼Æ¦r, ¥u·Q¤F¸Ñ¬yµ{. ³oÀ³¸Ó¤£¶·Áô¿f§a ? ÁÙ¬O³o°ÝÃD¤Ó±Ó·P ? ¤S¬°¤°»ò±Ó·P©O ? |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/9 ¤U¤È 04:04:06²Ä 1155 ½g¦^À³
|
§Ú¤W¦¸°Ý¨ì¦n¹³¸ò§A¤£¤@¼Ë¡Aµo¨¥³æ¦ì»¡±i¸³ªº¼Æ¾Ú¬OCR´£¨Ñªº¡A¦Ü©ó§A°Ý¨ìªº¤½¥q±q¥¼¦¬¨ìCRªºdata¡A§Ú·QCRªºdata¥u¯àµ¹¤½¥q°ª¼hÄÝ·¥¾÷±K¤å¥ó¡A©Ò¥H¡A¤£·|´£¨Ñµ¹¤½¥qªº...ÀHÓ¤H¸ÑŪ¡C |
|
|
·|û¡GOOXX10022393 µoªí®É¶¡:2015/6/9 ¤U¤È 03:49:35²Ä 1154 ½g¦^À³
|
¤½¥q±q¥¼¦¬¨ì¹L CRªºdata ----------------- ¨º³o¼Ë¤½¥q«ç»ò¨M©w¦ó®É¸Ñª¼¡H |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/9 ¤U¤È 03:12:04²Ä 1153 ½g¦^À³
|
±i¸³Á¿ªº¸Ü¯à¬Û«H¶Ü? ®£©Ènµ¥¸Ñª¼«á.§Ṳ́~·|ª¾¹D³o®a¤½¥qªº¸Û«H |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2015/6/9 ¤U¤È 02:51:26²Ä 1152 ½g¦^À³
|
¦U¦ì¤j¤j: ·Q½Ð±Ð¦U¦ì¤j¤j£¸Ó°ÝÃD. §Ú¥h¹q¤½¥q°Ýµo¨¥¤H§õ¤p©j¦³ÃöCR. 1) ¤½¥q¦h¤[·|¦¬¨ì¤@¦¸CRªºdata ? 2) ¤W¦¸ªºCR data ¬O¦ó®É±o¨ìªº? §Úì·Q¨Ì¾Ú®É¶¡ÂI¨Ó²Ê²¤±À¦ôCR/LRªº®t¶Z% ¤Î¦X²z¤Æ±i¸³¦b¤WÂd«eªk»¡©Ò³zÅSªº¥¼¹F142¤H. ¦ý¥X¥G·N¥~ªº¬O§õ¤p©jªí¥Ü, ¤½¥q±q¥¼¦¬¨ì¹L CRªºdata, ³o¥u¦³¦b³Ì«á¸Ñª¼®É¤~¯à±oª¾. ½Ð°Ý³o¬O¥¿±`ªº¶Ü ? ÁÙ¥u¬O¦o¤£Ä@·N¦^µªªº¼Ål¤§Ãã ? |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/9 ¤U¤È 02:46:30²Ä 1151 ½g¦^À³
|
µ½¤H¤j¡A 8¤ë¤¤¥ª¥k´N¥i¥H½T©w5/25=229³oÓLR©Ò¹ïÀ³ªºCR ¦pªG¸ò¤½¥q¦Û¤v¹w¦ôªº®t¤£¦h ´N¥i¥H¹w¦ô¸Ñª¼®É¶¡¤F ¤½¥q¥u¬OÂÔ·V¤@ÂI¡Aµ¥¼Æ¾Ú§ó¦¨¼ô¤@ÂI ¤£·|®ö¶O®É¶¡©M¸ê·½ªº |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/9 ¤U¤È 12:55:14²Ä 1150 ½g¦^À³
|
¦pªGPFS¬O9Ó¤ë©Î16.5Ó¤ë, ¦´N¸Ñª¼, ³Ì¿ð¥»¤ë¤]n¸Ñª¼, ¤£À³¸ÓÄ~Äòªá¿ú°µÁ{§É¸ÕÅç, ®ö¶O®É¶¡©M¸ê·½, ¤]¤£¥²µ¥¨ì8¤ëÁÙnªá¿ú½Ð±M®a¶}·|, Å¥±M®aªº¬Ýªk©M·N¨£? ¦pªG³sPFS³£¤£¦pLetrozole³æÃĪº10.2Ó¤ë, ¦p¦ó¸ò¤H®aÄvª§? ¦pªGPFS¨S¦³20Ó¤ë¥H¤W, ¦p¦ó¸òIbranceÄvª§? Àø®Ä®t¤£¦h®É, ¤~¤ñ°Æ§@¥Î©M¥Í¬¡«~½è, ¯f¤H©M®aÄÝ¿ïÃĪvÀø, ¥DnÁÙ¬O§Æ±æ±N¸~½FÁY¤p©Î¤£nÄ~Äò´c¤ÆÂX´², ±±¨î¯f±¡©µªø¦s¬¡´Á. ¤£n§C¦ô¦Û¤vªº¹ê¤O. ªÑ»ù¤U¶^¬O¨Æ¹ê, ©MÄw½X¾Ô¤Î®É¶¡®Ä²v¦³Ãö, ¨S«H¤ß¨S@¤ßªÌ±þ¥X¬O¦ÛµM¤ÏÀ³. ¥Ø«e¤j¤á̬O³{§C©Ó±µ, µ¥®É¾÷±N¦¨¼ô®É, ¤~·|ºCºC©¹¤W©Ô. ¦ôp¥»¤ë¤U¦¯©Î¤U¤ëªì. |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/9 ¤U¤È 12:28:26²Ä 1149 ½g¦^À³
|
¤@¯ë¤H°õµÛ¦b¸Ñª¼ªº¤ÀªR¡Aµø¨ä¬°³Ì¤j°ò¥»±¡A©Î³\¹ï¤]©Î³\¤£§¹¥þ¹ï! ¤½¥qªv²z»PºÞ²zºâ¤£ºâ°ò¥»±? ªÑªF¸ê¥»ªº¤À°tºâ¤£ºâ°ò¥»±? §ë¸ê»P®wÂ꺮ɾ÷ÂI»Pª÷ÃB¥§¡¤À°tÄݤ_°]°È¡Aºâ¤£ºâ°ò¥»±? ¥«³õ«ù¦³ªº§¡»ù¦¨¥»ºâ¤£ºâ°ò¥»±? ¸s²³¤ß²z¾Çºâ¬ì¾ÇÁÙ¬O¥È¾Ç?¦p¬O¬ì¾Ç¡Aºâ¤£ºâ°ò¥»±? ¦pªG¥H¤W³£¥¼¥J²Óªº¤ÀªR©Î±N¨äµø¬°¤£¤J¬yªº¸Ø½Í¡A¨º»ò´N·|¸ò¤H¥Í¤@¼Ë ¥Ã»·¬O©È¤°»ò´N¨Ó¤°»ò! ¬Ý¤£°_¤°»ò,´N¥Ã»·¦b¨º¤@ÓÃöÁäÂI¶^Ë! ¤@Ó¤w¸g§¹¥þ¤W¥«ªº¤½¥q¡A¨ä©Ò¾Ö¦³²£«~ªº»ùȵûÂ_¡A¸U¤£¯à³æ¥H²£«~¥»¨µø¤§¡C ¤]¤£n¥Ç~ªñ¥@¶i¤hºÉ¬Oªñµø~³o¼Ëªº¿ù Áa¸ò¾îÆ[¥þ±¤~¯à·Ç½T¹w³]¥«³õÅܤơC ³s¤½¥q¬£¤£³£¬O³o¼Ë¶Ü?«÷©R©¹¾î¸ò²`µo®i! |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2015/6/9 ¤U¤È 12:28:11²Ä 1148 ½g¦^À³
|
wison37¤j µ¹±z«öÓÆg ¯E¹©²z½×¤W¤w¸g¹L¤F¦MÀI´Á ¬Û«H±zªº§ë¸ê©ÒÀò§Qªº·|»·¤ñ§A·íªì¹w´Á¥¢±ÑÁ«·l°µ¤½¯q¨Óªº¦h ¤jÀò§Q«á§O§Ñ°OÃÙ§U¤@¨Ç°µ¤½¯q ·P®¦~ |
|
|
·|û¡Gwison3710140346 µoªí®É¶¡:2015/6/9 ¤W¤È 11:24:32²Ä 1147 ½g¦^À³
|
§Ú§ë¸ê¯E¹©ªº°²³]¬O 1.§Ú¶RªºªÑ»ù29¤¸.30¤¸.31¤¸.32¤¸.33¤¸...¨ä¹ê«á±n¦A¥[£¸Ó0¡]ªÑ»ùªi°Ê´N¤£·P¨ì¤j¡^ 2.§Ún½æªº»ù®æ¬O60¤¸.90¤¸.120¤¸.150¤¸.180¤¸..¨ä¹ê«á±n¦A¥[£¸Ó0¡]¤£·|°µµu½uÁÈÃÇÀY¤p§Q¡^ 3.ÃĦ¨¥\¤FªÑªF¨S¦³±o¨ìÀ³¦³ªº³ø¹S.¨º§Ú¨M©w¥Nªí¤½¥q¥h¸òÀq§JÃļt½Í.§â¤½¥q½æ¤F»ù®æÀ³¸Ó¤£¿ù¡]°²³]¡^.´N¥Î¥LÌ»¡ªº50»õ¨ì100»õ¬üª÷§C»ù½æ¤F 4.¨º¸U¤@ÃÄ¥¢±Ñ¤F.¨ºÁ«·l´N·í§@¤½¯q§a.§ë¸ê¥»¨Ó´N¦³·ÀI |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/9 ¤W¤È 11:14:18²Ä 1146 ½g¦^À³
|
¥´¥´®ðÅo ~ ~ µû½× : ¥Í§Þ²£·~ ¡A¤´¬O¥xÆW¥¼¨Ó³Ì¦³§Æ±æªº©ú¬P²£·~¡C Âê©w: 1st ¯E¹©¡A2nd ¤¤¸Î¡C ªñ¥b¦~¨Ó¡A¬õ¦â¸ê¥»¤S¦A«×¥´À» ¥xÆW¹q¤l²£·~¡A IC³]pÁpµo¬ì¡BApple¨ÑÀ³Ãì¡B±ªO¡BIJ±±¡B¡B¡B¡B¤@¨®ªº¹q¤l¤W¤U´å¡A¤S¶}©lµo¥Xĵ°T¡C ¦³¬Ý¨ì¬õ¦â¸ê¥»¡A«Iŧ¨ì ¡§¥xÆW·sÃĬãµo²£·~¶Ü¡¨ ? ¡÷ ¡÷ ¨S¦³ ! ¥xÆW²£·~Â૬¡A¹A(¿¼¡B½©)¡÷¯¼¡÷¶ì¡÷ª÷¿Ä(®q¤º)¡÷¤U´å¹q¤l¹s¥ó¡÷¤W´å ¡÷ ? ¡÷ ? ½Ö¨Ó±µ´Î ? ³QÂI¦W±µ´Î : ¥Í§Þ(·sÂå§÷&·sÃÄ) ¬O³Ì¦³§Æ±æªº¡C(¬ãµoªùÂe¶W°ª¡A±M§Q«OÅ@¶W¡B¶W¡B¶Wªø´Á) À\¶¼ªA°È ? (¤@«×¦³§Æ±æ¦ý³Q¹¦w«³Ð¡A¥BKnowHow°V½mªùÂe¬Û¹ï§C¡A±M§Q«OÅ@·¥§C) ¤å³Ð? (¤p¸ê¤p«~¨Æ·~¬°¥D¡An§ß´Ó 1billion USD ²£·~? §O°µ¹Ú¤F) ®È¹C? (¤p®q°ê¤p±¿n¤p¾÷³õ¡A¯à¶ë¦h¤Ö¤H? ¤Hµy¦h«~½è¨³³t¤U°¡A¸gÀÙ³W¼ÒÁÙ¬O¦³) ¥Í§Þ(·sÃÄ)À³¸Ó¬O¥xÆW¥¼¨Ó³Ì¦³§Æ±æªº©ú¬P²£·~¡C Âê©w: 1st ¯E¹©¡A2nd ¤¤¸Î¡C ¥H¤U¡A¸`¿ý¾ã²z¡A2015/04/21/ ¤u°Ó ¬ð¯}ªvÀø(BTD)ªº2012¦~¶}©l°õ¦æ¨ì²{¦b¡A¦³¤@Óº}«Gªº¦¨¥\®×¨Ò¡A ´N¬OPharmacyclics¡]ÃÄ°é°é¡^ªºBTK¡]Bruton¡¦s Tyrosine Kinase¡^§í¨î¾¯ Imbruvica¡]ibrutinib¡^¡C¤p¤À¤l·sÃÄIMB 1991 : Pharmacyclics(ÃÄ°é°é¡^¦¨¥ß 1995/10/24 : ¥¿¦¡¤W¥«¡]IPO¡^¡AªÑ»ù¬O¬üª÷12¤¸ 2006 : ¥ÑCelera¶R¨ÓImbruvica¡]ibrutinib¡^¤p¤À¤l·sÃÄIMB 2008: ªÑ»ù§C©ó1¬ü¤¸ ! ¨ä¥Dn§Þ³N¨Ã¥¼¨ú±o¶¥¬q©Êªº¦¨¥\¡C 2009: ¤jªÑªF¹D®æ(Duggan)¦¬Áʧó¦hÃÄ°é°éªÑ²¼®É¡AªÑ»ù¤´¦b¬üª÷1.28¤¸ 2011: IMB¦¨¥\¶i¤JÁ{§É¢¹/¢º´Á¡AÀò±oªì¨BÀø®Ä¡A J&J©ó2011¦~ ¥Î¬üª÷9.75»õ¶R¤U¦@¦P¦æ¾PÅv¡]co promotion¡^ 2015/3/5 : ¥H¨CªÑ261.25¬ü¤¸¡AÁ`»ù210»õ¬üª÷¡]¬ù·s¥x¹ô6¤d4¦Ê»õ¡^½æµ¹AbbVie ¶ZÂ÷¤½¥qIPO¤wªñ20¦~¡A ªÑ»ùªº°_¥ñ¡A¤S°Z¬O¥xÆW¥Í§ÞªÑ¥i¤ñÀÀ ! ¯E¹©¡A2015/06/09¥«»ù294¤¸¡A¥«È¶È 16.4»õ¬üª÷ ! ¤¤¸Î¡A2015/06/09 ¥«»ù106.5¤¸¡A¥«È¶È 7.5 »õ¬üª÷ ! |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/9 ¤W¤È 11:08:38²Ä 1145 ½g¦^À³
|
²{¦b¯à±ÏªÑ»ùªº ¥u¯à¤½¥¬¬ü°ê¤G´Áªº¸Ñª¼.¬Ý¯E¹©n¤£n |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/9 ¤W¤È 11:07:04²Ä 1144 ½g¦^À³
|
¨ü¤£¤F²´«eªºªÑ»ù¸Ñ¨M¤è¦¡¦³¤G¡A¤@¬O¥ý½æ¥XÂ÷¶}¥«³õÀR¤ß«á¦A§ä®É¾÷ÂI¶i³õ¡A¤G¬O§âªÑ»ùªº¾_ÀúÂ\¦b¤@Ãä(¯u¤ßªº)»·Â÷½L±¡A¤ß¤~·|¦Û¥Ñ¡C¤µ¦~²Ä¤G¤Î²Ä¤T©uªº¥Í§ÞªÑ¥i¯à§CÀɽL¶^©Î¥H¶^¤î¶^¨Ó¥´©³¡A°ò¥»±±N³oÃä°_¤£¤F§@¥Î¡A¤×¨ä¦pªG©ú¦~ªì¤~¨M©w¸Ñª¼¡A¸Ñª¼«á¼Æ¾Ú¤ÀªRÁÙn¥b¦~¥ª¥k®É¶¡¡A³oÓ®ÉԪѻù©Ô°_¨Ó®É¶¡¤WÁÙ¤Ó¦¡A¦b¦¨¥æ¶q·¥«×µäÁYªº¥«³õ¡A®Ä²v¸êª÷«ç»ò·|³§Aµ¥©O?¥¼¨Ó¦³ªk¤H³sÄòÂI¤õ¤U(¤×¨ä¥~¸ê)¡A¸êª÷¤~¦³¥i¯à¤jÁ|¶i¾n¡A©Ò¥H¤£¥Î¨C¤Ñpºâ¤S½ß¤F¦h¤Ö©Î¬OÀò§Q¤S¦R¦^¦h¤Ö¡A§An°µªº´N¬O½æ¥X©Î»·Â÷¥«³õ¡Aµ½«Ý¦Û¤v¤~¦³§NÀRªº¤ß·Q§´¤U¤@¨B¸Ó¦p¦ó°Ê§@¡A¯E¤ÍÌ©¼¦¹¥[ªo! |
|
|
·|û¡Gwison3710140346 µoªí®É¶¡:2015/6/9 ¤W¤È 11:03:10²Ä 1143 ½g¦^À³
|
¥unÃĢݢÙ.ªÑ»ù®Ú¥»¤£¬O°ÝÃD.¥«³õ®£·W¤Ï¦Ón¦M¾÷¤J¥« |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/9 ¤W¤È 10:47:24²Ä 1142 ½g¦^À³
|
Faith¤j,±z¸ò§Ú©Ò¹w´Áªºthe worst case 822 M PFS = 15 «D±`±µªñ ¤£¹L¤@ª½¥O§Ú©Ò¤£¸Ñªº¬O¡A´NºâPFS¥u¦³15, ¬°¦óÁÙ¬O¦³¤Hn¤£Â_½æ¥X¯}300? ³o»ò¤£¬Ý¦n? ´Nºâ¤¨¦Ñ¨C¤Ñ¶R¡AÁÙ¬O¦³¤H¤@ª½½æ¡A¤¨¦Ñ¬O¤@©w¸ò±i¸³¾Ö¦³¦P¼Ë¸ê°Tªº¤j©@¡A ¥L³£³o¼Ë¤j»¶»¶¶R¶i¡A«çÁÙ¦³¤HÀ³¬On½æ? §Úı±o¥Ø«e¥Í§ÞªÑ¤H®ðµA´²¡A¸T¤£°_¥ô¦ó·§j¯ó°Ê ´N¹³"¬õ¥´¹q"¬ðµM°°]´ú²`²`¶Ë®`§ë¸êªºªÑªF¤@¼Ë ÁöµM±i¸³ªÑªF·|»¡229¬O»~´Ó¡A¶È¥u©ó¸ÑÄÀ¨ÓÀs¥h¯ß¡A¹ï©ó«áÄò¦^À³»y®ð§C¨I¥¼¨£µ·²@·N®ð·µo? ¹ï³\¦hªÑªF´£°Ý¡A¤]»´»´±a¹L¡A¤]¨S¦³¶i¦æ"¥O¤H´Á«Ý©Î®¶¾Äªº§Q¦h«Å¥Ü" ³oÅý§Ú«Ü¤£¸Ñ¡A¦pªG¦p3¤ëªk»¡·|¯ëªº«e´º¥ú©ú¡A¦ü¥GÀ³¸Ó¹ï8¤ë«Å¥¬¸Ñª¼®É¾÷¥Rº¡´Á«Ý ²¦³º¤w¸g¨¯W¤F¶W¹L¤Q¦~¡A²×©ón¨£¨ì¶}ªáµ²ªG¤F¤~¬O¡A ªÑ»ù³o¼Ë¤l¶^ªk¡A§ÚÁÙ¦n¡A¦ý¦U¦ì¯E¤Í«ùªÑ«H¤ß¯uªº¯à°÷µL°Ê©ó°J¶Ü? ÂûÀnªÑ»ù¥ý¦æ¦ü¥G¤w¸g¹w§i¸Ñª¼µ²ªG¡A¸ò¬õ¥´¹qªºªÑ»ù´X¥G¥ç¨B¥çÁÍ¡A§Æ±æ«¥Ì¯Eô¤]®¶§@¤@ÂI§a |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/9 ¤W¤È 10:30:46²Ä 1141 ½g¦^À³
|
¦U¦ì¤j¤j 1¤é²±¥H»~®t24%¦ô¨ì¤¤ë¹ê»Ú¨â²Õ´c¤ÆÁ`¼Æ¤H¼Æ174¤H,¤é²±¬ã§P¨Ì¾ÚOBI822¹L¥h¤wª¾ ªº¼Æ¾Ú»~®t´X¥G¤£¥i¯à¤p©ó30% 2¤é²±¥Î·¥«O¦uªº¦ôºâ:¹êÅç²Õ233¤H°²³]¥þ³¡¦b2014¦~8¤ë¦¬®× ¨ì2015¦~12¤ë¸Ñª¼ ¹êÅç²Õ´c¤Æ¤@¥b107¤H,¹ï·Ó²Õ´c¤Æ107¤H PFS 16.5Ó¤ë 3±i¬ã¨sû¤]»{¬°¨Æ¹ê¤W¹êÅç²Õ¦¬®×®É¶¡«Ü¦h¨Ó¦Û2014¦~8¤ë¥H«e(2011 1 ¦Ü2014 7) ¥[¤WNED¤]¯Ç¤J¹êÅç²ÕpºâPFS,¬G¹êÅç²Õ½T¤ÁªºPFS©Î±N¸û«O¦u¦ôpÈ°ª¥X50%¦Ü100% («O¦u¦ôpÈPFS 16.5Ó¤ë)°ª¥X50% ¬O24.7 °ª¥X100%¬O33 (¤é²±¹w¦ô½d³ò16.5 ¦Ü 33) 4¤j®a³£ª¾¹D:¹êÅç²Õ¦¬®×®É¶¡¤j³¡¤À¨Ó¦Û2011¦~ 1¤ë ¦Ü2014¦~ 7¤ë 5¤j®an°O±o:¤@¬ñ¶i¬}ªº«eÃD¬O¸Ñª¼¼Æ¾Únrobust,¨«¤@¨Bºâ¤@¨B,±i¸³ªÑªF·|¦³»¡¨ì ¬ü°ê¤G´ÁÀH®É¥i¸Ñª¼,·|¤£·|¬O¼Æ¾Ú¤w¾ã²z¦n¤F¦bµ¥¥xÆW¤T´Á¼Æ¾Ú,Ó¤H²q´ú¦³¥i¯à¬O»P FDA¹F¦¨¬Y¨Ç¨ó°Ó 6¥¼¨Ó¸Ñª¼¼Æ¦rÀH®É·|¤½§i,¤£½×¬O¤j®a»¡ªº¨}ÃĩάO¥P¤¦ ³£±N¥ß©óªF¤è(¤£±Ñ) ¥H¤W´£¨Ñ¬ÛÃö¸ê°T»PÓ¤H²L¨£¤À¨É ¦p¦³»~½Ð§ó¥¿ ¥ò´º¤j §Úµo²{§Aªº¼ÒÀÀ»PJolin¤jªº¼ÒÀÀ ¼Æ¦r©~µM¬Û¦P ,¤]²Å¦X¤w¤½§iªº822¤@´ÁÁ{§É¸ê°T |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/9 ¤W¤È 10:17:32²Ä 1140 ½g¦^À³
|
Faith¤j¡A ±z»¡ ¡y¡K¤p§Ì¨Ì¤p§Ì³Ì«O¦uªº¦ôp,´N¨ú´c¤Æ¤H¼Æ229¤H,¦w¼¢²Õ¥´8§é´c¤Æ¨Ó¬Ý,ºâ¨ì5¤ë¥÷,ªº½T¬O15-16Ӥ륪¥k¡z ¤é²±±i¥ý¥Í¡G ¡y¡K¡u229¤H¡v«D¯u¹ê´c¤Æªº¼Æ¦r¡A05/2015¯u¹ê´c¤Æ¤H¼Æ¦ôp¬°174¤H(=229*76%)¡K¡z ¡y¡K¯E¹©´¿¦b03/03/2015ªí¥Ü¡Aª½¦Ü01/2015¡A´c¤Æ¤H¼Æ¥¼¹F»Ýn´Á¤¤¤ÀªRªºCR PD 142¤HªùÂe¡A¬G¸Ó142¤H(¹ê»Ú¤W¸û¥i¯à¬°130¤H)¥i°µ¬°2014/12ªº¹ê»Ú´c¤Æ¤H¼Æªº¡u³Ì«O¦u¦ôp¡v¡A·í®ÉLR PDªº¤H¼Æ¬°187¤H¡A¬G76%(=142/187)¬O±qLR½Õ¾ã¬°CRªº³Ì°ª¤ñ²v¡K¡z ±z©M¤é²±±i¥ý¥Íªº°²³]°ò¦¦³»á¤jªº®t²§¡A·|±o¨ìªñ¦üªºµ²½×¶Ü¡H |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/9 ¤W¤È 10:14:05²Ä 1139 ½g¦^À³
|
¥Í§ÞªÑ¨a ~ ~ ( 2015.06.09) ±q°ªÂI¤U¶^ ¨ìªñ´Á§CÂI¡A¥«È´î¤Ö ±Æ¦æ : ²Ä¤@¦W : °ò¨È¡A´î¤Ö 571»õ¡C ( 486¤¸ ¡÷ 74¤¸ ) ²Ä¤G¦W : ¤Ó´º¡A´î¤Ö 361»õ¡C(¬ù80¤¸ ¡÷ 29.6¤¸) ²Ä¤T¦W : ÃĵءA´î¤Ö330»õ¡C(¬ù250¤¸ ¡÷74¤¸) ²Ä¥|¦W : ¬ü®É¡A´î¤Ö¬ù 300»õ¡C( 184¤¸ ¡÷71¤¸)¡C (µù:¨p¶Ò¥R¥÷µ}ÄÀpºâ) ²Ä¤¦W : ¯E¹©¡A´î¤Ö¬ù280»õ¡C(455¤¸ ¡÷282¤¸)¡C(µù: IPO¼W¸êªÑ¥»ÅÜ°Ê) ²Ä¤»¦W : ¦w¦¨¡A´î¤Ö¬ù231»õ¡C(379¤¸ ¡÷ 175¤¸)¡C ²Ä¤C¦W: ¤¤¸Î¡A´î¤Ö¬ù214»õ¡C(198¤¸ ¡÷ 99¤¸)¡C ¡K ¡K ¡K ¡K ¡K ¡K ¡K ¡K ¡K ¶È¤Wz 1 ~ 7¦W ¥[Á`¡A2287»õ !! |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/6/9 ¤W¤È 09:31:13²Ä 1138 ½g¦^À³
|
«¼C¤j ¤p§Ì«D±`ÃÙ¦P±zªº·Qªk,·PÁ¤À¨É ¤p§Ì¤]¦³¤@¨Ç·Qªk»P¤j®a¤À¨É 1.¸g¾ú¦¹¦¸»~´ÓPD229¨Æ¥ó«á,¤p§Ì»{¬°¹ï¤½¥q¬O¦n¨Æ,¹ï§ë¸ê¤H¤]¬O¦n¨Æ 2.¹ï¤½¥q¦Ó¨¥,±N¨Ó¥ô¦ó¨Æ³£¥²¶·¤p¤ß³B²z;¹ï§ë¸ê¤H¦Ó¨¥,§ó¼f·Vªº±¹ï¨C¤@¶µ¸ê°T¨Ó·½ 3.¤½¥q·íªìªº³]p´N9Ó¤ë¹F°},©Ò¥HY¸Ñª¼¥X¨Ó«á¤j©ó©Îµ¥©ó9Ӥ볣ºâ¦¨¥\¤F 4.¥u¬O¤p§Ì¨Ì·Ó¤p§Ì¦Û¤v³Ì«O¦uªººâªkn¨ì24Ó¤ë¥H¤W¬O«Ü«÷ªº 5.¤£±o¤£¨ØªA¤é²±±i¬ã¨sû,°Ñ¦Ò¬P¨°¤jªº¦¬®×¤H¼Æ§Y¤@¨Ç¼Æ¦r,¤p§Ì¨Ì¤p§Ì³Ì«O¦uªº¦ôp,´N¨ú´c¤Æ¤H¼Æ229¤H,¦w¼¢²Õ¥´8§é´c¤Æ¨Ó¬Ý,ºâ¨ì5¤ë¥÷,ªº½T¬O15-16Ӥ륪¥k 6.ªGµM¦pRabbit¤j¤ÎCliff¤j¦Ó¨¥,Áö¤£¬O¥P¤¦,¤]¬O¨}ÃĤF 7.Y³Ì«á¸Ñª¼µ²ªGY¥u¦³9Ó¤ë,¨ä¹ê,¹ï¯f¤H¦Ó¨¥,¦³¥t¥~¤@ºØ´X¥GµL°Æ§@¥ÎªºÃÄ¥i¿ï¾Ü,¤]¬O¬Û·í¦n!ÁÙ¦³§O§Ñ¤F, ÁÙ¦³¥Ø«eµLÃÄ¥iÂ媺¤T³±©Ê¯f¤H,³£¬O¦n¨Æ¤@¥ó! ³Ì«áÁÙ¬Onµ¹¯E¹©¥[ªo¤@¤U ¥H¤W¬°Ó¤H¬Ýªk¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/8 ¤U¤È 10:18:31²Ä 1137 ½g¦^À³
|
¥ò´º¤j §A¥Î¤wµo¥Í¤§¹ê»Ú±¡¹Ò¤U,±À¦ôªº³Ì«O¦uPFS ¦A¥[¤W510¹Ú¹Ò¶i¦æºtĶµ²ªG ,¥O¤H«HªA,·PÁ¤F ¥t¥~˼ƲĤT¦æ¼Æ¦r²q´úÀ³¸Ó¬O22 |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/8 ¤U¤È 01:29:33²Ä 1136 ½g¦^À³
|
¥ò´º¤j¡G FDA¦Û2007¦~¥Xª©ªº²£·~«ü¤Þ´£¥X¿W¥ß§PŪ¤¤¤ßªº²z©À¡A2011/08¹{¥¬¡uStandards for Clinical Trial Imaging Endpoints¡v´£¥X¿W¥ß§PŪ¤¤¤ßªº³W©w¡]³o¬Oªìª©¡^¡A¨äªu²¥i°Ñ¦Ò¤U±ªº¤@¬qì¤å»¡©ú¡C§Ú¬Q¤é¶K¥Xªº¡G¡uClinical Trial Imaging Endpoint Process Standards -Guidance for Industry¡v¬O2015/03ªº×q²Ä¤@ª©¡A©Ò¥HÀ³¸Ó»¡2011/08«á³W¹ºªºÁ{§É¸ÕÅçn²Å¦X·sªk³W¡A822ªºPhase II/III©ó2011¦~¶}©l¡A©Î³\¦ì©ó©|¥¼±j¨î³W©wªº¦~¥N¡C ¡uDecentralization Of Imaging- Benefits and caveats for sponsors¡v¡]https://www.iconplc.com/icon-files/docs/thought-leadership/public/Contract-Pharma_Decentralization.pdf ¡^¡G Central Review In the 1990s there were several prominent instances of serious problems with trial data quality resulting from local interpretations of imaging studies, which led to a developing consensus that central reads were key for successful trial conduct. The FDA¡¦s first reference to the need for independent reads was in the agency¡¦s industry guidance published in 2007. The document stated, ¡§At a minimum, the assessments should be subjected to a blinded independent adjudication team, generally consisting of radiologists and clinicians.¡¨ In August, 2011, the FDA released a draft guidance document on its standards for clinical trial imaging endpoints, which allowed for exceptions to this requirement: ¡§. . . a site-based image interpretation may be reasonable in a randomized, double-blinded clinical trial of an investigational therapeutic drug where the imaging technology is widely available, the image is easily assessed by a clinical radiologist, and the investigational drug has shown little or no evidence of unblinding effects.2 In this situation, the use of randomization and blinding controls bias in image interpretation.¡¨¡K |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/8 ¤U¤È 01:12:45²Ä 1135 ½g¦^À³
|
¥ò´º¤j ÁÂÁ§A¸ÔºÉªº¸Ñ»¡ ,¨ü¯q¨}¦h,¥H«e¬ü°êµØº¸µó¦b¿ï°]°È¤uµ{¤H¤~®É³ßÅw±q¼Æ¾Ç¨t ª«²z¨t¤¤¥h¬D¿ï,¦]¬°ÅÞ¿è²MªR, ³Ì¶i§Úµo²{¥»ª©¦³¤@¨Ç«Ü¤Ö¶K¤å,¤@¶K¤å´N¥O¤HÆg½àªºª©¤Í ,³o¬O¥i³ßªº²{¶H,§Æ±æ¦³§ó¦hª×ªêÂÃÀsªº°ª¤â¾A®É¥X²{ 10139510¤j ªº¹Ú¹Òµo²{>>> »¼´î»¡ ½Ðµ¹¤©³Ì°ªªºÃöª` |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/8 ¤U¤È 12:16:45²Ä 1134 ½g¦^À³
|
Cliff ¤j¡B¥xÁÞ¤j : Cliff¤j§Aªº»¡ªk¥i¯àn×¥¿ : ¤½¥q»¡Á{§É§PŪ¤£§¹¥þ³£¤@©wn¥HCR ¬°·Ç ³o¬OÓ¤H¥H«e½Ð±ÐÁ{§ÉL³Bªø»¡ªº ( §A¦n¹³¤]»{ÃÑ ) ,©Ò¥H¥xÁÞ¤j¬O¹ïªº©Ô Á{§ÉL³Bªø»¡, ¤]¦³ªºÀù¯gProtocal¬O¤½¥q¦Û¤v³]©w¥ÎLocal Read §PŪªº , FDA¤]¥i±µ¨ü Ó¤H·Q·Q , ³o©Î³\¸ò¬Y¨ÇÀù¯gµo²{¥½´Á®É , ¦s¬¡´Á«Üµu¦³Ãö§a ¥xÁÞ¤j: ¥ò´º¤j : §A¬Ý5¤ë¥÷®É LR 229, YK »¡¥H¥Lªº¸gÅç¬O¦b¦X²z½d³ò,¦pªG¬O¦b¦X²z½d³ò «ç»ò·|¬OÃa®ø®§? §A¦p¦ó¸ÑŪ³\°Æ¸³ªº¸Ü? 1> Ó¤H²L¨£ : ·íµM¬O¦n®ø®§, «ö10139510¤j ªº¹Ú¹ÒCR¼Æ¦r, Ó¤H±q¤£¦P¨Ó·½ªº ¡¨¹Ú¹Ò¡¨ ±o¨ìªº«e¨âÓCR ¼Æ¦r , ¥i»¡¬O¦p¦³¹p¦P, ¯ÂÄÝ¥©¦X¡C 2> ©Ò¥H Ó¤H·íµM¿ï¾Ü¥H510¤j 2015/5/25 _CRªº¼Æ¦r¥h±À¦ô¥¼¨Ó ( 3¤Ñ«e¦³±À¦ôªí ), ©Ò¥H¤~§âPFS 22+6=28 ( ³o¬O²Å¦X¤wµo¥Í¤§¹ê»Ú±¡¹Ò¤U ,±À¦ôªº³Ì«O¦uPFS=22 , ¦A¥[¤W510¹Ú¹ÒªººtĶµ²ªG ) 3> ¤p§Ì´¿½Ð±ÐLÂå®v¹ïPFS ªº¬Ýªk, ¥L»¡ ¡§ §O®ö¶O®É¶¡¥h¹w´ú, ÅܼƤӦh , ¤£¥i¯à·Çªº , ¦pªG¥i¥H¹w´úªº¸Ü µØº¸µó¨º¨ÇÂå¾ÇI´ºªº¤ÀªR®v¦´N³£µo¤j°]¤F¡¨¡C ¦ý§Ú§i¶D¥L ¦Ü¤Ö°µ³Ì«O¦uªº¹w´ú¥i¥H¦ôp±o¥X¨Ó§a ¤£µM¤ß¤¤¨SÓ©³ §ë¸êµLªk §PÂ_( ¥L¤£¦A¦³²§Ä³), ¬°¤°»òµØº¸µó¤ÀªR®v¥H«e¤£°µPFS¹w´ú, Ó¤H»{¬°¬O ¥H«eªºÃÄ, PFS ³£¤Ó§C¤F, PFS ¤S³£«Ü±µªñ, ¹w´úµy¦³»~®t, §ë¸ê´NµLªk¤U§PÂ_¤F, ¤£¹w´ú¬O¹ïªº¡C ¦ý822 ¤£¤@¼Ë¤F ,¨ì¥Ø«e¤wª¾µ²ªG , ¸ò¨ä¥LÀù¯gÃĪº®t¶Z, ¦³ÂI¹³¤u·~1.0 ¸ò 3.0 ªº®t¶Z¤F, PFS¸òÄvª§ªÌ¦³©úÅã®t¶Z, ©Ò¥H¦Ü¤Ö¥i°µ³Ì«O¦uªºPFS¹w´ú, ¡C 4> ¤µ¤Ñ¬O104/6/8 §ÚªB¤Í¹Ú¨ì»¡ ¥L104/8 ·|°µ¤@Ó¹Ú, ¹Ú¹Ò¬O: ¤}ªø¤Í¤H¶¢²á : ±qCRµû¦ô, ¹êÅç²Õ¨ì²{¦bPFS À³¸ÓÁÙ¨S¨ì¤¤¦ì¼Æ´c¤Æ¤H¼Æ , 822ªºPFS¦Ü¤Ö12Ó¤ë¤F, ¯E¹©¥H«á·|Åܦ¨¥Í§Þ·~ªº¥x¿n¹q¡C ¤}ªø»¡ : ¾¼, ªø´Á¨Ó¬Ý, ¥x¿n¹qªºÁ`¥«È(4¥ü) ¸ò ¯E? À³¸Ó¨S±o¤ñ¡C, ¥H¤W¤Í¤Hªº¹Ú¹Ò ´N¬O¤p§Ì¹ï³\°Æ¸³¸Üªº¸ÑŪ |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/8 ¤W¤È 11:04:38²Ä 1133 ½g¦^À³
|
¦Ñ¥v¤j¡G ¡u¡K¨ºall depend on the table(¦³2Ó^¤å³æ¦r¨SÅ¥²M·¡)¡K¡v §ÚÅ¥°_¨Ó¹³¬O¡G¡u¡K¨ºall depends of what¡¦s on the table¡K¡v¡]...¬Ý¯à½Í§P¥X¤°»ò±ø¥ó¦Ó©w...¡^ ¨Ñ±z°Ñ¦Ò¡C |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/6/8 ¤W¤È 09:33:46²Ä 1132 ½g¦^À³
|
Q¡G¦³Ãö±ÂÅv¡A½Ð°Ý¤½¥q³W¹ºªº±ÂÅv®É¶¡¬O¦b¸Ñª¼«e¡H¸Ñª¼«á¡H¥Ø«e¬O§_¤w¦³Âê©wªº±ÂÅv¹ï¶H¡H±ÂÅv¤À¦¨´XÓ°Ï°ì¡H±ÂÅvª÷ÃB¬O¸¨¦b¤°»ò°Ï¶¡¡H ¶ÀÁ`¡G§Ú̳̫nªºµ¦²¤¬O§Æ±æ¸Ñª¼«á¯à°÷§â¯u¹ê¼Æ¾Ú§e²{§Ú̪º¯u¹ê»ùÈ¡AµM«á¦A¥h¸ò¤jªºÃļt°µ°Q½×¡A¦b¦h¦¸ªk»¡¸Ì±¸ò¦U¦ì¸ÑÄÀ¹L¡A¯E¹©¬O§Æ±æ§âmaximumªºvalue¯d¦b¤½¥q¤º³¡¡A¥un¤½¥q¦³¯à¤O¥h¸gÀ窺°Ï°ì¡A¥Ø«e´N¬O¼È©w¤j¤¤°ê°ÏÁÙ¦³¬ü°ê§Ú̧Ʊæ¥i¥H¦Û¤v¥h¸gÀç¡A¦ý¬O³o¤£¬O¦ºªº¡A«Ü¦hªºbusiness¡A§Ú̦³«Ü¦hªºpipeline¡A¦³«Ü¦hªºindicationn¥h°µ¡A©Ò¥H¦X§@¤è¦¡§Ú¬Û«H¬O«D±`¬¡ªº¡A¨ºall depend on the table(¦³2Ó^¤å³æ¦r¨SÅ¥²M·¡)¡A¦pªG§Ú̪º¦X§@¹Ù¦ñ´£¥X«D±`¦³§l¤Þ¤Oªº±ø¥ó¡A§Ú̳£·|¥HªÑªF³Ì¤jªº§Q¯q°µ¦Ò¶q¡A¤ñ¤è»¡§A¦Û¤v««Ø¹Î¶¤©Ò»Ýn®É¶¡«Üªø¡A©ÎªÌ¬O¤ñ¤è»¡¦b¦UÓ¤£¦P¥«³õ§ä¨ì¾A·íªº¹Ù¦ñ¬Æ¦Ü¸ò¥L¦X¨Ö¡A©ÎªÌ¥h¶R¤@Ócommercial¹Î¶¤¡K¡K¡Cµ¦²¤ÁöµM¬O³o¼Ë¡Apµe¬O³o¼Ë¡AÁÙ¬O¥H¹ïªÑªF³Ì¤j§Q¯q¥h±Ä¨ú§Ú̪ºµ¦²¤¡A¦b°µ¨C¤@¨Bªº°Ê§@¤§«e¡A¤]·|¸ò¤j®a»¡©ú¡Aª§¨úªÑªF¹ï§Ú̪º¤ä«ù ±i¸³¸É¥R¡G 1>§Ú̸ò¤j¤½¥q¤¤¶¡ªº·¾³q¬O¤@ª½¦b¶i¦æªº¡A¦ý¦b²Ä¤T´Á¸Ñª¼µ²ªG¨S¦³¥X¨Ó¤§«e¡A»ùȬOµLªkµû¦ôªº¡A³Ì²×ªºterm¤@©w¬Onµ¥¨ì¸Ñª¼¥H«á¤~¯à°÷½Í¡A§Ú̸ò¦h¼Æªº¤½¥q¨ä¹ê³£¦³«Ü¦hªº·¾³q 2>§Ú̾å±oOptimer·í¦~¥À¤½¥q¦³¤@Ófirst right of refusal¡A³oÓ«á¨Ó³QCubist¶R¥h«á¡Aright´NÂà¨ìCubist¤â¤W¡A¤µ¦~ªº®É¶¡¤S³QMerck¶R¥h¤F¡A©Ò¥HMerck³o®a¤½¥q¹ï§ÚÌ822ªº²£«~ªº½T¦³first right of refusal¡A³o¼ËªºÅv§Q¤]´N¬O¥L¦³Àu¥ý¨Ó¸ò§ÚÌ°Ó°Q±N¨Óªº¦@¦P¶}µo¤]¦n¡A±ÂÅv¤]¦n¡A¤£¹L¥Lªº±ø¥ó¤@©wn³Ì¦nªº¡A³o¬Ofirst right of refusalªº©w¸q |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/8 ¤W¤È 09:23:05²Ä 1131 ½g¦^À³
|
·PÁÂ¥ò´º¤j, ¦pªG¤£¥i¯à¦b¬ü°ê°µ¨âÓphase 3, ¨º´N§â§Ú²Ä4¶µ®³±¼, ¨ä¥LÀ³¸ÓÅÞ¿è¤W¨S¦³¿ù§a? |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/8 ¤W¤È 09:11:47²Ä 1130 ½g¦^À³
|
½Ñ¦ì¤j: ( FDA¤£¥i¯àn¨D¦b¬ü°ê·í¦a°µ2 Ó¤T´ÁÁ{§É ) FDA¥u¥i¯àn¨DÃļt¦b¬ü°ê·í¦a°µ1¦¸¤T´ÁÁ{§É, ¤£¥i¯à2¦¸, ³oºØ°ÝÃD¤£¥Î°Ý¤½¥q, ¤]¤£¥Î¬dªk³W , ³o¬O°ò¥»ªk³W±`ÃѤUªº ¡§ÅÞ¿è°ÝÃD¡¨ ¤j®a¹ï°ÝÃD©âµ·éõ©TµM«Ü¦n, ¦ý¹ï³o°ÝÃDªº°Q½×¹ê¦b¤w¸g§@õ¦Û¿£¤F, ¦pªG¦³¤H¤£«H, ¥i¥H¬d¨ìFDA ¹ïÀù¯gÃĪ«, n¨D¦b¬ü°ê·í¦a¥²¶·°µ2¦¸¤T´ÁÁ{§ÉªÌ, ¨º»ò , ¤p§Ì´N¤j¤j¤è¤è½Ð³o¦ì¯E¤Í¦Y ¡§¤j¤è¾i¥Í®Æ²z¡¨ YK »¡ªº2Ó¤T´Á, ¥²µM¬O²Ä¤@Ó¤T´Á¦pªG¬O ¦b¼Ú¬ü¥H¥~¶i¦æªÌ, ¨º»ò, ¶Õ¥²n¦b¼Ú¬ü¦A°µ1¦¸¤T´Á¡C ¦]¦¹, **822¦b¬ü°êªº¤G´Á¦]¬°¬O¥Î¤T´Áªº³W®æ¶i¦æ, ©Ò¥H : 1> ¦pªG¼Æ¾Ú¬Û·í¦n, ´N¥iª½±µ¥Ó½ÐÃÄÃÒ¤F ¡C 2> ¦pªG¼Æ¾ÚÁÙ¤£¿ù, ¨º´N»Ýn¦A°µ bridge study¡C 3> ¦pªG¼Æ¾Ú¥u¦bP=0.05¤W¤U, °¨°¨ªêªê, ´N¥²¶·°µÂX¤j¤T´Á¡C ¥H¤W1.2.3ÂI, ¤w¸gÅܦ¨¹ïªk³W»{ª¾¤UªºÅÞ¿è°ÝÃD, ¤£«HªÌ, ¥h¬d¬dªk³W ¬Ý¬Ý¦³¨S¦³¾÷·|¦Y ¡§¤j¤è¡¨ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/8 ¤W¤È 09:11:42²Ä 1129 ½g¦^À³
|
§Ú§â±¡¹Ò¦A¤À±o²Ó¤@ÂI´yz,¸ò¤j®a¤Á½R¬Ýªk: 1. ¥un¼Æ¾Ú¥Û¯}¤ÑÅå,¤½¥q¬O·|³w°eµ¹¬ü°êFDAÂôÃö¬Ý¬Ý,¬Ý¯à¤£¯à¸òpfizer¨ºÓÃĤ@¼Ë°µ§¹¤G´Á´N´£¦¤W¥«,²¦³º¯à«÷Hole in one´N«÷«÷¬Ý(±i¸³ªº·N«äÀ³¸Ó¬O³o¼Ë) 2. ¦pªG¤£¬O¥Û¯}¤ÑÅå¼Æ¾Ú,¥u¬Oº}«Gªº¼Æ¾Ú,·íµM´N¬O«÷new global phase 3 trial with rolling review (¥Ó½ÐBTD)+ supportive phase 3 trial(²{¦b³oÓ2b¸ÕÅç·íphase 3¬Ý),¤]´N¬O¬Ù¤@Óphase 3 trial±¡§Î¤U¥Ó½ÐBLA, §ìÓEagle¤]¤£¿ù 3. ÁÙ¥i¥Hªº¼Æ¾Ú´N¦A°µ¤@Ó¤j³W¼Òªºnew global phase 3 trial(¥i¯à¦Ü¤Ön°µÓ1-2¦~)+ supportive phase 3 trial(²{¦b³oÓ2b¸ÕÅç·íphase 3¬Ý),ÁÙ¬O¬Ù¤@Óphase 3 trial±¡§Î¤U¥Ó½ÐBLA, §ìÓBirdie¬Ý¬Ý 4. ´¶´¶ªº¼Æ¾Ú´N¥i¯àn¦A°µ"¨âÓ"¤j³W¼Òªº"¥þ·sªº" ¬ü°êglobal phase 3 trial(¥i¯àn°µ?¦~), ¦]¬°¬ü°êFDA¤£©Ó»{²{¦b³oÓphase 2b¹êÅç¥i¥H·íphase 3¬Ý(¬Ù¤£¤F¤@Óphase 3 trial), §ìÓPar, ¦ý§Ú·Q¨ì³oÃä¤j®a¤w¸g¤£·Q¬Ý¤F. 5. ³ÌºGªº±¡ªp: ¼Æ¾Ú¤£²z·Q,bogey,³y¦¨°©µP®ÄÀ³,§Ú¤£´±¦A»¡¤U¥h. |
|
|
·|û¡GBRN10138015 µoªí®É¶¡:2015/6/8 ¤W¤È 08:58:58²Ä 1128 ½g¦^À³
|
¦U¦ì¤j¤j! ¤@°_«ä¦Ò¤@Ó°ÝÃD? OBI-822Á{§É¸ÕÅç¬O¥H¡i¶PÀù¥-PFS 6Ó¤ë¡j§@¹ï·Ó, OBI-822¸ÕÅç¥Ø¼Ð¥unPFS°ª©ó9Ó¤ë,¯E¹©¸ÕÅç´Nºâ¦¨¥\¤F! ²{¦b¤j®a¤@¤ù¼ÖÆ[¤U,¸Ñª¼«áYOBI-822 PFS°ª¹F15Ó¤ë! ½Ð°Ý¹j¤Ñ¯E¹©·|¥Hº¦°±ªO©Î¶^°±ªO¶}¥X©O? |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/8 ¤W¤È 12:18:32²Ä 1127 ½g¦^À³
|
µ½¤H¤j: ±z»{¬°: ¥xÆWTFDAªk³Wªº¤T´Á¬OYK¸£¤¤ªº²Ä¤@ӲĤT´ÁÁ{§É¸ÕÅç; ¬ü°êFDAªk³Wªº¤G´Á¬OYK¸£¤¤ªº"³oÓ¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç" ¦ý§Úı±oYÃĮĻPP value¤£¨ì¥Û¯}¤ÑÅ媺¸Ü,³o¨âÓ°©¤l¸Ì§¹¥þ¬Û¦P¥u¦³¦WºÙ¤£¦PªºÁ{§É¸ÕÅç,¬O«ÜÃøÅý¬ü°êFDA¥h»{©w¥L¬O¨âÓ"¿W¥ß"ªºÁ{§É¸ÕÅç(§Ú»{¬°¨âÓ¿W¥ßªºÁ{§É¸ÕÅçÀ³¸Ó¬On§¹¥þ¤£¦Pªº¯f¤H¸s²Õ,³o¼Ë¤~¤ñ¸û¯à¨Ï¤H«HªA),Åý¤½¥q®³BLAªº,©Ò¥HÂÔ·Vªº³\°Æ¸³À³¸Ó¬On§â²{¦b³oÓÁ{§É¸ÕÅç·í§@supportive phase 3 trialªº·N«ä¤ñ¸û¦X²z,¤]¤ñ¸û¯à¸ò¥H«eªº»¡ªk«e«á©IÀ³(½Ð°Ñ·Ó¤§«eCliff¤jªº¶K¤å),¤]´N¬O»¡,²{¦b³oÓphase 2bªºtrial¥i¥H¬Ù±¼¤@Ó¬ü°êphase 3ªºÁ{§É¸ÕÅç,¥un¦A°µ¤@ÓÅý¬ü°êFDA»{¥iªºphase 3 trial´N¦n. |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/7 ¤U¤È 11:14:47²Ä 1126 ½g¦^À³
|
Cliff¤j, «D±`·PÁ±z¸Ô²Óªº¤ÀªR©M¸Ñ»¡. ¥un¯à 1.¤@±ì¶i¬} - ª½±µ¥Ó½ÐFDA薬ÃÒ; ©Î 2.·Ó§ÚÌÁ{§É³]p, ÃĮĤ£¿ù, ¤]ºâ¦¨¥\, ³o®ÉÔ·|ª½±µ¸òFDA¥Ó½ÐBreakthrough Therapy, ¦P®É·¾³q¦A¸É²Ä¤T´Á¼Æ¾Ú, ¼Ú¬w¤]¬O¤@¼Ë. ³£¬O§Ú´Á±æªº²z·Qµ²ªG. ¤@¤ÁÁÙ¬Oµ¥¸Ñª¼µ²ªG, ¬Ý¤½¥q±Ä¨ú³Ì¦³§Q¤½¥q¥¼¨Óµo®iªº°Ê§@. |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/7 ¤U¤È 10:51:01²Ä 1125 ½g¦^À³
|
§Úªº°ÝÃD: "¸Ñª¼«á, ¦pªGmedian PFS¶W¹L24Ó¤ë, ¯à§_ª½±µ¥Ó½ÐFDAªº·sÃĤW¥«³\¥i? ¯à§_§K°µFDA¤T´Á? ©Î¥u°µ¤p«¬¤T´Á, ¬O200¤H©Î500¤H?" Àò±o±i¸³©M³\°Æ¸³ªº¸Ô²Ó¦^µª, ÁöµM¶¤F¦n¦h°é°é, ¨S¦³ª½±µ©ú½Tªºµª®×, Á`ºâÁ¿¥X«ÂI©M¤è¦V. Michaelªº«ÂI¡G....., §Ú̦b¸Ñª¼¥H«á¡A¦pªG¥¦ªºÀø®Ä«Ü¦n¡A§Ṳ́@©w·|¥h°µ³oӥӽЪº¡A¤@©w·|¥h¤½§i³o¼Ëªºµ²ªG, ....... YKªº«ÂI¡G....., ·Óªk³W¨ÓÁ¿, §An¦b¼Ú¬ü¤W¥«¤@©wn¦³¨âӲĤT´ÁÁ{§É¹êÅ窺µ²ªG¤~¯à¤W¥«, §Ú̲{¦b³Wµe´N¬O¤@ӲĤT´ÁÁ{§É¸ÕÅç, µM«á´Nn¥Ó½Ð¤W¥«, ..... ¨ä¹ê§Ú̳oÓÁöµM¦b§Ąº¬Ophase 2, ¦ý¬O¾ãӼƾڳW®æ³£²Å¦X²Ä¤T´ÁÁ{§É¸ÕÅ窺³W®æ, ³oÓ¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç, ³o¼Ë¤l§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡. Ó¤Hªº¸ÑŪ 1. Michael³¡¤À: "§Ṳ́@©w·|¥h°µ³oӥӽЪº" - ª½±µ¥Ó½ÐFDAªº·sÃĤW¥«³\¥i? 2. YK³¡¤À: "·Óªk³W¨ÓÁ¿, §An¦b¼Ú¬ü¤W¥«¤@©wn¦³¨âÓ("ªk³Wªº")²Ä¤T´ÁÁ{§É¹êÅ窺µ²ªG¤~¯à¤W¥«, ¥xÆWTFDAªk³Wªº¤T´Á¬OYK¸£¤¤ªº²Ä¤@ӲĤT´ÁÁ{§É¸ÕÅç; ¬ü°êFDAªk³Wªº¤G´Á¬OYK¸£¤¤ªº"³oÓ¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç", ³o¼Ë¤l§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡. (¬Ù±¼FDA²Ä¤T´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡) Michael©MYK¬°¦ó·|¥Ø¼Ð¤@Pªº¦^µª°ÝÃD - ¯à§_ª½±µ¥Ó½ÐFDAªº·sÃĤW¥«³\¥i? - ÁöµM¨S¦³©ú»¡«o¤w¸g«ü¦V"ª½±µ¥Ó½Ð"? ¬O¬°¤F¦w¼¾ªÑªF, ÅýªÑªF·|¶¶§Qµ²§ô? ©Î¬O¥LÌ´x´¤ªº¸ê®Æ, ¤ÀªRµû¦ô«á, ¤w¸gÀò±o¦@ÃÑ? Ó¤Hªº²q·Q Á{§É¸ÕÅç¥ÎÃĬO¯E¹©¨ÑÀ³ªº, ·|¬ö¿ý¸ÕÅç²Õ©M¹ï·Ó²Õªº¥ÎÃļƶq©M®É¶¡, ¤¤³~¦³¤H°h¥X©Î¦]¬G°±¤î¥ÎÃÄ(¦p¦º¤`©Î³Q§P´c¤Æ), ¸ÕÅç²Õ©M¹ï·Ó²Õ°±¤î¥ÎÃĪº®É¶¡©M¼Æ¶q³£·|¬ö¿ý, ©Ò¥H¯E¹©ªº¦³Ãö°ª¼h, ¹ï¸ÕÅç²Õ©M¹ï·Ó²Õ´c¤Æªº¤H¼ÆÀ³¸Ó«ÜÁA¸Ñ, ¤~¯à¦w±Æ8¤ë¥l¶}±M®a·|ij, ±i¸³»¡: ťť±M®a̪º·N¨£©M·Qªk, ¦b¥J²Óµû¦ô³Ì¦³§Qªº¸Ñª¼®É¾÷. ±i¸³©M³\°Æ¸³¤w´x´¤¾ãÓÁ{§É¸ÕÅ窺¶iµ{, §ÚÌ´N¬Û«H¥L̪º¸gÅç©M´¼¼z. ¯Q¾~¤j, §Ú³o¼Ë¸ÑŪ, ¤£ª¾¹D±z¬O§_ÁA¸Ñ ¦P·N? ©Î¬O¥t¦³°ª¨£? ¥H¤W¬OÓ¤Hªº¸ÑŪ©M²q·Q, ¦pªG¿ù»~, «ô°U¯E¤ÍÌ«ü¥¿. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/7 ¤U¤È 09:11:33²Ä 1124 ½g¦^À³
|
¦U¦ì¤j¤j ¥Î¤ßªº±á¬P¤j¦bªÑªF·|ªºªº¬ö¿ý²Ä5ÂI¦³Ãö±¡¹Ò1¦³¸Ô²Ó»¡©ú http://obipharma.blogspot.tw/2015/06/201463-104.html#more PERJETA® +trastuzumab + docetaxel n=402 Á`¦s¬¡´Á²Ä2 ¦¸´Á¤¤¤ÀªR¤½§iªº¹êÅç²Õ¦º¤`ªº¯f±w¼Æ113 (28.1%) ¨ÅÀù822OBI¨ü¸Õ¦º¤`±¡ªp±á¬P¤j¦bªÑªF·|ªºªº¬ö¿ý²Ä5ÂI¦³¤½¥qªº»¡©ú ¥i§@¬°³o¨âÓ¨ÅÀùÃĬù²¤¤§¤ñ¸û Cliff ¤j ¸g¹L§Aªº»¡©ú§Ú·Q¦U¦ì¤j¤j¤µ±ß·|ºÎÓ¦n¯v,·PÁ¤F ¦p§A©Ò»¡ªº¨ä¹ê¤j®a´Á±æ³£¬Û¦P ,§Æ±æ822¸Ñª¼«á¬O¡]1¡^¤@§ý¶i¬}ªº±¡¹Ò¡A³oÂI¤£»ÝÃhºÃ¡C¦A«×·PÁ¤F |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2015/6/7 ¤U¤È 08:21:22²Ä 1123 ½g¦^À³
|
·s»D:°¨¶³¤µ¤G«×¨Ó¥x¡A±µ¨ü¥x®v¤j¹{ÃئWÅA³Õ¤h¾Ç¦ì¡A¬¡°Êµ²§ô«á¡A¯S§O©M¦nªB¤ÍÂE®ü¶°¹Î¸³¨Æªø³¢¥x»Ê¦Y¶º¡AªF´Ë°]¸g·s»D¿W®aª½À»±M³X¡A¨â¤H½Í¨ì¥¼¨Ó¥Í§Þ¦X§@¡A³¢¸³ÃÒ¹ê¥H°òª÷·|¦W¸q¡A®½¥X¨â¸U±i¥«È19.8»õªºªÑ²¼¡An¥´³yµØ¤H³ÌÀuªºÀù¯gÂåÀø¤¤¤ß¡A§ón©M°¨¶³¦X§@¡A«Ø¥ß¨â©¤°·±d¶³ ~~~~~~~~~~~~~~~~~~~~ ´Á«Ý³¢¸³¹J¨£±i¸³ |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/7 ¤U¤È 07:24:11²Ä 1122 ½g¦^À³
|
¥xÁÞ¤j¡G 1.±z»¡¡G¡uCliff¤j¡G§A¥H«e¶K¤å»¡¨ìPD229, LR/PD »P CR/PD ¤£·|®t¤Ó¦h Åý¤j®a¤ßÅåÅå,½Ð±ÐªÑªF·|«á§Aªº·QªkÁÙ¤@¼Ë¶Ü?¡v³o¬O¤@Ó«Ü©_©Çªº°ÝÃD¡C¤½¥q¤½¶}»¡©ú¤§«e¡A¤j®aºÉ¤O¥h²q¥h¸ÑÄÀ¡AªÑªF·|¤W¤½¥q¬JµM¤w¸g°µ¤F»¡©ú¡A·íµM´N¥H¤½¥qªº»¡©ú¬°¥D¡A¤×¨ä¤jijÃD/¤j¤è¦V/¤jì«h§ó¬O¥H¤½¥q©Òªí©úªº¬°·Ç¡F°£«D¥X²{¹³¡u´c¤Æ¡v©Î¡u´_µo¡v³oºØ¥Î¦rªº¤p·å²«¡A¤~½ü±o¨ì¤p§Ì§Ú³oÓ©`¦Ì©@AA¼L¥Ö¡C±z³o¤@ÃD¡A§Ú«Ü·Q¦^µª¡A¦ý¨ä¹ê¤£»Ýn¦^µª¡A¦]¬°¥H²{¦bªº®É¶¡ÂI¦Ó¨¥¡A¬O¤@ÓµL·N¸qªºÄ³ÃD¡C´N¹³§Ú²{¦b¦pªGÁٰݱz¡A¡u¤W¶g±zı±oPD¬OPharmacodynamics¡A½Ð±ÐªÑªF·|«á§Aªº·QªkÁÙ¤@¼Ë¶Ü?¡v±z¤]¤£»Ýn¦^µª¡A¦]¬°¦P¼Ë¬O¤@ÓµL·N¸qªºÄ³ÃD¡C 2.YKªº¡u¡K³o¼Ë¤l§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡¡K¡v§Úı±o¥L¤w¸g»¡±o«Ü²M·¡¤F¡A«Øij±z¦A¦hŪ´X¦¸¶K¤å¡C¡]¹ï·Ó2015/03/03»P2015/06/04¨â³õªº¿ýµ½Z¡^¡A¨p©³¤U§Ú»P±z³£¬O¦P¼ËÄ@±æ¡A§Æ±æ822¸Ñª¼«á¬O¡]1¡^¤@§ý¶i¬}ªº±¡¹Ò¡A³oÂI¤£»ÝÃhºÃ¡C 3.¡u¯E¹©Á{§É¬O±Ä¥Î¿W¥ß§PŪ¤¤¤ßªº§P©w¡v³o¥y¸Ü¤ð±e¯S§O±j½Õ¡A¦]¬°¤£¥u¬O¯E¹©¡A©Ò¦³·Q¥Ó½ÐFDAÃÄÃÒªº·sÃÄ¡A¥¦ªºÁ{§É¸ÕÅç¼v¹³§PŪ³£¬On¥Hcentral image¬°·Ç¡A¦]¬°³o¬OFDA©wªº·Ç«h¡G¡uClinical Trial Imaging Endpoint Process Standards -Guidance for Industry¡v ¡]Á{§É¸ÕÅç¼v¹³«ü¼Ð§@·~¼Ð·Ç-²£·~«ü¤Þ¡v¡^http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm268555.pdf ¡^¡F ¬°¤°»òn¦p¦¹³W©w¡H¸Ô¾\¥H¤U¬q¸¨¤º®e¡G page 7/34¡G¡uA. Why Use an Imaging-Based Primary Endpoint?¡v¡]¬°¦ó±Ä¥Î¼v¹³¬°°ò¦ªº¥DnÁ{§É«ü¼Ð¡^ page 8/34¡G¡uB. Is Centralized Image Interpretation Important for an Imaging-Based Primary Endpoint?¡v¡]¤¤¥¡¼v¹³§PŪ¹ï¼v¹³¬°°ò¦ªº¥DnÁ{§É«ü¼Ð«n¶Ü¡H¡^ ©Ò¿×local read¥u¯à¤½¥q¤º³¡¥Î¨Ó¦Û¦æµû¦ô°Ñ¦Òªºªì¨B¼Æ¦r¡A°¾°¾·d¤FÓ¯QÀs³ºµMª½±µµn¤J²³ø¤º®e¡A¥¿±`±¡ªp¤U¡A±i¸³¤Î¤½¥q¹ï¥~ªº®ø®§µo¥¬¥»¨Ó´NÀ³¸Ó¥Hcentral read¬°°ß¤@¿ï¾Ü¡C ¥t¥~¡AMrs. Serenity»PMrs. Siamitu ²×©ó·f¤W½u¤F¡A¯f¤Í¬Û¤¬§ß«ù¼ÖÆ[¨ä¦¨¡A¯¬ºÖ¦oÌ¡C¡]http://www.inspire.com/groups/advanced-breast-cancer/discussion/opt-821-822/?reply_sort=desc#replies |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/6/7 ¤U¤È 02:08:46²Ä 1121 ½g¦^À³
|
CDK4/6¥«场开启¦b±æ¡X¡XFDAɬ¥ý审¬d辉·ç¨Å¸¢Àù©ú¬P药palbociclib 来·½¡G¥Íª«¨¦ 2014-10-15 10:39 http://news.bioon.com/article/6660055.html 辉·çªv疗¨Å¸¢Àù药ª«palbociclib¦A获FDA«C睐 §@ªÌ¡Gyangtao来·½¡G¥Íª«¨¦2015-2-4 9:09:32 http://www.bioon.com/industry/enterprisenews/608764.shtml 辉·ç¨Å¸¢Àù·s药获±oFDA¥[³t§åã 2015-02-12 14:26:00环²yÊI http://health.huanqiu.com/health_news/2015-02/5664169.html |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/7 ¤U¤È 01:23:56²Ä 1120 ½g¦^À³
|
¬Q±ß¹Ú¨ì 5/24 ¶À00¤@Ã䮳µÛ¹q¸Üq¾÷²¼¡A°¨¤W¦A¤Wºô§ó§ï®y¦ì¸¹¡A ¦]¬°¦Ñ¤j³ßÅw¬Ýµ¡¥~·´ºÃä«ä¦Ò°ÝÃD¡C §ï§¹«á»°ºò¶ñ¼g½Ð´Ú³æ¡A¶×³ø¦P®É¶¶«Kñ³æ½Ð¿ú¡A¤£µM¹Ô´Ú¤Ó¦h¡A®a¸ÌnÂ_ª¤¤F¡C ¶i¿ì¤½«Ç¡A¤@Ãä¶×³øÁÙ°½ºË¤@¤U¡A³\00¥¿Ã̦M§¤¡A§e·q¥õª¬..........¦Õ¦·¥J²Ó²âÅ¥±i¦Ñ¤j«ü¥Ü¡A ¨³¹p¤£¤Î±»¦Õªº§Ö§âNB¥´¶}¡A¥Î§¹¥þ»P¦~ÄÖ¤£²Åªº³t«×¦b¥´¦r ¶À00Àþ¶¡Åå¥X¤@¨§N¦½¡A§Ö¦Û¤v¤£¥u¤@¿...........°_½X95¦r/min 5/25 ³\00ÅX¨®©¹¤G¯è·H«e¶i¡A±i¦Ñ¤j¤@Ãä®Õ½Z²³ø¤º®e¡A ¥k¦ÕÅ¥¶À00¶×³ø¥«³õ³Ì·sÀùÃÄPfizerªº¯S©Ê¡A¥ª¦ÕÅ¥¹q¸Ü¤¤ ¼í0·s¼tªº¤T¯Å¨¾Å@¾÷¨î³Ì·s¶i«×¡C ¹ê¦b¬O¦]¬°¤j®a³£¤Ó¦£¡A©Ò¥H¤£¤p¤ß......229........ ¯u¬O¯îðªº¹Ú ·í¤@®a¥ø·~¦b°ò¦´Á¥B¦³¸êª÷¤U§V¤O¹B°µ¡A³q±`¶È¯à±N¿ú¶°¤¤¦b¤Ö¼Æµ×^©Î¹ïªº¤è¦V°õ¦æ¡A ¼õ¹L¥´©³¤S¦³¥i¨£ªº¦¨ªG«á¡A¸û©ö¨ú±oªÑªF«H¥ô¡A¨ú±o¬Û¹ï¦³§Q¸êª÷ª`¤J¡C ·Ç³Æ°_¸Åo..........¤j°ÝÃD¨Ó¤F.......... °ª¼h¬Oµ×^¡A¤×¨ä¬ãµo¥X±Ï¥@·sÃĪº¤½¥q¡A§ó¬Ò¬Obest of the best , ªZ«L¤p»¡¤¤±Ôz.......¸U¤¤µL¤@ªº°ª¤â¡A³Ì¬ì¾Ç¡A³Ì²Ó¤ß¡A³Ì·|¤ÀªR¡A³ÌÀ´²Îp¡A³Ì¯à¤ÏÃÒ.........etc¡A´N¬O³o¸s¦Ü´L¡C ¦b¨ú±o¤Fªì¨B¦¨´N¥B¤w¥i¹wp«áÄòµo®i¨Ã±o¨ì§ó¤j¸êª÷«á¡A ¬O¤@®a¥ø·~³W¼Ò¦b¾Ç²ß¦±½u¦V¤WÅs¦±³Ì¬°°~¼ªº¤@¬q¡C ³°Äòªº¼x¶i³\¦h¤H¤~«á¡A©|¶·Æ[¹î¨ä¯u¤~¹ê¾Ç/¾³õ°V½m/¤å¤Æ¿Ñ¦X/¹D¼w´ú¸Õ/¤H»ÚÃö«Y/¦M¾÷³B²z~~~~~~¤@°ï°ï........... ¦Ó³o¨Ç¶Ô¾ÇªÖ¬°ªÌ¡A©|n°²¥H®É¤é¿iÁå¡A¤è¯à¤j¾¹¡C ²¦³º¥L̵Lªk¹³¤p«½«½¡AªÏÅé¨ó½Õ©ÊÀHµÛ¤ß´¼µ¥¤ñ¦¨ªø¡A§Y«K¥LÌ«Ü·Q~ ¦b¦¹¤§«e¡A¤½¥q¥²±o®e§Ô«Ü¦h©³¤UµL¤ß©Î²Ê¤ßªº¿ù¡A ³o¬O©Ò¦³·Q¦¨ªø¥ø·~¥²¶·¥Iªº¦¨¥»¡C ¹ï¤@®a³Q©ñ¦bÅã·LÃè¤UÀ˵øªºµJÂI¤½¥q¡A¦³¨S¦³¥i¯à¾ûµL¤ßªº¿ù,·|³Q¦³®Äªº©ñ¤j¡A Åܦ¨¥i©Èªº½¹½º®ÄÀ³¡A¥Î¥Hº¡¨¬¬Y¨Ç¯S©w¤H¨p¤ß? ¥i¯à¦³¡A¤]¥i¯à¨S¦³....... ¨¬°¤@Ó¥DºÞ ¦³³d¥ô¤ß~¤W¹ï¦ÑÁó¡A¤U¹ï¤ä«ùªºªÑ¥Á¡AÅé½Ìû¤uªº¨¯W¡Aµ¹¤©¾÷·|±Ð¨|¡A°£¤F§]¤U¨{¡AÅó¦b¦Û¤v¨¤W¡A¨S¦³¨ä¥¦¿ï¾Ü! ¨S³d¥ô¤ß~±N¿ù¥þ±Àµ¹û¤u¨Ã¥H¥¿¸q§Î¹³¤½¶}ªºÄþ³d! ¦pªG¬O¦b¦Û¤vºÊ·þ¤U³£¯à§â"µL®¢"·í³Ì°ª¥Í¦sì«h¡A³oÃþµL®¢¤§®¢µL®¢¨o......¤§¬y(¤S¤£¬O¬F«È)¡A ¤]¤£È±o¤j®a®³¨®a¬Û®¼! ¤å¥½ ´¢¼¯¤@¤U............¦pªG±z¬O±i00/¶À00/³\00¡A¨Æ¥ó©|¥¼µo»Ã§¹¡A§A·|¥H¤°»òºA«×¶}ªÑªF·|? ¶}Ãh¼ÖÆ[&¼H¥Ö¯ºÁy&¤j¸vºZ¨¥.....?¥ç©Î¬O¬Û¤Ï¡A§Ù·V®£Äߦý¤£¥¢«H¤ßªº»y½Õ¸òºA«×? «Ü©úÅã¡A¥L̤w¸g¦b¾á°_©³¤Uªº¿ù»~¡A©Ò¥H¤£ª¾«ç¤\»¡¡A¤]¤£¯à¦h»¡¡A ¦]¬°¹ê¦b¦Û¤v¤]¦³ÂI¶¡±µ³d¥ô¡C ·d¤£¦n¡A¤º¤ß³Ì*&:~")∑";¡Ûªº¬O¶W¯Å¤j¦ÑÁó..........®ð¨ì¦í°|........... ªá¤Q´XÓE©M¤T¬P´Á§V¤O¡Aµ²ªG...........¨â¤Ñ¥[°_¨Ó¥ÎÁÙ¤£¨ì¤T¤p®É¡A³Q¦R¥ú.................. ¤S¥²¶·¦AÀqÀqªºªá¼Æ¿¤O¡A«¨Ó¤@¦¸¡C¦ý¥L¨S¦h»¡¥b¥y¡A°£¤F¦Aªá§ó¦h¿ú¡AÁÙ¬O¦Aªá§ó¦h¿ú¡C ®ð«×¤w¸g¨M©w¤F¥L̪º°ª«×! ¦Ó§ë¸êªÌ°£¤F«ÈÆ[¤ÀªR¤§¥~¡A¦A¨Ó¥i¯à§ó«nªº¬O¥t¤@Ó·s»â°ì×ù³õ........ ¥@¨Æ¬}©ú¬Ò¾Ç°Ý¡A¤H±¡½m¹F§Y¤å³¹! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/7 ¤U¤È 01:07:57²Ä 1119 ½g¦^À³
|
1OBI-822Á{§É¸ÕÅç¼Æ¾Ú¦w¥þºÊ·þ©eû·|¡]DSMB¡^²Ä¤K¦¸³ø§i¡A«ØijÁ{§ÉÄ~Äò°µ (¶ÀÁ`:°Æ§@¥Î¤Ó¤j©Î¨â²Õ¦³¥ÎÃĨS¥ÎÃÄ®t²§¤£¤j®É¤~·|«Øij°±¤îÁ{§É), °Æ§@¥Î¤£¤j¤S¥iÄ~ÄòÁ{§É¤U¦X²z±À½×¨â²Õ¦³®t²§ 2¨ÌÁ{§É¸ÕÅç¬ÛÃöªk³W³W©w¡AÀ³±Ä¥Î¿W¥ß§PŪ¤¤¤ßªº§P©w¼Æ¾Ú CR/PD¬°¥D, ¿W¥ß§PŪ¤¤¤ßªº§P©w»¡¤F¤~ºâ 3¯E¹©Á{§É¬O±Ä¥Î¿W¥ß§PŪ¤¤¤ßªº§P©w ¥ò´º¤j §A¬Ý5¤ë¥÷®É LR 229, YK »¡¥H¥Lªº¸gÅç¬O¦b¦X²z½d³ò,¦pªG¬O¦b¦X²z½d³ò «ç»ò·|¬OÃa®ø®§?§A¦p¦ó¸ÑŪ³\°Æ¸³ªº¸Ü? ¥t¥~³\°ÆÁ`:§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡,¨ì©³¬O±¡¹Ò1ªº°^Äm? ÁÙ¬O±¡¹Ò2ªº°^Äm?¨º¤@ºØ±¡¹Ò¤~¯à¬Ù±¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/7 ¤W¤È 10:51:11²Ä 1118 ½g¦^À³
|
¥ò´º¤j Ó¦ì¤j¤j 1§Aªº¨£¸Ñ¤ñ¸û²Å¦X¹ê»Ú,±ø²z¤À©ú ,¨ä¥L¤j¤j¤ÀªR¦³¤]«Ü¦³¹D²z,¦]¨S¨¬°÷¦³®É¶¡ ¦A°l°Ý ,¥Ø«e³´¤J¦U¦Ûªí³t±¡ªp,¤£¹L¸Ñª¼4ºØ±¡¹Ò ¤£ºÞ¬O±¡ªp¹Ò1 ©Î±¡ªp¹Ò2 ³£¤£¬O´CÅ黡ªº©µ«á¬ü°ê¤W¥« ,¤Ï¦Ó¬O¥[³t¤W¥«,³o¬O§Ú©ßYK½Í¸Ü»é¥¸ªºì¦] 2¦Ñ¥v¤jÁÂÁ§A§¹¾ã¬ö¿ý ³£¬O«ÂI¤¤ªº«ÂI 3Cliff¤j: §A¥H«e¶K¤å»¡¨ìPD229, LR/PD »P CR/PD ¤£·|®t¤Ó¦h Åý¤j®a¤ßÅåÅå,½Ð±ÐªÑªF·|«á§Aªº·QªkÁÙ¤@¼Ë¶Ü? 4Ó¤H¯Ç´eªº¬O³\°ÆÁ`:§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡¡v¡A·|¬O±¡¹Ò2¶Ü ? ±¡¹Ò2¤]nªá¶OÁ{§É¹êÅ窺¸g ¶O»P®É¶¡,±¡¹Ò2¦³¿ìªk¬Ù±¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡¶Ü? 5¬Ý¨Ó¤µ¤Ñ¬O¦n¤é¥h°Ý¶ý¯ª¬Ý¬Ý¬O±¡±¡¹Ò1,©Î¬O±¡¹Ò2 ,¤µ¤é¦N¯« ¥ÀÜ¡B¤T¦X¡B»ï§p¹ï¡B¤Ñ°¨¡B¯q«á |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/7 ¤W¤È 09:46:59²Ä 1117 ½g¦^À³
|
·PÁÂCliff¤jªºcomments, obi822¦b¬ü°êÀ³¸Ó¬OBLA. ±zªGµM¬O¤@¥X¤â«Kª¾¦³¨S¦³. |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/6/7 ¤W¤È 08:11:30²Ä 1116 ½g¦^À³
|
ÁÂÁÂCliff¥S¡AProvisional approvalÀ³§ï¬°Conditional approval ¬P±á¥S±N´£°Ý¦X¨Ö¿@ÁY¬° 7. pºâMedium PFS §Ú¦A¸É¤W§ó§¹¾ãªº¤å¦r¥H«K½Ñ§g¤ÀªR Q¡G¸Ñª¼«á¦pªGmedianPFS¶W¹L24Ó¤ë(¶ÀÁ`¡G§Úı±o³o¬O¤@Ó°²³]©ÊªºÄ³ÃD)¡A¯à§_ª½±µ¥Ó½ÐFDAªº·sÃĤW¥«³\¥i¡H¯à§_§K°µFDA¤T´Á¡H©Î¥u°µ¤p«¬¤T´Á¦Ü200¤H©Î500¤H¡H ±i¸³¡G¨C¤@°ê®aªºªk³W³æ¦ì³£¬O¥H¯f¤Hªºwelfare¬°Àu¥ý¦Ò¶q......§Ú¤£·Q»~¾É§ë¸ê¤H¡Anµ¥¨ì¥¿¦¡¸Ñª¼¥H«á¤~¯à®Ú¾Ú³Ì«áªºµ²ªG¡A§ÚÌ°µªº¨C¤@Ӱʧ@³£·|¹ï¤j®a¤½§i(......½Ð°Ñ¦Ò¬Q¤å) YK¡u¤S¡v¸É¥R¡G¨ä¹ê³oÁ{§É¹êÅç¼Æ¾Ú¦n¤£¦n¨Ã¤£¬O¥u¦³¬ÝPFS¡A¦Ó¬On¬Ý¨â²ÕPFSªº¤ñ¸û®t²§¡A¨º¤ñ¸û®t²§¤¤¶¡·|¦³Ó¼Æ¦r¥X¨Ó¥s°µP value¡C¤@¸Ñª¼¤§«ápower´N¨S¦³¬Æ»ò·N¸q¡A·N¸q´N¬O¦bP value³oÃä¡AP value´N¬O¨âÓ²Õ¸sªº®t²§¡A°²¦pP value¤p©ó0.05ªº·N¸q¬O¤°»ò¡Hªí¥Ü»¡§Ú³oÓÁ{§É¸ÕÅ窺µ²ªG¬O¦¨¥\ªº¡A¦ý¬O¥¦¿ù»~ªº¾÷·|¬O¤p©ó5%¡AP valueªº·N¸q¬O³o¼Ë¤l¡C©Ò¥H¦bªk»¡·|ªº®ÉÔ¡A¦³¤H°Ý»¡ª½±µ¤W¥«ªº±¡ªp¡A¤¤¶¡¦³¨âÓ0©Î¤TÓ0¡A¦³¨âÓ0¡A0.001ªí¥Ü»¡§Ú³oÓÁ{§É¹êÅç¥X¨Ó¿ù»~ªºµ²ªG¬O¤p©ó0.1%¡A·íµMªk³W³æ¦ì´N·|«D±`¦w¤ßªº¸ò§A¥Î§Ö³t³q¹Dµ¹§A©¹«e¨«¡A©Ò¥H½µP¤§«á³Ì¥Dn´N¬O»¡¬Ý¨â²Õ®t²§ªºP value YK«D±`ÂÔ·V¡A¸õ°wÂصü»á¦h¡A«Ü¥i·R |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/6/7 ¤W¤È 07:49:31²Ä 1115 ½g¦^À³
|
¤Þ¥Î¦Ñ¥v¤j¶K¤å±i¸³³¡¤À(µoªí®É¶¡:2015/6/6 ¤U¤È 11:21:23) ¡§±i¸³ ¨C¤@°ê®aªºªk³W³æ¦ì³£¬O¥H¯f¤Hªºwelfare¬°Àu¥ý¦Ò¶q¡A¦pªG¤@Ó²£«~ªº¦w¥þ©Ê«D±`¦n¡AÀø®Ä¸ò²{¦³ªº¼Ð·ÇªvÀøªk¤S§ó¦nªº®ÉÔ¡A¥L¤@©w·|¦Ò¼{Åý¥¦ºÉ¦Åý¯f¤H±o¨ì³o¼ËªºÂåÀø¡A¨S¦³»¡¤@©wªº¼Ð·Ç¬O§AªºPFS¬O´XÓ¤ë´N¥i¥H°µ³o¼Ëªº¨Æ±¡¡C§Ú̦b¸Ñª¼¥H«á¡A¦pªG¥¦ªºÀø®Ä«Ü¦n¡A§Ṳ́@©w·|¥h°µ³oӥӽЪº¡A¤@©w·|¥h¤½§i³o¼Ëªºµ²ªG¡A³Ì²×þ¤@Ó°ê®a¥i¥HÅý§Ų́줰»òµ{«×¡A¦b¨S¦³¸Ñª¼¥H«e¯ÂÄÝÁr´ú¡C³Ì¦nªº¨Ò¤l´N¬O³Ìªñ¤@Ó¬r©Ê«D±`¤jªºPfizerªºÃÄ¡A¥¦¬O´£¦¤G´Á´N¸Ñª¼¤F¡AÀò±oProvisional approval¡A³o¤]¬O¨ÅÀùªºÃÄ¡A³o¼Ë¤lªº«e±ªº¨Ò¤l¬O¦³ªº¡A¥i¬O³o¤£ªí¥Ü»¡§Ú̪º²£«~¤@©w·|³q¹L¡A©Î¤@©w·|±o¨ì¬Æ»ò¼Ëªº«Ý¹J¡A§Ú¤£·Q»~¾É§ë¸ê¤H¡Anµ¥¨ì¥¿¦¡¸Ñª¼¥H«á¤~¯à®Ú¾Ú³Ì«áªºµ²ªG¡A§ÚÌ°µªº¨C¤@Ӱʧ@³£·|¹ï¤j®a¤½§i¡¨ 1.¡§¡K¡C³Ì¦nªº¨Ò¤l´N¬O³Ìªñ¡K.¡¨=>¯E¹©¸Ñª¼«á,¥i¯à´«¥L¬O³Ìªñ, 2¡K..¡§¬r©Ê«D±`¤jªºPfizerªºÃÄ¡¨¡K.=> ¬r©Ê¤W,822¦n¹³(«O¦uÂI)¤£¬O,©Î¬O»¡¤£¬O(¦n¹³¬O¨Æ¹ê) ,822¥i±N¯f¤HªºwelfareÅU¨ì¤F 3¡K..¡§Pfizer´£¦¤G´Á´N¸Ñª¼¤F¡AÀò±oProvisional approval¡¨¡K.=>§ï¤U¡K.822¤G´Á¸Ñª¼¤F¡AÀò±o¡¨?????¡¨(¤£ª¾·|¬OÔ£)¡K..,¦P®É¬O§_¦³±N¡¨¯f¤Hªºwelfare¡¨ÅU¨ì§ó¦n,¦P®É¤]±NYK»¡ªº¤@¤j¬q¡¨¡K¡K¡¨,Á|¨ÒÃÒ©ú¤F,ÁÙ¹êÃÒ¤F,Á٥Ρ¨¤T´Á³W®æ¡¨¹êÃÒ,¥B¬O¨âÓ¤T´Á(¤½¥q¤è¦V¬O) 4. ¡§¡K..¯f¤Hªºwelfare¬°Àu¥ý¦Ò¶q¡K¡A..´£¦¤G´Á´N¸Ñª¼¤F¡K.³o¤]¬O¨ÅÀùªºÃÄ¡K¡¨=>Y¬O822¤ñPfizer¦n¤Î¦P¬O¤G´Á¸Ñª¼¤U,³Ì²×·|¬OÔ£????? ¨S½µP«e¤@¤Á³£¬O¥¼©w |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/7 ¤W¤È 07:23:44²Ä 1114 ½g¦^À³
|
·PÁÂCliff¤j¤j«äºû²M´·¦³±ø¤£¯¿ªº»¡©ú¡A¦Ü¦¹¾ãÅé½ü¹ø¤w¦³³z¹ýªº²z¸Ñ¡A±z¦A«×¥X¤â¡A¤å³¹©CÄZ¦³«l¡C |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/7 ¤W¤È 01:00:31²Ä 1113 ½g¦^À³
|
³oÓª§Ä³¡A½Ð¤j®a¦A¥h¦^ÅU2015/03/03¤WÂd«eªk¤H»¡©ú·|¤WYK¦^µª¬O§_¥i¯à¥Ñ822¸Ñª¼«áªº¼Æ¾Ú¥h¸òFDAª½±µ¥Ó½ÐÃÄÃÒ¡H©Î¬On°µPhase III¤§«á¤~¥i¥Ó½ÐÃÄÃÒ¡H½Ð°Ñ¦Ò¬P±á¤jªº¡uOBI Pharma Observer¡v2015/03/03 ªº¤å¦r°O¿ý--Question 13¡]http://obipharma.blogspot.tw/2015/03/2015333q.html#more ¡^ ®e§Úª½±µÉ¥Î¬P±á¤j¤å³¹¤¤ªº¤@¬qºK¿ý©ó¤U¡G ¡u(1)¤@±ì¶i¬}¡A¤]´N¬O»¡®ÄªG«D±`¦n¡APȫܤp¡A¤p©ó0.001¡A§ÚÌ·|§V¤O¸òFDA¡A¸ò¥L̽ͧPª½±µ¥Ó½ÐProvisional Approval(¼È®É®Öã)¡C¥i¯à©Ê©O¡H³o¬O²Ä¤@Ó¥D°Ê§K¬ÌÀøªk·sÃÄ¡A¥i¯à©Ê¬O¦³¡A¦ý¬O«e´£¬O³oÓÃÄn«D±`Robust(¦³¤O¶qªº)¡C (2)·Ó§ÚÌÁ{§É³]p¡AÃĮĤ£¿ù¡A¤]ºâ¦¨¥\¡A³o®ÉÔ·|ª½±µ¸òFDA¥Ó½ÐBreakthrough Therapy¡A¦P®É·¾³q¦A¸É²Ä¤T´Á¼Æ¾Ú¡A¼Ú¬w¤]¬O¤@¼Ë¡A¦]¬°²{¦bªºPhase II¥i¥H§@¬°Supporting Phase III¡C¡v ¤Wz(2)ªº¤º®e§â¥¦»P2015/06/03ªÑªF·|¤WYKªº¦^µª¡A¥»¦¸YK©Ò¨¥¡u©Ò¥H³oÓÁ{§É¹êÅçÁöµM¦b¬ü°ê¬O²Ä¤G´Á¡A¦ý§ÚÌÁÙ¬O¥Î²Ä¤T´Áªº³W®æ¨Ó°µ¡A¨ì®ÉÔ°²¦p»¡¨ºÓÁ{§É¸ÕÅç¤]¥¿±ªº¡A§ÚÌ¥i¥H¸ò¬ü°ê»P¼Ú¬wªºªk³W³æ¦ì»¡¡A¨ä¹ê§Ú̳oÓÁöµM¦b§Ąº¬Ophase2¡A¦ý¬O¾ãӼƾڳW®æ³£²Å¦X²Ä¤T´ÁÁ{§É¸ÕÅ窺³W®æ¡A³oÓ¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç¡A³o¼Ë¤l§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡¡v¡AÅãµM¬O«ü¤Wz(2)ªº±¡¹Ò¡A²{¦æªº¬ü°ê Phase II¬O°µ¬°Supporting Phase III¡A¤£¹L¦ü¥G³Q»{¬°¬O«ü(1)¤@±ì¶i¬}ªº±¡¹Ò¡C ©Ò¥H³o¦¸¦n¤ßªº¯Q¾~¬O¹ïªº¡C±Û«a¤j©Ò¨¥¤]¨S¿ù¡C¦ý¬OYK©Ò¨¥¹ê»Ú¤W´|¦X¤F(1)»P(2)¡A§é·Ù¤F³o¨Ç§V¤OÅ¥Á¿ªºªÑªFÌ¡C³o¦¸¤½¥q¤jÀYÌÁy¦â¾®«®ðª^ºò±i¡AYK¤×¨äºòÁ^¡A¦h¦YÁ³µ·¥B¤º®e¸õ±o¥û¡AÅ¥°_¨Ó¯uªº¥Ù¬ÞÅܦh¡A·f°t2015/03/03ªº¤º®e¨Ó¬Ý·|¤ñ¸û²M·¡¡C ¥t¥~¡A¦Ñ¥v¤jªºÄ¶¤å¤¤¡AProvisional approvalÀ³¬°Conditional approval. ¬P±á¤j¤w§â2015/06/04ªÑªF·|¿ýµ¤Æ¬°¤å¦rÀÉ¡A»{¯uªº¤H³Ì¬ü¡A¥»¦¸·|«á±o¨£¥»´L¡AªGµM¤~»ª¥X²³¡A¦p¦¹»{¯u¥i¿×¹ê¦Ü¦WÂk¡ANice work!! 822¥¼¨Ó¦VFDA¥Ó½Ðªº¬OBLA¡A¤p¤À¤lÃĪ«¤~¬O¥h¥Ó½ÐNDA¡C ÁÙ¦³822ªº¥Dn«ü¼Ð¬O¬ÝPFS¡A©Ò¥Hn¬Ýprogression¡u´c¤Æ¡vªº±¡§Î¦p¦óÅܤơF°ò¨ÈªºPI-88«h¬O³]©w¥Dn«ü¼Ð¬°¡uµL¯e¯f¦s¬¡´Á¡v-DFS¡]Disease Free Survival¡^¡AÆ[¹î¡u´_µo¡v»P§_¡C°¾°¾¾ã³õ±i¸³¤@¦A±aÀYÁ¿´_µo¡A¥u¯à³ç¼Û¬ü°ê«Ý¤[¤F¡A¹ï¤¤¤åªº´x´¤¨«¤F¼Ë¡C |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/7 ¤W¤È 12:50:22²Ä 1112 ½g¦^À³
|
¹ï¤F~ÁÙn½s»s£¸¬q±qµ´±æ¨ì¶H¼x§Æ±æªº¶§¥ú¡A¤S¥iIJ°Ê·P°Ê¤H¤ßªº¼s§i¡AçE¤Ñ»\¦a¦b¥þ²y¼½©ñ~£¸¦¸´Nn¥´ÅT¥xÆW¯E¹©¦W¸¹¡A¦æ¾P«Ü«n ¦ýY¼Æ¾Ú´¶´¶¡A¨º´N§C½ÕÁ¾µêÂI¦n~ ¥H¤W¦sÄݹº¤j¹Ú~ |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/7 ¤W¤È 12:28:39²Ä 1111 ½g¦^À³
|
¯E¹©¸Ñª¼®É¤½¥q¹Î¶¤©Ô¨ì¬ü°ê¶}°OªÌ·|¤½¥¬¼Æ¾Ú ¨ì¬ü°ê¤½¥¬´Nµ¥©ó©Û§i¤Ñ¤U~¥á²yµ¹¬ü°ê ·í¥þ¥@¬É³£ª¾¹D¼Æ¾Ú«á¡A¥xÆW¥ý¤W¥«¡A¬°¤F§Q¯q¡A¥LÌ·|»{¯u¦Ò¼{µû¦ô~ ¥xÆWÃø±o¾÷·| ¦³¦nªº¬ãµo¦ì¶¥¦b°ê»Ú¤W À³¸Ó®i²{¯T©Ê~ ¥H¤W¦sºé·Q¤Ó¦h¦Ó¤w~ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/6 ¤U¤È 11:40:25²Ä 1110 ½g¦^À³
|
YK³o¨Ç¸Ü: "²{¦b³Wµe´N¬O¤@ӲĤT´ÁÁ{§É¸ÕÅç¡AµM«á´Nn¥Ó½Ð¤W¥«" "§ÚÌ¥i¥H¸ò¬ü°ê»P¼Ú¬wªºªk³W³æ¦ì»¡¡A¨ä¹ê§Ú̳oÓÁöµM¦b§Ąº¬Ophase2¡A¦ý¬O¾ãӼƾڳW®æ³£²Å¦X²Ä¤T´ÁÁ{§É¸ÕÅ窺³W®æ¡A³oÓ¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç" §Úªº¸ÑŪ¬O: "²{¦b§ÚÌ´N¬O³W¹º±N¨Ó¥u°µ¤@Ó¬ü°ê²Ä¤T´ÁªºÁ{§É¸ÕÅç(¥þ·sªº),°µ§¹Y¼Æ¾Ú¦n,´Nª½±µ¥Ó½Ð¤W¥«,ÁöµM¼Ú¬ün¨Dn¨âÓ¿W¥ß¤T´ÁÁ{§É¸ÕÅçµ²ªG,§ÚÌ·|¥Î¤§«eªºphase 2 trial¨Ó»¡ªA¬ü°ê»P¼Ú¬wªºªk³W³æ¦ì,³o¾ãӼƾڳW®æ³£²Å¦X²Ä¤T´ÁÁ{§É¸ÕÅ窺³W®æ,©Ò¥H¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç" |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/6 ¤U¤È 11:35:20²Ä 1109 ½g¦^À³
|
Âǥѳo¼Ëªº°Q½×¡A¯à¿Eµo¥X¦U¦ì¤j¤jªº°ª¨£¡A¨ü¯q¨}¦h¡A§^¤ß©ÒÄ@¡I |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/6/6 ¤U¤È 11:21:23²Ä 1108 ½g¦^À³
|
YK ¦U¦ì¤@©w·Q»¡¯E¹©¬°¤°»ò¹ï³oÓ¶}ª¼³o¥ó¨Æ±¡³o»ò¤p¤ß¡A´X¥G¨ìÀt¤òªºµ{«×¤F¡A¨ä¹ê³o¤£¬O¥u¦³¸òÁ{§Éµ¦²¤²o¡A§Ṳ́]¸òªk³W¤Wªºµ¦²¤¬O¦³¤@Pªº¡C¦P¼Ë¤@ÓÁ{§É¦b¥xÆW¬O²Ä¤G²Ä¤T´Á¡A¦b¬ü°ê¬O²Ä¤G´Á2b¡A·Óªk³W¨ÓÁ¿¡A§An¦b¼Ú¬ü¤W¥«¤@©wn¦³¨âӲĤT´ÁÁ{§É¹êÅ窺µ²ªG¤~¯à¤W¥«¡A§Ú̲{¦b³Wµe´N¬O¤@ӲĤT´ÁÁ{§É¸ÕÅç¡AµM«á´Nn¥Ó½Ð¤W¥«¡A©Ò¥H³oÓÁ{§É¹êÅçÁöµM¦b¬ü°ê¬O²Ä¤G´Á¡A¦ý§ÚÌÁÙ¬O¥Î²Ä¤T´Áªº³W®æ¨Ó°µ¡A¨ì®ÉÔ°²¦p»¡¨ºÓÁ{§É¸ÕÅç¤]¥¿±ªº¡A§ÚÌ¥i¥H¸ò¬ü°ê»P¼Ú¬wªºªk³W³æ¦ì»¡¡A¨ä¹ê§Ú̳oÓÁöµM¦b§Ąº¬Ophase2¡A¦ý¬O¾ãӼƾڳW®æ³£²Å¦X²Ä¤T´ÁÁ{§É¸ÕÅ窺³W®æ¡A³oÓ¥i¥H¥Î°µ²Ä¤GӲĤT´ÁÁ{§É¸ÕÅç¡A³o¼Ë¤l§Ú̬ٱ¼°µ¤@ӲĤT´ÁÁ{§É¸ÕÅ窺¸g¶OÁÙ¦³®É¶¡ ±i¸³ ¨C¤@°ê®aªºªk³W³æ¦ì³£¬O¥H¯f¤Hªºwelfare¬°Àu¥ý¦Ò¶q¡A¦pªG¤@Ó²£«~ªº¦w¥þ©Ê«D±`¦n¡AÀø®Ä¸ò²{¦³ªº¼Ð·ÇªvÀøªk¤S§ó¦nªº®ÉÔ¡A¥L¤@©w·|¦Ò¼{Åý¥¦ºÉ¦Åý¯f¤H±o¨ì³o¼ËªºÂåÀø¡A¨S¦³»¡¤@©wªº¼Ð·Ç¬O§AªºPFS¬O´XÓ¤ë´N¥i¥H°µ³o¼Ëªº¨Æ±¡¡C§Ú̦b¸Ñª¼¥H«á¡A¦pªG¥¦ªºÀø®Ä«Ü¦n¡A§Ṳ́@©w·|¥h°µ³oӥӽЪº¡A¤@©w·|¥h¤½§i³o¼Ëªºµ²ªG¡A³Ì²×þ¤@Ó°ê®a¥i¥HÅý§Ų́줰»òµ{«×¡A¦b¨S¦³¸Ñª¼¥H«e¯ÂÄÝÁr´ú¡C³Ì¦nªº¨Ò¤l´N¬O³Ìªñ¤@Ó¬r©Ê«D±`¤jªºPfizerªºÃÄ¡A¥¦¬O´£¦¤G´Á´N¸Ñª¼¤F¡AÀò±oProvisional approval¡A³o¤]¬O¨ÅÀùªºÃÄ¡A³o¼Ë¤lªº«e±ªº¨Ò¤l¬O¦³ªº¡A¥i¬O³o¤£ªí¥Ü»¡§Ú̪º²£«~¤@©w·|³q¹L¡A©Î¤@©w·|±o¨ì¬Æ»ò¼Ëªº«Ý¹J¡A§Ú¤£·Q»~¾É§ë¸ê¤H¡Anµ¥¨ì¥¿¦¡¸Ñª¼¥H«á¤~¯à®Ú¾Ú³Ì«áªºµ²ªG¡A§ÚÌ°µªº¨C¤@Ӱʧ@³£·|¹ï¤j®a¤½§i |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/6 ¤U¤È 10:59:42²Ä 1107 ½g¦^À³
|
§ÚÁÙ¬O«Øij¤j®a¡A§â ¡§§K°µ¤T´Á¡Aª½±µ®³FDAÃĵý¡¨ ³o¥y¸Ü¡Aµ¹§Ñ¤F§a ¡§¿W¥ß¤T´ÁÁ{§É(TFDA)¹F¨ì·¥¬°ÅãµÛªºÀø®Ä¡A±N¾Ú¦¹Àu²§ªº¼Æ¾Ú¦VFDA¥Ó½Ð§K°µ¤T´Áª½±µ¥nÃöÃÄÃÒ¡¨ ¡÷ ¡÷ §Ñ¤F ¥¦ !! ¼K ~ Ãø±o ¯Q¥S Á¿¤F¤@¥y§ÚÅ¥±o¶i¥hªº ~ : ¡§Y¼Æ¾Ú²z·Qªº¸Ü,¥Ó½Ðbreakthrough therapy¨Ã¥Îºu°Ê¦¡¼f¬d§@£¸Ó·sªºglobal phase 3 trial, §Ú·Q³o¬O³Ì¼ÖÆ[ªºµ²ªG¤F¡¨ ªÑ¥««Ý¤[¤F¡A§Ú̳£ª¾¹D¡A ¡§¹w´Á¡¨ ¼vÅTªÑ»ù«Ü¤jªº¡C ¨Ò¦p¡AYoY +50% ¬O«Ü¦n¡A¦ý¦pªG´¶¹M ¹w¥¦À³¸Ó¬O YoY +100% ¡A«h¯uªº¤½¥¬ ¥¦¦¨ªø 50%®É¡AªÑ»ù¬O ¤U¶^¤ÏÀ³ªº¡C ¤¤¸Î¬O¤@ӫܦnªº¨Ò¤l¡C ·í¤¤¸Î®³¨ì BTD®É¡A¬Û·í¦hªº ¡§¿ù»~¹w´Á¡¨ ¡A»¡¥i¥H ¡§§K°µ Phase III¡¨ ª½®³Ãĵý¡C µ²ªG¤½§Gµª®×¡AFDA Åý¤¤¸Î ¡§¥un°µ30¤H¡¨ ¡A©ú©ú¬O §Q¦h¡A¤]Åܦ¨ §QªÅ¤F¡C ¡§¤¤¸Î§K°µPhase III¡¨ vs ¡§¸É°µ30¤H¤p¤T´Á¡¨ ¨ä¹ê¤¤¶¡ªº®É¶¡®t¡A ¥i¯à¥u¦³6Ó¤ë (©Î9Ó¤ë¥H¤º) WuXiªº¤T§å½T®Ä¡A¤j¬ù¤]¬O¦b¤µ¦~9¤ë¡C °µ¤p¤T´Á¡Aºu°Ê¼f¬d¡A¤j¬ù¬O¤µ¦~12¤ë´£¥XÃĵý¥Ó½Ð¡C (´¼Àº Phase III §¹¦¨¬Û·í¤@¬q®É¶¡¤F¡A¤]ÁÙ¨S¦³®³¨ì Ãĵý¡C CMC¡B¡B¡B¡B¡B¡B) ¯E¹©ªº°ª¼h½T¹ê»¡¹L¡A¦pªG¼Æ¾Ú«Ü¦n¡B¡B¡B¡B ¡A ¡§¹³¤@±ì¶i¬}¡¨ (ª½®³FDAÃĵý) 100½X¡B200½X¡B(300½X)¡A ¤@±ì¶i¬}¡A·íµM¤£´±§_»{¡A¾÷²v¬O¦³ªº¡C ¦ý¡A ¡§¤£¬O±`ºA¡¨ ¡C ®Æ¼Ä±q¼e ¿m¼Ä±qÄY¡C §ë¸ê¡An¦h¦h¥h·Q ¡§¸û«O¦u¡¨ ªºª¬ªp¡A (1)¹ï¦Û¤vªº ¸ê²£°t¸m¡A§ë¸ê¤ñ¨Ò½Õ±±¡A¬O¤ñ¸û¦³À°§Uªº¡C (2)¡§¨Æ¥ó¯uªºµo¥Í«á¡¨ ¡A¹ï¯E¹©ªºªÑ»ù¡A¤]¬O¤ñ¸û¦³À°§Uªº¡C W¤f±C¤ß¡A¥ý·Q ¡§¤ñ¸ûÃaªºª¬ªp¡¨ ¡A¯uªº¬O¹ï¦Û¤v¾Þ§@¦³§Qªº¡C ³o¦¸¯E¹©IPO¡A¤]¬O«Ü¦nªº¨Ò¤l¡C «Ü¦h¤H´N¤@ª½·Q¡A¯E¹© ±¾µP´N ¸Às¦b¤Ñ¡A¦p¦ó¦p¦ó¡A ·í®É§Ú©M«Ü¦h¤H ¡§ª§ÅG¡¨ ¹L¡A ·í¤@¤ß·Q ¡§¦h¤è¡¨ ¡A´N«Ü®e©ö ¡§Ã©¦íªÅ¤è°T®§¡¨ ¡K ¡K ¯E¹© ¿³Âd¥½´Á¡A¤j®a³£ª¾¹D¡AªL¤j¤á¦b¤j¶q½æ¯E¹©¤F (°¾°¾¦³¤H´Nµwn»¡¡Aµ¥±¾µP«á¥L´N¶R¦^¨Ó ? ) (ªL¤j¤á¸U±i¤j½æÀ£) + ( ªÑ»ù°ªÂIªº¿³Âdµ|ÄÀ¥XÄw½X ) + (2¸U±iIPO ¼W¸ê ) ¤W±¤T¶µ¡A³£¬O ¡§Â\©ú¦b¨º¨àªº¡¨ ¡A¦pªG¤@¤ß徧¦h¡A ¡§´Né¦í²´·ú¤F¡¨ (§Úªº¯E¹©¡A¤]¬O ¡§ªø§ë¡¨ ¡A¦ýtrade ¥¦¤@¤U®t»ù¡A¤]¬O¶W¯Å¸É¡A ·íµM¡A¸U¸U¨S¦³·Q¨ì·|¥Ñ390¤¸¶^§Ö³t¶^¨ì290¤¸³o»ò²` ) ÂPö¤Ó¦h¡A¦Aµ²½×¤@¤U: (¤£¦P·Nªº ªB¤Í ´N¤@¯º¸m¤§§a ~ ) (1)°ò©ó·RÅ@¯E¹©(ªÑ»ù)¡A¤£n¦A¥h·Q ¡§ª½®³FDAÃĵý¡¨ ¡A¡¨2017¦~®³FDAÃĵý¡¨ (2)¥Ñ¼í®õ¦^¸Éµ¥½Ñ¦h¸ñ¶H¡A§Ú¹ï¯E¹©²{¦bªºªÑ»ù¡A¬O«Ü¤ß°Ê (¦æ°Ê)ªº¡C |
|
|
·|û¡Gªü©v10140551 µoªí®É¶¡:2015/6/6 ¤U¤È 10:55:48²Ä 1106 ½g¦^À³
|
Á¿¤@¤U²³øÀÉÓ¤H¬Ýªk¡AP22¸Ì±¦³¤@ӼƾÚSAEs °Æ§@¥Î¤H¼Æ63¡A¦û¥þ³¡¹êÅçªÌ27%¡AÓ¤H»{¬°³o¬O§K¬Ì¨t²Î¬Û¹ï¦nªº¯f¤H¡A¥X²{ªºGrade 2²{¶H¡Aªí¥ÜT²ÓM¦³°Ñ»P§K¬Ì¤ÏÀ³¡A²£¥ÍIgGªø´Á°O¾Ð¡A¤@´Á¹êÅ禳41%¦s¬¡10¦~¡A¤T´Á¦b¾¯¶q¥[¤j¡B°w¼Æ¤]¼W¥[¡A±À´ú²£¥ÍIgGªº¤ñ¨Ò¥i¥H°ª©ó¤@´Á¡C ¦A¨Ó¬OLR»PCRªº°ÝÃD¡A¹L¥hÆ[¹î¨ì¸~½F®û¼í¡A¤J«I©PÃ䥿±`²Õ´¡A·|³Q§P©wÃĵL®Ä¡An´«ÃÄ¡A¤£¹L§K¬ÌÀøªkªº¯S©Ê«h¬O§K¬Ì²ÓM·|¥]³ò¸~½F¡ACT¤ù¤l¤W¬Ý¨ì¸~½FÅܤj¡A«Ü¹³®û¼í¡A®t§O¦b©ó«eªÌ¬OÀù²ÓM¤J«I¥¿±`²Õ´¡A¦Ó«áªÌ«h¬O§K¬Ì²ÓM¥]³ò¸~½F²Õ´¡C ¤T´ÁÁÙ¦³«Ü¦hÅܼơA¦pªG²{¦b¥i¥H¹wª¾PFS¡A¨º¬Oé¨ìªº¡A¥unPFS>15´N«ÜÀu¨q¤F¡A¥H¤¤ë©³LR 229¨Ó¬Ý¡AOBI-822À³¸Ó¬O¦³®Äªº¡A¦ýFDA¤G´Ánp<0.001¨Ã¤£®e©ö¡A©Ò¥HªÑªF·|¤~·|¤@ª½±j½Õ¡APhase 2b¬O¥Î¤T´Áªº³W®æ¡A¥[¤WTFDAªº¤T´Á¡Aµ¥©ó¬O¨âÓ¤T´Á¡A¦pªGFDA±µ¨ü¡A¨ºPÈ<0.05´N¥i¥H¡C¤½¥q©È¸U¤@¼Æ¾Ú¤£°÷¦n¡A¥i¥Hµw¥W¨ì¤@±ì¶i¬}ªº·N«ä¡C ¤£¹LÓ¤H¬Oı±o¡A¨«¬ð¯}©ÊÀøªkªº¾÷²v¡A·|¤ñ¸û¤j¨Ç¡AFDAªº¼f¬d©eû¡A«Ü¦h¦³®³¤jÃļtªº¦n³B¡A¤j¼t¹B¥Î¼vÅT¤O»P³W«h¡A§Þ³N©Ê¤zÂZ¡A©ì©µ¹ï¤âªº·sÃĤW¥«¶i«×¡A¬O«Ü±`¨£ªº¡C Á`¤§¡A822¸Ñª¼«á¥un¥x¬ü¨âÃ䪺p³£¤p©ó0.05¡A¯E¹©ªº»ùÈ´N¤£¥u³o¼Ë¤F¡C ¸Ü»¡³o¦¸ASCO«Ü¬õªºCAR-T¡AÃĤj³¡¤À³£ÁÙ¦b¤@´Á¡A³Ìªñº¦¤£¤Ö¡K |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/6 ¤U¤È 10:46:00²Ä 1105 ½g¦^À³
|
¥xÁÞ¤j¡B±Û«a¤j: ( ¦³Ãö2ÓÁ{§É¤T´Á ) ¤p§ÌÁö¤£À´ªk³W , ¦ýÅãµM¯E¤Í»~¸Ñ¤FYK ªº»¡ªk, ¥¿½Tªº»¡ªkÀ³¬O (Y¦³¿ù»~ Àµ½Ð«ü¥¿) : 1> ¦pªGÃĪ«¦Û©l¦Ü²×³£¥u¦b¬ü°ê°µÁ{§É, «h¥un¤@Ó¬ü°êÁ{§É¤T´Á´N¥i¥Ó½ÐÃÄÃÒ¡C 2> ¦pªGÃĪ«¬O¦b¬ü°ê¡B¼Ú·ù¥H¥~¨ä¥L°ê®a°µÁ{§É¤T´ÁªÌ, ¨º»ò, ´N¥²¶·¸É°µ¬ü°ê©Î¼Ú·ù¤T´Á, ´N¬O©Ò¿×ªº2ÓÁ{§É¤T´Áªºn¨D¡C¦ý 2.1> ¦pªG¬ü°êªº¤G´Á¼Æ¦r¦³°÷º}«G¡B¦³®ð½è¡B¤S¦³¤º²[, ¨¬¥H¥OFDA§é¸y §ë¦a , §Y¥i¥ý¥Ó½ÐÃÄÃÒ(BLA) , µ¥ÃĪ«¤W¥««á¦A¸É°µ¤T´Á (³o¦b¥H«eªk»¡·|¦³´£¹L)¡C 2.2> ¦pªG¬ü°êªº¤G´Á¼Æ¦r¶È¤î©óº}«G, ¨ºFDA ·|n¨D°µ¤p«¬¤T´Á(Bridge study) 3> ²{¦b822 ªºµo®i¼Æ¾Ú, ¬Ý°_¨Ó¹³¬O¦³®ð½è¡B¦³¤º²[ªºµ´¥@¬ü¤k , ¨«ªº¬O 2.1ªº¸ô½u¡C 4> ±q6/4°OªÌ¶Ã¼gªº¤º®e,, Ó¤H»{¬°°OªÌ¬O¬G·Nªº ( ³o¨Ç°OªÌÃø¹D¤£ª¾¹D¦³«Ü¦h°OªÌ¶Ã¼g, °t¦Xª£§@©Î¨rÆN , ³Q§ì¥hÃö¤F¶Ü ? ¯u¬O¤£ª¾¦º¬¡ ) §_«h ¤£·|Å¥§¹ªÑªF·|, ·|§â ¡§°l¨DÃĪ«´£«e¤W¥«¡¨ ¼g¦¨ ¡§©µ«á¤W¥«¡¨ §âPD229 ªº»~´Ó, ¼g¦¨ ¡¨ ¤j¤p²´, ¹ï°ê¥~Á¿¯u¸Ü ¹ï°ê¤ºÁ¿°²¸Ü¡¨ ©Î¦³ªº¼g¦¨ ¡§¬Ì]ºÃ¦ü³y°²¡¨ ³o¤w¸g¯A¶û´²¼½ªÑ¥«¤£¹ê¨¥½×, ·N¹Ï¼vÅT¦æ±¡, ¦³¿ýµªº¯u¾Ì¹ê¾Ú¥i¸ê¬°ÃÒ , ¦³¶¢¤u¤Òªº¯E¤Í¦pªG´£§i, ¨ÌÓ¤H¹ïªk«ßªº²z¸Ñ , ¥²³Ó¡C³o¥iª½±µ¦V§ë¸ê¤H«OÅ@¤¤¤ß´£§i§Y¥i, ¥i¦P®É´£§i¥Á¦D¨Æ , ¤w¥¿µøÅ¥¡C§_«h, ³o¨Ç¶Â¤ß ( «D¦n¤ß) ªº¯Q¾~¥H«á¤´·|Ä~Äò¨è·NÄA˶¥Õ,ÂZ¶Ã¯E¹©¦æ±¡¡C |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/6 ¤U¤È 06:47:42²Ä 1104 ½g¦^À³
|
³\¤Í®¥104/04/20 ¥Ó³ø±i¼ÆÃØ»P100 ©Ç©Çªº |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/6 ¤U¤È 06:43:03²Ä 1103 ½g¦^À³
|
¥xÁÞ¤j¡A§Ú¦³Å¥¨ìYKªº»¡ªk¡A¦P®É·P¨ìºÃ´b¡A¦]¬°¥H¬ü°ê¤G´ÁÁ{§É·í°µ²Ä¤GÓ¤T´ÁÁ{§É¡A°Z¤£§¤¹ê¯Q¾~¤jªºÁ¿ªk¡A¬ü°ê¤G´Á©MTFDA¤G¤T´Á³£¬O¦P¤@trial¶Ü¡H³o¼Ë¬O¤£¬O¹HIFDA¨âÓ¿W¥ß¤T´ÁÁ{§Éªºn¨D¡H |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/6 ¤U¤È 05:54:55²Ä 1102 ½g¦^À³
|
±Û«a¤j YK»¡©«: ¨Ì¾Úªk³W¤@ÓÃÄn¦b¼Ú¬ü¤W¥«»Ý¦³¨âӲĤT´ÁÁ{§É¸ÕÅç,¯E¹©³W¹º¥Î¤@ӲĤT´ÁÁ{§É¸ÕÅç¨Ó¥Ó½Ð¤W¥«,¦]¬°¬ü°ê¤G´Á³W®æ²Å¦X²Ä¤T´ÁÁ{§É¸ÕÅçªk³Wªºn¨D,¥¼¨Ó¦pªGÁ{§É¼Æ¾Ú¥¿±·|»P¼Ú¬w»P¬ü°êªk³W³æ¦ì·¾³q¥H¬ü°ê¤G´ÁÁ{§É¼Æ¾Ú·í°µ²Ä¤GÓ¤T´ÁÁ{§É¸ÕÅç,¥Ó½Ð¼Ú¬üÃÄÃÒ ,¦p¦¹¥i¸`¬Ù¤T´ÁÁ{§É¸ÕÅç®É¶¡»Pª÷¿ú ÃöÁä¦r¥y¬O: ¥H¬ü°ê¤G´ÁÁ{§É·í°µ²Ä¤GÓ¤T´ÁÁ{§É (¨S¦³»¡·í°µ²Ä¤@Ó¤T´ÁÁ{§É) ¥H¬ü°ê¤G´ÁÁ{§É·í°µ²Ä¤GÓ¤T´ÁÁ{§É (¨S¦³»¡·í°µ²Ä¤@Ó¤T´ÁÁ{§É) ¥H¬ü°ê¤G´ÁÁ{§É·í°µ²Ä¤GÓ¤T´ÁÁ{§É (¨S¦³»¡·í°µ²Ä¤@Ó¤T´ÁÁ{§É) 1 ¥xÆW¥D¾Éªº2/3Á{§É¬O²Ä¤@Ó¤T´ÁÁ{§É 2 ±q»¡¶KÅ¥¥X¯E¹©³W¹º¥Î¤@ӲĤT´ÁÁ{§É¸ÕÅç¨Ó¥Ó½Ð¤W¥«,YK¸Ñª¼¥|ºØ±¡ªp¤¤ªº²Ä¤@ºØ±¡ªp¾÷²v¤j¤j¼W¥[ http://vlog.xuite.net/play/NkU5Mm03LTIzMjE0MjM2LmZsdg 25¤ÀÄÁ³B³Ì«O¦uªº³\¦³®¥·m³Á§J·³£·Qªí¹F¬O±¡¹Ò1,¤£ª¾¤j®a¦b©È¤°»ò~ ·PÁ 10139510¤j ¤À¨É |
|
|
·|û¡G10139510 µoªí®É¶¡:2015/6/6 ¤U¤È 05:45:16²Ä 1101 ½g¦^À³
|
¤@¥y¸Ü¡A§O¦A®ö¶O®B¦Þª§ÅG¤F¡A©êºò´N¹ï¤F¡A¤£²nªº¤H½æ¤@½æ´N¦n¤F¡AÄ~Äò¼ç¤ô¡C |
|
|
|